LYEL NASDAQ
Lyell Immunopharma, Inc.
1W: +4.3%
1M: +3.9%
3M: -22.0%
YTD: -65.1%
1Y: -42.6%
3Y: -67.3%
5Y: -96.4%
$10.12
+0.81 (+8.70%)
Pre-Market: $9.05 (-1.06, -10.52%)
Weekly Expected Move ±10.3%
$7
$8
$9
$10
$11
Credit Risk of going bust: higher than 72% of companies Debt: 13.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.23 (down 98%), Lyell Immunopharma, Inc. would be worth roughly what it owes.
Total debt $36.9M against a stock market value of $248.0M.
Distance to default 3.28 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $18.5M (short-term plus half of long-term), stock volatility 79.5%; Altman Z'' -16.22. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.23 (down 98%), Lyell Immunopharma, Inc. would be worth roughly what it owes.
Total debt $36.9M against a stock market value of $248.0M.
Distance to default 3.28 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $18.5M (short-term plus half of long-term), stock volatility 79.5%; Altman Z'' -16.22. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
#360
of 1060
Biotechnology
Technical Signal Map
130 Bullish
45 Neutral
604 Bearish
LYEL
$230M
Lyell Immunopharma, Inc.
BULLISH
+73
SEPN
$1.9B
Septerna Inc
BULLISH
+100
COAG
$1.6B
Hemab Therapeutics Holdings, Inc. Common Stock
BULLISH
+100
VSTM
$910M
Verastem, Inc.
BULLISH
+100
SOLTF
$770M
Nxera Pharma Co., Ltd.
BULLISH
+100
PYPD
$110M
PolyPid Ltd.
BULLISH
+100
ANIX
$100M
Anixa Biosciences, Inc.
BULLISH
+100
GRDX
$40M
GridAI Technologies Corp.
BULLISH
+100
KLRA
$1.7B
Kailera Therapeutics, Inc.
BULLISH
+91
SPTX
$1.1B
Seaport Therapeutics, Inc. Common Stock
BULLISH
+91
SGP
$950M
SpyGlass Pharma, Inc. Common Stock
BULLISH
+91
ENTX
$510M
Entera Bio Ltd.
BULLISH
+91
ATNM
$50M
Actinium Pharmaceuticals, Inc.
BULLISH
+91
PRME
$670M
Prime Medicine, Inc.
BULLISH
+87
XFOR
$320M
X4 Pharmaceuticals, Inc.
BULLISH
+87
CING
$70M
Cingulate Inc.
BULLISH
+87
ESLA
$40M
Estrella Immunopharma, Inc.
BULLISH
+87
INDP
$360M
Indaptus Therapeutics, Inc.
BULLISH
+84
KRRO
$180M
Korro Bio, Inc.
BULLISH
+84
VIR
$1.8B
Vir Biotechnology, Inc.
BULLISH
+82
MAZE
$1.7B
Maze Therapeutics, Inc.
BULLISH
+78
ZIVO
$20M
ZIVO Bioscience, Inc.
BULLISH
+78
LBRX
$1.2B
LB Pharmaceuticals Inc Common Stock
BULLISH
+75
OABIW
$1.1B
OmniAb, Inc.
BULLISH
+75
RIGL
$900M
Rigel Pharmaceuticals, Inc.
BULLISH
+75
MXCT
$140M
MaxCyte, Inc.
BULLISH
+75
HURA
$140M
TuHURA Biosciences, Inc.
BULLISH
+75
IRLA
$30M
IRulya Therapeutics Inc.
BULLISH
+74
AGTX
—
Agentix Corp.
BULLISH
+73
NAUT
$410M
Nautilus Biotechnolgy, Inc.
BULLISH
+69
RARE
$1.5B
Ultragenyx Pharmaceutical Inc.
BULLISH
+68
XNCR
$1.9B
Xencor, Inc.
BULLISH
+66
TRAX
$1.6B
First Tracks Biotherapeutics Inc
BULLISH
+66
SLN
$930M
Silence Therapeutics plc
BULLISH
+66
PBYI
$570M
Puma Biotechnology, Inc.
BULLISH
+66
SGMT
$310M
Sagimet Biosciences Inc.
BULLISH
+66
HOWL
$50M
Werewolf Therapeutics, Inc.
BULLISH
+66
NNVC
$40M
NanoViricides, Inc.
BULLISH
+66
MBRX
$10M
Moleculin Biotech, Inc.
BULLISH
+66
AZTR
—
Azitra, Inc.
BULLISH
+66
NBTX
$1.5B
Nanobiotix S.A.
BULLISH
+62
BOLT
$10M
Bolt Biotherapeutics, Inc.
BULLISH
+62
BDRX
—
Biodexa Pharmaceuticals Plc
BULLISH
+62
CBDG
—
THC Farmaceuticals, Inc.
BULLISH
+60
NTLA
$1.6B
Intellia Therapeutics, Inc.
BULLISH
+59
PHAR
$710M
Pharming Group N.V.
BULLISH
+59
PCSA
$10M
Processa Pharmaceuticals, Inc.
BULLISH
+59
ICCC
$90M
ImmuCell Corporation
BULLISH
+58
PLUR
$10M
Pluri Inc.
BULLISH
+53
CASBF
$1.4B
CanSino Biologics Inc.
BULLISH
+52
REPL
$1.1B
Replimune Group, Inc.
BULLISH
+52
PPCB
—
Propanc Biopharma, Inc.
BULLISH
+52
HALB
—
Halberd Corporation
BULLISH
+51
ABSI
$1.6B
Absci Corporation
BULLISH
+50
CRMD
$610M
CorMedix Inc.
BULLISH
+50
DTIL
$180M
Precision BioSciences, Inc.
BULLISH
+50
NRXS
$90M
NeurAxis, Inc.
BULLISH
+50
OKYO
$70M
OKYO Pharma Limited
BULLISH
+50
XERS
$1.9B
Xeris Biopharma Holdings, Inc.
BULLISH
+49
ADCT
$180M
ADC Therapeutics S.A.
BULLISH
+49
SCNLF
$170M
Scancell Holdings plc
BULLISH
+49
ZEOX
$10M
Zeo ScientifiX, Inc.
BULLISH
+48
CLGN
—
CollPlant Biotechnologies Ltd.
BULLISH
+44
VOR
$990M
Vor Biopharma Inc.
BULLISH
+43
ALEC
$200M
Alector, Inc.
BULLISH
+43
ACUT
—
Accustem Sciences Inc.
BULLISH
+43
KNBIF
—
Kane Biotech Inc.
BULLISH
+43
RXRX
$2.0B
Recursion Pharmaceuticals, Inc.
BULLISH
+42
KROS
$220M
Keros Therapeutics, Inc.
BULLISH
+42
TXTM
$90M
ProText Mobility, Inc.
BULLISH
+42
IMCR
$1.6B
Immunocore Holdings plc
BULLISH
+41
DMAC
$470M
DiaMedica Therapeutics Inc.
BULLISH
+41
DMRA
$1.3B
Damora Therapeutics, Inc.
BULLISH
+40
MLTX
$1.0B
MoonLake Immunotherapeutics
BULLISH
+40
PDSB
$60M
PDS Biotechnology Corporation
BULLISH
+38
NYMXF
$10M
Nymox Pharmaceutical Corporation
BULLISH
+38
IPIX
—
Innovation Pharmaceuticals Inc.
BULLISH
+38
PULM
$10M
Pulmatrix, Inc.
BULLISH
+36
TCRT
$10M
Alaunos Therapeutics, Inc.
BULLISH
+35
EDIT
$370M
Editas Medicine, Inc.
BULLISH
+34
PEPG
$170M
PepGen Inc.
BULLISH
+33
NGNE
$370M
Neurogene Inc.
LEAN BULL
+27
BCYC
$250M
Bicycle Therapeutics plc
LEAN BULL
+27
LCTX
$250M
Lineage Cell Therapeutics, Inc.
LEAN BULL
+27
ABOS
$140M
Acumen Pharmaceuticals, Inc.
LEAN BULL
+27
IUGNF
$30M
Imugene Limited
LEAN BULL
+27
BSSP
—
Baseline Productions, Inc.
LEAN BULL
+27
INFIQ
—
Infinity Pharmaceuticals, Inc.
LEAN BULL
+27
ARDS
—
Aridis Pharmaceuticals, Inc.
LEAN BULL
+27
PTCHF
$390M
PureTech Health plc
LEAN BULL
+26
OBIO
$340M
Orchestra BioMed Holdings, Inc.
LEAN BULL
+26
ACOG
$130M
Alpha Cognition Inc
LEAN BULL
+26
PRVCF
$10M
PreveCeutical Medical Inc.
LEAN BULL
+26
CKDXF
$10M
Ceryvyn Therapeutics Ltd
LEAN BULL
+26
CALA
—
Calithera Biosciences, Inc.
LEAN BULL
+26
CYYNF
—
Cynata Therapeutics Limited
LEAN BULL
+26
EFTR
—
eFFECTOR Therapeutics, Inc.
LEAN BULL
+26
ENSC
$10M
Ensysce Biosciences, Inc.
LEAN BULL
+25
NTRR
—
Neutra Corp.
LEAN BULL
+20
STOK
$1.6B
Stoke Therapeutics, Inc.
LEAN BULL
+18
CCCC
$380M
C4 Therapeutics, Inc.
LEAN BULL
+18
ZURA
$320M
Zura Bio Limited
LEAN BULL
+18
LOBEF
$10M
Lobe Sciences Ltd.
LEAN BULL
+18
BIVI
$10M
BioVie Inc.
LEAN BULL
+18
VSBC
$10M
VitaSpring Biomedical Co. Ltd.
LEAN BULL
+18
HEPA
—
Hepion Pharmaceuticals, Inc.
LEAN BULL
+18
BTAX
—
Biostax Corp.
LEAN BULL
+18
VAXX
—
Vaxxinity, Inc.
LEAN BULL
+18
REVB
—
Revelation Biosciences, Inc.
LEAN BULL
+18
PXMD
—
PaxMedica, Inc. Common Stock
LEAN BULL
+18
ACHFF
$40M
Arch Biopartners Inc.
LEAN BULL
+17
PRLD
$210M
Prelude Therapeutics Incorporated
LEAN BULL
+16
BRVE
$1.5B
Braveheart Bio, Inc.
LEAN BULL
+15
SRZN
$190M
Surrozen, Inc.
LEAN BULL
+15
MDNAF
$20M
Medicenna Therapeutics Corp.
LEAN BULL
+15
ABPO
—
Abpro Holdings, Inc.
LEAN BULL
+15
CYDY
$380M
CytoDyn Inc.
LEAN BULL
+13
SPRB
$130M
Spruce Biosciences, Inc.
LEAN BULL
+13
OCEA
—
Ocean Biomedical, Inc.
LEAN BULL
+13
PVLA
$1.8B
Palvella Therapeutics, Inc.
LEAN BULL
+11
TYRA
$1.2B
Tyra Biosciences, Inc.
LEAN BULL
+11
PRTA
$420M
Prothena Corporation plc
LEAN BULL
+11
ENTA
$340M
Enanta Pharmaceuticals, Inc.
LEAN BULL
+11
GLSI
$240M
Greenwich LifeSciences, Inc.
LEAN BULL
+11
CLNN
$60M
Clene Inc.
LEAN BULL
+11
EHOS
—
Ehouse Global, Inc.
LEAN BULL
+11
DNAG
—
DNAPrint Genomics, Inc.
LEAN BULL
+10
ONCSQ
—
OncoSec Medical Incorporated
LEAN BULL
+10
RBSH
—
Rebus Holdings, Inc.
LEAN BULL
+10
CPMV
—
Mosaic ImmunoEngineering Inc.
LEAN BULL
+10
SRPT
$1.9B
Sarepta Therapeutics, Inc.
NEUTRAL
+9
ABVC
$30M
ABVC BioPharma, Inc.
NEUTRAL
+9
ANAB
$1.5B
AnaptysBio, Inc.
NEUTRAL
+8
STAB
—
Statera Biopharma, Inc.
NEUTRAL
+8
OBX
$10M
Obsidian Therapeutics Inc.
NEUTRAL
+6
GBIM
—
GlobeImmune, Inc.
NEUTRAL
+4
CNSP
$10M
CNS Pharmaceuticals, Inc.
NEUTRAL
+3
NWBO
$260M
Northwest Biotherapeutics, Inc.
NEUTRAL
+2
SABS
$260M
SAB Biotherapeutics, Inc.
NEUTRAL
+2
MLLCF
$150M
Molecular Partners AG
NEUTRAL
+2
HESG
—
Health Sciences Group, Inc.
NEUTRAL
+2
CTXR
$10M
Citius Pharmaceuticals, Inc.
NEUTRAL
+1
CFRXQ
—
ContraFect Corp.
NEUTRAL
+1
RGIN
—
Regenicin, Inc.
NEUTRAL
+1
RCAR
—
RenovaCare, Inc.
NEUTRAL
+1
NMTRQ
—
9 Meters Biopharma, Inc.
NEUTRAL
+1
LYCA
$1.6B
Lycia Therapeutics Inc.
N/A
0
CTY
$200M
City Therapeutics Inc.
N/A
0
IAM
$130M
Iambic Therapeutics Inc.
N/A
0
ATOS
$30M
Atossa Therapeutics, Inc.
NEUTRAL
0
LONA
$20M
LeonaBio, Inc.
NEUTRAL
0
ORGS
—
Orgenesis Inc.
NEUTRAL
0
JANX
$1.0B
Janux Therapeutics, Inc.
NEUTRAL
-1
ODTX
$940M
Odyssey Therapeutics, Inc.
NEUTRAL
-2
DRUG
$520M
Bright Minds Biosciences Inc.
NEUTRAL
-2
PHMMF
$1.6B
Pharma Mar, S.A.
NEUTRAL
-3
NMAD
$50M
NOMAD Power Solutions, Inc.
NEUTRAL
-4
KLDO
—
Kaleido Biosciences, Inc.
NEUTRAL
-5
CNBX
—
CNBX Pharmaceuticals Inc.
NEUTRAL
-5
CALC
—
CalciMedica, Inc.
NEUTRAL
-5
YARW
$180M
Yarrow Bioscience Inc
NEUTRAL
-6
ELUT
$40M
Elutia Inc
NEUTRAL
-6
GSTC
—
GlobeStar Therapeutics Corporation
NEUTRAL
-6
YDESW
—
YD Bio Limited Warrants
NEUTRAL
-6
BPTH
—
Bio-Path Holdings, Inc.
NEUTRAL
-6
RNXT
$60M
RenovoRx, Inc.
NEUTRAL
-7
USRM
—
U.S. Stem Cell, Inc.
NEUTRAL
-7
ZBIO
$1.8B
Zenas BioPharma, Inc.
NEUTRAL
-8
VCRE
$260M
Vicore Pharma Holding AB
NEUTRAL
-8
ENGNW
$10M
enGene Holdings Inc. Warrants
NEUTRAL
-8
PBLA
—
Panbela Therapeutics, Inc.
NEUTRAL
-8
NXTC
$20M
NextCure, Inc.
NEUTRAL
-9
EVAX
$20M
Evaxion Biotech A/S
NEUTRAL
-9
ATXI
—
Avenue Therapeutics, Inc.
NEUTRAL
-9
MRPI
—
Mera Pharmaceuticals, Inc.
NEUTRAL
-9
MBXBF
$30M
Microbix Biosystems Inc.
LEAN BEAR
-10
INRLF
$640M
Valneva SE
LEAN BEAR
-12
POLBF
$70M
Poolbeg Pharma PLC
LEAN BEAR
-12
QPTFF
$10M
Quest PharmaTech Inc.
LEAN BEAR
-12
CLYYF
$10M
Celyad Oncology S.A.
LEAN BEAR
-12
OKUR
$100M
OnKure Therapeutics, Inc.
LEAN BEAR
-14
SNGX
$10M
Soligenix, Inc.
LEAN BEAR
-14
ENDV
—
Endonovo Therapeutics, Inc.
LEAN BEAR
-14
APLMW
$170M
Apollomics, Inc.
LEAN BEAR
-15
ARMP
$140M
Armata Pharmaceuticals, Inc.
LEAN BEAR
-15
EQ
$80M
Equillium, Inc.
LEAN BEAR
-15
KPTI
$10M
Karyopharm Therapeutics Inc.
LEAN BEAR
-15
LEXX
$10M
Lexaria Bioscience Corp.
LEAN BEAR
-15
ADXN
—
Addex Therapeutics Ltd
LEAN BEAR
-15
REPCF
—
RepliCel Life Sciences Inc.
LEAN BEAR
-16
IMVIF
—
IMV Inc.
LEAN BEAR
-16
JUNS
—
Jupiter Neurosciences, Inc.
LEAN BEAR
-16
MCET
—
MultiCell Technologies, Inc.
LEAN BEAR
-16
SRBCF
—
Sirona Biochem Corp.
LEAN BEAR
-16
NKGN
—
NKGen Biotech, Inc.
LEAN BEAR
-16
SLGL
$230M
Sol-Gel Technologies Ltd.
LEAN BEAR
-17
MMIRF
$30M
MedMira Inc.
LEAN BEAR
-17
JBIO
$930M
Jade Biosciences, Inc.
LEAN BEAR
-18
CGEM
$880M
Cullinan Therapeutics, Inc.
LEAN BEAR
-18
ACRS
$550M
Aclaris Therapeutics, Inc.
LEAN BEAR
-18
IFRX
$230M
InflaRx N.V.
LEAN BEAR
-18
LYRA
—
Lyra Therapeutics, Inc.
LEAN BEAR
-18
PARD
—
Poniard Pharmaceuticals, Inc.
LEAN BEAR
-18
LADX
—
LadRx Corporation
LEAN BEAR
-18
ADRX
$1.9B
ADARx Pharmaceuticals, Inc.
LEAN BEAR
-20
AOBI
—
American Oriental Bioengineering, Inc.
LEAN BEAR
-20
HSTC
$210M
HST Global, Inc.
LEAN BEAR
-21
DBVT
$230M
DBV Technologies S.A.
LEAN BEAR
-22
RNA
$140M
Atrium Therapeutics, Inc.
LEAN BEAR
-22
ADAPY
$10M
Adaptimmune Therapeutics plc
LEAN BEAR
-22
PBIGF
$10M
Paradigm Biopharmaceuticals Limited
LEAN BEAR
-22
FPMI
—
FluoroPharma Medical, Inc.
LEAN BEAR
-22
PREDQ
—
Predictive Discovery Limited
LEAN BEAR
-22
GBLX
—
GB Sciences, Inc.
LEAN BEAR
-22
IMMB
—
Immunotech Laboratories, Inc.
LEAN BEAR
-22
FENC
$350M
Fennec Pharmaceuticals Inc.
LEAN BEAR
-23
INBX
$1.4B
Inhibrx Biosciences Inc.
LEAN BEAR
-24
KARD
$1.1B
Kardigan, Inc.
LEAN BEAR
-24
YDES
$350M
YD Bio Limited Ordinary Shares
LEAN BEAR
-24
FATE
$250M
Fate Therapeutics, Inc.
LEAN BEAR
-24
BDTX
$110M
Black Diamond Therapeutics, Inc.
LEAN BEAR
-24
NTHI
$90M
Neonc Technologies Holdings, Inc.
LEAN BEAR
-24
SGMOQ
$50M
Sangamo Therapeutics, Inc.
LEAN BEAR
-24
ENVB
$10M
Enveric Biosciences, Inc.
LEAN BEAR
-24
NNLX
—
NanoLogix, Inc.
LEAN BEAR
-24
CLAZF
—
Claritas Pharmaceuticals, Inc.
LEAN BEAR
-24
NNBP
—
Nanobac Pharmaceuticals, Incorporated
LEAN BEAR
-24
PZRXQ
—
PhaseRx, Inc.
LEAN BEAR
-24
GWIN
$360M
Glorywin Entertainment Group, Inc.
LEAN BEAR
-25
FGHQF
$360M
Frontage Holdings Corporation
LEAN BEAR
-25
KNTPF
$120M
Kintor Pharmaceutical Limited
LEAN BEAR
-25
LVCLF
$20M
Algorae Pharmaceuticals Limited
LEAN BEAR
-25
BCLI
$10M
Brainstorm Cell Therapeutics Inc.
LEAN BEAR
-25
CMND
—
Clearmind Medicine Inc.
LEAN BEAR
-25
VINC
—
Vincerx Pharma, Inc.
LEAN BEAR
-25
FORU
—
ForU Holdings, Inc.
LEAN BEAR
-25
CHNXF
—
ChitogenX Inc.
LEAN BEAR
-25
HLSQ
—
Tessera Defense and Homeland Security Inc
LEAN BEAR
-25
NURPF
$1.8B
Neuren Pharmaceuticals Limited
LEAN BEAR
-26
CUBT
—
Curative Biotechnology, Inc.
LEAN BEAR
-26
KZIA
$10M
Kazia Therapeutics Ltd ADR
LEAN BEAR
-27
LIANY
—
LianMedical
LEAN BEAR
-28
TSHA
$1.3B
Taysha Gene Therapies, Inc.
BEARISH
-31
ARVN
$470M
Arvinas, Inc.
BEARISH
-31
CAMP
$210M
CAMP4 Therapeutics Corporation
BEARISH
-31
CARM
—
Carisma Therapeutics, Inc.
BEARISH
-31
TRVN
—
Trevena, Inc.
BEARISH
-31
PKTX
—
ProtoKinetix, Incorporated
BEARISH
-31
PBMWW
—
Psyence Biomedical Ltd. Warrant
BEARISH
-31
INNMF
$30M
Amplia Therapeutics Limited
BEARISH
-32
IMUC
$10M
EOM Pharmaceuticals Holdings, Inc.
BEARISH
-32
BXRXQ
—
Baudax Bio, Inc.
BEARISH
-32
AAGH
—
America Great Health
BEARISH
-32
SNBIF
$1.3B
SanBio Company Limited
BEARISH
-33
OVID
$420M
Ovid Therapeutics Inc.
BEARISH
-33
RZLT
$370M
Rezolute, Inc.
BEARISH
-33
MDWD
$150M
MediWound Ltd.
BEARISH
-33
CSBR
$70M
Champions Oncology, Inc.
BEARISH
-33
DTCFF
$20M
Defence Therapeutics Inc.
BEARISH
-33
MRKR
$20M
Marker Therapeutics, Inc.
BEARISH
-33
XCUR
$10M
Exicure, Inc.
BEARISH
-33
HAVLF
—
HAVN Life Sciences Inc.
BEARISH
-33
PSYBF
—
PsyBio Therapeutics Corp
BEARISH
-33
TLOG
—
TetraLogic Pharmaceuticals Corporation
BEARISH
-33
MRZM
—
Marizyme, Inc.
BEARISH
-33
VRCI
—
Verde Science, Inc.
BEARISH
-33
HLUN
—
HEALTHeUNIVERSE, Inc.
BEARISH
-33
SNNAQ
—
Sienna Biopharmaceuticals, Inc.
BEARISH
-33
IBOGF
—
Universal Ibogaine Inc.
BEARISH
-33
NTII
—
Neurobiological Technologies, Inc.
BEARISH
-33
GLSHQ
—
Gelesis Holdings, Inc.
BEARISH
-33
CMRA
—
Comera Life Sciences Holdings, Inc.
BEARISH
-33
TRVI
$1.8B
Trevi Therapeutics, Inc.
BEARISH
-34
QURE
$1.6B
uniQure N.V.
BEARISH
-34
BPMUF
$960M
Basilea Pharmaceutica AG
BEARISH
-34
DNA
$670M
Ginkgo Bioworks Holdings, Inc.
BEARISH
-34
INKT
$50M
MiNK Therapeutics, Inc.
BEARISH
-34
CURX
$10M
Curanex Pharmaceuticals Inc Common Stock
BEARISH
-34
SYGGF
—
Synairgen plc
BEARISH
-34
RAPP
$1.2B
Rapport Therapeutics, Inc. Common Stock
BEARISH
-35
ATGGF
$140M
Actinogen Medical Limited
BEARISH
-35
NRXP
$110M
NRx Pharmaceuticals, Inc.
BEARISH
-35
SQZB
—
SQZ Biotechnologies Company
BEARISH
-35
MEOBF
$2.0B
Mesoblast Limited
BEARISH
-37
CEROW
—
CERo Therapeutics Holdings, Inc.
BEARISH
-39
BCRX
$1.9B
BioCryst Pharmaceuticals, Inc.
BEARISH
-40
APMD
$790M
Apnimed, Inc.
BEARISH
-40
STTK
$550M
Shattuck Labs, Inc.
BEARISH
-40
BNTC
$300M
Benitec Biopharma Inc.
BEARISH
-40
ELDN
$190M
Eledon Pharmaceuticals, Inc.
BEARISH
-40
CHRS
$160M
Coherus Oncology, Inc.
BEARISH
-40
FHTX
$120M
Foghorn Therapeutics Inc.
BEARISH
-40
MAIA
$70M
MAIA Biotechnology, Inc.
BEARISH
-40
AURX
$60M
Nuo Therapeutics, Inc.
BEARISH
-40
RNTX
$50M
Rein Therapeutics Inc.
BEARISH
-40
ELTX
$40M
Elicio Therapeutics, Inc.
BEARISH
-40
JSPR
$20M
Jasper Therapeutics, Inc.
BEARISH
-40
GDTC
$10M
CytoMed Therapeutics Limited
BEARISH
-40
NCNA
$10M
NuCana plc
BEARISH
-40
BIXT
—
Bioxytran, Inc.
BEARISH
-40
ITMC
—
Itoco Inc.
BEARISH
-40
RLFTY
—
MindMaze Therapeutics Holding S.A.
BEARISH
-40
JAGX
—
Jaguar Health, Inc.
BEARISH
-40
HTDS
—
Hard to Treat Diseases Inc.
BEARISH
-40
PPTDF
$870M
PeptiDream Inc.
BEARISH
-41
TRDA
$170M
Entrada Therapeutics, Inc.
BEARISH
-41
MRES
—
Institute of Biomedical Research Corp.
BEARISH
-41
ERNA
—
Ernexa Therapeutics Inc.
BEARISH
-41
CSPHF
$1.4B
CStone Pharmaceuticals
BEARISH
-42
DRTSW
$1.2B
Alpha Tau Medical Ltd.
BEARISH
-42
RLYB
$90M
Rallybio Corporation
BEARISH
-42
AEON
$10M
AEON Biopharma, Inc.
BEARISH
-42
LSTA
$10M
Lisata Therapeutics, Inc.
BEARISH
-42
PFND
—
Pathfinder Cell Therapy, Inc.
BEARISH
-42
CDXI
—
Cardax, Inc.
BEARISH
-42
ADYX
—
Adynxx, Inc.
BEARISH
-42
PANC
—
Panacos Pharmaceuticals, Inc.
BEARISH
-42
SYVC
—
Synovics Pharmaceuticals, Inc.
BEARISH
-42
PROT
—
Proteonomix, Inc.
BEARISH
-42
NBIO
—
Nascent Biotech, Inc.
BEARISH
-42
SIGY
—
Sigyn Therapeutics, Inc.
BEARISH
-42
ONCO
—
Onconetix, Inc.
BEARISH
-42
RNUGF
—
ReNeuron Group plc
BEARISH
-42
BRAXF
—
Braxia Scientific Corp.
BEARISH
-42
WHWK
$180M
Whitehawk Therapeutics Inc
BEARISH
-43
ATRA
$90M
Atara Biotherapeutics, Inc.
BEARISH
-43
HNSBF
$330M
Hansa Biopharma AB (publ)
BEARISH
-44
VICP
$10M
Vicapsys Life Sciences, Inc.
BEARISH
-44
VOGX
$260M
Vogenx Inc.
BEARISH
-45
CASIF
—
CASI Pharmaceuticals, Inc.
BEARISH
-46
IDRSF
$1.4B
Idorsia Ltd
BEARISH
-47
VBIZF
$400M
Viva Biotech Holdings
BEARISH
-47
RCKT
$250M
Rocket Pharmaceuticals, Inc.
BEARISH
-47
CRVS
$890M
Corvus Pharmaceuticals, Inc.
BEARISH
-48
SVRA
$870M
Savara Inc.
BEARISH
-48
IMRX
$240M
Immuneering Corporation
BEARISH
-48
PMN
$70M
ProMIS Neurosciences, Inc.
BEARISH
-48
IMTX
$1.1B
Immatics N.V.
BEARISH
-49
KURA
$850M
Kura Oncology, Inc.
BEARISH
-49
ATTO
$630M
Attovia Therapeutics, Inc.
BEARISH
-49
OCS
$490M
Oculis Holding AG
BEARISH
-49
DYAI
$20M
Dyadic International, Inc.
BEARISH
-49
DVHGF
$20M
Devonian Health Group, Inc.
BEARISH
-49
ALLR
$10M
Allarity Therapeutics, Inc.
BEARISH
-49
SCPS
—
Scopus BioPharma Inc.
BEARISH
-49
BIORQ
—
Biora Therapeutics, Inc.
BEARISH
-49
BITRF
—
Biotron Limited
BEARISH
-49
THER
—
Theralink Technologies, Inc.
BEARISH
-49
AURA
$650M
Aura Biosciences, Inc.
BEARISH
-50
TTRX
$310M
Turn Therapeutics Inc.
BEARISH
-50
ARCT
$280M
Arcturus Therapeutics Holdings Inc.
BEARISH
-50
SPHRY
$220M
Starpharma Holdings Limited
BEARISH
-50
BETRF
$110M
BetterLife Pharma Inc.
BEARISH
-50
NTRB
$70M
Nutriband Inc.
BEARISH
-50
HRGN
$30M
Harvard Apparatus Regenerative Technology Inc.
BEARISH
-50
PVCT
$20M
Provectus Biopharmaceuticals, Inc.
BEARISH
-50
APUS
—
Apimeds Pharmaceuticals US, Inc
BEARISH
-50
ERNAW
—
Ernexa Therapeutics Inc. Warrants
BEARISH
-50
RNAZ
—
TransCode Therapeutics, Inc.
BEARISH
-50
VRPX
—
Virpax Pharmaceuticals, Inc.
BEARISH
-50
VRAX
—
Virax Biolabs Group Limited
BEARISH
-50
SCNI
—
Scinai Immunotherapeutics Ltd.
BEARISH
-50
GHRS
$1.2B
GH Research PLC
BEARISH
-52
ABUS
$830M
Arbutus Biopharma Corp
BEARISH
-52
QTTB
$260M
Q32 Bio Inc.
BEARISH
-52
HOPHF
$20M
Hemogenyx Pharmaceuticals Plc
BEARISH
-52
ANL
$560M
Adlai Nortye Ltd.
BEARISH
-53
ARTV
$300M
Artiva Biotherapeutics, Inc.
BEARISH
-53
PLX
$210M
Protalix BioTherapeutics, Inc.
BEARISH
-53
FBIOP
$130M
Fortress Biotech, Inc.
BEARISH
-53
ALZN
$10M
Alzamend Neuro Inc
BEARISH
-53
XBIO
—
Xenetic Biosciences, Inc.
BEARISH
-53
AFFY
—
Affymax, Inc.
BEARISH
-53
PLYX
$90M
Polaryx Therapeutics, Inc. Common Stock
BEARISH
-55
SYRS
—
Syros Pharmaceuticals, Inc.
BEARISH
-56
MLYS
$1.8B
Mineralys Therapeutics, Inc.
BEARISH
-58
GENB
$1.6B
Generate Biomedicines, Inc.
BEARISH
-58
CMPS
$1.6B
COMPASS Pathways plc
BEARISH
-58
NKTR
$1.1B
Nektar Therapeutics
BEARISH
-58
AVBP
$1.0B
ArriVent BioPharma, Inc.
BEARISH
-58
ALMS
$880M
Alumis Inc.
BEARISH
-58
SANA
$700M
Sana Biotechnology, Inc.
BEARISH
-58
FULC
$280M
Fulcrum Therapeutics, Inc.
BEARISH
-58
IPSC
$260M
Century Therapeutics, Inc.
BEARISH
-58
TARA
$140M
Protara Therapeutics, Inc.
BEARISH
-58
OTLK
$130M
Outlook Therapeutics, Inc.
BEARISH
-58
VERU
$40M
Veru Inc.
BEARISH
-58
SEOVF
$30M
Sernova Corp.
BEARISH
-58
AKTX
$20M
Akari Therapeutics, Plc
BEARISH
-58
SNANF
$20M
Sona Nanotech Inc.
BEARISH
-58
SNTI
$10M
Senti Biosciences, Inc.
BEARISH
-58
PLRZ
$10M
Polyrizon Ltd.
BEARISH
-58
ANEB
$10M
Anebulo Pharmaceuticals, Inc.
BEARISH
-58
LTRN
$10M
Lantern Pharma Inc.
BEARISH
-58
HMTXF
$10M
Hemostemix Inc.
BEARISH
-58
ADIL
$10M
Adial Pharmaceuticals, Inc.
BEARISH
-58
SLXN
—
Silexion Therapeutics Ltd.
BEARISH
-58
LIPO
—
Lipella Pharmaceuticals Inc.
BEARISH
-58
EVGN
—
Evogene Ltd.
BEARISH
-58
AMPE
—
Ampio Pharmaceuticals, Inc.
BEARISH
-58
AMBS
—
Amarantus BioScience Holdings, Inc.
BEARISH
-58
ANTH
—
Anthera Pharmaceuticals, Inc.
BEARISH
-58
ATRX
—
Adhera Therapeutics Inc
BEARISH
-58
ORIC
$1.4B
ORIC Pharmaceuticals, Inc.
BEARISH
-59
IMRN
$10M
Immuron Limited
BEARISH
-59
BCTXZ
—
BriaCell Therapeutics Corp. Warrant
BEARISH
-59
ANRO
$860M
Alto Neuroscience, Inc.
BEARISH
-60
DSGN
$640M
Design Therapeutics, Inc.
BEARISH
-60
BRIBF
$90M
Brii Biosciences Limited
BEARISH
-60
ELOX
$40M
Eloxx Pharmaceuticals, Inc.
BEARISH
-60
AUTL
$410M
Autolus Therapeutics plc
BEARISH
-62
BVAXF
—
BioVaxys Technology Corp.
BEARISH
-62
AVLN
$1.1B
Avalyn Pharma Inc. Common Stock
BEARISH
-65
BCAX
$1.1B
Bicara Therapeutics Inc. Common Stock
BEARISH
-65
MNKD
$1.0B
MannKind Corporation
BEARISH
-65
GLUE
$920M
Monte Rosa Therapeutics, Inc.
BEARISH
-65
WVE
$630M
Wave Life Sciences Ltd.
BEARISH
-65
LRMR
$240M
Larimar Therapeutics, Inc.
BEARISH
-65
ALXO
$160M
ALX Oncology Holdings Inc.
BEARISH
-65
HUMA
$120M
Humacyte, Inc.
BEARISH
-65
IMUX
$100M
Immunic, Inc.
BEARISH
-65
ADAG
$90M
Adagene Inc.
BEARISH
-65
TELO
$70M
Telomir Pharmaceuticals, Inc. Common Stock
BEARISH
-65
RECEF
$70M
Recce Pharmaceuticals Ltd
BEARISH
-65
TENX
$50M
Tenax Therapeutics, Inc.
BEARISH
-65
CVM
$30M
CEL-SCI Corporation
BEARISH
-65
ARTL
$10M
Artelo Biosciences, Inc.
BEARISH
-65
SYBE
—
SYBLEU Inc
BEARISH
-65
RGRX
—
RegeneRx Biopharmaceuticals, Inc.
BEARISH
-65
BICTF
—
Biocure Technology Inc.
BEARISH
-65
FNAM
—
Evolutionary Genomics, Inc.
BEARISH
-65
WINT
—
Windtree Therapeutics, Inc.
BEARISH
-65
INVA
$1.5B
Innoviva, Inc.
BEARISH
-66
ACHV
$670M
Achieve Life Sciences, Inc.
BEARISH
-66
EIKN
$390M
Eikon Therapeutics, Inc. Common Stock
BEARISH
-66
TECX
$390M
Tectonic Therapeutic, Inc.
BEARISH
-66
CLVLF
$250M
Clinuvel Pharmaceuticals Limited
BEARISH
-66
RNAC
$190M
Cartesian Therapeutics, Inc.
BEARISH
-66
NAGE
$190M
Niagen Bioscience Inc
BEARISH
-66
VRXA
$140M
Veraxa Biotech Holding AG
BEARISH
-66
CNXU
$90M
Conexeu Sciences Inc.
BEARISH
-66
TNXP
$90M
Tonix Pharmaceuticals Holding Corp.
BEARISH
-66
GNLX
$90M
Genelux Corporation
BEARISH
-66
INO
$60M
Inovio Pharmaceuticals, Inc.
BEARISH
-66
NDTP
$50M
NDT Pharmaceuticals Inc.
BEARISH
-66
ONCY
$50M
Oncolytics Biotech Inc.
BEARISH
-66
CLCS
$40M
Cell Source, Inc.
BEARISH
-66
CNTX
$20M
Context Therapeutics Inc.
BEARISH
-66
RVXCF
$20M
Resverlogix Corp.
BEARISH
-66
NEUP
$20M
Neuphoria Therapeutics Inc.
BEARISH
-66
ICU
$10M
SeaStar Medical Holding Corporation
BEARISH
-66
PHIO
$10M
Phio Pharmaceuticals Corp.
BEARISH
-66
LPCN
$10M
Lipocine Inc.
BEARISH
-66
SPRC
—
SciSparc Ltd.
BEARISH
-66
MTNB
—
Matinas BioPharma Holdings, Inc.
BEARISH
-66
BLEG
—
Branded Legacy, Inc.
BEARISH
-66
GRI
—
GRI Bio, Inc.
BEARISH
-66
VCNX
—
Vaccinex, Inc.
BEARISH
-66
LNAI
—
Lunai Bioworks Inc.
BEARISH
-66
DRMA
—
Dermata Therapeutics, Inc.
BEARISH
-66
VIVS
—
VivoSim Labs, Inc.
BEARISH
-66
CDT
—
CDT Equity Inc.
BEARISH
-66
BRTX
—
BioRestorative Therapies, Inc.
BEARISH
-66
BBLG
—
Bone Biologics Corporation
BEARISH
-66
AFMDQ
—
Affimed N.V.
BEARISH
-66
SXTP
—
60 Degrees Pharmaceuticals, Inc.
BEARISH
-66
LITS
$40M
Lite Strategy, Inc.
BEARISH
-68
DRTS
$1.2B
Alpha Tau Medical Ltd
BEARISH
-69
SLDB
$630M
Solid Biosciences Inc.
BEARISH
-69
ORMP
$170M
Oramed Pharmaceuticals Inc.
BEARISH
-69
AMGXF
$140M
AnGes, Inc.
BEARISH
-69
ANTX
$130M
AN2 Therapeutics, Inc.
BEARISH
-69
BBIXF
$50M
Bonus BioGroup Ltd.
BEARISH
-69
INTI
$10M
Inhibitor Therapeutics, Inc.
BEARISH
-69
RMTG
—
Regenerative Medical Technology Group Inc.
BEARISH
-69
MYMX
—
Mymetics Corporation
BEARISH
-69
NWPHF
$410M
Newron Pharmaceuticals S.p.A.
BEARISH
-71
VRXAW
—
Veraxa Biotech AG
BEARISH
-71
SRNE
—
Sorrento Therapeutics, Inc.
BEARISH
-73
OLMA
$560M
Olema Pharmaceuticals, Inc.
BEARISH
-74
CBIO
$480M
Crescent Biopharma, Inc.
BEARISH
-74
BLSM
$430M
BlossomHill Therapeutics, Inc.
BEARISH
-74
GOSS
$60M
Gossamer Bio, Inc.
BEARISH
-74
IBO
$30M
Impact BioMedical Inc.
BEARISH
-74
AIM
$10M
AIM ImmunoTech Inc.
BEARISH
-74
SILO
—
Silo Pharma, Inc.
BEARISH
-74
LGVN
—
Longeveron Inc.
BEARISH
-74
BTAIQ
—
BioXcel Therapeutics, Inc.
BEARISH
-74
AAPG
$1.4B
Ascentage Pharma Group International
BEARISH
-75
OMER
$1.2B
Omeros Corporation
BEARISH
-75
ASCLF
$770M
Ascletis Pharma Inc.
BEARISH
-75
NVCT
$650M
Nuvectis Pharma, Inc.
BEARISH
-75
FDMT
$600M
4D Molecular Therapeutics, Inc.
BEARISH
-75
PHAT
$460M
Phathom Pharmaceuticals, Inc.
BEARISH
-75
EPRX
$450M
Eupraxia Pharmaceuticals Inc.
BEARISH
-75
AGEN
$290M
Agenus Inc.
BEARISH
-75
GALT
$210M
Galectin Therapeutics Inc.
BEARISH
-75
CGEN
$180M
Compugen Ltd.
BEARISH
-75
SEER
$110M
Seer, Inc.
BEARISH
-75
VANI
$100M
Vivani Medical, Inc.
BEARISH
-75
COYA
$90M
Coya Therapeutics, Inc.
BEARISH
-75
PMVP
$70M
PMV Pharmaceuticals, Inc.
BEARISH
-75
MNOV
$70M
MediciNova, Inc.
BEARISH
-75
HRTX
$60M
Heron Therapeutics, Inc.
BEARISH
-75
OSTX
$60M
OS Therapies Incorporated
BEARISH
-75
SPRO
$60M
Spero Therapeutics, Inc.
BEARISH
-75
ALPS
$50M
Alps Group Inc
BEARISH
-75
XLO
$50M
Xilio Therapeutics, Inc.
BEARISH
-75
MREO
$40M
Mereo BioPharma Group plc
BEARISH
-75
CRVO
$30M
CervoMed Inc.
BEARISH
-75
COCP
$20M
Cocrystal Pharma, Inc.
BEARISH
-75
KPRX
$10M
Kiora Pharmaceuticals, Inc.
BEARISH
-75
GLWLF
$10M
Glow Lifetech Corp.
BEARISH
-75
PASG
$10M
Passage Bio, Inc.
BEARISH
-75
OTLC
$10M
Oncotelic Therapeutics, Inc.
BEARISH
-75
PHYOF
$10M
IXICO plc
BEARISH
-75
CHMMF
—
Chimeric Therapeutics Limited
BEARISH
-75
CVKD
—
Cadrenal Therapeutics, Inc. Common Stock
BEARISH
-75
AGNPF
—
Grey Matters Health Inc.
BEARISH
-75
MAJI
—
Nextel Medical Corp.
BEARISH
-75
LIMNW
—
Liminatus Pharma, Inc. Warrants
BEARISH
-75
RGBPP
—
Regen BioPharma, Inc.
BEARISH
-75
ADTX
—
Aditxt, Inc.
BEARISH
-75
EVLO
—
Evelo Biosciences, Inc.
BEARISH
-75
ISCO
—
International Stem Cell Corporation
BEARISH
-75
YECO
—
EV Biologics, Inc.
BEARISH
-75
ELAB
—
PMGC Holdings Inc.
BEARISH
-75
HMGN
—
Hemagen Diagnostics, Inc.
BEARISH
-75
NUVB
$1.6B
Nuvation Bio Inc.
BEARISH
-78
NVAX
$1.6B
Novavax, Inc.
BEARISH
-78
MGTX
$880M
MeiraGTx Holdings plc
BEARISH
-78
LXRX
$630M
Lexicon Pharmaceuticals, Inc.
BEARISH
-78
CLYM
$590M
Climb Bio, Inc.
BEARISH
-78
MDXG
$570M
MiMedx Group, Inc.
BEARISH
-78
MNPR
$470M
Monopar Therapeutics Inc.
BEARISH
-78
AVIR
$320M
Atea Pharmaceuticals, Inc.
BEARISH
-78
PRQR
$180M
ProQR Therapeutics N.V.
BEARISH
-78
PYXS
$110M
Pyxis Oncology, Inc.
BEARISH
-78
INMB
$40M
INmune Bio, Inc.
BEARISH
-78
BMEA
$40M
Biomea Fusion, Inc.
BEARISH
-78
TVGN
$30M
Tevogen Bio Holdings Inc.
BEARISH
-78
CELU
$30M
Celularity Inc.
BEARISH
-78
SER
$20M
Serina Therapeutics, Inc.
BEARISH
-78
AVEFF
$20M
Avecho Biotechnology Limited
BEARISH
-78
SYBX
$10M
Synlogic, Inc.
BEARISH
-78
CMMB
$10M
Chemomab Therapeutics Ltd.
BEARISH
-78
OZYMF
—
Strategic Partners A/S
BEARISH
-78
GNLKQ
—
GeneLink, Inc.
BEARISH
-78
GLABF
—
Gemina Laboratories Ltd.
BEARISH
-78
HXBM
—
Helix BioMedix, Inc.
BEARISH
-78
XRTX
—
XORTX Therapeutics Inc.
BEARISH
-78
XTLB
—
XTL Biopharmaceuticals Ltd.
BEARISH
-78
KRSA
$150M
Korsana Biosciences, Inc.
BEARISH
-80
HBMHF
$1.3B
HBM Holdings Limited
BEARISH
-82
GERN
$720M
Geron Corporation
BEARISH
-82
SLBT
$640M
SL Science Holding Ltd
BEARISH
-82
GYRE
$620M
Gyre Therapeutics, Inc.
BEARISH
-82
ANNX
$610M
Annexon, Inc.
BEARISH
-82
AGMB
$450M
AgomAb Therapeutics N.V. American Depositary Shares
BEARISH
-82
ASMB
$400M
Assembly Biosciences, Inc.
BEARISH
-82
RLMD
$350M
Relmada Therapeutics, Inc.
BEARISH
-82
MPLT
$340M
MapLight Therapeutics, Inc.
BEARISH
-82
CTNM
$270M
Contineum Therapeutics, Inc.
BEARISH
-82
LXEO
$230M
Lexeo Therapeutics, Inc. Common Stock
BEARISH
-82
BOVNF
$220M
BioInvent International AB (publ)
BEARISH
-82
BBOT
$210M
BridgeBio Oncology Therapeutics Inc.
BEARISH
-82
MENS
$130M
Jyong Biotech Ltd. Ordinary Shares
BEARISH
-82
MIST
$80M
Milestone Pharmaceuticals Inc.
BEARISH
-82
NMRA
$70M
Neumora Therapeutics, Inc. Common Stock
BEARISH
-82
HBPCF
$60M
Helix BioPharma Corp.
BEARISH
-82
IMA
$50M
ImageneBio Inc
BEARISH
-82
PRRUF
$20M
Immutep Limited
BEARISH
-82
CLRB
$10M
Cellectar Biosciences, Inc.
BEARISH
-82
ENLV
—
Enlivex Therapeutics Ltd.
BEARISH
-82
MYNDF
—
MYND Life Sciences Inc.
BEARISH
-82
SEPSF
—
Asep Medical Holdings Inc
BEARISH
-82
ARUXF
—
Acrux Limited
BEARISH
-82
ARNI
—
Arno Therapeutics, Inc.
BEARISH
-82
BIOAF
—
Bioasis Technologies Inc.
BEARISH
-82
ZVRA
$580M
Zevra Therapeutics, Inc.
BEARISH
-84
IRD
$290M
Opus Genetics, Inc.
BEARISH
-84
MGNX
$140M
MacroGenics, Inc.
BEARISH
-84
CUE
$140M
Cue Biopharma, Inc.
BEARISH
-84
ACRV
$70M
Acrivon Therapeutics, Inc. Common Stock
BEARISH
-84
SKYE
$10M
Skye Bioscience, Inc.
BEARISH
-84
RVLPQ
—
RVL Pharmaceuticals plc
BEARISH
-84
PTIX
—
Protagenic Therapeutics, Inc.
BEARISH
-84
EMMA
—
Emmaus Life Sciences, Inc.
BEARISH
-84
PHRRF
—
PharmaTher Holdings Ltd.
BEARISH
-84
URGN
$1.7B
UroGen Pharma Ltd.
BEARISH
-87
MDCLF
$1.1B
MedinCell S.A.
BEARISH
-87
IMMX
$680M
Immix Biopharma, Inc.
BEARISH
-87
CADL
$610M
Candel Therapeutics, Inc.
BEARISH
-87
GNFTF
$470M
Genfit S.A.
BEARISH
-87
IKT
$220M
Inhibikase Therapeutics, Inc.
BEARISH
-87
TRGNF
$120M
Transgene S.A.
BEARISH
-87
PRNAF
$50M
Alterity Therapeutics Limited
BEARISH
-87
BOLD
$50M
Boundless Bio, Inc.
BEARISH
-87
BMNDF
$20M
Biomind Labs Inc.
BEARISH
-87
PBM
—
Psyence Biomedical Ltd.
BEARISH
-87
GENSF
$1.8B
Genus plc
BEARISH
-91
OCUL
$1.4B
Ocular Therapeutix, Inc.
BEARISH
-91
GPCR
$1.2B
Structure Therapeutics Inc.
BEARISH
-91
SNDX
$1.2B
Syndax Pharmaceuticals, Inc.
BEARISH
-91
AKTS
$850M
Aktis Oncology, Inc.
BEARISH
-91
ARDX
$770M
Ardelyx, Inc.
BEARISH
-91
CTMX
$510M
CytomX Therapeutics, Inc.
BEARISH
-91
PROK
$470M
ProKidney Corp.
BEARISH
-91
FTH
$440M
Faeth Therapeutics, Inc.
BEARISH
-91
ALLO
$430M
Allogene Therapeutics, Inc.
BEARISH
-91
AVCTF
$420M
Avacta Group Plc
BEARISH
-91
SPRY
$400M
ARS Pharmaceuticals, Inc.
BEARISH
-91
CAPR
$340M
Capricor Therapeutics, Inc.
BEARISH
-91
KYTX
$330M
Kyverna Therapeutics, Inc.
BEARISH
-91
SPHDF
$280M
Santhera Pharmaceuticals Holding AG
BEARISH
-91
ABEO
$250M
Abeona Therapeutics Inc.
BEARISH
-91
OCGN
$250M
Ocugen, Inc.
BEARISH
-91
ORYZF
$250M
Oryzon Genomics S.A.
BEARISH
-91
HLOSF
$240M
Healios K.K.
BEARISH
-91
VNDA
$240M
Vanda Pharmaceuticals Inc.
BEARISH
-91
IPHYF
$210M
Innate Pharma S.A.
BEARISH
-91
EVMN
$190M
Evommune, Inc.
BEARISH
-91
BIOA
$190M
BioAge Labs Inc.
BEARISH
-91
ZNTL
$160M
Zentalis Pharmaceuticals, Inc.
BEARISH
-91
SION
$160M
Sionna Therapeutics, Inc.
BEARISH
-91
NBP
$160M
NovaBridge Biosciences
BEARISH
-91
AKBA
$160M
Akebia Therapeutics, Inc.
BEARISH
-91
STRO
$150M
Sutro Biopharma, Inc.
BEARISH
-91
NGEN
$150M
NervGen Pharma Corp. Common stock
BEARISH
-91
CNTN
$150M
Canton Strategic Holdings Inc
BEARISH
-91
CDXS
$140M
Codexis, Inc.
BEARISH
-91
NKTX
$130M
Nkarta, Inc.
BEARISH
-91
AVXL
$120M
Anavex Life Sciences Corp.
BEARISH
-91
UNCY
$110M
Unicycive Therapeutics, Inc.
BEARISH
-91
CBUS
$110M
Cibus, Inc.
BEARISH
-91
ORPOF
$100M
OSE Immunotherapeutics S.A.
BEARISH
-91
VXRT
$100M
Vaxart, Inc.
BEARISH
-91
CLLS
$100M
Cellectis S.A.
BEARISH
-91
TNYA
$90M
Tenaya Therapeutics, Inc.
BEARISH
-91
JWCTF
$80M
JW (Cayman) Therapeutics Co. Ltd
BEARISH
-91
CRBP
$80M
Corbus Pharmaceuticals Holdings, Inc.
BEARISH
-91
CGTX
$70M
Cognition Therapeutics, Inc.
BEARISH
-91
CRDF
$70M
Cardiff Oncology, Inc.
BEARISH
-91
CRBU
$60M
Caribou Biosciences, Inc.
BEARISH
-91
VTIAF
$50M
FamiCord AG
BEARISH
-91
HYFT
$50M
MindWalk Holdings Corp.
BEARISH
-91
CNTB
$50M
Connect Biopharma Holdings Limited
BEARISH
-91
IBIO
$50M
iBio, Inc.
BEARISH
-91
ANVS
$40M
Annovis Bio, Inc.
BEARISH
-91
RANI
$40M
Rani Therapeutics Holdings, Inc.
BEARISH
-91
DWTX
$40M
Dogwood Therapeutics, Inc.
BEARISH
-91
ALDX
$40M
Aldeyra The
BEARISH
-91
EXOZ
$40M
eXoZymes, Inc.
BEARISH
-91
TIL
$40M
Instil Bio, Inc.
BEARISH
-91
GRCE
$30M
Grace Therapeutics, Inc.
BEARISH
-91
FLNA
$30M
Filana Therapeutics, Inc.
BEARISH
-91
BCTX
$30M
BriaCell Therapeutics Corp.
BEARISH
-91
IGC
$30M
IGC Pharma, Inc.
BEARISH
-91
IXHL
$30M
Incannex Healthcare Limited
BEARISH
-91
ATYR
$20M
aTyr Pharma, Inc.
BEARISH
-91
MVMDF
$20M
More Life Company Corp.
BEARISH
-91
BYSI
$20M
BeyondSpring Inc.
BEARISH
-91
QNTM
$10M
Quantum BioPharma Ltd.
BEARISH
-91
GSGTF
$10M
GenSight Biologics S.A.
BEARISH
-91
KTTA
$10M
Pasithea Therapeutics Corp.
BEARISH
-91
GTBP
$10M
GT Biopharma, Inc.
BEARISH
-91
PXXLF
$10M
Poxel S.A.
BEARISH
-91
TVRD
$10M
Tvardi Therapeutics, Inc.
BEARISH
-91
DARE
$10M
Dare Bioscience, Inc.
BEARISH
-91
IMNN
$10M
Imunon, Inc.
BEARISH
-91
INTS
$10M
Intensity Therapeutics, Inc.
BEARISH
-91
BLRX
$10M
BioLineRx Ltd.
BEARISH
-91
INAB
$10M
IN8bio, Inc.
BEARISH
-91
RDTCF
$10M
Rapid Dose Therapeutics Corp.
BEARISH
-91
PTN
$10M
Palatin Technologies, Inc.
BEARISH
-91
VTGN
$10M
VistaGen Therapeutics, Inc.
BEARISH
-91
QNRX
$10M
Quoin Pharmaceuticals, Ltd.
BEARISH
-91
TPST
$10M
Tempest Therapeutics, Inc.
BEARISH
-91
MSLE
$10M
Satellos Bioscience Inc.
BEARISH
-91
CDIO
$10M
Cardio Diagnostics Holdings, Inc.
BEARISH
-91
GUTS
$10M
Fractyl Health, Inc.
BEARISH
-91
OPTBF
$10M
OptiBiotix Health Plc
BEARISH
-91
APRE
$10M
Aprea Therapeutics, Inc.
BEARISH
-91
TRAW
$10M
Traws Pharma, Inc.
BEARISH
-91
TOVX
$10M
Theriva Biologics, Inc.
BEARISH
-91
TCRX
$10M
TScan Therapeutics, Inc.
BEARISH
-91
NBRVF
—
Nabriva Therapeutics plc
BEARISH
-91
BNIGF
—
Beroni Group Limited
BEARISH
-91
ZVSA
—
ZyVersa Therapeutics, Inc.
BEARISH
-91
NIKI
—
Niki BioSolutions, Inc.
BEARISH
-91
GOVX
—
GeoVax Labs, Inc.
BEARISH
-91
VBIO
—
Valion Bio, Inc.
BEARISH
-91
AXIM
—
AXIM Biotechnologies, Inc.
BEARISH
-91
TNGNQ
—
Tengion, Inc.
BEARISH
-91
XENO
—
Xeno Transplants Corporation
BEARISH
-91
ZHCLF
—
Zenith Capital Corp.
BEARISH
-91
MLECW
—
Moolec Science S.A.
BEARISH
-91
MDCX
—
Medicus Pharma Ltd. Common Stock
BEARISH
-91
VPRO
—
Viropro Inc.
BEARISH
-91
SUVZ
—
Suvanza Pharma, LLC
BEARISH
-91
HCWB
—
HCW Biologics Inc.
BEARISH
-91
LIFS
—
Life Stem Genetics Inc.
BEARISH
-91
RADX
—
Radiopharm Theranostics Limited
BEARISH
-91
MBAI
—
MBody AI Ltd.
BEARISH
-91
APVO
—
Aptevo Therapeutics Inc.
BEARISH
-91
KAPA
—
Kairos Pharma, Ltd.
BEARISH
-91
DCOY
—
Decoy Therapeutics Inc.
BEARISH
-91
ENZC
—
Enzolytics Inc.
BEARISH
-91
RASP
—
Actavia Life Sciences, Inc.
BEARISH
-91
EVFM
—
Evofem Biosciences, Inc.
BEARISH
-91
CLDI
—
Calidi Biotherapeutics, Inc.
BEARISH
-91
MBIO
—
Mustang Bio, Inc.
BEARISH
-91
LIMN
—
Liminatus Pharma, Inc. Class A Common Stock
BEARISH
-91
GNPX
—
Genprex, Inc.
BEARISH
-91
KALA
—
KALA BIO, Inc.
BEARISH
-91
TSOI
—
Therapeutic Solutions International, Inc.
BEARISH
-91
WSNAF
—
Wesana Health Holdings Inc.
BEARISH
-91
NCEL
—
NewcelX Ltd.
BEARISH
-91
OGEN
—
Oragenics, Inc.
BEARISH
-91
IVEVF
$750M
Inventiva S.A.
BEARISH
-100
RGNX
$440M
REGENXBIO Inc.
BEARISH
-100
ALT
$410M
Altimmune, Inc.
BEARISH
-100
AVTX
$370M
Avalo Therapeutics, Inc.
BEARISH
-100
DMTRF
$310M
3-D Matrix, Ltd.
BEARISH
-100
SCTX
$250M
Scribe Therapeutics Inc.
BEARISH
-100
ACIU
$250M
AC Immune S.A.
BEARISH
-100
CABA
$250M
Cabaletta Bio, Inc.
BEARISH
-100
PALI
$230M
Palisade Bio, Inc.
BEARISH
-100
IVVD
$180M
Invivyd, Inc.
BEARISH
-100
UPB
$150M
Upstream Bio, Inc.
BEARISH
-100
CMPX
$140M
Compass Therapeutics, Inc.
BEARISH
-100
VYGR
$110M
Voyager Therapeutics, Inc.
BEARISH
-100
NERV
$110M
Minerva Neurosciences, Inc.
BEARISH
-100
ENGN
$100M
enGene Holdings Inc.
BEARISH
-100
VTVT
$100M
vTv Therapeutics Inc.
BEARISH
-100
LENZ
$100M
LENZ Therapeutics, Inc.
BEARISH
-100
PTHS
$70M
Pelthos Therapeutics Inc.
BEARISH
-100
VRCA
$60M
Verrica Pharmaceuticals Inc.
BEARISH
-100
XBIT
$60M
XBiotech Inc.
BEARISH
-100
TLSA
$60M
Tiziana Life Sciences Ltd
BEARISH
-100
GANX
$50M
Gain Therapeutics, Inc.
BEARISH
-100
PLRX
$50M
Pliant Therapeutics, Inc.
BEARISH
-100
ACET
$40M
Adicet Bio, Inc.
BEARISH
-100
KLRS
$40M
Kalaris Therapeutics Inc
BEARISH
-100
MGX
$30M
Metagenomi, Inc. Common Stock
BEARISH
-100
AARD
$30M
Aardvark Therapeutics, Inc. Common Stock
BEARISH
-100
BSEM
$30M
BioStem Technologies, Inc.
BEARISH
-100
NRXBF
$30M
NurExone Biologic Inc.
BEARISH
-100
EDSA
$30M
Edesa Biotech, Inc.
BEARISH
-100
EYPT
$30M
EyePoint Pharmaceuticals, Inc.
BEARISH
-100
ALGS
$30M
Aligos Therapeutics, Inc.
BEARISH
-100
MCRB
$20M
Seres Therapeutics, Inc.
BEARISH
-100
TELIF
$20M
Telescope Innovations Corp.
BEARISH
-100
KYNB
$20M
Kyntra Bio, Inc.
BEARISH
-100
BXPHF
$20M
Botanix Pharmaceuticals Limited
BEARISH
-100
BCDA
$10M
BioCardia, Inc.
BEARISH
-100
HIND
$10M
Vyome Holdings, Inc.
BEARISH
-100
RVPH
$10M
Reviva Pharmaceuticals Holdings, Inc.
BEARISH
-100
MTVA
$10M
MetaVia Inc.
BEARISH
-100
ACTU
$10M
Actuate Therapeutics Inc
BEARISH
-100
FBLG
$10M
FibroBiologics, Inc. Common Stock
BEARISH
-100
AIMD
$10M
Ainos, Inc.
BEARISH
-100
ACXP
$10M
Acurx Pharmaceuticals, Inc.
BEARISH
-100
NRSN
—
NeuroSense Therapeutics Ltd.
BEARISH
-100
NMLSF
—
Restart Life Sciences Corp.
BEARISH
-100
ZLDAF
—
Zelira Therapeutics Limited
BEARISH
-100
PMCB
—
PharmaCyte Biotech, Inc.
BEARISH
-100
SCPX
—
Scorpius Holdings, Inc.
BEARISH
-100
CELZ
—
Creative Medical Technology Holdings, Inc.
BEARISH
-100
CRIS
—
Curis, Inc.
BEARISH
-100
OXBOF
—
Oxford BioDynamics Plc
BEARISH
-100
XSNX
—
NovAccess Global Inc.
BEARISH
-100
NAVBQ
—
Navidea Biopharmaceuticals, Inc.
BEARISH
-100
CODX
—
Co-Diagnostics, Inc.
BEARISH
-100
LABT
—
Lakewood-Amedex Biotherapeutics, Inc.
BEARISH
-100
FAMDF
—
Futura Medical plc
BEARISH
-100
NSHSF
—
NanoSphere Health Sciences Inc.
BEARISH
-100
CANF
—
Can-Fite BioPharma Ltd.
BEARISH
-100
PPBT
—
Purple Biotech Ltd.
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| LYEL Lyell Immunopharma, Inc. | $230M | -0.6 | -93.3 | -227.7 | -1118875.0 | -55.0 | 3 | BULLISH | -42.6 |
| SEPN Septerna Inc | $1.9B | -81.7 | -6.3 | -93.1 | -48.7 | 17878.5 | 5 | BULLISH | 103.7 |
| COAG Hemab Therapeutics Holdings, Inc. Common Stock | $1.6B | — | — | — | — | — | — | BULLISH | — |
| VSTM Verastem, Inc. | $910M | -4.1 | -471.2 | 6197.3 | -86.5 | 3995.7 | 4 | BULLISH | 27.0 |
| SOLTF Nxera Pharma Co., Ltd. | $770M | -16.0 | -12.0 | -1.7 | -2.6 | 7.5 | 4 | BULLISH | 38.2 |
| PYPD PolyPid Ltd. | $110M | -3.9 | -1913.8 | 231.6 | — | — | 3 | BULLISH | 67.7 |
| ANIX Anixa Biosciences, Inc. | $100M | -10.8 | -67.1 | -1110.2 | — | — | 3 | BULLISH | -20.8 |
| GRDX GridAI Technologies Corp. | $40M | -1.4 | -55.6 | -51.7 | -14927.4 | 67.4 | 2 | BULLISH | 44.5 |
| KLRA Kailera Therapeutics, Inc. | $1.7B | — | — | — | — | — | — | BULLISH | — |
| SPTX Seaport Therapeutics, Inc. Common Stock | $1.1B | — | — | — | — | — | — | BULLISH | — |
| SGP SpyGlass Pharma, Inc. Common Stock | $950M | — | — | — | — | — | — | BULLISH | — |
| ENTX Entera Bio Ltd. | $510M | -8.8 | -138.9 | 314.4 | — | -100.0 | 1 | BULLISH | 37.8 |
| ATNM Actinium Pharmaceuticals, Inc. | $50M | 3.9 | 45.9 | -197.8 | 79.7 | — | 3 | BULLISH | -15.0 |
| PRME Prime Medicine, Inc. | $670M | -4.0 | -373.3 | -271.3 | -3649.0 | -17.9 | 3 | BULLISH | -18.4 |
| XFOR X4 Pharmaceuticals, Inc. | $320M | -2.7 | -113.1 | -281.1 | -183.5 | -51.6 | 4 | BULLISH | -14.5 |
| CING Cingulate Inc. | $70M | -1.1 | -198.7 | -1452.8 | — | — | 4 | BULLISH | 43.3 |
| ESLA Estrella Immunopharma, Inc. | $40M | -3.8 | 148.1 | 102.1 | — | — | 3 | BULLISH | -60.8 |
| INDP Indaptus Therapeutics, Inc. | $360M | -0.5 | -318.0 | 6437.4 | — | — | 4 | BULLISH | -8.8 |
| KRRO Korro Bio, Inc. | $180M | -1.3 | -97.7 | -196.6 | — | -62.1 | 2 | BULLISH | -65.1 |
| VIR Vir Biotechnology, Inc. | $1.8B | -6.3 | -26.1 | -38.8 | 33.5 | 1495.9 | 5 | BULLISH | 93.5 |
| MAZE Maze Therapeutics, Inc. | $1.7B | -11.6 | -37.3 | -112.3 | — | — | 3 | BULLISH | 4.3 |
| ZIVO ZIVO Bioscience, Inc. | $20M | -4.5 | 185.9 | 147.5 | — | -62.5 | 2 | BULLISH | -53.1 |
| LBRX LB Pharmaceuticals Inc Common Stock | $1.2B | -13.3 | -25.8 | -768.9 | — | — | 2 | BULLISH | 148.2 |
| OABIW OmniAb, Inc. | $1.1B | -13.8 | -16.9 | -16.8 | -43.7 | 66.9 | 6 | BULLISH | -17.6 |
| RIGL Rigel Pharmaceuticals, Inc. | $900M | 2.9 | 126.9 | 88.5 | 22.0 | 3.3 | 4 | BULLISH | 68.7 |
| MXCT MaxCyte, Inc. | $140M | -4.6 | -20.4 | -38.9 | -122.0 | -13.2 | 2 | BULLISH | -5.5 |
| HURA TuHURA Biosciences, Inc. | $140M | -3.9 | -161.4 | -137.6 | — | — | 2 | BULLISH | -7.9 |
| IRLA IRulya Therapeutics Inc. | $30M | — | — | — | — | — | — | BULLISH | — |
| AGTX Agentix Corp. | — | -5.1 | 12.0 | 8.1 | — | — | 3 | BULLISH | 6.9 |
| NAUT Nautilus Biotechnolgy, Inc. | $410M | -6.3 | -41.0 | -89.2 | -6682.1 | — | 2 | BULLISH | 136.9 |
| RARE Ultragenyx Pharmaceutical Inc. | $1.5B | -2.9 | 839.4 | -67.5 | -43.0 | 17.5 | 2 | BULLISH | -50.0 |
| XNCR Xencor, Inc. | $1.9B | -13.8 | -29.1 | -152.4 | -42.4 | -36.1 | 2 | BULLISH | 127.0 |
| TRAX First Tracks Biotherapeutics Inc | $1.6B | — | — | — | — | — | — | BULLISH | — |
| SLN Silence Therapeutics plc | $930M | -5.2 | -90.4 | 157.8 | — | -97.6 | 1 | BULLISH | 171.0 |
| PBYI Puma Biotechnology, Inc. | $570M | 20.4 | 22.0 | 52.8 | 14.5 | -2.9 | 6 | BULLISH | 108.8 |
| SGMT Sagimet Biosciences Inc. | $310M | -8.1 | -24.4 | -231.4 | — | — | 3 | BULLISH | 14.0 |
| HOWL Werewolf Therapeutics, Inc. | $50M | -1.4 | -119.9 | 354.7 | 17.5 | — | 4 | BULLISH | -41.2 |
| NNVC NanoViricides, Inc. | $40M | -3.5 | -101.5 | -111.4 | — | — | 3 | BULLISH | -4.6 |
| MBRX Moleculin Biotech, Inc. | $10M | -0.0 | -1371.6 | -494.1 | — | — | 3 | BULLISH | -23.7 |
| AZTR Azitra, Inc. | — | -0.1 | -256.7 | -959.6 | — | — | 5 | BULLISH | 94.8 |
| NBTX Nanobiotix S.A. | $1.5B | -27.5 | 104.2 | 62.0 | -626.0 | 49.1 | 4 | BULLISH | 79.8 |
| BOLT Bolt Biotherapeutics, Inc. | $10M | -0.4 | -111.6 | -138.8 | -154400.0 | 12.8 | 3 | BULLISH | 6.2 |
| BDRX Biodexa Pharmaceuticals Plc | — | -0.1 | -42.3 | -117.9 | — | — | 2 | BULLISH | -89.1 |
| CBDG THC Farmaceuticals, Inc. | — | -30.9 | 2.0 | -0.9 | — | 28.1 | 5 | BULLISH | -63.1 |
| NTLA Intellia Therapeutics, Inc. | $1.6B | -3.7 | -55.4 | -92.1 | -1392.3 | 12.6 | 5 | BULLISH | -52.0 |
| PHAR Pharming Group N.V. | $710M | 81.7 | 3.6 | 3.2 | 1.8 | 7.8 | 7 | BULLISH | -12.7 |
| PCSA Processa Pharmaceuticals, Inc. | $10M | -0.3 | -464.2 | 1977.5 | — | — | 2 | BULLISH | -76.5 |
| ICCC ImmuCell Corporation | $90M | 121.3 | 2.6 | 10.2 | 25.5 | 8.5 | 6 | BULLISH | 68.8 |
| PLUR Pluri Inc. | $10M | -0.5 | 163.6 | -483.9 | -1755.2 | -24.0 | 2 | BULLISH | -69.5 |
| CASBF CanSino Biologics Inc. | $1.4B | 383.8 | 0.8 | -1.2 | 11.0 | 32.5 | 7 | BULLISH | -25.5 |
| REPL Replimune Group, Inc. | $1.1B | -4.1 | -134.3 | -1055.2 | — | — | 1 | BULLISH | 48.3 |
| PPCB Propanc Biopharma, Inc. | — | -0.1 | -161.9 | -166.7 | — | — | 4 | BULLISH | 59.9 |
| HALB Halberd Corporation | — | -25.4 | 11.6 | 12.4 | — | -52.1 | 1 | BULLISH | -13.9 |
| ABSI Absci Corporation | $1.6B | -13.2 | -57.7 | -213.1 | -10443.4 | -62.3 | 5 | BULLISH | 147.5 |
| CRMD CorMedix Inc. | $610M | 3.3 | 54.9 | 57.2 | 25.5 | 280.5 | 5 | BULLISH | -28.4 |
| DTIL Precision BioSciences, Inc. | $180M | -2.4 | -135.1 | 203.1 | — | 3473.0 | 5 | BULLISH | 1.0 |
| NRXS NeurAxis, Inc. | $90M | -9.6 | -143.2 | 464.1 | -118.1 | 65.2 | 6 | BULLISH | 110.9 |
| OKYO OKYO Pharma Limited | $70M | -6.2 | -263.8 | 88.0 | — | — | 3 | BULLISH | -37.7 |
| XERS Xeris Biopharma Holdings, Inc. | $1.9B | -107.6 | 118.2 | 18.3 | -33.8 | 36.3 | 6 | BULLISH | 13.5 |
| ADCT ADC Therapeutics S.A. | $180M | -2.4 | 45.3 | 260.9 | -86.1 | 2.0 | 2 | BULLISH | -61.1 |
| SCNLF Scancell Holdings plc | $170M | -5.1 | 153.2 | 179.2 | — | -100.0 | 2 | BULLISH | 969.8 |
| ZEOX Zeo ScientifiX, Inc. | $10M | -2.4 | -140.0 | 105.8 | -5.6 | — | 2 | BULLISH | — |
| CLGN CollPlant Biotechnologies Ltd. | — | -0.4 | -162.0 | -369.3 | -2524.1 | -86.8 | 2 | BULLISH | -82.9 |
| VOR Vor Biopharma Inc. | $990M | 0.1 | -73.6 | 22.2 | — | — | 3 | BULLISH | -28.1 |
| ALEC Alector, Inc. | $200M | -1.9 | -385.1 | 66.8 | -692.5 | -82.9 | 1 | BULLISH | 40.0 |
| ACUT Accustem Sciences Inc. | — | -1.4 | 49.7 | 34.0 | -256.7 | 2610.7 | 4 | BULLISH | -88.8 |
| KNBIF Kane Biotech Inc. | — | -2.4 | 439.7 | -2166.6 | -10238.1 | -97.9 | 2 | BULLISH | -27.9 |
| RXRX Recursion Pharmaceuticals, Inc. | $2.0B | -3.9 | -56.6 | -99.7 | -1708.0 | -14.9 | 4 | BULLISH | -33.0 |
| KROS Keros Therapeutics, Inc. | $220M | -3.1 | -17.2 | -392.2 | — | -93.6 | 3 | BULLISH | -24.0 |
| TXTM ProText Mobility, Inc. | $90M | 86.0 | -0.4 | -0.3 | — | -100.0 | 1 | BULLISH | 273.9 |
| IMCR Immunocore Holdings plc | $1.6B | -177.3 | -2.3 | -472.0 | -0.7 | 13.4 | 4 | BULLISH | -3.4 |
| DMAC DiaMedica Therapeutics Inc. | $470M | -12.1 | -114.6 | 616.3 | — | — | 2 | BULLISH | 26.3 |
| DMRA Damora Therapeutics, Inc. | $1.3B | — | — | — | — | — | — | BULLISH | — |
| MLTX MoonLake Immunotherapeutics | $1.0B | -3.1 | -67.4 | 2902.7 | — | — | 1 | BULLISH | 25.3 |
| PDSB PDS Biotechnology Corporation | $60M | -2.0 | -544.0 | 456.9 | — | — | 1 | BULLISH | 41.4 |
| NYMXF Nymox Pharmaceutical Corporation | $10M | -0.9 | 193.9 | 89.4 | — | — | 2 | BULLISH | -63.2 |
| IPIX Innovation Pharmaceuticals Inc. | — | -0.1 | -115.7 | -377.9 | — | -133.3 | 3 | BULLISH | -25.0 |
| PULM Pulmatrix, Inc. | $10M | -1.4 | -98.3 | -835.1 | — | -100.0 | 3 | BULLISH | -69.2 |
| TCRT Alaunos Therapeutics, Inc. | $10M | -1.1 | -185.9 | -607.2 | — | -50.0 | 1 | BULLISH | -26.9 |
| EDIT Editas Medicine, Inc. | $370M | -3.5 | -118.8 | 71.4 | -153.3 | 20.8 | 4 | BULLISH | -30.1 |
| PEPG PepGen Inc. | $170M | -1.7 | -75.5 | -327.5 | — | — | 4 | BULLISH | -43.1 |
| NGNE Neurogene Inc. | $370M | -4.9 | -45.3 | -111469.0 | — | — | 2 | LEAN BULL | -9.7 |
| BCYC Bicycle Therapeutics plc | $250M | -1.4 | -32.3 | -1197.0 | -8002.1 | 217.4 | 4 | LEAN BULL | -52.0 |
| LCTX Lineage Cell Therapeutics, Inc. | $250M | -7.3 | -59.0 | -171.3 | 138.6 | 19.9 | 5 | LEAN BULL | -39.4 |
| ABOS Acumen Pharmaceuticals, Inc. | $140M | -1.5 | -162.7 | 466.8 | — | — | 2 | LEAN BULL | 2.3 |
| IUGNF Imugene Limited | $30M | -0.1 | -389.5 | -458.5 | — | -100.0 | 1 | LEAN BULL | -74.0 |
| BSSP Baseline Productions, Inc. | — | -0.0 | 167.7 | 64.9 | — | — | 2 | LEAN BULL | 100.0 |
| INFIQ Infinity Pharmaceuticals, Inc. | — | -0.0 | 109.5 | 60.9 | -1707.7 | — | 2 | LEAN BULL | 0.0 |
| ARDS Aridis Pharmaceuticals, Inc. | — | -0.0 | 4.8 | 10.0 | -19.9 | 2227.6 | 4 | LEAN BULL | -92.3 |
| PTCHF PureTech Health plc | $390M | 156.9 | 0.2 | 50.8 | 1890.6 | 7.7 | 4 | LEAN BULL | -5.4 |
| OBIO Orchestra BioMed Holdings, Inc. | $340M | -5.8 | -397.3 | 468.3 | -26994.3 | 986.1 | 4 | LEAN BULL | 46.0 |
| ACOG Alpha Cognition Inc | $130M | -8.2 | -55.3 | -198.4 | -144.3 | 232.7 | 2 | LEAN BULL | 11.1 |
| PRVCF PreveCeutical Medical Inc. | $10M | -16.7 | 9.9 | 96.4 | — | — | 3 | LEAN BULL | -44.7 |
| CKDXF Ceryvyn Therapeutics Ltd | $10M | 0.1 | -243.9 | 2882.8 | — | -97.3 | 3 | LEAN BULL | -97.6 |
| CALA Calithera Biosciences, Inc. | — | -0.0 | -141.5 | 979.6 | — | -100.0 | 1 | LEAN BULL | 200.0 |
| CYYNF Cynata Therapeutics Limited | — | -0.3 | -326.4 | 584.9 | — | -100.0 | 1 | LEAN BULL | -93.9 |
| EFTR eFFECTOR Therapeutics, Inc. | — | -0.0 | 1737.6 | 607.9 | — | -91.9 | 4 | LEAN BULL | 300.0 |
| ENSC Ensysce Biosciences, Inc. | $10M | -0.2 | -968.3 | 792.9 | -220.8 | -77.6 | 3 | LEAN BULL | -79.8 |
| NTRR Neutra Corp. | — | 2.0 | -139.6 | -802.5 | -3.8 | 142.2 | 7 | LEAN BULL | -33.3 |
| STOK Stoke Therapeutics, Inc. | $1.6B | -7.8 | -61.1 | -318.5 | -660.8 | -86.2 | 2 | LEAN BULL | -19.1 |
| CCCC C4 Therapeutics, Inc. | $380M | -3.2 | -48.1 | -175.0 | -355.9 | 2.3 | 4 | LEAN BULL | 31.0 |
| ZURA Zura Bio Limited | $320M | -3.8 | -65.4 | 806.5 | — | — | 2 | LEAN BULL | 15.7 |
| LOBEF Lobe Sciences Ltd. | $10M | -2.7 | 359.0 | 181.6 | — | — | 2 | LEAN BULL | 29.6 |
| BIVI BioVie Inc. | $10M | -0.4 | -0.0 | -0.0 | — | — | 3 | LEAN BULL | -23.4 |
| VSBC VitaSpring Biomedical Co. Ltd. | $10M | -13.8 | 10.3 | 15.9 | — | -100.0 | 4 | LEAN BULL | -96.8 |
| HEPA Hepion Pharmaceuticals, Inc. | — | -0.6 | -125.6 | 710.2 | — | — | 3 | LEAN BULL | 92.1 |
| BTAX Biostax Corp. | — | -0.0 | 7.3 | 5.8 | — | — | 2 | LEAN BULL | 100.0 |
| VAXX Vaxxinity, Inc. | — | -0.2 | -150.6 | 2534.7 | — | — | 0 | LEAN BULL | 23.3 |
| REVB Revelation Biosciences, Inc. | — | -0.1 | -154.8 | 1317.2 | — | — | 4 | LEAN BULL | 194.5 |
| PXMD PaxMedica, Inc. Common Stock | — | -0.0 | -7716.2 | 572.1 | — | — | 2 | LEAN BULL | 600.0 |
| ACHFF Arch Biopartners Inc. | $40M | -20.5 | 73.5 | 165.4 | — | 100.0 | 2 | LEAN BULL | -12.6 |
| PRLD Prelude Therapeutics Incorporated | $210M | -4.9 | -57.7 | 14236.3 | -244.1 | 220.3 | 5 | LEAN BULL | 139.5 |
| BRVE Braveheart Bio, Inc. | $1.5B | — | — | — | — | — | — | LEAN BULL | — |
| SRZN Surrozen, Inc. | $190M | -0.7 | 387.2 | 11.1 | 1003.5 | -8.8 | 2 | LEAN BULL | 114.8 |
| MDNAF Medicenna Therapeutics Corp. | $20M | — | — | — | — | — | — | LEAN BULL | — |
| ABPO Abpro Holdings, Inc. | — | — | — | — | — | — | — | LEAN BULL | — |
| CYDY CytoDyn Inc. | $380M | -5.0 | 57.8 | 24.6 | — | 100.0 | 4 | LEAN BULL | -16.2 |
| SPRB Spruce Biosciences, Inc. | $130M | -1.1 | -106.0 | 772.2 | — | -100.0 | 4 | LEAN BULL | -65.7 |
| OCEA Ocean Biomedical, Inc. | — | -0.0 | 36.5 | 0.3 | — | — | 1 | LEAN BULL | -20.0 |
| PVLA Palvella Therapeutics, Inc. | $1.8B | -27.5 | -46.6 | 137.5 | — | — | 3 | LEAN BULL | 82.1 |
| TYRA Tyra Biosciences, Inc. | $1.2B | -9.0 | -45.3 | -2390.9 | — | — | 2 | LEAN BULL | 51.2 |
| PRTA Prothena Corporation plc | $420M | -10.6 | -14.4 | -871.5 | -1839.9 | 427.3 | 5 | LEAN BULL | -10.3 |
| ENTA Enanta Pharmaceuticals, Inc. | $340M | -5.1 | -70.1 | 141.5 | -135.8 | 0.7 | 4 | LEAN BULL | 15.9 |
| GLSI Greenwich LifeSciences, Inc. | $240M | -11.3 | -951.6 | 299.9 | — | — | 2 | LEAN BULL | 74.4 |
| CLNN Clene Inc. | $60M | -1.1 | 237.2 | 132.5 | -14915.6 | -31.1 | 2 | LEAN BULL | -52.4 |
| EHOS Ehouse Global, Inc. | — | -0.0 | 161.0 | 52.5 | — | — | 1 | LEAN BULL | 0.0 |
| DNAG DNAPrint Genomics, Inc. | — | -0.0 | 63.1 | -156.0 | -826.7 | -15.2 | 3 | LEAN BULL | 100.0 |
| ONCSQ OncoSec Medical Incorporated | — | -0.0 | -410.2 | 452.1 | — | — | 2 | LEAN BULL | -90.0 |
| RBSH Rebus Holdings, Inc. | — | -0.0 | -9.7 | 8.9 | — | — | 2 | LEAN BULL | 0.0 |
| CPMV Mosaic ImmunoEngineering Inc. | — | -2.8 | 9.2 | 7.5 | — | — | 2 | LEAN BULL | -51.2 |
| SRPT Sarepta Therapeutics, Inc. | $1.9B | -13.1 | -9.5 | -6.3 | -1.2 | -20.4 | 4 | NEUTRAL | -17.2 |
| ABVC ABVC BioPharma, Inc. | $30M | -3.6 | -82.2 | -43.0 | — | -100.0 | 2 | NEUTRAL | -64.4 |
| ANAB AnaptysBio, Inc. | $1.5B | 7.4 | -1146.3 | 466.0 | 668.9 | 92.9 | 5 | NEUTRAL | 112.3 |
| STAB Statera Biopharma, Inc. | — | -0.0 | -298.8 | 2085.4 | -769.5 | 1459.1 | 3 | NEUTRAL | -50.0 |
| OBX Obsidian Therapeutics Inc. | $10M | — | — | — | — | — | — | NEUTRAL | — |
| GBIM GlobeImmune, Inc. | — | -0.0 | -66.2 | 25.0 | -91.5 | 55.1 | 4 | NEUTRAL | 0.0 |
| CNSP CNS Pharmaceuticals, Inc. | $10M | -0.2 | -106.6 | 748.6 | — | — | 3 | NEUTRAL | -38.4 |
| NWBO Northwest Biotherapeutics, Inc. | $260M | -6.5 | 55.8 | -188.7 | -1142.6 | 98.6 | 3 | NEUTRAL | -33.7 |
| SABS SAB Biotherapeutics, Inc. | $260M | 0.9 | -11.3 | -48.4 | — | -100.0 | 3 | NEUTRAL | 1.3 |
| MLLCF Molecular Partners AG | $150M | -2.3 | -62.1 | 650.3 | — | -100.0 | 2 | NEUTRAL | 14.6 |
| HESG Health Sciences Group, Inc. | — | -0.0 | 69.4 | 44.6 | -19219.1 | 101.6 | 3 | NEUTRAL | 900.0 |
| CTXR Citius Pharmaceuticals, Inc. | $10M | -0.2 | -70.3 | -85.4 | -593.3 | 4456.8 | 3 | NEUTRAL | -71.9 |
| CFRXQ ContraFect Corp. | — | -0.0 | 544.7 | 276.9 | — | — | 1 | NEUTRAL | -90.0 |
| RGIN Regenicin, Inc. | — | -0.0 | 16.9 | 4.1 | — | — | 4 | NEUTRAL | 0.0 |
| RCAR RenovaCare, Inc. | — | -0.0 | -436.6 | 812.3 | — | — | 2 | NEUTRAL | 9900.0 |
| NMTRQ 9 Meters Biopharma, Inc. | — | — | — | — | — | — | — | NEUTRAL | 900.0 |
| LYCA Lycia Therapeutics Inc. | $1.6B | — | — | — | — | — | — | N/A | — |
| CTY City Therapeutics Inc. | $200M | — | — | — | — | — | — | N/A | — |
| IAM Iambic Therapeutics Inc. | $130M | — | — | — | — | — | — | N/A | — |
| ATOS Atossa Therapeutics, Inc. | $30M | -0.5 | -89.2 | -4213.1 | — | — | 2 | NEUTRAL | -83.0 |
| LONA LeonaBio, Inc. | $20M | — | — | — | — | — | — | NEUTRAL | — |
| ORGS Orgenesis Inc. | — | -0.2 | 764.3 | 1083.0 | 2628.2 | -192.0 | 1 | NEUTRAL | 66.7 |
| JANX Janux Therapeutics, Inc. | $1.0B | -10.5 | -10.7 | 516.9 | -214.0 | 7162.0 | 4 | NEUTRAL | -30.7 |
| ODTX Odyssey Therapeutics, Inc. | $940M | — | — | — | — | — | — | NEUTRAL | — |
| DRUG Bright Minds Biosciences Inc. | $520M | -26.2 | -13.7 | -105758.3 | — | — | 3 | NEUTRAL | -11.7 |
| PHMMF Pharma Mar, S.A. | $1.6B | 21.2 | 24.9 | 35.9 | -2.0 | 15.5 | 7 | NEUTRAL | 1.7 |
| NMAD NOMAD Power Solutions, Inc. | $50M | — | — | — | — | — | — | NEUTRAL | — |
| KLDO Kaleido Biosciences, Inc. | — | -0.0 | -591.2 | 1121.9 | -4292.5 | 13.2 | 2 | NEUTRAL | -96.7 |
| CNBX CNBX Pharmaceuticals Inc. | — | -0.5 | 17.8 | 13.3 | — | 100.0 | 3 | NEUTRAL | -57.1 |
| CALC CalciMedica, Inc. | — | -0.2 | -365.7 | 118.3 | — | — | 4 | NEUTRAL | -91.3 |
| YARW Yarrow Bioscience Inc | $180M | — | — | — | — | — | — | NEUTRAL | — |
| ELUT Elutia Inc | $40M | 0.6 | -397.0 | -290.2 | -315.0 | -48.8 | 6 | NEUTRAL | -10.6 |
| GSTC GlobeStar Therapeutics Corporation | — | -0.0 | 60.9 | 49.1 | — | — | 4 | NEUTRAL | 9900.0 |
| YDESW YD Bio Limited Warrants | — | — | — | — | — | — | — | NEUTRAL | -69.4 |
| BPTH Bio-Path Holdings, Inc. | — | -0.0 | 49.0 | 15.2 | — | -100.0 | 1 | NEUTRAL | -99.6 |
| RNXT RenovoRx, Inc. | $60M | -4.4 | -125.2 | 4391.9 | -320.2 | 198.5 | 3 | NEUTRAL | 17.8 |
| USRM U.S. Stem Cell, Inc. | — | -0.0 | 20.8 | 23.4 | -2836.8 | -59.1 | 5 | NEUTRAL | 100.0 |
| ZBIO Zenas BioPharma, Inc. | $1.8B | -2.8 | -199.0 | 5842.1 | -11145.6 | -93.3 | 2 | NEUTRAL | 14.2 |
| VCRE Vicore Pharma Holding AB | $260M | — | — | — | — | — | — | NEUTRAL | — |
| ENGNW enGene Holdings Inc. Warrants | $10M | -5.5 | -2.3 | 134.1 | — | -100.0 | 2 | NEUTRAL | -64.6 |
| PBLA Panbela Therapeutics, Inc. | — | -0.0 | 270.3 | 240.0 | — | 100.0 | 3 | NEUTRAL | 0.0 |
| NXTC NextCure, Inc. | $20M | -0.5 | -195.2 | 949.7 | — | — | 2 | NEUTRAL | -37.8 |
| EVAX Evaxion Biotech A/S | $20M | -0.5 | -109.8 | -260.4 | — | 135.9 | 6 | NEUTRAL | -48.4 |
| ATXI Avenue Therapeutics, Inc. | — | -0.5 | -120.0 | 178.4 | — | -100.0 | 2 | NEUTRAL | -43.9 |
| MRPI Mera Pharmaceuticals, Inc. | — | -10000.0 | 24.3 | 18.3 | -159.9 | 4.8 | 5 | NEUTRAL | 0.0 |
| MBXBF Microbix Biosystems Inc. | $30M | -8.6 | -16.4 | -14.6 | -19.9 | -27.1 | 3 | LEAN BEAR | 24.3 |
| INRLF Valneva SE | $640M | -2.8 | -118.0 | -54.8 | -89.3 | -27.2 | 1 | LEAN BEAR | -25.4 |
| POLBF Poolbeg Pharma PLC | $70M | -8.5 | -58.8 | -255.9 | — | — | 1 | LEAN BEAR | 125.4 |
| QPTFF Quest PharmaTech Inc. | $10M | 1.6 | 3.9 | -1.7 | — | — | 4 | LEAN BEAR | 125.6 |
| CLYYF Celyad Oncology S.A. | $10M | 2.5 | -11.7 | -979.7 | 64360.6 | -88.7 | 5 | LEAN BEAR | 40.0 |
| OKUR OnKure Therapeutics, Inc. | $100M | -0.7 | -46.9 | 1464.5 | — | — | 4 | LEAN BEAR | -21.7 |
| SNGX Soligenix, Inc. | $10M | -0.3 | -241.7 | 304.6 | — | — | 4 | LEAN BEAR | -86.5 |
| ENDV Endonovo Therapeutics, Inc. | — | -0.2 | 9.2 | 4.5 | — | -100.0 | 3 | LEAN BEAR | -50.0 |
| APLMW Apollomics, Inc. | $170M | -2.6 | -233.7 | 845.7 | 1188.0 | -75.9 | 3 | LEAN BEAR | -56.5 |
| ARMP Armata Pharmaceuticals, Inc. | $140M | -0.7 | 127.8 | -54.7 | 2953.8 | -35.1 | 2 | LEAN BEAR | -42.4 |
| EQ Equillium, Inc. | $80M | -5.3 | -59.0 | 2703.6 | — | -100.0 | 3 | LEAN BEAR | -3.5 |
| KPTI Karyopharm Therapeutics Inc. | $10M | -0.0 | 79.0 | 36.3 | -200.5 | 6.8 | 2 | LEAN BEAR | -92.4 |
| LEXX Lexaria Bioscience Corp. | $10M | -0.6 | -150.3 | -504.2 | — | -68.5 | 4 | LEAN BEAR | -78.8 |
| ADXN Addex Therapeutics Ltd | — | -0.4 | -150.5 | -168.4 | -17543.0 | -48.1 | 2 | LEAN BEAR | -68.8 |
| REPCF RepliCel Life Sciences Inc. | — | -9.4 | -248.8 | -13.9 | -80.9 | 200.0 | 6 | LEAN BEAR | 0.0 |
| IMVIF IMV Inc. | — | -0.2 | -503.3 | -2870.5 | — | — | 1 | LEAN BEAR | 1900.0 |
| JUNS Jupiter Neurosciences, Inc. | — | -0.1 | -1888.7 | 5586.0 | -9380.9 | — | 3 | LEAN BEAR | -97.7 |
| MCET MultiCell Technologies, Inc. | — | -0.1 | 101.2 | 99.1 | -81.8 | 1532.7 | 5 | LEAN BEAR | 900.0 |
| SRBCF Sirona Biochem Corp. | — | -0.7 | 111.4 | 1025.7 | -34808.5 | -119.4 | 2 | LEAN BEAR | -50.5 |
| NKGN NKGen Biotech, Inc. | — | -0.0 | 150.9 | — | -4511.3 | — | 3 | LEAN BEAR | -47.5 |
| SLGL Sol-Gel Technologies Ltd. | $230M | -12.1 | -35.9 | -228.0 | 36.4 | 282.9 | 3 | LEAN BEAR | 74.8 |
| MMIRF MedMira Inc. | $30M | -11.4 | 11.8 | 21.7 | -200.5 | 45.7 | 4 | LEAN BEAR | -20.4 |
| JBIO Jade Biosciences, Inc. | $930M | -5.4 | -47.8 | 629.9 | — | — | 3 | LEAN BEAR | 47.4 |
| CGEM Cullinan Therapeutics, Inc. | $880M | -4.4 | -50.3 | 1635.6 | — | — | 1 | LEAN BEAR | 91.2 |
| ACRS Aclaris Therapeutics, Inc. | $550M | -6.5 | -59.1 | -206.5 | -1320.1 | -51.0 | 3 | LEAN BEAR | 76.3 |
| IFRX InflaRx N.V. | $230M | -3.1 | -38.5 | 251.5 | — | -106.2 | 4 | LEAN BEAR | 18.6 |
| LYRA Lyra Therapeutics, Inc. | — | -0.0 | -6595.0 | -671.6 | -99300.0 | -74.1 | 4 | LEAN BEAR | -97.6 |
| PARD Poniard Pharmaceuticals, Inc. | — | -0.0 | -210.4 | -442.5 | — | — | 3 | LEAN BEAR | 0.0 |
| LADX LadRx Corporation | — | -0.0 | 278.9 | 118.4 | — | -61.0 | 1 | LEAN BEAR | -99.0 |
| ADRX ADARx Pharmaceuticals, Inc. | $1.9B | — | — | — | — | — | — | LEAN BEAR | — |
| AOBI American Oriental Bioengineering, Inc. | — | -0.0 | -28.2 | -16.5 | -118.1 | -10.2 | 3 | LEAN BEAR | 983.3 |
| HSTC HST Global, Inc. | $210M | -538.5 | -2.5 | -1.2 | -13.7 | 564.0 | 5 | LEAN BEAR | 349900.0 |
| DBVT DBV Technologies S.A. | $230M | -2.6 | -142.6 | -2201.5 | — | -100.0 | 2 | LEAN BEAR | -34.3 |
| RNA Atrium Therapeutics, Inc. | $140M | -2.2 | -36.9 | 455.9 | -672.0 | 235.3 | 5 | LEAN BEAR | -82.9 |
| ADAPY Adaptimmune Therapeutics plc | $10M | -0.1 | -1341.1 | 268.4 | -221.8 | -54.0 | 0 | LEAN BEAR | -55.3 |
| PBIGF Paradigm Biopharmaceuticals Limited | $10M | -1.6 | -456.6 | 1081.8 | -60158.9 | 53.6 | 4 | LEAN BEAR | -96.1 |
| FPMI FluoroPharma Medical, Inc. | — | -0.0 | 22.7 | 39.7 | — | — | 2 | LEAN BEAR | 100.0 |
| PREDQ Predictive Discovery Limited | — | — | — | — | — | — | — | LEAN BEAR | — |
| GBLX GB Sciences, Inc. | — | -0.0 | 19.5 | 17.2 | -103.2 | — | 3 | LEAN BEAR | -75.0 |
| IMMB Immunotech Laboratories, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 100.0 |
| FENC Fennec Pharmaceuticals Inc. | $350M | -81.7 | -18.6 | -76.2 | 11.0 | 77.8 | 6 | LEAN BEAR | 18.1 |
| INBX Inhibrx Biosciences Inc. | $1.4B | -10.8 | -1773.6 | 55.8 | — | -100.0 | 4 | LEAN BEAR | 67.0 |
| KARD Kardigan, Inc. | $1.1B | — | — | — | — | — | — | LEAN BEAR | — |
| YDES YD Bio Limited Ordinary Shares | $350M | — | — | — | — | — | — | LEAN BEAR | -64.9 |
| FATE Fate Therapeutics, Inc. | $250M | -2.0 | -60.7 | -140.1 | -1448.6 | -23.4 | 2 | LEAN BEAR | 115.1 |
| BDTX Black Diamond Therapeutics, Inc. | $110M | -2.4 | -37.2 | -1604.9 | — | -100.0 | 1 | LEAN BEAR | -55.5 |
| NTHI Neonc Technologies Holdings, Inc. | $90M | — | — | — | — | — | — | LEAN BEAR | -66.1 |
| SGMOQ Sangamo Therapeutics, Inc. | $50M | — | — | — | — | — | — | LEAN BEAR | — |
| ENVB Enveric Biosciences, Inc. | $10M | -0.1 | -170.0 | 3225.6 | — | — | 4 | LEAN BEAR | -80.8 |
| NNLX NanoLogix, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -20.0 |
| CLAZF Claritas Pharmaceuticals, Inc. | — | 0.0 | -170.1 | 15.9 | — | — | 3 | LEAN BEAR | 0.0 |
| NNBP Nanobac Pharmaceuticals, Incorporated | — | 0.0 | 358.0 | 221.2 | -26718.6 | -92.2 | 3 | LEAN BEAR | 0.0 |
| PZRXQ PhaseRx, Inc. | — | -0.0 | -228.2 | 8803.4 | — | — | 2 | LEAN BEAR | 0.0 |
| GWIN Glorywin Entertainment Group, Inc. | $360M | -26081.4 | 11.7 | 5.1 | — | — | 1 | LEAN BEAR | 229.5 |
| FGHQF Frontage Holdings Corporation | $360M | 36.5 | 3.1 | 3.0 | 4.6 | 9.8 | 7 | LEAN BEAR | 16.8 |
| KNTPF Kintor Pharmaceutical Limited | $120M | -3.0 | -116.6 | -74.4 | -145.6 | 2237.9 | 3 | LEAN BEAR | -10.2 |
| LVCLF Algorae Pharmaceuticals Limited | $20M | -5.1 | -47.4 | -24288.6 | — | -100.0 | 3 | LEAN BEAR | 51.6 |
| BCLI Brainstorm Cell Therapeutics Inc. | $10M | -0.8 | 119.2 | 76.7 | — | -100.0 | 1 | LEAN BEAR | 12.7 |
| CMND Clearmind Medicine Inc. | — | -0.1 | -104.0 | 593.4 | — | — | 2 | LEAN BEAR | -99.8 |
| VINC Vincerx Pharma, Inc. | — | -0.0 | -3136.4 | 910.2 | — | -18.7 | 5 | LEAN BEAR | -53.1 |
| FORU ForU Holdings, Inc. | — | -0.0 | 759.2 | -476.4 | — | -100.0 | 2 | LEAN BEAR | 100.0 |
| CHNXF ChitogenX Inc. | — | -0.2 | 23.2 | 36.2 | — | — | 2 | LEAN BEAR | 586.4 |
| HLSQ Tessera Defense and Homeland Security Inc | — | — | — | — | — | — | — | LEAN BEAR | — |
| NURPF Neuren Pharmaceuticals Limited | $1.8B | 121.2 | 6.2 | 22.4 | 14.6 | -68.5 | 5 | LEAN BEAR | 20.8 |
| CUBT Curative Biotechnology, Inc. | — | -2.0 | 31.0 | 15.3 | — | — | 4 | LEAN BEAR | 8.5 |
| KZIA Kazia Therapeutics Ltd ADR | $10M | -1.1 | -104.5 | 62.7 | — | -99.2 | 4 | LEAN BEAR | 17.1 |
| LIANY LianMedical | — | 1.3 | 74.7 | -612.1 | — | — | 6 | LEAN BEAR | -28.6 |
| TSHA Taysha Gene Therapies, Inc. | $1.3B | -10.1 | -47.1 | 961.0 | — | -32.3 | 3 | BEARISH | -10.5 |
| ARVN Arvinas, Inc. | $470M | 39.2 | 1.6 | -519.3 | 67.8 | -15.0 | 4 | BEARISH | -19.1 |
| CAMP CAMP4 Therapeutics Corporation | $210M | -1.6 | -545.9 | 48.4 | -1884.8 | 40.2 | 2 | BEARISH | -1.9 |
| CARM Carisma Therapeutics, Inc. | — | 0.0 | -134.1 | -376.4 | 98.8 | 159.7 | 3 | BEARISH | -99.2 |
| TRVN Trevena, Inc. | — | -0.0 | 344.3 | -3198.4 | -1745.2 | -82.9 | 3 | BEARISH | -7.5 |
| PKTX ProtoKinetix, Incorporated | — | -1.0 | -117.2 | -115.0 | — | — | 2 | BEARISH | -95.4 |
| PBMWW Psyence Biomedical Ltd. Warrant | — | — | — | — | — | — | — | BEARISH | -58.1 |
| INNMF Amplia Therapeutics Limited | $30M | -4.9 | -24.9 | -86.9 | — | -100.0 | 2 | BEARISH | -35.3 |
| IMUC EOM Pharmaceuticals Holdings, Inc. | $10M | -4.9 | 64.4 | 131.0 | — | — | 4 | BEARISH | -42.8 |
| BXRXQ Baudax Bio, Inc. | — | — | — | — | — | — | — | BEARISH | 900.0 |
| AAGH America Great Health | — | 2.0 | -12.2 | 22.4 | -635.8 | -5.1 | 4 | BEARISH | 33.3 |
| SNBIF SanBio Company Limited | $1.3B | -19.9 | -55.8 | -2935.2 | — | — | 3 | BEARISH | 0.0 |
| OVID Ovid Therapeutics Inc. | $420M | -4.7 | -26.0 | -43.7 | -2047.6 | -76.2 | 3 | BEARISH | 38.6 |
| RZLT Rezolute, Inc. | $370M | -5.4 | -59.0 | 1060.6 | — | — | 2 | BEARISH | -55.3 |
| MDWD MediWound Ltd. | $150M | -7.8 | -72.4 | -255.1 | -239.1 | -40.3 | 2 | BEARISH | -31.9 |
| CSBR Champions Oncology, Inc. | $70M | -61.1 | -30.7 | -7.8 | -2.8 | 6.7 | 3 | BEARISH | -29.9 |
| DTCFF Defence Therapeutics Inc. | $20M | -3.8 | -237.8 | -86.8 | — | — | 4 | BEARISH | -53.1 |
| MRKR Marker Therapeutics, Inc. | $20M | -2.0 | -76.9 | -1014.3 | — | -77.1 | 2 | BEARISH | -7.6 |
| XCUR Exicure, Inc. | $10M | -0.8 | -168.4 | 779.8 | — | — | 2 | BEARISH | -78.0 |
| HAVLF HAVN Life Sciences Inc. | — | -0.0 | -275.3 | -163.4 | 5734.1 | 876.8 | 3 | BEARISH | 0.0 |
| PSYBF PsyBio Therapeutics Corp | — | -0.0 | 344.6 | 135.0 | — | — | 2 | BEARISH | -90.0 |
| TLOG TetraLogic Pharmaceuticals Corporation | — | -0.0 | 382.3 | 479.8 | — | — | 1 | BEARISH | 0.0 |
| MRZM Marizyme, Inc. | — | -0.0 | 117.5 | -190.1 | — | -69.0 | 3 | BEARISH | 0.0 |
| VRCI Verde Science, Inc. | — | -0.0 | 72.3 | 23.0 | — | — | 5 | BEARISH | 100.0 |
| HLUN HEALTHeUNIVERSE, Inc. | — | — | — | — | — | — | — | BEARISH | 900.0 |
| SNNAQ Sienna Biopharmaceuticals, Inc. | — | -0.0 | -140.9 | -331.4 | — | — | 2 | BEARISH | 0.0 |
| IBOGF Universal Ibogaine Inc. | — | -0.5 | -94.8 | 5.5 | -9.4 | 208.2 | 4 | BEARISH | -98.4 |
| NTII Neurobiological Technologies, Inc. | — | 0.0 | 48.7 | 441.6 | 89.7 | 99.7 | 4 | BEARISH | 0.0 |
| GLSHQ Gelesis Holdings, Inc. | — | -0.0 | 391.0 | -233.6 | -693.9 | -45.8 | 3 | BEARISH | 0.0 |
| CMRA Comera Life Sciences Holdings, Inc. | — | -0.0 | 235.6 | 124.2 | -1580.0 | 81.8 | 4 | BEARISH | 0.0 |
| TRVI Trevi Therapeutics, Inc. | $1.8B | -39.5 | -19.7 | -1451.7 | — | — | 3 | BEARISH | 27.0 |
| QURE uniQure N.V. | $1.6B | -6.0 | -157.6 | 37.9 | -1387.8 | 30.2 | 4 | BEARISH | -60.2 |
| BPMUF Basilea Pharmaceutica AG | $960M | 16.9 | 39.5 | 75.9 | 23.5 | 4.5 | 7 | BEARISH | 27.1 |
| DNA Ginkgo Bioworks Holdings, Inc. | $670M | -2.2 | -56.3 | -44.0 | -231.7 | -51.5 | 2 | BEARISH | -16.9 |
| INKT MiNK Therapeutics, Inc. | $50M | -4.4 | 57.9 | 42.8 | — | — | 4 | BEARISH | -29.0 |
| CURX Curanex Pharmaceuticals Inc Common Stock | $10M | -0.6 | -218.7 | -392.2 | — | — | 1 | BEARISH | -64.0 |
| SYGGF Synairgen plc | — | -0.2 | -71.9 | -381.4 | — | — | 1 | BEARISH | -50.0 |
| RAPP Rapport Therapeutics, Inc. Common Stock | $1.2B | -9.1 | -40.0 | 3981.5 | — | — | 4 | BEARISH | 6.2 |
| ATGGF Actinogen Medical Limited | $140M | -8.5 | -77.5 | -235.8 | — | -100.0 | 1 | BEARISH | 17.2 |
| NRXP NRx Pharmaceuticals, Inc. | $110M | -3.6 | 131.2 | 61.3 | -1500.5 | — | 5 | BEARISH | -14.6 |
| SQZB SQZ Biotechnologies Company | — | -0.0 | -203.4 | -410.2 | — | -44.6 | 0 | BEARISH | 4.3 |
| MEOBF Mesoblast Limited | $2.0B | -30.0 | -9.9 | -14.4 | -23.4 | 613.8 | 5 | BEARISH | -20.0 |
| CEROW CERo Therapeutics Holdings, Inc. | — | -0.0 | 101.5 | 60.5 | — | -100.0 | 1 | BEARISH | -75.2 |
| BCRX BioCryst Pharmaceuticals, Inc. | $1.9B | -5.6 | 87.8 | 62.3 | 35.9 | 68.7 | 5 | BEARISH | 12.5 |
| APMD Apnimed, Inc. | $790M | — | — | — | — | — | — | BEARISH | — |
| STTK Shattuck Labs, Inc. | $550M | -11.3 | -39.2 | -29.3 | — | -66.6 | 4 | BEARISH | 200.5 |
| BNTC Benitec Biopharma Inc. | $300M | -8.9 | -33.2 | 1840.8 | — | — | 3 | BEARISH | -35.5 |
| ELDN Eledon Pharmaceuticals, Inc. | $190M | -2.4 | -110.7 | 411.1 | — | — | 2 | BEARISH | -30.8 |
| CHRS Coherus Oncology, Inc. | $160M | -1.0 | -145.4 | 1854.0 | -144.2 | -64.3 | 2 | BEARISH | -35.1 |
| FHTX Foghorn Therapeutics Inc. | $120M | -2.1 | 81.9 | 26.3 | -44.7 | 52.0 | 4 | BEARISH | -49.6 |
| MAIA MAIA Biotechnology, Inc. | $70M | -1.8 | -218.7 | 330.4 | — | — | 3 | BEARISH | -18.2 |
| AURX Nuo Therapeutics, Inc. | $60M | -31.1 | 170.6 | 280.3 | -15.7 | 166.6 | 3 | BEARISH | -47.8 |
| RNTX Rein Therapeutics Inc. | $50M | -0.4 | -753.6 | 53.9 | — | — | 3 | BEARISH | -51.1 |
| ELTX Elicio Therapeutics, Inc. | $40M | -0.9 | -774.6 | 2147.3 | — | — | 4 | BEARISH | -81.1 |
| JSPR Jasper Therapeutics, Inc. | $20M | -0.3 | -255.0 | 773.9 | — | — | 2 | BEARISH | -78.1 |
| GDTC CytoMed Therapeutics Limited | $10M | -2.6 | -66.1 | -87.8 | -1125.6 | -11.3 | 0 | BEARISH | -62.8 |
| NCNA NuCana plc | $10M | -0.3 | -70.7 | -739.9 | — | — | 4 | BEARISH | -74.2 |
| BIXT Bioxytran, Inc. | — | -0.7 | 92.2 | 68.7 | — | — | 4 | BEARISH | -56.8 |
| ITMC Itoco Inc. | — | -0.0 | 303.4 | 96.7 | — | — | 2 | BEARISH | 0.0 |
| RLFTY MindMaze Therapeutics Holding S.A. | — | -4.6 | -36.8 | -30.3 | -1182.3 | -95.8 | 2 | BEARISH | -95.4 |
| JAGX Jaguar Health, Inc. | — | -0.0 | -501.9 | -118.9 | -1035.3 | 135.5 | 4 | BEARISH | -99.8 |
| HTDS Hard to Treat Diseases Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PPTDF PeptiDream Inc. | $870M | -39.2 | -7.1 | -9.6 | -25.7 | 47.8 | 4 | BEARISH | -38.7 |
| TRDA Entrada Therapeutics, Inc. | $170M | -1.1 | -54.1 | -236.6 | -4762.0 | -94.1 | 1 | BEARISH | -35.4 |
| MRES Institute of Biomedical Research Corp. | — | -2.3 | 301783.0 | -6062.7 | — | — | 1 | BEARISH | -81.2 |
| ERNA Ernexa Therapeutics Inc. | — | -0.1 | -320.7 | 626.9 | — | -100.0 | 5 | BEARISH | -93.6 |
| CSPHF CStone Pharmaceuticals | $1.4B | -15.3 | -51.4 | -340.2 | -123.0 | 135.6 | 5 | BEARISH | -15.4 |
| DRTSW Alpha Tau Medical Ltd. | $1.2B | -13.0 | -141.7 | -17.1 | — | — | 3 | BEARISH | 807.7 |
| RLYB Rallybio Corporation | $90M | 3.5 | 34.5 | -1198.7 | — | -35.6 | 6 | BEARISH | 2511.5 |
| AEON AEON Biopharma, Inc. | $10M | -0.1 | 350.0 | 98.0 | — | — | 2 | BEARISH | -73.5 |
| LSTA Lisata Therapeutics, Inc. | $10M | -0.6 | -99.9 | 590.1 | — | -90.7 | 2 | BEARISH | -56.6 |
| PFND Pathfinder Cell Therapy, Inc. | — | -0.0 | 22.4 | 46.3 | — | — | 2 | BEARISH | 0.0 |
| CDXI Cardax, Inc. | — | -0.0 | 81.1 | 38.5 | -1740.8 | -27.3 | 2 | BEARISH | 0.0 |
| ADYX Adynxx, Inc. | — | -0.0 | 1148.3 | 259.7 | — | -95.1 | 2 | BEARISH | 0.0 |
| PANC Panacos Pharmaceuticals, Inc. | — | -0.0 | -168.8 | -792.8 | -33966.7 | -45.9 | 1 | BEARISH | 0.0 |
| SYVC Synovics Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PROT Proteonomix, Inc. | — | -0.0 | 77.5 | -1239.4 | — | -63.1 | 4 | BEARISH | 0.0 |
| NBIO Nascent Biotech, Inc. | — | -0.0 | 230.6 | 328.8 | — | — | 5 | BEARISH | -75.0 |
| SIGY Sigyn Therapeutics, Inc. | — | -0.0 | 61.7 | 32.8 | — | -100.0 | 1 | BEARISH | -98.5 |
| ONCO Onconetix, Inc. | — | -0.1 | -105.2 | -83.7 | -16748.3 | -51.3 | 3 | BEARISH | -86.8 |
| RNUGF ReNeuron Group plc | — | -0.0 | -106.8 | 210.1 | -1809.6 | -68.2 | 1 | BEARISH | 0.0 |
| BRAXF Braxia Scientific Corp. | — | -0.1 | -254.6 | -2393.3 | -184.2 | 27.6 | 3 | BEARISH | -99.9 |
| WHWK Whitehawk Therapeutics Inc | $180M | -3.0 | -45.0 | 963.4 | — | -100.0 | 1 | BEARISH | 38.2 |
| ATRA Atara Biotherapeutics, Inc. | $90M | -7.0 | 46.3 | 30.3 | -767.3 | -96.7 | 2 | BEARISH | -42.7 |
| HNSBF Hansa Biopharma AB (publ) | $330M | -4.6 | 159.8 | 1182.7 | -541.7 | -3.7 | 2 | BEARISH | -28.2 |
| VICP Vicapsys Life Sciences, Inc. | $10M | -20.5 | 31.3 | 17.6 | — | — | 5 | BEARISH | -73.3 |
| VOGX Vogenx Inc. | $260M | — | — | — | — | — | — | BEARISH | — |
| CASIF CASI Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| IDRSF Idorsia Ltd | $1.4B | -3.5 | 27.1 | -344.5 | -203.1 | -8.1 | 1 | BEARISH | 19.6 |
| VBIZF Viva Biotech Holdings | $400M | 13.3 | 4.5 | 4.2 | 8.0 | 2.9 | 7 | BEARISH | -35.1 |
| RCKT Rocket Pharmaceuticals, Inc. | $250M | -15.3 | -4.8 | -137.8 | — | — | 3 | BEARISH | -36.4 |
| CRVS Corvus Pharmaceuticals, Inc. | $890M | -16.5 | -35.4 | -415.6 | — | — | 4 | BEARISH | 43.4 |
| SVRA Savara Inc. | $870M | -8.4 | -105.5 | -15438.9 | — | — | 2 | BEARISH | 11.5 |
| IMRX Immuneering Corporation | $240M | -3.7 | -52.1 | -112.8 | — | — | 4 | BEARISH | -36.6 |
| PMN ProMIS Neurosciences, Inc. | $70M | -0.6 | -172.3 | 844.3 | — | — | 2 | BEARISH | -10.3 |
| IMTX Immatics N.V. | $1.1B | -4.1 | -47.8 | -858.3 | -683.4 | -68.0 | 2 | BEARISH | -28.7 |
| KURA Kura Oncology, Inc. | $850M | -2.9 | -167.7 | 56.3 | -327.3 | -7.3 | 1 | BEARISH | 2.1 |
| ATTO Attovia Therapeutics, Inc. | $630M | -16.1 | -294.4 | -1137.2 | -4597.1 | -50.5 | 4 | BEARISH | 272.2 |
| OCS Oculis Holding AG | $490M | -4.6 | -44.0 | -31.0 | — | -6.9 | 3 | BEARISH | -63.1 |
| DYAI Dyadic International, Inc. | $20M | -1.8 | 522.6 | 1288.0 | -221.0 | 1.5 | 3 | BEARISH | -65.5 |
| DVHGF Devonian Health Group, Inc. | $20M | — | -76.1 | -75.1 | -1098.1 | -91.5 | 1 | BEARISH | 37.7 |
| ALLR Allarity Therapeutics, Inc. | $10M | -1.2 | -157.1 | -96.5 | — | — | 2 | BEARISH | -33.8 |
| SCPS Scopus BioPharma Inc. | — | -0.0 | 132.3 | 53.6 | — | — | 2 | BEARISH | 33.3 |
| BIORQ Biora Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| BITRF Biotron Limited | — | -3.6 | -87.5 | -87.8 | -113.4 | -71.0 | 0 | BEARISH | -90.7 |
| THER Theralink Technologies, Inc. | — | -0.0 | 6.0 | -69.7 | 5363.6 | 32.8 | 2 | BEARISH | 0.0 |
| AURA Aura Biosciences, Inc. | $650M | -3.5 | -53.5 | -1360.0 | — | — | 4 | BEARISH | 7.5 |
| TTRX Turn Therapeutics Inc. | $310M | -35.8 | -952.4 | 115.0 | — | — | 2 | BEARISH | 105.1 |
| ARCT Arcturus Therapeutics Holdings Inc. | $280M | -3.4 | -46.3 | -2501.0 | -803.8 | -79.1 | 1 | BEARISH | 0.1 |
| SPHRY Starpharma Holdings Limited | $220M | -26.9 | -46.5 | -441.4 | -725.1 | 186.8 | 4 | BEARISH | 73.3 |
| BETRF BetterLife Pharma Inc. | $110M | -10.2 | 34.9 | 21.6 | — | — | 4 | BEARISH | 243.4 |
| NTRB Nutriband Inc. | $70M | -10.4 | -100.7 | -264.9 | -201.3 | -37.3 | 3 | BEARISH | -16.8 |
| HRGN Harvard Apparatus Regenerative Technology Inc. | $30M | -4.9 | 239.0 | 256.6 | -409.4 | — | 2 | BEARISH | — |
| PVCT Provectus Biopharmaceuticals, Inc. | $20M | -4.3 | 78.1 | 83.4 | — | -100.0 | 5 | BEARISH | -33.9 |
| APUS Apimeds Pharmaceuticals US, Inc | — | -0.1 | -100.1 | -12.6 | — | — | 2 | BEARISH | -85.1 |
| ERNAW Ernexa Therapeutics Inc. Warrants | — | — | — | — | — | — | — | BEARISH | — |
| RNAZ TransCode Therapeutics, Inc. | — | -0.0 | -59.2 | -21.0 | — | — | 1 | BEARISH | -87.5 |
| VRPX Virpax Pharmaceuticals, Inc. | — | -0.0 | 2.6 | 0.4 | — | — | 1 | BEARISH | -96.2 |
| VRAX Virax Biolabs Group Limited | — | -0.0 | -110.9 | -481.7 | -40439.1 | 121.6 | 4 | BEARISH | 103.4 |
| SCNI Scinai Immunotherapeutics Ltd. | — | -0.0 | -19.2 | -53.3 | -435.4 | 162.7 | 2 | BEARISH | -63.6 |
| GHRS GH Research PLC | $1.2B | -20.0 | -18.8 | 2015.5 | — | — | 2 | BEARISH | 43.5 |
| ABUS Arbutus Biopharma Corp | $830M | 5.4 | 89.6 | 86.7 | -507.2 | 1078.8 | 4 | BEARISH | -1.6 |
| QTTB Q32 Bio Inc. | $260M | 3.1 | 72.1 | 435.2 | — | — | 5 | BEARISH | 193.3 |
| HOPHF Hemogenyx Pharmaceuticals Plc | $20M | -3.7 | -628.5 | -474.6 | — | — | 4 | BEARISH | 0.0 |
| ANL Adlai Nortye Ltd. | $560M | -5.5 | -22.4 | -317.5 | -36.3 | 223.4 | 4 | BEARISH | 549.1 |
| ARTV Artiva Biotherapeutics, Inc. | $300M | -1.3 | -36.6 | -954.6 | — | — | 3 | BEARISH | -21.1 |
| PLX Protalix BioTherapeutics, Inc. | $210M | 10.5 | 31.2 | 47.1 | 19.0 | 30.1 | 5 | BEARISH | 7.2 |
| FBIOP Fortress Biotech, Inc. | $130M | 0.6 | 107.5 | -87.8 | -2.5 | 15.5 | 6 | BEARISH | 131.0 |
| ALZN Alzamend Neuro Inc | $10M | -0.5 | -163.2 | 401.5 | — | — | 1 | BEARISH | -54.6 |
| XBIO Xenetic Biosciences, Inc. | — | -1.5 | -47.0 | 523.4 | -140.7 | 33.3 | 4 | BEARISH | -54.6 |
| AFFY Affymax, Inc. | — | -0.0 | 98.1 | -302.0 | 17164.3 | -99.9 | 5 | BEARISH | -11.1 |
| PLYX Polaryx Therapeutics, Inc. Common Stock | $90M | -15.4 | -35.9 | 437.3 | — | — | 2 | BEARISH | — |
| SYRS Syros Pharmaceuticals, Inc. | — | -0.0 | -777.0 | 960.6 | — | -90.5 | 0 | BEARISH | 0.0 |
| MLYS Mineralys Therapeutics, Inc. | $1.8B | -5.0 | -80.9 | 2274.6 | — | — | 2 | BEARISH | -47.0 |
| GENB Generate Biomedicines, Inc. | $1.6B | -7.8 | -28.2 | -175.0 | -1065.2 | — | 1 | BEARISH | — |
| CMPS COMPASS Pathways plc | $1.6B | -2.1 | -319.1 | 48.8 | — | — | 2 | BEARISH | 88.1 |
| NKTR Nektar Therapeutics | $1.1B | -5.7 | -35.8 | -29.2 | -401.0 | -27.2 | 3 | BEARISH | -36.8 |
| AVBP ArriVent BioPharma, Inc. | $1.0B | -4.2 | -53.1 | 2345.1 | — | — | 3 | BEARISH | -17.2 |
| ALMS Alumis Inc. | $880M | -1.7 | -93.6 | 2645.2 | -8557.2 | -63.1 | 2 | BEARISH | 47.2 |
| SANA Sana Biotechnology, Inc. | $700M | -3.3 | -152.9 | -242.3 | — | — | 3 | BEARISH | -55.8 |
| FULC Fulcrum Therapeutics, Inc. | $280M | -3.1 | -32.4 | 2389.1 | — | — | 4 | BEARISH | -59.9 |
| IPSC Century Therapeutics, Inc. | $260M | -1.4 | -49.7 | -60.0 | — | -100.0 | 2 | BEARISH | 151.2 |
| TARA Protara Therapeutics, Inc. | $140M | -1.8 | -45.8 | -41.3 | — | — | 2 | BEARISH | -51.6 |
| OTLK Outlook Therapeutics, Inc. | $130M | -0.5 | 256.9 | 1372.0 | -225766.7 | -169.4 | 3 | BEARISH | -61.9 |
| VERU Veru Inc. | $40M | -3.8 | -62.3 | -211.2 | — | -100.0 | 3 | BEARISH | -40.0 |
| SEOVF Sernova Corp. | $30M | -3.7 | 57.0 | 76.3 | — | — | 3 | BEARISH | -35.6 |
| AKTX Akari Therapeutics, Plc | $20M | -0.0 | -139.9 | -175.8 | — | — | 3 | BEARISH | -71.0 |
| SNANF Sona Nanotech Inc. | $20M | -12.9 | 526.4 | 252.2 | — | — | 1 | BEARISH | -58.7 |
| SNTI Senti Biosciences, Inc. | $10M | -0.1 | -466.5 | -430.9 | -75000.0 | — | 2 | BEARISH | -91.0 |
| PLRZ Polyrizon Ltd. | $10M | -1.9 | -21.4 | -68.2 | — | — | 0 | BEARISH | 39.6 |
| ANEB Anebulo Pharmaceuticals, Inc. | $10M | -1.7 | -69.7 | 650.7 | — | — | 1 | BEARISH | -90.5 |
| LTRN Lantern Pharma Inc. | $10M | -0.4 | -400.9 | 115.9 | — | — | 2 | BEARISH | -84.3 |
| HMTXF Hemostemix Inc. | $10M | -2.0 | 69.9 | 190.1 | — | — | 1 | BEARISH | -44.5 |
| ADIL Adial Pharmaceuticals, Inc. | $10M | -0.2 | -2011.6 | 159.6 | — | — | 3 | BEARISH | -58.8 |
| SLXN Silexion Therapeutics Ltd. | — | -0.0 | -17022.0 | -931.4 | — | — | 3 | BEARISH | -95.0 |
| LIPO Lipella Pharmaceuticals Inc. | — | -0.0 | -361.8 | 4105.8 | — | -64.1 | 1 | BEARISH | -99.9 |
| EVGN Evogene Ltd. | — | -0.4 | 265.3 | 101.3 | -509.5 | -80.4 | 3 | BEARISH | -69.6 |
| AMPE Ampio Pharmaceuticals, Inc. | — | -0.0 | -114.0 | 1652.6 | -838.4 | — | 4 | BEARISH | 5806.4 |
| AMBS Amarantus BioScience Holdings, Inc. | — | -0.0 | 7.3 | 3.8 | -4080.5 | — | 3 | BEARISH | -66.7 |
| ANTH Anthera Pharmaceuticals, Inc. | — | -0.0 | -251.4 | 1107.5 | — | — | 1 | BEARISH | 0.0 |
| ATRX Adhera Therapeutics Inc | — | -0.0 | 18.6 | 6.5 | — | — | 1 | BEARISH | 0.0 |
| ORIC ORIC Pharmaceuticals, Inc. | $1.4B | -6.7 | -39.8 | -102.9 | — | — | 3 | BEARISH | -31.3 |
| IMRN Immuron Limited | $10M | -2.7 | -40.2 | -187.8 | -54.4 | -29.7 | 5 | BEARISH | -56.7 |
| BCTXZ BriaCell Therapeutics Corp. Warrant | — | -0.3 | -168.1 | -2016.9 | — | — | 1 | BEARISH | -68.2 |
| ANRO Alto Neuroscience, Inc. | $860M | -9.4 | -49.2 | -201.4 | — | — | 3 | BEARISH | 110.7 |
| DSGN Design Therapeutics, Inc. | $640M | -9.0 | -34.1 | 1787.8 | — | — | 1 | BEARISH | 85.5 |
| BRIBF Brii Biosciences Limited | $90M | -3.4 | -10.3 | -62.6 | — | 22.5 | 4 | BEARISH | -46.0 |
| ELOX Eloxx Pharmaceuticals, Inc. | $40M | -8.8 | -107.5 | 81.5 | — | — | 4 | BEARISH | 13339900.4 |
| AUTL Autolus Therapeutics plc | $410M | -1.5 | -132.9 | 451.5 | -85.6 | 292.0 | 3 | BEARISH | 1.3 |
| BVAXF BioVaxys Technology Corp. | — | -0.9 | 310.6 | 48.4 | — | — | 1 | BEARISH | -45.4 |
| AVLN Avalyn Pharma Inc. Common Stock | $1.1B | — | — | — | — | — | — | BEARISH | — |
| BCAX Bicara Therapeutics Inc. Common Stock | $1.1B | -5.6 | -41.0 | 583.9 | — | — | 2 | BEARISH | 2.0 |
| MNKD MannKind Corporation | $1.0B | -23.6 | 71.4 | 4.0 | -17.4 | 30.5 | 2 | BEARISH | -38.0 |
| GLUE Monte Rosa Therapeutics, Inc. | $920M | -4.9 | -42.7 | 149.9 | -483.9 | -83.9 | 3 | BEARISH | -4.3 |
| WVE Wave Life Sciences Ltd. | $630M | -3.2 | -80.0 | -1243.7 | -470.5 | -35.1 | 4 | BEARISH | -51.6 |
| LRMR Larimar Therapeutics, Inc. | $240M | -1.2 | -139.6 | 590.9 | — | — | 2 | BEARISH | -43.2 |
| ALXO ALX Oncology Holdings Inc. | $160M | -1.0 | -80.6 | -851.1 | — | — | 4 | BEARISH | -37.1 |
| HUMA Humacyte, Inc. | $120M | -0.9 | -547.9 | -500.7 | -9064.5 | -73.6 | 3 | BEARISH | -73.9 |
| IMUX Immunic, Inc. | $100M | -1.6 | -138.2 | 345.6 | — | — | 5 | BEARISH | -0.9 |
| ADAG Adagene Inc. | $90M | -5.5 | -28.6 | 111.8 | -1011.1 | 8927.0 | 5 | BEARISH | 45.8 |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | $70M | -0.7 | -213.1 | 3515.1 | — | — | 4 | BEARISH | -32.0 |
| RECEF Recce Pharmaceuticals Ltd | $70M | -6.0 | 151.4 | 200.5 | — | -100.0 | 2 | BEARISH | -56.0 |
| TENX Tenax Therapeutics, Inc. | $50M | -1.2 | -59.8 | 1235.8 | — | — | 1 | BEARISH | -76.7 |
| CVM CEL-SCI Corporation | $30M | -0.6 | -252.5 | -142.9 | — | -100.0 | 4 | BEARISH | -82.9 |
| ARTL Artelo Biosciences, Inc. | $10M | -0.0 | -705.7 | -1031.2 | — | — | 5 | BEARISH | -92.8 |
| SYBE SYBLEU Inc | — | -3.1 | 71.5 | -202.2 | -685.7 | — | 2 | BEARISH | 0.0 |
| RGRX RegeneRx Biopharmaceuticals, Inc. | — | -0.0 | 53.5 | 45.8 | -2006.3 | -0.0 | 3 | BEARISH | 450.0 |
| BICTF Biocure Technology Inc. | — | -0.1 | -889.9 | 60.0 | — | — | 1 | BEARISH | 0.0 |
| FNAM Evolutionary Genomics, Inc. | — | -0.0 | 62.2 | -99.6 | — | — | 2 | BEARISH | 0.0 |
| WINT Windtree Therapeutics, Inc. | — | -0.0 | 1111.0 | -2375.5 | — | — | 3 | BEARISH | -99.6 |
| INVA Innoviva, Inc. | $1.5B | 4.3 | 36.7 | 15.0 | -69.8 | 19.8 | 7 | BEARISH | 18.2 |
| ACHV Achieve Life Sciences, Inc. | $670M | -4.5 | -845.0 | 24.6 | — | — | 2 | BEARISH | 38.6 |
| EIKN Eikon Therapeutics, Inc. Common Stock | $390M | — | — | — | — | — | — | BEARISH | — |
| TECX Tectonic Therapeutic, Inc. | $390M | -4.5 | -33.8 | -6371.3 | — | — | 1 | BEARISH | 18.6 |
| CLVLF Clinuvel Pharmaceuticals Limited | $250M | 10.6 | 13.2 | 126.7 | 41.1 | -1.1 | 6 | BEARISH | -32.0 |
| RNAC Cartesian Therapeutics, Inc. | $190M | -1.1 | 241.0 | 37.3 | — | 44.0 | 2 | BEARISH | -29.5 |
| NAGE Niagen Bioscience Inc | $190M | 12.9 | 21.8 | 44.7 | 3.2 | 11.0 | 6 | BEARISH | -67.0 |
| VRXA Veraxa Biotech Holding AG | $140M | — | — | — | — | — | — | BEARISH | — |
| CNXU Conexeu Sciences Inc. | $90M | — | — | — | — | — | — | BEARISH | — |
| TNXP Tonix Pharmaceuticals Holding Corp. | $90M | -0.4 | -81.8 | -276.2 | -299.4 | 196.0 | 3 | BEARISH | -72.3 |
| GNLX Genelux Corporation | $90M | -2.3 | -168.9 | 20537.7 | — | — | 2 | BEARISH | -73.8 |
| INO Inovio Pharmaceuticals, Inc. | $60M | -0.8 | -409.9 | 257.7 | — | -100.0 | 1 | BEARISH | -61.8 |
| NDTP NDT Pharmaceuticals Inc. | $50M | -39.2 | -3.8 | -1.5 | -458.3 | — | 4 | BEARISH | -83.3 |
| ONCY Oncolytics Biotech Inc. | $50M | -1.9 | 90135.4 | 285.1 | — | — | 1 | BEARISH | -61.5 |
| CLCS Cell Source, Inc. | $40M | -4.6 | 27.7 | 34.5 | — | — | 4 | BEARISH | 24.0 |
| CNTX Context Therapeutics Inc. | $20M | -0.5 | -76.1 | 841.7 | — | — | 2 | BEARISH | -81.4 |
| RVXCF Resverlogix Corp. | $20M | -1.5 | 11.5 | 25.3 | — | — | 4 | BEARISH | -30.1 |
| NEUP Neuphoria Therapeutics Inc. | $20M | -0.5 | -0.2 | -0.2 | -417.7 | -91.9 | 4 | BEARISH | -45.7 |
| ICU SeaStar Medical Holding Corporation | $10M | -0.6 | -356.9 | 415.0 | -606.5 | 123.6 | 4 | BEARISH | -59.0 |
| PHIO Phio Pharmaceuticals Corp. | $10M | -0.7 | -113.7 | 2701.6 | — | — | 2 | BEARISH | -57.1 |
| LPCN Lipocine Inc. | $10M | -0.8 | -60.9 | 662.3 | -1379.6 | -62.7 | 2 | BEARISH | -49.7 |
| SPRC SciSparc Ltd. | — | -0.0 | -519.9 | -161.9 | -1891.2 | -26.8 | 5 | BEARISH | -78.9 |
| MTNB Matinas BioPharma Holdings, Inc. | — | -0.1 | -154.3 | -504.1 | — | — | 4 | BEARISH | -92.4 |
| BLEG Branded Legacy, Inc. | — | -0.0 | 2011.7 | 147.0 | — | -29.4 | 2 | BEARISH | -99.5 |
| GRI GRI Bio, Inc. | — | -0.0 | -142.0 | 1227.5 | — | — | 5 | BEARISH | -97.2 |
| VCNX Vaccinex, Inc. | — | -0.4 | 776.6 | 414.6 | -1584.0 | 226.6 | 3 | BEARISH | -20.1 |
| LNAI Lunai Bioworks Inc. | — | -0.3 | -21.6 | 30.2 | — | — | 2 | BEARISH | -97.1 |
| DRMA Dermata Therapeutics, Inc. | — | -0.2 | -183.9 | 734.5 | — | — | 2 | BEARISH | -80.8 |
| VIVS VivoSim Labs, Inc. | — | -0.0 | -343.1 | 241.9 | -7433.3 | 202.7 | 2 | BEARISH | -93.5 |
| CDT CDT Equity Inc. | — | -0.0 | 13.1 | 5.4 | 9.1 | — | 7 | BEARISH | -97.3 |
| BRTX BioRestorative Therapies, Inc. | — | -0.1 | -241.1 | 2112.9 | -9298.3 | -8.5 | 3 | BEARISH | -95.7 |
| BBLG Bone Biologics Corporation | — | -0.2 | -47.5 | 1744.6 | — | — | 2 | BEARISH | -83.6 |
| AFMDQ Affimed N.V. | — | — | — | — | — | — | — | BEARISH | — |
| SXTP 60 Degrees Pharmaceuticals, Inc. | — | -0.1 | -321.8 | -390.2 | -1089.2 | 68.0 | 3 | BEARISH | -50.5 |
| LITS Lite Strategy, Inc. | $40M | -0.1 | -170.9 | -28.2 | — | — | 2 | BEARISH | -40.2 |
| DRTS Alpha Tau Medical Ltd | $1.2B | -13.0 | -141.7 | -17.1 | — | — | 3 | BEARISH | 219.4 |
| SLDB Solid Biosciences Inc. | $630M | -3.2 | -65.5 | -1012.6 | — | — | 3 | BEARISH | 10.1 |
| ORMP Oramed Pharmaceuticals Inc. | $170M | 1.0 | 74.1 | -4.3 | — | -100.0 | 4 | BEARISH | 74.1 |
| AMGXF AnGes, Inc. | $140M | -2.9 | -160.6 | -111.8 | -531.3 | -16.1 | 4 | BEARISH | 0.0 |
| ANTX AN2 Therapeutics, Inc. | $130M | -3.6 | -50.1 | 1243.3 | — | — | 2 | BEARISH | 229.9 |
| BBIXF Bonus BioGroup Ltd. | $50M | -17.4 | 3245.0 | 2543.1 | — | — | 2 | BEARISH | 13233.3 |
| INTI Inhibitor Therapeutics, Inc. | $10M | -4.2 | 358.8 | 88.0 | — | — | 1 | BEARISH | 59.8 |
| RMTG Regenerative Medical Technology Group Inc. | — | -0.1 | 9.6 | -3.3 | -72.2 | — | 3 | BEARISH | — |
| MYMX Mymetics Corporation | — | -0.0 | 16.6 | 357.9 | -3012.0 | -62.8 | 2 | BEARISH | 0.0 |
| NWPHF Newron Pharmaceuticals S.p.A. | $410M | -6.7 | 83.9 | -32.1 | -513.4 | — | 1 | BEARISH | — |
| VRXAW Veraxa Biotech AG | — | — | — | — | — | — | — | BEARISH | — |
| SRNE Sorrento Therapeutics, Inc. | — | -0.0 | 1502.8 | 468.4 | -633.7 | 16.9 | 2 | BEARISH | -96.7 |
| OLMA Olema Pharmaceuticals, Inc. | $560M | -3.3 | -52.7 | 585.3 | — | — | 2 | BEARISH | -12.3 |
| CBIO Crescent Biopharma, Inc. | $480M | -1.8 | -107.7 | 1928.6 | — | — | 5 | BEARISH | 4.6 |
| BLSM BlossomHill Therapeutics, Inc. | $430M | — | — | — | — | — | — | BEARISH | — |
| GOSS Gossamer Bio, Inc. | $60M | -0.2 | 178.7 | 117.2 | 182.9 | 32.4 | 3 | BEARISH | -95.1 |
| IBO Impact BioMedical Inc. | $30M | -2.9 | 10.8 | -30.4 | -23300.0 | — | 5 | BEARISH | -50.1 |
| AIM AIM ImmunoTech Inc. | $10M | -0.0 | -2382.3 | -513.5 | -14569.2 | -21.5 | 5 | BEARISH | -93.5 |
| SILO Silo Pharma, Inc. | — | -0.2 | -91.2 | 645.1 | — | -25.0 | 3 | BEARISH | 116.9 |
| LGVN Longeveron Inc. | — | -0.2 | -203.6 | -2062.6 | -2116.0 | -42.7 | 4 | BEARISH | -81.2 |
| BTAIQ BioXcel Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| AAPG Ascentage Pharma Group International | $1.4B | -6.4 | -236.8 | -144.8 | -270.2 | 170.9 | 3 | BEARISH | -58.7 |
| OMER Omeros Corporation | $1.2B | 9.2 | -89.2 | 71.8 | 46.4 | — | 5 | BEARISH | 131.7 |
| ASCLF Ascletis Pharma Inc. | $770M | -8.0 | -28.4 | -7144.0 | — | -60.6 | 2 | BEARISH | -40.0 |
| NVCT Nuvectis Pharma, Inc. | $650M | -14.1 | -214.6 | 174.4 | — | — | 1 | BEARISH | 197.4 |
| FDMT 4D Molecular Therapeutics, Inc. | $600M | -4.4 | -43.3 | -182.0 | -1929.0 | 278712.1 | 4 | BEARISH | 5.5 |
| PHAT Phathom Pharmaceuticals, Inc. | $460M | -4.7 | 26.4 | 8.9 | -23.7 | 110.2 | 4 | BEARISH | -55.7 |
| EPRX Eupraxia Pharmaceuticals Inc. | $450M | -7.0 | -68.6 | 8742.2 | — | — | 3 | BEARISH | 29.4 |
| AGEN Agenus Inc. | $290M | 2.4 | -33.2 | -20.4 | -1.6 | 30.5 | 6 | BEARISH | 60.6 |
| GALT Galectin Therapeutics Inc. | $210M | -7.9 | 21.9 | 99.4 | — | — | 2 | BEARISH | -35.4 |
| CGEN Compugen Ltd. | $180M | 5.2 | 49.6 | -90.2 | -269.3 | 886.7 | 5 | BEARISH | 9.4 |
| SEER Seer, Inc. | $110M | -1.6 | -26.4 | -58.8 | -544.8 | -13.3 | 3 | BEARISH | -15.2 |
| VANI Vivani Medical, Inc. | $100M | -3.3 | -220.4 | -127.1 | — | — | 4 | BEARISH | -29.6 |
| COYA Coya Therapeutics, Inc. | $90M | -3.9 | -60.5 | -18820.6 | -2723.4 | 1793.8 | 4 | BEARISH | -34.6 |
| PMVP PMV Pharmaceuticals, Inc. | $70M | -0.9 | -70.9 | 815.8 | — | — | 2 | BEARISH | -19.9 |
| MNOV MediciNova, Inc. | $70M | -6.5 | -25.6 | -78.2 | -504.8 | 583.9 | 3 | BEARISH | 14.6 |
| HRTX Heron Therapeutics, Inc. | $60M | -1.6 | 334.6 | -7.6 | -14.6 | 1.0 | 3 | BEARISH | -74.9 |
| OSTX OS Therapies Incorporated | $60M | -1.1 | 1924.5 | 268.9 | — | — | 1 | BEARISH | -34.4 |
| SPRO Spero Therapeutics, Inc. | $60M | 8.1 | 19.2 | -128.5 | — | -7.0 | 7 | BEARISH | -48.4 |
| ALPS Alps Group Inc | $50M | — | — | — | — | — | — | BEARISH | — |
| XLO Xilio Therapeutics, Inc. | $50M | -5.4 | -55.0 | 43.1 | -34.1 | 327.3 | 6 | BEARISH | 913.9 |
| MREO Mereo BioPharma Group plc | $40M | -1.6 | -67.8 | 6194.3 | — | -100.0 | 2 | BEARISH | -85.4 |
| CRVO CervoMed Inc. | $30M | -0.7 | -107.6 | 1244.8 | — | — | 2 | BEARISH | -68.6 |
| COCP Cocrystal Pharma, Inc. | $20M | -1.2 | -311.7 | -3697.6 | -3013.3 | — | 2 | BEARISH | -16.9 |
| KPRX Kiora Pharmaceuticals, Inc. | $10M | -0.9 | -56.4 | -2884.1 | — | — | 2 | BEARISH | -10.2 |
| GLWLF Glow Lifetech Corp. | $10M | -50.0 | -11.1 | -21.1 | -26.6 | 59.2 | 5 | BEARISH | -16.1 |
| PASG Passage Bio, Inc. | $10M | -0.3 | -169.1 | 159.0 | — | — | 3 | BEARISH | -53.1 |
| OTLC Oncotelic Therapeutics, Inc. | $10M | 0.0 | 181.4 | -1.4 | 155.3 | — | 5 | BEARISH | -79.2 |
| PHYOF IXICO plc | $10M | -6.0 | -15.8 | -23.6 | -28.5 | 13.2 | 2 | BEARISH | 0.0 |
| CHMMF Chimeric Therapeutics Limited | — | -0.0 | 655.2 | 80.8 | — | -100.0 | 2 | BEARISH | 0.0 |
| CVKD Cadrenal Therapeutics, Inc. Common Stock | — | -0.2 | -275.2 | -540.4 | — | — | 3 | BEARISH | -93.6 |
| AGNPF Grey Matters Health Inc. | — | — | -140.9 | -64.7 | — | — | 3 | BEARISH | -55.6 |
| MAJI Nextel Medical Corp. | — | 0.5 | -2.6 | 42.9 | — | — | 1 | BEARISH | — |
| LIMNW Liminatus Pharma, Inc. Warrants | — | -0.1 | -4165.9 | 252.1 | — | — | 2 | BEARISH | -83.3 |
| RGBPP Regen BioPharma, Inc. | — | -0.0 | 20.3 | 12.8 | -1079.8 | 0.0 | 4 | BEARISH | -98.9 |
| ADTX Aditxt, Inc. | — | -0.0 | 622.6 | 49.4 | -131159.8 | -74.1 | 1 | BEARISH | -100.0 |
| EVLO Evelo Biosciences, Inc. | — | -0.0 | 948.0 | 605.0 | — | — | 2 | BEARISH | -80.0 |
| ISCO International Stem Cell Corporation | — | -2.4 | 30.4 | -10.8 | -2.7 | 3.4 | 6 | BEARISH | 2.4 |
| YECO EV Biologics, Inc. | — | -0.0 | 16.2 | 18.1 | 18.6 | 264.7 | 5 | BEARISH | -99.9 |
| ELAB PMGC Holdings Inc. | — | -0.0 | -73.0 | -66.6 | -225.1 | 408.6 | 3 | BEARISH | -100.0 |
| HMGN Hemagen Diagnostics, Inc. | — | -0.0 | 29.1 | -24.6 | -18.6 | -21.4 | 2 | BEARISH | 100.0 |
| NUVB Nuvation Bio Inc. | $1.6B | -10.5 | -47.8 | 70.2 | -198.3 | 1083.6 | 4 | BEARISH | -6.2 |
| NVAX Novavax, Inc. | $1.6B | -6.6 | 323.7 | 29.2 | -94.2 | -61.6 | 2 | BEARISH | 17.6 |
| MGTX MeiraGTx Holdings plc | $880M | 12.4 | 72.3 | 96.7 | 50.0 | 948.3 | 7 | BEARISH | 7.8 |
| LXRX Lexicon Pharmaceuticals, Inc. | $630M | -9.8 | -40.2 | -99.7 | -4591.8 | -29.0 | 3 | BEARISH | 24.4 |
| CLYM Climb Bio, Inc. | $590M | -11.5 | -27.1 | -88.6 | — | — | 2 | BEARISH | 380.9 |
| MDXG MiMedx Group, Inc. | $570M | 97.5 | 2.9 | 5.8 | -23.1 | -2.4 | 6 | BEARISH | -42.3 |
| MNPR Monopar Therapeutics Inc. | $470M | -30.7 | -19.5 | 523.8 | — | — | 2 | BEARISH | -11.9 |
| AVIR Atea Pharmaceuticals, Inc. | $320M | -2.0 | -58.1 | 974.6 | — | — | 3 | BEARISH | 29.9 |
| PRQR ProQR Therapeutics N.V. | $180M | -3.0 | -57.9 | 139.7 | -99.6 | 12.7 | 2 | BEARISH | -54.0 |
| PYXS Pyxis Oncology, Inc. | $110M | -1.3 | -179.1 | 1953.9 | — | 291.4 | 2 | BEARISH | -46.8 |
| INMB INmune Bio, Inc. | $40M | -2.2 | -74.8 | -475.4 | — | -100.0 | 2 | BEARISH | -20.0 |
| BMEA Biomea Fusion, Inc. | $40M | -1.3 | -164.1 | 210.3 | — | — | 2 | BEARISH | -56.0 |
| TVGN Tevogen Bio Holdings Inc. | $30M | -1.1 | 235.3 | 244.1 | — | — | 5 | BEARISH | 842.5 |
| CELU Celularity Inc. | $30M | -0.4 | 150.9 | 40592.8 | 13.0 | -58.1 | 4 | BEARISH | -61.4 |
| SER Serina Therapeutics, Inc. | $20M | -0.9 | -206.3 | 1868.6 | — | -100.0 | 3 | BEARISH | -67.7 |
| AVEFF Avecho Biotechnology Limited | $20M | -9.3 | -268.2 | 103.4 | -3227.5 | -46.6 | 3 | BEARISH | 0.0 |
| SYBX Synlogic, Inc. | $10M | -19.6 | -5.3 | 306.3 | — | — | 2 | BEARISH | -39.0 |
| CMMB Chemomab Therapeutics Ltd. | $10M | -1.0 | -82.7 | -314.7 | — | — | 1 | BEARISH | -68.6 |
| OZYMF Strategic Partners A/S | — | 19.0 | 0.8 | -117.5 | 1019.0 | — | 6 | BEARISH | 0.0 |
| GNLKQ GeneLink, Inc. | — | -0.0 | 73.0 | 82.1 | -183.0 | -33.6 | 3 | BEARISH | 0.0 |
| GLABF Gemina Laboratories Ltd. | — | -3.0 | 42.7 | 32.4 | -7838.5 | — | 5 | BEARISH | -78.3 |
| HXBM Helix BioMedix, Inc. | — | — | — | — | — | — | — | BEARISH | -6.0 |
| XRTX XORTX Therapeutics Inc. | — | -0.4 | -99.1 | -68.5 | — | — | 3 | BEARISH | 66.6 |
| XTLB XTL Biopharmaceuticals Ltd. | — | -0.6 | -26.8 | -38.7 | -88.2 | — | 3 | BEARISH | 47.1 |
| KRSA Korsana Biosciences, Inc. | $150M | — | — | — | — | — | — | BEARISH | — |
| HBMHF HBM Holdings Limited | $1.3B | 12.9 | 24.1 | 53.0 | 53.0 | 54.6 | 4 | BEARISH | -38.1 |
| GERN Geron Corporation | $720M | -11.5 | -29.2 | -74.1 | -29.0 | 24.4 | 2 | BEARISH | -7.3 |
| SLBT SL Science Holding Ltd | $640M | — | — | — | — | — | — | BEARISH | — |
| GYRE Gyre Therapeutics, Inc. | $620M | -32.8 | -15.6 | -22.3 | -36.4 | 16.8 | 3 | BEARISH | -20.1 |
| ANNX Annexon, Inc. | $610M | -3.2 | -105.3 | -11323.3 | — | — | 2 | BEARISH | 17.1 |
| AGMB AgomAb Therapeutics N.V. American Depositary Shares | $450M | — | — | — | — | — | — | BEARISH | — |
| ASMB Assembly Biosciences, Inc. | $400M | 36.9 | -0.0 | 56.2 | -28.8 | 125.1 | 4 | BEARISH | -30.6 |
| RLMD Relmada Therapeutics, Inc. | $350M | -3.5 | -55.7 | 460.5 | — | — | 3 | BEARISH | 52.9 |
| MPLT MapLight Therapeutics, Inc. | $340M | -1.6 | -57.5 | -366.6 | — | — | 2 | BEARISH | — |
| CTNM Contineum Therapeutics, Inc. | $270M | -5.2 | -28.0 | -541.6 | — | — | 4 | BEARISH | -18.6 |
| LXEO Lexeo Therapeutics, Inc. Common Stock | $230M | -2.5 | -46.8 | -249.1 | — | — | 3 | BEARISH | -68.9 |
| BOVNF BioInvent International AB (publ) | $220M | -2.8 | -88.2 | 20101.5 | -964.0 | -87.2 | 1 | BEARISH | 0.0 |
| BBOT BridgeBio Oncology Therapeutics Inc. | $210M | -0.0 | -56.4 | -157.3 | — | — | 1 | BEARISH | -75.5 |
| MENS Jyong Biotech Ltd. Ordinary Shares | $130M | — | — | — | — | — | — | BEARISH | -96.9 |
| MIST Milestone Pharmaceuticals Inc. | $80M | -1.0 | -35522.6 | 587.8 | -5118.8 | — | 5 | BEARISH | -64.0 |
| NMRA Neumora Therapeutics, Inc. Common Stock | $70M | -0.3 | -187.1 | 231.9 | — | — | 2 | BEARISH | -79.1 |
| HBPCF Helix BioPharma Corp. | $60M | -23.6 | -50.8 | -21.5 | — | — | 3 | BEARISH | -55.5 |
| IMA ImageneBio Inc | $50M | -0.8 | -40.7 | -594.7 | — | — | 3 | BEARISH | -49.8 |
| PRRUF Immutep Limited | $20M | -0.4 | -77.3 | 1092.5 | -328.8 | 255.0 | 3 | BEARISH | -89.5 |
| CLRB Cellectar Biosciences, Inc. | $10M | -0.3 | -119.6 | 717.6 | — | — | 3 | BEARISH | -69.8 |
| ENLV Enlivex Therapeutics Ltd. | — | 0.0 | 209.7 | -0.4 | — | — | 5 | BEARISH | -99.0 |
| MYNDF MYND Life Sciences Inc. | — | -2.2 | 9.5 | 34.0 | — | — | 5 | BEARISH | -41.3 |
| SEPSF Asep Medical Holdings Inc | — | -0.3 | -36.4 | -75.5 | -844.8 | 208.8 | 5 | BEARISH | -97.2 |
| ARUXF Acrux Limited | — | -7.1 | -48.5 | -74.2 | -26.5 | 289.9 | 7 | BEARISH | -99.0 |
| ARNI Arno Therapeutics, Inc. | — | -0.0 | 250.7 | 111.6 | — | — | 3 | BEARISH | 0.0 |
| BIOAF Bioasis Technologies Inc. | — | -0.1 | 135.1 | 538.8 | -661.8 | 614.1 | 2 | BEARISH | -50.0 |
| ZVRA Zevra Therapeutics, Inc. | $580M | 10.5 | 34.8 | -1356.4 | 22.1 | 119.4 | 6 | BEARISH | -5.2 |
| IRD Opus Genetics, Inc. | $290M | -2.7 | -4796.5 | 59.8 | -1072.6 | -36.1 | 3 | BEARISH | 73.9 |
| MGNX MacroGenics, Inc. | $140M | -11.1 | -32.6 | 33.8 | 59.4 | 2.3 | 2 | BEARISH | 32.6 |
| CUE Cue Biopharma, Inc. | $140M | -0.7 | -1603.5 | 1241.9 | -1943.2 | 354.4 | 3 | BEARISH | -22.2 |
| ACRV Acrivon Therapeutics, Inc. Common Stock | $70M | -0.9 | -64.6 | 5251.5 | — | — | 1 | BEARISH | -15.9 |
| SKYE Skye Bioscience, Inc. | $10M | -0.1 | -233.9 | 389.5 | — | — | 3 | BEARISH | -5.8 |
| RVLPQ RVL Pharmaceuticals plc | — | -0.0 | -182.4 | -101.1 | -289.3 | 5.6 | 3 | BEARISH | 0.0 |
| PTIX Protagenic Therapeutics, Inc. | — | 0.2 | -485.4 | -367.8 | — | 100.0 | 6 | BEARISH | -78.7 |
| EMMA Emmaus Life Sciences, Inc. | — | -0.4 | 9.9 | -9.3 | 21.2 | 11.0 | 4 | BEARISH | 292.2 |
| PHRRF PharmaTher Holdings Ltd. | — | -7.6 | -76.9 | 234.4 | — | — | 2 | BEARISH | -56.0 |
| URGN UroGen Pharma Ltd. | $1.7B | -17.1 | 86.5 | 119.0 | -19.8 | 169.5 | 2 | BEARISH | 78.8 |
| MDCLF MedinCell S.A. | $1.1B | -29.2 | 472.2 | 81.6 | -152.1 | -14.8 | 3 | BEARISH | 333.5 |
| IMMX Immix Biopharma, Inc. | $680M | -9.1 | -34.2 | 1509.2 | — | — | 4 | BEARISH | 123.0 |
| CADL Candel Therapeutics, Inc. | $610M | -5.9 | -81.8 | 219.4 | — | — | 2 | BEARISH | 52.8 |
| GNFTF Genfit S.A. | $470M | -5.2 | -5084.0 | -322.7 | -124.0 | 27.5 | 3 | BEARISH | 153.5 |
| IKT Inhibikase Therapeutics, Inc. | $220M | -3.3 | -52.0 | 920.5 | — | — | 3 | BEARISH | 1.9 |
| TRGNF Transgene S.A. | $120M | -4.1 | -64.1 | -184.9 | -5760.7 | -185.8 | 4 | BEARISH | -53.1 |
| PRNAF Alterity Therapeutics Limited | $50M | -2.2 | -55.0 | -401.1 | — | -100.0 | 2 | BEARISH | 8233.3 |
| BOLD Boundless Bio, Inc. | $50M | -0.8 | -67.9 | 807.9 | — | — | 2 | BEARISH | 65.1 |
| BMNDF Biomind Labs Inc. | $20M | -13.3 | 85.8 | 101.7 | — | — | 2 | BEARISH | 1483.5 |
| PBM Psyence Biomedical Ltd. | — | — | — | — | — | — | — | BEARISH | -9.9 |
| GENSF Genus plc | $1.8B | 5.4 | 45.4 | 9.0 | 80.4 | -3.8 | 5 | BEARISH | -19.4 |
| OCUL Ocular Therapeutix, Inc. | $1.4B | -4.7 | -73.0 | -31671.3 | -584.5 | -8.1 | 3 | BEARISH | -41.5 |
| GPCR Structure Therapeutics Inc. | $1.2B | -7.1 | -20.2 | -1134.3 | — | — | 3 | BEARISH | -18.3 |
| SNDX Syndax Pharmaceuticals, Inc. | $1.2B | -5.4 | -255.9 | -270.9 | -67.8 | 222.3 | 4 | BEARISH | 1.2 |
| AKTS Aktis Oncology, Inc. | $850M | -15.7 | -29.9 | 276.4 | -713.5 | -36.1 | 5 | BEARISH | 373763.6 |
| ARDX Ardelyx, Inc. | $770M | -13.3 | -38.6 | -22.7 | -13.8 | 16.8 | 4 | BEARISH | -40.5 |
| CTMX CytomX Therapeutics, Inc. | $510M | -5.1 | -37.8 | 305.9 | -1457.4 | -87.0 | 2 | BEARISH | -29.1 |
| PROK ProKidney Corp. | $470M | -2.7 | 9.2 | 13.2 | -18948.0 | 55.2 | 1 | BEARISH | -52.5 |
| FTH Faeth Therapeutics, Inc. | $440M | — | — | — | — | — | — | BEARISH | — |
| ALLO Allogene Therapeutics, Inc. | $430M | -1.8 | -42.4 | -81.9 | -919.8 | — | 5 | BEARISH | 2.5 |
| AVCTF Avacta Group Plc | $420M | -6.7 | -2083.2 | -753.6 | -33970.3 | -99.7 | 5 | BEARISH | -18.7 |
| SPRY ARS Pharmaceuticals, Inc. | $400M | -1.7 | -210.3 | -424.3 | -185.2 | 4.1 | 2 | BEARISH | -59.1 |
| CAPR Capricor Therapeutics, Inc. | $340M | -2.5 | -73.7 | -107.5 | — | -100.0 | 3 | BEARISH | -1.6 |
| KYTX Kyverna Therapeutics, Inc. | $330M | -1.9 | -87.2 | 14267.8 | — | — | 2 | BEARISH | -24.3 |
| SPHDF Santhera Pharmaceuticals Holding AG | $280M | -6.6 | 729.6 | 111.3 | -44.5 | 106.3 | 7 | BEARISH | 49.1 |
| ABEO Abeona Therapeutics Inc. | $250M | -3.9 | -43.1 | -5983.3 | -177.4 | 6280.0 | 2 | BEARISH | -18.8 |
| OCGN Ocugen, Inc. | $250M | -3.0 | 1211.7 | 190.2 | -1671.8 | -3.7 | 2 | BEARISH | -52.4 |
| ORYZF Oryzon Genomics S.A. | $250M | -80.4 | -3.0 | -7.2 | -1.6 | 12.6 | 4 | BEARISH | -14.1 |
| HLOSF Healios K.K. | $240M | 57.7 | 3.7 | -129.2 | 17028.6 | -47.1 | 4 | BEARISH | -48.6 |
| VNDA Vanda Pharmaceuticals Inc. | $240M | -0.9 | -77.8 | -201.0 | -123.7 | 6.0 | 3 | BEARISH | -27.4 |
| IPHYF Innate Pharma S.A. | $210M | -2.5 | 267.9 | 119.2 | -343.8 | 32.0 | 3 | BEARISH | -24.5 |
| EVMN Evommune, Inc. | $190M | -1.5 | -29.6 | -82.4 | — | — | 2 | BEARISH | — |
| BIOA BioAge Labs Inc. | $190M | -2.3 | -28.2 | -142.3 | -1064.7 | 168.1 | 4 | BEARISH | -28.0 |
| ZNTL Zentalis Pharmaceuticals, Inc. | $160M | -0.8 | -83.7 | -2245.4 | — | -100.0 | 2 | BEARISH | 15.8 |
| SION Sionna Therapeutics, Inc. | $160M | -1.8 | -32.3 | -137.7 | — | — | 0 | BEARISH | -90.1 |
| NBP NovaBridge Biosciences | $160M | -2.2 | -45.7 | -617.8 | — | — | 1 | BEARISH | -70.4 |
| AKBA Akebia Therapeutics, Inc. | $160M | -6.1 | -109.4 | 15.6 | -18.1 | 7.5 | 6 | BEARISH | -78.2 |
| STRO Sutro Biopharma, Inc. | $150M | -0.5 | 266.8 | 43.6 | -391.6 | -56.3 | 4 | BEARISH | -15.5 |
| NGEN NervGen Pharma Corp. Common stock | $150M | — | — | — | — | — | — | BEARISH | — |
| CNTN Canton Strategic Holdings Inc | $150M | -1.2 | -14.6 | -7.2 | -1287.2 | — | 2 | BEARISH | — |
| CDXS Codexis, Inc. | $140M | -3.8 | -69.4 | -37.8 | -80.5 | 35.9 | 3 | BEARISH | -52.6 |
| NKTX Nkarta, Inc. | $130M | -1.1 | -38.8 | -75.4 | — | — | 1 | BEARISH | -15.0 |
| AVXL Anavex Life Sciences Corp. | $120M | -5.0 | -23.6 | 411.7 | — | — | 2 | BEARISH | -84.8 |
| UNCY Unicycive Therapeutics, Inc. | $110M | -2.2 | -101.1 | 349.9 | — | — | 4 | BEARISH | -29.6 |
| CBUS Cibus, Inc. | $110M | -0.8 | -225.9 | -157.2 | -2227.9 | -10.3 | 2 | BEARISH | -11.0 |
| ORPOF OSE Immunotherapeutics S.A. | $100M | — | — | — | — | — | — | BEARISH | — |
| VXRT Vaxart, Inc. | $100M | 2.7 | 67.0 | 149.6 | -49.6 | 201.1 | 6 | BEARISH | 10.8 |
| CLLS Cellectis S.A. | $100M | -1.7 | -94.6 | 118.6 | -417.3 | 0.5 | 2 | BEARISH | -69.8 |
| TNYA Tenaya Therapeutics, Inc. | $90M | -0.8 | -121.9 | 1769.3 | -3909.3 | — | 3 | BEARISH | -75.8 |
| JWCTF JW (Cayman) Therapeutics Co. Ltd | $80M | -2.3 | -49.0 | -68.1 | -45.3 | 60.7 | 3 | BEARISH | -55.3 |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | $80M | -0.6 | -95.6 | 738.2 | — | — | 1 | BEARISH | -75.4 |
| CGTX Cognition Therapeutics, Inc. | $70M | -4.0 | -83.8 | 6061.8 | — | — | 3 | BEARISH | -56.1 |
| CRDF Cardiff Oncology, Inc. | $70M | -1.5 | -94.1 | 443.4 | -8876.9 | -7.0 | 3 | BEARISH | -60.8 |
| CRBU Caribou Biosciences, Inc. | $60M | -0.4 | -78.3 | -695.0 | -1619.9 | 10.0 | 3 | BEARISH | -81.5 |
| VTIAF FamiCord AG | $50M | -6.4 | -84.3 | -13.6 | -5.1 | 0.1 | 5 | BEARISH | -55.7 |
| HYFT MindWalk Holdings Corp. | $50M | -4.5 | -123.5 | -481.3 | -158.7 | -15.9 | 4 | BEARISH | -29.3 |
| CNTB Connect Biopharma Holdings Limited | $50M | -1.0 | -105.5 | 1034.1 | -1249.0 | 49.8 | 2 | BEARISH | -50.4 |
| IBIO iBio, Inc. | $50M | -2.4 | -65.7 | 21688.6 | — | -75.0 | 4 | BEARISH | -36.6 |
| ANVS Annovis Bio, Inc. | $40M | -0.6 | -703.7 | 170.2 | — | — | 1 | BEARISH | -49.8 |
| RANI Rani Therapeutics Holdings, Inc. | $40M | -2.3 | -179.1 | 245.5 | -432.7 | 306.4 | 5 | BEARISH | -66.5 |
| DWTX Dogwood Therapeutics, Inc. | $40M | -0.1 | -47.8 | -39.7 | — | — | 2 | BEARISH | -80.3 |
| ALDX Aldeyra The | $40M | -1.7 | -49.5 | 269.3 | — | — | 4 | BEARISH | -87.8 |
| EXOZ eXoZymes, Inc. | $40M | -3.2 | -187.2 | 913.0 | — | — | 2 | BEARISH | -68.4 |
| TIL Instil Bio, Inc. | $40M | -1.3 | -25.3 | -69.1 | — | — | 4 | BEARISH | -69.9 |
| GRCE Grace Therapeutics, Inc. | $30M | -1.5 | -38.4 | -58.9 | — | — | 2 | BEARISH | -40.5 |
| FLNA Filana Therapeutics, Inc. | $30M | -0.7 | -13.5 | 38.9 | — | — | 2 | BEARISH | — |
| BCTX BriaCell Therapeutics Corp. | $30M | -0.3 | -179.9 | -2435.2 | — | — | 2 | BEARISH | -74.2 |
| IGC IGC Pharma, Inc. | $30M | -3.0 | -129.2 | -127.6 | -1107.9 | -15.4 | 1 | BEARISH | -39.1 |
| IXHL Incannex Healthcare Limited | $30M | -2.3 | -31.9 | 5284.2 | — | -100.0 | 4 | BEARISH | -75.0 |
| ATYR aTyr Pharma, Inc. | $20M | -0.2 | -98.4 | -1890.1 | — | — | 2 | BEARISH | -87.4 |
| MVMDF More Life Company Corp. | $20M | -5.2 | -167.0 | -602.2 | -5006.5 | 43.0 | 4 | BEARISH | 115.8 |
| BYSI BeyondSpring Inc. | $20M | -2.8 | 20.3 | 15.7 | — | 100.0 | 2 | BEARISH | -77.0 |
| QNTM Quantum BioPharma Ltd. | $10M | -0.4 | -425.3 | 175.1 | — | — | 4 | BEARISH | -83.3 |
| GSGTF GenSight Biologics S.A. | $10M | -1.0 | 46.5 | 47.3 | 1190.6 | -401.7 | 3 | BEARISH | -57.9 |
| KTTA Pasithea Therapeutics Corp. | $10M | -0.2 | -65.5 | -453.2 | — | — | 4 | BEARISH | -44.7 |
| GTBP GT Biopharma, Inc. | $10M | -0.1 | -798.9 | 927.8 | — | — | 2 | BEARISH | -67.4 |
| PXXLF Poxel S.A. | $10M | -0.4 | 34.8 | 129.6 | -624.6 | 41.5 | 4 | BEARISH | -12.0 |
| TVRD Tvardi Therapeutics, Inc. | $10M | -0.3 | -126.2 | 296.9 | — | — | 1 | BEARISH | -82.6 |
| DARE Dare Bioscience, Inc. | $10M | -0.8 | 165.3 | 136.8 | -1590.4 | 7816.7 | 3 | BEARISH | -68.6 |
| IMNN Imunon, Inc. | $10M | -0.2 | -429.7 | -226.7 | — | — | 2 | BEARISH | -81.9 |
| INTS Intensity Therapeutics, Inc. | $10M | -0.7 | -195.9 | 4123.4 | — | — | 5 | BEARISH | -46.4 |
| BLRX BioLineRx Ltd. | $10M | -1.0 | -63.5 | -113.0 | -1029.3 | -94.3 | 3 | BEARISH | -44.6 |
| INAB IN8bio, Inc. | $10M | -0.5 | -111.1 | -576.1 | — | — | 4 | BEARISH | -55.1 |
| RDTCF Rapid Dose Therapeutics Corp. | $10M | -4.2 | 49.3 | 80.2 | -86.2 | 4.3 | 4 | BEARISH | -58.4 |
| PTN Palatin Technologies, Inc. | $10M | -0.9 | -877.5 | 1176.9 | -1449.1 | — | 5 | BEARISH | -20.5 |
| VTGN VistaGen Therapeutics, Inc. | $10M | -0.1 | -166.5 | 851.1 | -882.8 | 287.3 | 4 | BEARISH | -95.7 |
| QNRX Quoin Pharmaceuticals, Ltd. | $10M | -0.3 | -578.6 | 221.3 | — | — | 1 | BEARISH | -68.7 |
| TPST Tempest Therapeutics, Inc. | $10M | -0.1 | -931.1 | -564.2 | — | — | 1 | BEARISH | -95.2 |
| MSLE Satellos Bioscience Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| CDIO Cardio Diagnostics Holdings, Inc. | $10M | -0.6 | -75.4 | -230.9 | -28012.5 | -25.9 | 3 | BEARISH | -58.0 |
| GUTS Fractyl Health, Inc. | $10M | -0.1 | 1063.0 | -568.7 | — | -100.0 | 5 | BEARISH | -94.7 |
| OPTBF OptiBiotix Health Plc | $10M | -1.4 | -102.1 | -102.1 | -231.5 | -12.9 | 4 | BEARISH | 109900.0 |
| APRE Aprea Therapeutics, Inc. | $10M | -0.5 | -47.4 | 378.1 | — | -99.8 | 2 | BEARISH | -62.7 |
| TRAW Traws Pharma, Inc. | $10M | -0.7 | -711.4 | 133.9 | — | -100.0 | 1 | BEARISH | -87.4 |
| TOVX Theriva Biologics, Inc. | $10M | -0.3 | -101.9 | -213.5 | — | — | 2 | BEARISH | -45.5 |
| TCRX TScan Therapeutics, Inc. | $10M | -0.2 | -95.8 | -159.4 | -2888.6 | 2.2 | 2 | BEARISH | -91.7 |
| NBRVF Nabriva Therapeutics plc | — | — | — | — | — | — | — | BEARISH | 0.0 |
| BNIGF Beroni Group Limited | — | -0.1 | -1153.4 | -274.8 | -15945.7 | 40.9 | 5 | BEARISH | 0.0 |
| ZVSA ZyVersa Therapeutics, Inc. | — | -0.0 | 817.1 | 242.0 | — | -100.0 | 1 | BEARISH | -99.3 |
| NIKI Niki BioSolutions, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| GOVX GeoVax Labs, Inc. | — | -0.0 | -891.6 | 1530.7 | — | -100.0 | 3 | BEARISH | -98.6 |
| VBIO Valion Bio, Inc. | — | -0.0 | -240.8 | -48.0 | — | -281.4 | 2 | BEARISH | — |
| AXIM AXIM Biotechnologies, Inc. | — | -1.6 | 3.0 | 24.9 | -90.9 | 2142.6 | 5 | BEARISH | -62.2 |
| TNGNQ Tengion, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| XENO Xeno Transplants Corporation | — | -0.0 | -286.5 | 78.1 | — | — | 1 | BEARISH | 0.0 |
| ZHCLF Zenith Capital Corp. | — | -0.2 | 35107.2 | 37766.2 | -360.0 | — | 3 | BEARISH | 3233.3 |
| MLECW Moolec Science S.A. | — | -0.0 | -174.7 | -31.5 | -91.8 | 170.4 | 3 | BEARISH | -38.8 |
| MDCX Medicus Pharma Ltd. Common Stock | — | -0.0 | -3904.0 | -693.1 | — | — | 3 | BEARISH | -98.2 |
| VPRO Viropro Inc. | — | -0.0 | -19.7 | -4.8 | -269.7 | 155.0 | 2 | BEARISH | 0.0 |
| SUVZ Suvanza Pharma, LLC | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HCWB HCW Biologics Inc. | — | -0.0 | -133.5 | -36.8 | -3849.9 | 707.0 | 3 | BEARISH | -95.2 |
| LIFS Life Stem Genetics Inc. | — | -2.5 | -126.7 | -111.5 | — | — | 2 | BEARISH | -50.0 |
| RADX Radiopharm Theranostics Limited | — | — | — | — | — | — | — | BEARISH | -83.1 |
| MBAI MBody AI Ltd. | — | — | — | — | — | — | — | BEARISH | — |
| APVO Aptevo Therapeutics Inc. | — | -0.0 | -420.3 | -4688.7 | — | — | 1 | BEARISH | -95.2 |
| KAPA Kairos Pharma, Ltd. | — | -0.3 | -114.0 | -301.0 | — | — | 3 | BEARISH | -93.0 |
| DCOY Decoy Therapeutics Inc. | — | — | — | — | — | — | — | BEARISH | — |
| ENZC Enzolytics Inc. | — | -11.2 | 105.9 | 1.4 | — | — | 7 | BEARISH | -25.0 |
| RASP Actavia Life Sciences, Inc. | — | -0.1 | 20.1 | 14.5 | — | — | 2 | BEARISH | -87.5 |
| EVFM Evofem Biosciences, Inc. | — | -0.1 | 20.1 | 26.0 | -419.1 | 4.5 | 2 | BEARISH | -27.3 |
| CLDI Calidi Biotherapeutics, Inc. | — | -0.0 | -713.6 | -1404.6 | — | — | 4 | BEARISH | -97.3 |
| MBIO Mustang Bio, Inc. | — | -0.8 | -58.1 | 36.6 | — | — | 2 | BEARISH | -75.9 |
| LIMN Liminatus Pharma, Inc. Class A Common Stock | — | -0.1 | 294.4 | 252.1 | — | — | 4 | BEARISH | -95.3 |
| GNPX Genprex, Inc. | — | -0.0 | -203.9 | 3484.8 | — | — | 4 | BEARISH | -99.1 |
| KALA KALA BIO, Inc. | — | -0.0 | -345.3 | -913.5 | — | -100.0 | 4 | BEARISH | -99.6 |
| TSOI Therapeutic Solutions International, Inc. | — | -0.1 | -187.6 | -130.3 | -5123.0 | -99.7 | 4 | BEARISH | -99.0 |
| WSNAF Wesana Health Holdings Inc. | — | -0.1 | 1113.6 | 90.8 | — | — | 3 | BEARISH | -80.1 |
| NCEL NewcelX Ltd. | — | 8.3 | -48.0 | -39.1 | — | — | 2 | BEARISH | -79.5 |
| OGEN Oragenics, Inc. | — | -0.1 | -1307.1 | 4273.7 | — | — | 3 | BEARISH | -72.3 |
| IVEVF Inventiva S.A. | $750M | -6.2 | -988.4 | -371.6 | -347346.6 | -99.7 | 3 | BEARISH | -22.8 |
| RGNX REGENXBIO Inc. | $440M | -1.7 | -137.6 | -368.4 | 21.0 | 12.0 | 2 | BEARISH | -49.4 |
| ALT Altimmune, Inc. | $410M | -2.6 | -28.9 | -43.1 | — | 55.0 | 4 | BEARISH | -46.0 |
| AVTX Avalo Therapeutics, Inc. | $370M | -1.4 | -36.3 | -148.4 | — | -86.6 | 4 | BEARISH | -61.6 |
| DMTRF 3-D Matrix, Ltd. | $310M | 12.3 | 75.0 | 31.1 | 9.4 | 57.0 | 6 | BEARISH | 61.3 |
| SCTX Scribe Therapeutics Inc. | $250M | — | — | — | — | — | — | BEARISH | — |
| ACIU AC Immune S.A. | $250M | -4.3 | -78.5 | 96.7 | 12.4 | -39.5 | 2 | BEARISH | -30.8 |
| CABA Cabaletta Bio, Inc. | $250M | -0.9 | -93.2 | -1308.0 | — | — | 3 | BEARISH | -40.9 |
| PALI Palisade Bio, Inc. | $230M | -2.3 | -51.4 | 815.6 | -2114.8 | — | 5 | BEARISH | -31.0 |
| IVVD Invivyd, Inc. | $180M | -1.5 | -95.9 | -302.5 | -310.8 | 26.3 | 2 | BEARISH | -73.2 |
| UPB Upstream Bio, Inc. | $150M | -1.0 | -46.0 | -1266.4 | -5136.1 | 49.2 | 3 | BEARISH | -83.0 |
| CMPX Compass Therapeutics, Inc. | $140M | -1.8 | -56.7 | 1526.3 | — | — | 4 | BEARISH | -81.2 |
| VYGR Voyager Therapeutics, Inc. | $110M | -1.0 | -54.1 | -131.1 | -773.2 | -19.1 | 2 | BEARISH | -62.8 |
| NERV Minerva Neurosciences, Inc. | $110M | -0.1 | 337.5 | 10.0 | — | — | 1 | BEARISH | -52.5 |
| ENGN enGene Holdings Inc. | $100M | -5.5 | -2.3 | 134.1 | — | -100.0 | 2 | BEARISH | -81.3 |
| VTVT vTv Therapeutics Inc. | $100M | -233.8 | -11.7 | 91.2 | — | 216600.0 | 4 | BEARISH | 23.1 |
| LENZ LENZ Therapeutics, Inc. | $100M | -0.8 | -59.2 | 17313.3 | -581.8 | 329.5 | 3 | BEARISH | -90.2 |
| PTHS Pelthos Therapeutics Inc. | $70M | -0.3 | 4767.3 | -97.0 | -150.1 | — | 2 | BEARISH | -54.0 |
| VRCA Verrica Pharmaceuticals Inc. | $60M | -2.0 | 473.3 | 437.4 | -224.4 | 106.2 | 5 | BEARISH | -9.9 |
| XBIT XBiotech Inc. | $60M | -1.2 | -29.9 | -201.2 | — | — | 2 | BEARISH | -28.0 |
| TLSA Tiziana Life Sciences Ltd | $60M | -4.3 | -780.6 | 375.0 | — | — | 1 | BEARISH | -55.0 |
| GANX Gain Therapeutics, Inc. | $50M | -2.3 | -268.3 | 1288.8 | — | — | 4 | BEARISH | -40.9 |
| PLRX Pliant Therapeutics, Inc. | $50M | -0.6 | -50.3 | -438.3 | — | — | 3 | BEARISH | -53.6 |
| ACET Adicet Bio, Inc. | $40M | -0.3 | -78.1 | -553.5 | — | — | 4 | BEARISH | -73.2 |
| KLRS Kalaris Therapeutics Inc | $40M | -0.9 | -79.9 | 109.5 | — | — | 0 | BEARISH | -61.0 |
| MGX Metagenomi, Inc. Common Stock | $30M | -0.3 | -60.6 | -268.2 | 10693.4 | -59.8 | 1 | BEARISH | -72.3 |
| AARD Aardvark Therapeutics, Inc. Common Stock | $30M | -0.4 | -66.0 | -3642.4 | — | — | 1 | BEARISH | -87.8 |
| BSEM BioStem Technologies, Inc. | $30M | -0.9 | -74.7 | -84.3 | -113.6 | -119.6 | 2 | BEARISH | -69.0 |
| NRXBF NurExone Biologic Inc. | $30M | — | — | — | — | — | — | BEARISH | — |
| EDSA Edesa Biotech, Inc. | $30M | -1.6 | -122.9 | 759.6 | — | — | 1 | BEARISH | -2.5 |
| EYPT EyePoint Pharmaceuticals, Inc. | $30M | -0.1 | -148.7 | -3014.8 | -18633.1 | -94.6 | 2 | BEARISH | -97.0 |
| ALGS Aligos Therapeutics, Inc. | $30M | -0.6 | -113.6 | -1246.4 | -5.4 | 893.0 | 2 | BEARISH | -51.1 |
| MCRB Seres Therapeutics, Inc. | $20M | -0.8 | -66.6 | -87.8 | 622.4 | — | 3 | BEARISH | -89.9 |
| TELIF Telescope Innovations Corp. | $20M | 5.8 | -229.2 | -80.7 | -116.8 | 66.3 | 2 | BEARISH | -21.7 |
| KYNB Kyntra Bio, Inc. | $20M | 0.1 | -115.2 | 29.6 | -812.3 | — | 2 | BEARISH | — |
| BXPHF Botanix Pharmaceuticals Limited | $20M | -0.3 | -96.3 | -131.6 | -203.1 | 495.6 | 4 | BEARISH | -91.5 |
| BCDA BioCardia, Inc. | $10M | -1.2 | -1803.2 | 519.4 | — | — | 3 | BEARISH | -33.7 |
| HIND Vyome Holdings, Inc. | $10M | -0.1 | -193.1 | 516.3 | -2543.3 | -98.0 | 4 | BEARISH | -69.0 |
| RVPH Reviva Pharmaceuticals Holdings, Inc. | $10M | -0.1 | -32.2 | 45.6 | — | — | 4 | BEARISH | -33.4 |
| MTVA MetaVia Inc. | $10M | -0.3 | -175.7 | 209.3 | — | — | 0 | BEARISH | -89.3 |
| ACTU Actuate Therapeutics Inc | $10M | -0.4 | 2457.6 | 541.3 | — | — | 3 | BEARISH | -94.5 |
| FBLG FibroBiologics, Inc. Common Stock | $10M | -0.2 | -660.1 | -511.6 | — | — | 4 | BEARISH | -89.3 |
| AIMD Ainos, Inc. | $10M | -0.3 | -196.3 | -69.4 | -3022849.3 | -87.7 | 1 | BEARISH | -77.5 |
| ACXP Acurx Pharmaceuticals, Inc. | $10M | -0.3 | -128.1 | 241.9 | — | — | 3 | BEARISH | -83.7 |
| NRSN NeuroSense Therapeutics Ltd. | — | -0.3 | 779.3 | 571.3 | — | — | 3 | BEARISH | -90.0 |
| NMLSF Restart Life Sciences Corp. | — | -1.8 | -214.3 | -153.9 | -307.0 | — | 2 | BEARISH | -63.3 |
| ZLDAF Zelira Therapeutics Limited | — | -1.6 | 80.8 | 147.8 | -185107971.7 | -99.3 | 1 | BEARISH | -7.8 |
| PMCB PharmaCyte Biotech, Inc. | — | -0.1 | -44.0 | 793.8 | — | — | 2 | BEARISH | -64.9 |
| SCPX Scorpius Holdings, Inc. | — | -0.0 | 0.0 | 0.0 | -428.3 | -75.5 | 0 | BEARISH | -66.7 |
| CELZ Creative Medical Technology Holdings, Inc. | — | -0.3 | -78.0 | 8335.2 | — | -50.0 | 2 | BEARISH | -85.9 |
| CRIS Curis, Inc. | — | -0.0 | 455.3 | -23281.0 | — | -62.2 | 3 | BEARISH | -98.8 |
| OXBOF Oxford BioDynamics Plc | — | -0.3 | -214.9 | -155.8 | -649.8 | 33.6 | 3 | BEARISH | -81.1 |
| XSNX NovAccess Global Inc. | — | -0.0 | 27.7 | 18.0 | — | — | 3 | BEARISH | 0.0 |
| NAVBQ Navidea Biopharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| CODX Co-Diagnostics, Inc. | — | -0.0 | -174.8 | -218.8 | -3782.4 | -28.1 | 3 | BEARISH | -95.5 |
| LABT Lakewood-Amedex Biotherapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| FAMDF Futura Medical plc | — | -0.3 | -145.8 | -370.5 | -72.8 | -70.7 | 2 | BEARISH | -86.7 |
| NSHSF NanoSphere Health Sciences Inc. | — | 9.5 | 4.6 | 11.1 | — | — | 0 | BEARISH | 0.0 |
| CANF Can-Fite BioPharma Ltd. | — | -0.3 | -184.2 | 353.7 | -2277.7 | -40.1 | 2 | BEARISH | -81.7 |
| PPBT Purple Biotech Ltd. | — | -0.0 | -111.3 | -99.1 | — | — | 2 | BEARISH | 56.6 |
| LYEL Lyell Immunopharma, Inc. | $230M | -0.6 | -93.3 | -227.7 | -1118875.0 | -55.0 | 3 | BULLISH | -42.6 |
| AMWL American Well Corporation | $230M | -2.8 | -31.0 | -215.3 | -19.1 | -19.0 | 4 | BULLISH | 144.5 |
| CBWTF Auxly Cannabis Group Inc. | $250M | 10.4 | 16.6 | 2.2 | 16.8 | 10.8 | 7 | BULLISH | 71.5 |
| HITI High Tide Inc. | $230M | -9.9 | -27.0 | 0.8 | 5.7 | 26.8 | 3 | LEAN BULL | -19.6 |
| KJFI Comjoyful International Company | $210M | -98.4 | 171.5 | -1549.9 | 44.3 | 38.8 | 6 | LEAN BULL | 459.8 |
| LFCR Lifecore Biomedical, Inc. | $240M | -5.9 | 202.6 | 0.1 | -18.0 | -4.1 | 5 | NEUTRAL | -5.0 |
| SIGA SIGA Technologies, Inc. | $220M | -73.4 | -1.5 | -18.3 | 30.4 | -70.1 | 1 | NEUTRAL | -62.1 |
| AMRN Amarin Corporation plc | $240M | -8.4 | -6.0 | -19.6 | -18.1 | -15.1 | 6 | LEAN BEAR | -39.4 |
| ACB Aurora Cannabis Inc. | $250M | -3.0 | -20.5 | -17.0 | -6.0 | -16.6 | 3 | LEAN BEAR | -20.9 |
| CELG-RI Bristol-Myers Squibb Company Ce | $250M | 0.0 | 46.7 | 22.0 | 25.6 | 3.1 | 8 | BEARISH | 247.9 |
| IMPZY Implanet S.A. | $230M | -5.1 | 275.6 | -110.9 | -30.0 | 24.3 | 5 | BEARISH | 0.2 |
| BHCCF Benchmark Holdings plc | $230M | -4.1 | 16.4 | -17.9 | 377.4 | -62.6 | 6 | BEARISH | 0.0 |
| UTMD Utah Medical Products, Inc. | $240M | 21.9 | 8.8 | 24.1 | 31.5 | -7.0 | 7 | BEARISH | 21.6 |
| CPHRF Cipher Pharmaceuticals Inc. | $240M | 8.2 | 23.5 | 24.9 | 33.3 | 3.7 | 6 | BEARISH | -9.6 |
| ELMD Electromed, Inc. | $220M | 19.5 | 23.3 | 32.5 | 17.5 | 15.3 | 8 | BEARISH | 9.8 |
| EDTXF Spectral Medical Inc. | $210M | -7.5 | 64.9 | 19.4 | 53.3 | 1.5 | 2 | BEARISH | -37.5 |
| TLSI TriSalus Life Sciences, Inc. | $220M | -2.9 | 438.3 | 453.7 | -80.5 | 25.2 | 4 | BEARISH | -25.8 |
| CRLBF Cresco Labs Inc. | $210M | -2.0 | -25.8 | 5.5 | 9.7 | -4.5 | 2 | BEARISH | -49.8 |
| LAB Standard BioTools Inc. | $240M | -2.7 | -18.1 | -69.4 | -133.1 | -45.2 | 5 | BEARISH | -56.6 |
| CUVL Clinuvel Pharmaceuticals Ltd. | $250M | — | — | — | — | — | — | BEARISH | — |
| SPOK Spok Holdings, Inc. | $220M | 17.0 | 8.4 | 10.0 | 11.8 | -3.4 | 5 | BEARISH | -36.0 |
| LYEL Lyell Immunopharma, Inc. | $230M | -0.6 | -93.3 | -227.7 | -1118875.0 | -55.0 | 3 | BULLISH | -42.6 |
| SEPN Septerna Inc | $1.9B | -81.7 | -6.3 | -93.1 | -48.7 | 17878.5 | 5 | BULLISH | 103.7 |
| COAG Hemab Therapeutics Holdings, Inc. Common Stock | $1.6B | — | — | — | — | — | — | BULLISH | — |
| CERT Certara, Inc. | $1.6B | -24.7 | -6.7 | 0.6 | -59.3 | 0.7 | 6 | BULLISH | -13.5 |
| MRCHF H.U. Group Holdings, Inc. | $1.3B | 21.8 | 7.2 | 3.3 | 2.5 | 1.8 | 9 | BULLISH | -7.4 |
| LTGHY Life Healthcare Group Holdings Limited | $1.1B | 2.7 | 68.5 | 10.7 | 6.2 | -3.0 | 4 | BULLISH | 14.5 |
| VSTM Verastem, Inc. | $910M | -4.1 | -471.2 | 6197.3 | -86.5 | 3995.7 | 4 | BULLISH | 27.0 |
| SOLTF Nxera Pharma Co., Ltd. | $770M | -16.0 | -12.0 | -1.7 | -2.6 | 7.5 | 4 | BULLISH | 38.2 |
| CTKB Cytek Biosciences, Inc. | $730M | -9.6 | -23.0 | -40.8 | -25.3 | 5.4 | 3 | BULLISH | 40.4 |
| RCEL Avita Medical Inc. | $390M | -11.1 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | BULLISH | 305.0 |
| OSUR OraSure Technologies, Inc. | $280M | -6.0 | -14.1 | -23.5 | 20.4 | -18.9 | 4 | BULLISH | 40.5 |
| PYPD PolyPid Ltd. | $110M | -3.9 | -1913.8 | 231.6 | — | — | 3 | BULLISH | 67.7 |
| ANIX Anixa Biosciences, Inc. | $100M | -10.8 | -67.1 | -1110.2 | — | — | 3 | BULLISH | -20.8 |
| GRDX GridAI Technologies Corp. | $40M | -1.4 | -55.6 | -51.7 | -14927.4 | 67.4 | 2 | BULLISH | 44.5 |
| AMN AMN Healthcare Services, Inc. | $1.9B | 17.3 | 15.6 | 8.9 | 3.1 | 24.0 | 8 | BULLISH | 120.8 |
| HCSG Healthcare Services Group, Inc. | $1.7B | 16.1 | 20.4 | 27.0 | 5.2 | 4.0 | 7 | BULLISH | 31.8 |
| ARDT Ardent Health Inc. | $1.7B | 21.5 | 6.0 | 13.5 | 1.0 | 3.3 | 5 | BULLISH | -22.3 |
| KLRA Kailera Therapeutics, Inc. | $1.7B | — | — | — | — | — | — | BULLISH | — |
| GDRX GoodRx Holdings, Inc. | $1.2B | 66.2 | 2.5 | 3.5 | 4.3 | -1.8 | 6 | BULLISH | -11.9 |
| SPTX Seaport Therapeutics, Inc. Common Stock | $1.1B | — | — | — | — | — | — | BULLISH | — |
| HSTM HealthStream, Inc. | $1.1B | 47.8 | 6.0 | 6.5 | 8.0 | 8.8 | 8 | BULLISH | 30.1 |
| CBLL CeriBell, Inc. | $1.0B | -15.5 | -43.9 | -263.7 | -68.6 | 69.3 | 3 | BULLISH | 111.2 |
| BVS Bioventus Inc. | $1.0B | 17.9 | 28.0 | 21.3 | 21.8 | 3.1 | 7 | BULLISH | 107.8 |
| SIBN SI-BONE, Inc. | $960M | -63.1 | -8.3 | -32.2 | -7.3 | 15.3 | 6 | BULLISH | 38.4 |
| SGP SpyGlass Pharma, Inc. Common Stock | $950M | — | — | — | — | — | — | BULLISH | — |
| PHR Phreesia, Inc. | $790M | 71.4 | 3.1 | 16.7 | 1.5 | 12.9 | 4 | BULLISH | -47.7 |
| AONC American Oncology Network, Inc. | $640M | -29.7 | 5.6 | -14.7 | 0.3 | 37.5 | 6 | BULLISH | 132.2 |
| ENTX Entera Bio Ltd. | $510M | -8.8 | -138.9 | 314.4 | — | -100.0 | 1 | BULLISH | 37.8 |
| MOBI Mobia Medical, Inc. Common Stock | $350M | — | — | — | — | — | — | BULLISH | — |
| ANIK Anika Therapeutics, Inc. | $290M | -79.2 | -2.7 | -3.3 | 10.1 | 31.4 | 7 | BULLISH | 113.3 |
| QSI Quantum-Si incorporated | $280M | -3.6 | -49.1 | -121.8 | -6841.3 | -53.0 | 3 | BULLISH | -27.9 |
| BIOYF BioSyent Inc. | $140M | 19.1 | 23.7 | 23.8 | 14.3 | 41.0 | 5 | BULLISH | 49.2 |
| ATNM Actinium Pharmaceuticals, Inc. | $50M | 3.9 | 45.9 | -197.8 | 79.7 | — | 3 | BULLISH | -15.0 |
| MCUJF Medicure Inc. | $30M | -6.3 | -49.9 | -54.9 | -19.2 | 38.3 | 4 | BULLISH | 291.0 |
| LWSCF Sienna Senior Living Inc. | $1.6B | 38.9 | 6.7 | 3.9 | 4.4 | 16.2 | 7 | BULLISH | 7.9 |
| AHG Akso Health Group | $1.1B | -21.0 | -50.1 | -44.9 | -546.5 | 22.7 | 4 | BULLISH | -17.1 |
| PRME Prime Medicine, Inc. | $670M | -4.0 | -373.3 | -271.3 | -3649.0 | -17.9 | 3 | BULLISH | -18.4 |
| MYGN Myriad Genetics, Inc. | $560M | -5.3 | -32.5 | -19.5 | -22.7 | -3.2 | 4 | BULLISH | -22.8 |
| XFOR X4 Pharmaceuticals, Inc. | $320M | -2.7 | -113.1 | -281.1 | -183.5 | -51.6 | 4 | BULLISH | -14.5 |
| INGN Inogen, Inc. | $190M | -7.9 | -13.1 | -27.8 | -4.0 | 3.2 | 5 | BULLISH | -18.7 |
| CING Cingulate Inc. | $70M | -1.1 | -198.7 | -1452.8 | — | — | 4 | BULLISH | 43.3 |
| ESLA Estrella Immunopharma, Inc. | $40M | -3.8 | 148.1 | 102.1 | — | — | 3 | BULLISH | -60.8 |
| TNDM Tandem Diabetes Care, Inc. | $1.2B | -20.7 | -48.0 | -8.2 | -8.3 | -7.1 | 4 | BULLISH | 28.6 |
| TDOC Teladoc Health, Inc. | $1.1B | -6.5 | -13.0 | -8.7 | -6.4 | -2.1 | 5 | BULLISH | -31.8 |
| STAA STAAR Surgical Company | $1.1B | 302.0 | 1.1 | 3.5 | 8.6 | 51.3 | 5 | BULLISH | -8.0 |
| LMRI Lumexa Imaging Holdings, Inc. Common Stock | $1.1B | -31.1 | -3.9 | 0.1 | 1.0 | — | 3 | BULLISH | — |
| INDP Indaptus Therapeutics, Inc. | $360M | -0.5 | -318.0 | 6437.4 | — | — | 4 | BULLISH | -8.8 |
| TMCI Treace Medical Concepts, Inc. | $280M | -4.9 | -72.0 | -44.8 | -35.0 | -4.0 | 2 | BULLISH | -33.8 |
| KRRO Korro Bio, Inc. | $180M | -1.3 | -97.7 | -196.6 | — | -62.1 | 2 | BULLISH | -65.1 |
| VIR Vir Biotechnology, Inc. | $1.8B | -6.3 | -26.1 | -38.8 | 33.5 | 1495.9 | 5 | BULLISH | 93.5 |
| KIDS OrthoPediatrics Corp. | $640M | -16.7 | -11.4 | -4.6 | -10.2 | 14.5 | 6 | BULLISH | 39.9 |
| MASS 908 Devices Inc. | $470M | -13.3 | -25.1 | -103.8 | -74.0 | 4.6 | 5 | BULLISH | 45.2 |
| AVHHL AVITA Medical, Inc. | $360M | -11.1 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | BULLISH | 149.1 |
| AMWL American Well Corporation | $230M | -2.8 | -31.0 | -215.3 | -19.1 | -19.0 | 4 | BULLISH | 144.5 |
| BIOE Bio Essence Corporation | $20M | 11.3 | -392.9 | 38.8 | 34.0 | 416.6 | 5 | BULLISH | 508.7 |
| MAZE Maze Therapeutics, Inc. | $1.7B | -11.6 | -37.3 | -112.3 | — | — | 3 | BULLISH | 4.3 |
| AZTA Azenta, Inc. | $1.6B | -14.2 | -7.7 | -1.4 | 1.5 | 1.5 | 4 | BULLISH | 21.1 |
| GRRMF Gerresheimer AG | $1.2B | -2.8 | 1.6 | 2.2 | -2.3 | 11.8 | 4 | BULLISH | -27.1 |
| ENOV Enovis Corporation | $1.2B | -1.1 | -54.3 | -13.5 | -0.2 | 4.9 | 4 | BULLISH | -34.4 |
| TDVXF Dynavox Group AB (publ) | $900M | 27.8 | 39.7 | 17.2 | 12.8 | 8.8 | 8 | BULLISH | -22.7 |
| OM Outset Medical, Inc. | $80M | -1.1 | -59.2 | -97.3 | -56.8 | -1.3 | 4 | BULLISH | -70.6 |
| ZIVO ZIVO Bioscience, Inc. | $20M | -4.5 | 185.9 | 147.5 | — | -62.5 | 2 | BULLISH | -53.1 |
| SAEYY Redcare Pharmacy N.V. | $1.7B | -37.3 | -8.7 | -1.2 | 0.6 | 20.5 | 2 | BULLISH | -5.2 |
| KMTS Kestra Medical Technologies, Ltd. | $1.7B | -11.2 | -73.7 | -113.5 | -142.3 | 191.6 | 3 | BULLISH | 15.3 |
| AGL Agilon Health, Inc. | $1.5B | -5.9 | -78.9 | -273.7 | 1.2 | 0.3 | 6 | BULLISH | 273.6 |
| NWKHY Netcare Limited | $1.4B | 12.5 | 16.9 | 8.1 | 6.7 | 5.0 | 7 | BULLISH | 59.5 |
| LBRX LB Pharmaceuticals Inc Common Stock | $1.2B | -13.3 | -25.8 | -768.9 | — | — | 2 | BULLISH | 148.2 |
| OABIW OmniAb, Inc. | $1.1B | -13.8 | -16.9 | -16.8 | -43.7 | 66.9 | 6 | BULLISH | -17.6 |
| ARRJF Arjo AB (publ) | $920M | 25.3 | 4.6 | 4.4 | 2.0 | -2.0 | 6 | BULLISH | 3.1 |
| RIGL Rigel Pharmaceuticals, Inc. | $900M | 2.9 | 126.9 | 88.5 | 22.0 | 3.3 | 4 | BULLISH | 68.7 |
| VMD Viemed Healthcare, Inc. | $370M | 25.7 | 10.2 | 11.8 | 3.5 | 25.2 | 4 | BULLISH | 39.9 |
| MXCT MaxCyte, Inc. | $140M | -4.6 | -20.4 | -38.9 | -122.0 | -13.2 | 2 | BULLISH | -5.5 |
| HURA TuHURA Biosciences, Inc. | $140M | -3.9 | -161.4 | -137.6 | — | — | 2 | BULLISH | -7.9 |
| CCEL Cryo-Cell International, Inc. | $40M | -22.1 | 18.1 | -0.7 | 16.2 | -2.0 | 6 | BULLISH | 14.0 |
| INM InMed Pharmaceuticals Inc. | $10M | 14.6 | -129.6 | 732.1 | -0.2 | 37942.8 | 3 | BULLISH | -24.1 |
| EVH Evolent Health, Inc. | $540M | -1.0 | -79.0 | -1.8 | -4.3 | -4.5 | 5 | BULLISH | -43.4 |
| INFU InfuSystem Holdings, Inc. | $280M | 33.6 | 15.0 | 11.4 | 8.7 | 2.5 | 9 | BULLISH | 39.5 |
| IRLA IRulya Therapeutics Inc. | $30M | — | — | — | — | — | — | BULLISH | — |
| AGTX Agentix Corp. | — | -5.1 | 12.0 | 8.1 | — | — | 3 | BULLISH | 6.9 |
| QDEL QuidelOrtho Corporation | $940M | -0.9 | -45.9 | -13.7 | -14.7 | 0.1 | 4 | BULLISH | -55.5 |
| PACB Pacific Biosciences of California, Inc. | $660M | -5.7 | -929.3 | -29.4 | -114.7 | 2.0 | 2 | BULLISH | 21.3 |
| NAUT Nautilus Biotechnolgy, Inc. | $410M | -6.3 | -41.0 | -89.2 | -6682.1 | — | 2 | BULLISH | 136.9 |
| NUWE Nuwellis, Inc. | — | -0.0 | 202.0 | 173.3 | -245.2 | 8.4 | 5 | BULLISH | 65.2 |
| RARE Ultragenyx Pharmaceutical Inc. | $1.5B | -2.9 | 839.4 | -67.5 | -43.0 | 17.5 | 2 | BULLISH | -50.0 |
| CBWTF Auxly Cannabis Group Inc. | $250M | 10.4 | 16.6 | 2.2 | 16.8 | 10.8 | 7 | BULLISH | 71.5 |
| KRMD KORU Medical Systems, Inc. | $150M | -80.9 | -10.5 | -8.8 | 2.1 | 22.4 | 6 | BULLISH | -25.2 |
| BMGL Basel Medical Group Ltd Ordinary Shares | $10M | — | — | — | — | — | — | BULLISH | -76.8 |
| XNCR Xencor, Inc. | $1.9B | -13.8 | -29.1 | -152.4 | -42.4 | -36.1 | 2 | BULLISH | 127.0 |
| TGLVY Top Glove Corporation Bhd. | $1.7B | 25.1 | 6.3 | 8.5 | 12.6 | 21.4 | 8 | BULLISH | 51.4 |
| TRAX First Tracks Biotherapeutics Inc | $1.6B | — | — | — | — | — | — | BULLISH | — |
| SLN Silence Therapeutics plc | $930M | -5.2 | -90.4 | 157.8 | — | -97.6 | 1 | BULLISH | 171.0 |
| BBNX Beta Bionics, Inc. | $860M | -11.4 | -26.2 | -79.6 | -73.1 | 191.1 | 3 | BULLISH | 2.1 |
| PBYI Puma Biotechnology, Inc. | $570M | 20.4 | 22.0 | 52.8 | 14.5 | -2.9 | 6 | BULLISH | 108.8 |
| CV CapsoVision, Inc. | $370M | -10.7 | -226.6 | -73.0 | -205.4 | — | 2 | BULLISH | 37.8 |
| SGMT Sagimet Biosciences Inc. | $310M | -8.1 | -24.4 | -231.4 | — | — | 3 | BULLISH | 14.0 |
| OPRX OptimizeRx Corp. | $170M | 37.2 | 3.7 | 6.1 | -3.4 | -5.8 | 8 | BULLISH | -58.2 |
| HOWL Werewolf Therapeutics, Inc. | $50M | -1.4 | -119.9 | 354.7 | 17.5 | — | 4 | BULLISH | -41.2 |
| NNVC NanoViricides, Inc. | $40M | -3.5 | -101.5 | -111.4 | — | — | 3 | BULLISH | -4.6 |
| RAPH Raphael Pharmaceutical Inc. | $30M | -30.7 | 59.9 | 47.0 | — | — | 2 | BULLISH | 277.5 |
| MBRX Moleculin Biotech, Inc. | $10M | -0.0 | -1371.6 | -494.1 | — | — | 3 | BULLISH | -23.7 |
| AZTR Azitra, Inc. | — | -0.1 | -256.7 | -959.6 | — | — | 5 | BULLISH | 94.8 |
| XRAY DENTSPLY SIRONA Inc. | $1.9B | -3.4 | -33.0 | 9.9 | 4.1 | -0.8 | 5 | BULLISH | -27.6 |
| IDGXF Integrated Diagnostics Holdings plc | $340M | 10.4 | 41.4 | 38.4 | 13.8 | 46.8 | 8 | BULLISH | 10.8 |
| HBIO Harvard Bioscience, Inc. | $40M | -3.6 | -89.9 | 1.8 | -12.8 | -1.1 | 7 | BULLISH | 104.7 |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. | $20M | -0.2 | -90.1 | -46.0 | — | — | 4 | BULLISH | 67.0 |
| TBIO Telesis Bio, Inc. | — | -0.0 | -180.9 | -154.3 | -424.1 | -54.9 | 3 | BULLISH | 250.9 |
| NBTX Nanobiotix S.A. | $1.5B | -27.5 | 104.2 | 62.0 | -626.0 | 49.1 | 4 | BULLISH | 79.8 |
| BOLT Bolt Biotherapeutics, Inc. | $10M | -0.4 | -111.6 | -138.8 | -154400.0 | 12.8 | 3 | BULLISH | 6.2 |
| BDRX Biodexa Pharmaceuticals Plc | — | -0.1 | -42.3 | -117.9 | — | — | 2 | BULLISH | -89.1 |
| CBDG THC Farmaceuticals, Inc. | — | -30.9 | 2.0 | -0.9 | — | 28.1 | 5 | BULLISH | -63.1 |
| NTLA Intellia Therapeutics, Inc. | $1.6B | -3.7 | -55.4 | -92.1 | -1392.3 | 12.6 | 5 | BULLISH | -52.0 |
| CSTL Castle Biosciences, Inc. | $1.0B | -52.3 | -4.2 | -10.6 | -2.0 | 3.2 | 4 | BULLISH | 40.8 |
| PHAR Pharming Group N.V. | $710M | 81.7 | 3.6 | 3.2 | 1.8 | 7.8 | 7 | BULLISH | -12.7 |
| CARL Carlsmed, Inc. | $400M | -11.3 | -43.8 | -122.7 | -55.5 | — | 2 | BULLISH | 14.4 |
| HLTRF HLS Therapeutics Inc. | $90M | -12.0 | -14.1 | -4.2 | -7.0 | -0.2 | 5 | BULLISH | -20.4 |
| BGMS Bio Green Med Solution, Inc. | $10M | -0.3 | -30.7 | -64.2 | -120.5 | — | 2 | BULLISH | -48.7 |
| PCSA Processa Pharmaceuticals, Inc. | $10M | -0.3 | -464.2 | 1977.5 | — | — | 2 | BULLISH | -76.5 |
| HYEX Healthy Extracts Inc. | $10M | -8.1 | -7.7 | -2.8 | -6.3 | 84.1 | 5 | BULLISH | -42.1 |
| PCRX Pacira BioSciences, Inc. | $1.4B | 103.4 | 2.0 | 1.8 | 2.4 | 5.7 | 8 | BULLISH | 67.4 |
| KHTRF Knight Therapeutics Inc. | $810M | 76.7 | 1.9 | 2.6 | -2.3 | 42.4 | 8 | BULLISH | 98.5 |
| SUSRF Surgical Science Sweden AB (publ) | $280M | 32.0 | 2.1 | 2.7 | 8.2 | 8.1 | 6 | BULLISH | -37.8 |
| ICCC ImmuCell Corporation | $90M | 121.3 | 2.6 | 10.2 | 25.5 | 8.5 | 6 | BULLISH | 68.8 |
| OMCL Omnicell, Inc. | $1.7B | 43.0 | 3.1 | 3.2 | 7.8 | 8.5 | 9 | BULLISH | 18.2 |
| VTRLY Vitrolife AB (publ) | $1.4B | -3.1 | -46.2 | -41.3 | 14.3 | -2.0 | 5 | BULLISH | -34.0 |
| OPK OPKO Health, Inc. | $1.2B | -16.9 | -5.9 | -3.0 | -5.1 | -11.5 | 2 | BULLISH | 7.3 |
| EMBC Embecta Corp. | $380M | 4.4 | -13.6 | 26.3 | 7.8 | -7.6 | 5 | BULLISH | -53.7 |
| DH Definitive Healthcare Corp. | $120M | -0.7 | -75.0 | 96.7 | -9.8 | -5.0 | 6 | BULLISH | -62.6 |
| CVALF Covalon Technologies Ltd. | $80M | 27.9 | 14.3 | 28.5 | 28.0 | 4.2 | 8 | BULLISH | 117.2 |
| PLUR Pluri Inc. | $10M | -0.5 | 163.6 | -483.9 | -1755.2 | -24.0 | 2 | BULLISH | -69.5 |
| VIBEF Vibe Growth Corporation | — | -0.2 | 40.9 | -1.4 | -8.6 | 24.4 | 6 | BULLISH | 626.0 |
| IDTA IDenta Corp. | — | 9.8 | 13.8 | 25.0 | -9.1 | 57.3 | 8 | BULLISH | 95.5 |
| EBYH Strainsforpains, Inc. | — | -23.4 | -3.4 | 16.3 | -603.3 | 1679.9 | 5 | BULLISH | 54.5 |
| CASBF CanSino Biologics Inc. | $1.4B | 383.8 | 0.8 | -1.2 | 11.0 | 32.5 | 7 | BULLISH | -25.5 |
| REPL Replimune Group, Inc. | $1.1B | -4.1 | -134.3 | -1055.2 | — | — | 1 | BULLISH | 48.3 |
| CTSO Cytosorbents Corporation | $20M | -0.8 | -336.2 | -46.3 | -45.9 | 3.1 | 4 | BULLISH | -72.2 |
| ACUR Acura Pharmaceuticals, Inc. | — | -0.0 | 30.8 | -306.4 | 80.6 | -56.2 | 4 | BULLISH | 0.0 |
| SNNC Sibannac, Inc. | — | -2.4 | 44.4 | 105.9 | — | -14.2 | 3 | BULLISH | -64.3 |
| PPCB Propanc Biopharma, Inc. | — | -0.1 | -161.9 | -166.7 | — | — | 4 | BULLISH | 59.9 |
| UMCN UMC, Inc. | $50M | -93.7 | -840.4 | -95.6 | -590.7 | 2325.0 | 4 | BULLISH | 483.3 |
| PFHO Pacific Health Care Organization, Inc. | $10M | 12.3 | 7.5 | 60.8 | 18.4 | -2.6 | 4 | BULLISH | -13.0 |
| HALB Halberd Corporation | — | -25.4 | 11.6 | 12.4 | — | -52.1 | 1 | BULLISH | -13.9 |
| FZMD Fuse Medical, Inc. | — | 15.0 | -177.1 | -13.7 | 6.2 | -5.8 | 5 | BULLISH | -50.0 |
| RDGT Ridgetech, Inc. | — | -0.0 | -3.6 | -5.9 | -1.7 | 170.8 | 4 | BULLISH | -52.8 |
| KOAN Resonate Blends, Inc. | — | -0.0 | 46.5 | -991.9 | -399.0 | -32.1 | 4 | BULLISH | -96.8 |
| HADV Health Advance Inc. | — | -4.4 | 77.3 | -29.9 | — | — | 1 | BULLISH | 0.0 |
| LMAT LeMaitre Vascular, Inc. | $1.9B | 28.9 | 16.8 | 25.6 | 24.2 | 11.8 | 8 | BULLISH | -5.8 |
| ABSI Absci Corporation | $1.6B | -13.2 | -57.7 | -213.1 | -10443.4 | -62.3 | 5 | BULLISH | 147.5 |
| CRON Cronos Group Inc. | $1.2B | 18.1 | 6.5 | 5.4 | 60.5 | 72.9 | 7 | BULLISH | 34.1 |
| PRCT PROCEPT BioRobotics Corporation | $1.1B | -10.2 | -30.2 | -47.6 | -28.4 | 22.7 | 2 | BULLISH | -43.4 |
| CRMD CorMedix Inc. | $610M | 3.3 | 54.9 | 57.2 | 25.5 | 280.5 | 5 | BULLISH | -28.4 |
| IOBCF Ion Beam Applications S.A. | $550M | 19.7 | 20.6 | 14.0 | 2.9 | 7.0 | 5 | BULLISH | 39.5 |
| TCMD Tactile Systems Technology, Inc. | $540M | 21.5 | 11.9 | 13.8 | 9.1 | 17.2 | 8 | BULLISH | 55.4 |
| NRC NRC Health | $490M | 71.9 | 42.0 | 9.9 | -9.3 | -0.2 | 6 | BULLISH | 48.3 |
| SI Shoulder Innovations, Inc. | $410M | -11.3 | -28.2 | -69.1 | -59.1 | — | 1 | BULLISH | 57.7 |
| DTIL Precision BioSciences, Inc. | $180M | -2.4 | -135.1 | 203.1 | — | 3473.0 | 5 | BULLISH | 1.0 |
| NRXS NeurAxis, Inc. | $90M | -9.6 | -143.2 | 464.1 | -118.1 | 65.2 | 6 | BULLISH | 110.9 |
| OKYO OKYO Pharma Limited | $70M | -6.2 | -263.8 | 88.0 | — | — | 3 | BULLISH | -37.7 |
| PROCF Sofgen Pharma S.A. | $60M | — | — | — | — | — | — | BULLISH | — |
| XERS Xeris Biopharma Holdings, Inc. | $1.9B | -107.6 | 118.2 | 18.3 | -33.8 | 36.3 | 6 | BULLISH | 13.5 |
| ADCT ADC Therapeutics S.A. | $180M | -2.4 | 45.3 | 260.9 | -86.1 | 2.0 | 2 | BULLISH | -61.1 |
| SCNLF Scancell Holdings plc | $170M | -5.1 | 153.2 | 179.2 | — | -100.0 | 2 | BULLISH | 969.8 |
| ZYBT Zhengye Biotechnology Holding Limited | $70M | — | — | — | — | — | — | BULLISH | -39.3 |
| ESTA Establishment Labs Holdings Inc. | $1.9B | -51.2 | -175.3 | -6.9 | -17.4 | 38.6 | 5 | BULLISH | 36.4 |
| ZEOX Zeo ScientifiX, Inc. | $10M | -2.4 | -140.0 | 105.8 | -5.6 | — | 2 | BULLISH | — |
| VRSEF Verisante Technology Inc. | — | 5.4 | 124.9 | 102.2 | — | — | 3 | BULLISH | 354.6 |
| CLGN CollPlant Biotechnologies Ltd. | — | -0.4 | -162.0 | -369.3 | -2524.1 | -86.8 | 2 | BULLISH | -82.9 |
| VOR Vor Biopharma Inc. | $990M | 0.1 | -73.6 | 22.2 | — | — | 3 | BULLISH | -28.1 |
| KMDA Kamada Ltd. | $450M | 21.0 | 8.4 | 11.0 | 16.9 | 13.2 | 7 | BULLISH | 17.2 |
| ALEC Alector, Inc. | $200M | -1.9 | -385.1 | 66.8 | -692.5 | -82.9 | 1 | BULLISH | 40.0 |
| SYRA Syra Health Corp. Class A Common Stock | $10M | 98.3 | 5.2 | 11.3 | 10.5 | 0.3 | 4 | BULLISH | 1006.2 |
| ACUT Accustem Sciences Inc. | — | -1.4 | 49.7 | 34.0 | -256.7 | 2610.7 | 4 | BULLISH | -88.8 |
| KNBIF Kane Biotech Inc. | — | -2.4 | 439.7 | -2166.6 | -10238.1 | -97.9 | 2 | BULLISH | -27.9 |
| HDVY Health Discovery Corporation | — | -0.1 | -3852.6 | 357.6 | — | -100.0 | 1 | BULLISH | 100.0 |
| RXRX Recursion Pharmaceuticals, Inc. | $2.0B | -3.9 | -56.6 | -99.7 | -1708.0 | -14.9 | 4 | BULLISH | -33.0 |
| PAHC Phibro Animal Health Corporation | $1.6B | 15.6 | 29.7 | 13.2 | 5.5 | 17.1 | 7 | BULLISH | -9.1 |
| KROS Keros Therapeutics, Inc. | $220M | -3.1 | -17.2 | -392.2 | — | -93.6 | 3 | BULLISH | -24.0 |
| TXTM ProText Mobility, Inc. | $90M | 86.0 | -0.4 | -0.3 | — | -100.0 | 1 | BULLISH | 273.9 |
| NEGXF NexgenRx Inc. | $30M | — | 30.1 | -9.7 | 19.7 | 12.0 | 4 | BULLISH | 120.0 |
| CNNC Cannonau Corp. | — | 0.0 | -96.5 | -93.3 | — | -100.0 | 2 | BULLISH | -33.3 |
| IMCR Immunocore Holdings plc | $1.6B | -177.3 | -2.3 | -472.0 | -0.7 | 13.4 | 4 | BULLISH | -3.4 |
| CNMD CONMED Corporation | $1.5B | 25.5 | 5.5 | 5.2 | 6.7 | 3.4 | 7 | BULLISH | -1.3 |
| PNTG The Pennant Group, Inc. | $1.5B | 44.3 | 9.6 | 5.5 | 3.0 | 37.9 | 6 | BULLISH | 72.8 |
| DMAC DiaMedica Therapeutics Inc. | $470M | -12.1 | -114.6 | 616.3 | — | — | 2 | BULLISH | 26.3 |
| DMRA Damora Therapeutics, Inc. | $1.3B | — | — | — | — | — | — | BULLISH | — |
| MLTX MoonLake Immunotherapeutics | $1.0B | -3.1 | -67.4 | 2902.7 | — | — | 1 | BULLISH | 25.3 |
| TNPH Tian'an Pharmaceutical Co., Ltd. | $20M | -1961.1 | 0.3 | 33.0 | — | -100.0 | 3 | BULLISH | 1150.0 |
| PDSB PDS Biotechnology Corporation | $60M | -2.0 | -544.0 | 456.9 | — | — | 1 | BULLISH | 41.4 |
| NYMXF Nymox Pharmaceutical Corporation | $10M | -0.9 | 193.9 | 89.4 | — | — | 2 | BULLISH | -63.2 |
| AIBT Aibotics Inc. | — | — | — | — | — | — | — | BULLISH | — |
| IPIX Innovation Pharmaceuticals Inc. | — | -0.1 | -115.7 | -377.9 | — | -133.3 | 3 | BULLISH | -25.0 |
| PULM Pulmatrix, Inc. | $10M | -1.4 | -98.3 | -835.1 | — | -100.0 | 3 | BULLISH | -69.2 |
| NUMIF Numinus Wellness Inc. | $10M | -0.8 | 57.6 | 40.6 | -18.7 | 429.3 | 5 | BULLISH | -46.4 |
| IGPK Integrated Cannabis Solutions, Inc. | $10M | 8.0 | -3.2 | -5.2 | 0.6 | 2762.5 | 5 | BULLISH | -75.0 |
| SHWGF Shandong Weigao Group Medical Polymer Company Limited | $1.9B | 9.2 | 5.6 | 7.4 | 11.3 | 2.2 | 6 | BULLISH | -39.1 |
| JCRRF JCR Pharmaceuticals Co., Ltd. | $460M | 75.7 | 1.9 | -0.5 | -19.7 | 66.6 | 4 | BULLISH | -17.1 |
| TCRT Alaunos Therapeutics, Inc. | $10M | -1.1 | -185.9 | -607.2 | — | -50.0 | 1 | BULLISH | -26.9 |
| CDXQ China De Xiao Quan Care Group Co., Ltd | — | 0.1 | -136.1 | -277.5 | — | — | 4 | BULLISH | 2000.0 |
| APLIF Appili Therapeutics Inc. | — | — | 27.8 | 79.4 | -1441.5 | 277.2 | 2 | BULLISH | -63.2 |
| UPHL UpHealth, Inc. | — | -0.0 | -84.2 | -4.7 | — | -46.7 | 3 | BULLISH | 50.0 |
| CNHC China Health Management Corp. | — | 13.7 | 3.2 | 3.3 | 29.8 | -1.0 | 6 | BULLISH | 53.6 |
| YBGJ Yubo International Biotech Limited | — | -1.7 | 28.2 | 30.1 | — | 9417.8 | 5 | BULLISH | -20.6 |
| EDIT Editas Medicine, Inc. | $370M | -3.5 | -118.8 | 71.4 | -153.3 | 20.8 | 4 | BULLISH | -30.1 |
| AIMV AI Maverick Intel, Inc. | $10M | — | — | — | — | — | — | BULLISH | — |
| CSWYF China Shineway Pharmaceutical Group Limited | $760M | 6.0 | 19.9 | 46.7 | 21.6 | 1081.8 | 8 | BULLISH | 0.0 |
| PEPG PepGen Inc. | $170M | -1.7 | -75.5 | -327.5 | — | — | 4 | BULLISH | -43.1 |
| BCCOY BICO Group AB (publ) | $190M | -2.0 | -41.5 | -8.4 | -11.1 | -19.8 | 6 | BULLISH | -9.6 |
| LGNDZ Ligand Pharmaceuticals, Inc. | — | 0.0 | 20.4 | 11.3 | 76.2 | — | 3 | BULLISH | — |
| SOPH SOPHiA GENETICS S.A. | $630M | -6.6 | -101.2 | -155.2 | -95.9 | 23.6 | 3 | LEAN BULL | 77.4 |
| NGNE Neurogene Inc. | $370M | -4.9 | -45.3 | -111469.0 | — | — | 2 | LEAN BULL | -9.7 |
| BCYC Bicycle Therapeutics plc | $250M | -1.4 | -32.3 | -1197.0 | -8002.1 | 217.4 | 4 | LEAN BULL | -52.0 |
| LCTX Lineage Cell Therapeutics, Inc. | $250M | -7.3 | -59.0 | -171.3 | 138.6 | 19.9 | 5 | LEAN BULL | -39.4 |
| ABOS Acumen Pharmaceuticals, Inc. | $140M | -1.5 | -162.7 | 466.8 | — | — | 2 | LEAN BULL | 2.3 |
| LUNG Pulmonx Corporation | $80M | -2.0 | -88.9 | -92.5 | -44.3 | -3.4 | 4 | LEAN BULL | 20.7 |
| IUGNF Imugene Limited | $30M | -0.1 | -389.5 | -458.5 | — | -100.0 | 1 | LEAN BULL | -74.0 |
| GRCU Global Roundtable Corporation | — | -2.9 | 28.1 | 25.5 | -673.8 | 35.7 | 7 | LEAN BULL | 9900.0 |
| BSSP Baseline Productions, Inc. | — | -0.0 | 167.7 | 64.9 | — | — | 2 | LEAN BULL | 100.0 |
| MICR Micron Solutions, Inc. | — | -0.1 | -32.9 | -10.2 | -16.0 | 19.3 | 3 | LEAN BULL | 25450.0 |
| AGFAF Digicann Ventures Inc. | — | -0.0 | 30.8 | 63.6 | — | — | 2 | LEAN BULL | 47.7 |
| INFIQ Infinity Pharmaceuticals, Inc. | — | -0.0 | 109.5 | 60.9 | -1707.7 | — | 2 | LEAN BULL | 0.0 |
| RLBD Real Brands, Inc. | — | -0.2 | 62.2 | 111.8 | — | 204.2 | 5 | LEAN BULL | 900.0 |
| MHTX Manhattan Scientifics, Inc. | — | -0.0 | 45.1 | 23.3 | — | 104.9 | 3 | LEAN BULL | 0.0 |
| ARDS Aridis Pharmaceuticals, Inc. | — | -0.0 | 4.8 | 10.0 | -19.9 | 2227.6 | 4 | LEAN BULL | -92.3 |
| SGHT Sight Sciences, Inc. | $500M | -16.2 | -48.4 | -145.7 | -19.0 | 9.3 | 4 | LEAN BULL | 71.0 |
| PTCHF PureTech Health plc | $390M | 156.9 | 0.2 | 50.8 | 1890.6 | 7.7 | 4 | LEAN BULL | -5.4 |
| OBIO Orchestra BioMed Holdings, Inc. | $340M | -5.8 | -397.3 | 468.3 | -26994.3 | 986.1 | 4 | LEAN BULL | 46.0 |
| ACOG Alpha Cognition Inc | $130M | -8.2 | -55.3 | -198.4 | -144.3 | 232.7 | 2 | LEAN BULL | 11.1 |
| EVGRF China Evergrande New Energy Vehicle Group Limited | $20M | -12.9 | 104.0 | 16.8 | -766929.9 | 284.5 | 4 | LEAN BULL | 185.7 |
| PRVCF PreveCeutical Medical Inc. | $10M | -16.7 | 9.9 | 96.4 | — | — | 3 | LEAN BULL | -44.7 |
| CKDXF Ceryvyn Therapeutics Ltd | $10M | 0.1 | -243.9 | 2882.8 | — | -97.3 | 3 | LEAN BULL | -97.6 |
| CALA Calithera Biosciences, Inc. | — | -0.0 | -141.5 | 979.6 | — | -100.0 | 1 | LEAN BULL | 200.0 |
| THCT THC Therapeutics, Inc. | — | -0.0 | 16.8 | 16.9 | — | — | 2 | LEAN BULL | 300.0 |
| NEWUF Newtopia Inc. | — | -0.1 | 75.4 | 107.5 | -166.7 | -36.4 | 2 | LEAN BULL | 0.0 |
| MSTH Mystic Holdings, Inc. | — | -0.2 | -35.2 | -19.8 | -27.1 | 24.7 | 5 | LEAN BULL | -79.2 |
| MNZO Manzo Pharmaceuticals, Inc. | — | -9.8 | 4.6 | 4.1 | — | — | 2 | LEAN BULL | 0.0 |
| CYYNF Cynata Therapeutics Limited | — | -0.3 | -326.4 | 584.9 | — | -100.0 | 1 | LEAN BULL | -93.9 |
| EFTR eFFECTOR Therapeutics, Inc. | — | -0.0 | 1737.6 | 607.9 | — | -91.9 | 4 | LEAN BULL | 300.0 |
| MSGP MedSmart Group Inc. | — | -0.6 | 33.6 | 85.8 | — | -100.0 | 1 | LEAN BULL | 2000.0 |
| BIEI Premier Graphene, Inc. | — | -28.3 | 9.8 | 7.4 | — | -100.0 | 5 | LEAN BULL | 28.6 |
| USPH U.S. Physical Therapy, Inc. | $1.3B | 513.8 | -1.3 | 7.7 | 0.7 | 17.1 | 5 | LEAN BULL | -3.7 |
| DBCCF Decibel Cannabis Company Inc. | $50M | -115.6 | -1.0 | -3.0 | 11.7 | 26.5 | 3 | LEAN BULL | -2.2 |
| IRIX IRIDEX Corporation | $10M | -3.6 | -73.1 | -73.9 | -10.1 | 3.7 | 5 | LEAN BULL | -32.7 |
| ENSC Ensysce Biosciences, Inc. | $10M | -0.2 | -968.3 | 792.9 | -220.8 | -77.6 | 3 | LEAN BULL | -79.8 |
| TSMRF Tsumura & Co. | $1.7B | 9.2 | 9.9 | 6.6 | 13.0 | 10.7 | 4 | LEAN BULL | 0.0 |
| SWGHF Sawai Group Holdings Co., Ltd. | $1.3B | 22.7 | 4.3 | 4.6 | 4.7 | 11.4 | 4 | LEAN BULL | 0.0 |
| TWAPF Towa Pharmaceutical Co., Ltd. | $1.3B | 21.0 | 4.7 | 3.2 | 7.7 | 7.1 | 7 | LEAN BULL | 54.4 |
| KKPCF Kaken Pharmaceutical Co., Ltd. | $980M | 14.0 | 6.9 | 7.9 | 28.0 | -6.6 | 4 | LEAN BULL | 8.3 |
| CPIVF Captiva Verde Wellness Corp. | $30M | -40.6 | -49.0 | -123.3 | — | — | 2 | LEAN BULL | 500.0 |
| NTRR Neutra Corp. | — | 2.0 | -139.6 | -802.5 | -3.8 | 142.2 | 7 | LEAN BULL | -33.3 |
| VREX Varex Imaging Corporation | $780M | 35.2 | 4.6 | 7.6 | 7.5 | 5.3 | 6 | LEAN BULL | 54.0 |
| STOK Stoke Therapeutics, Inc. | $1.6B | -7.8 | -61.1 | -318.5 | -660.8 | -86.2 | 2 | LEAN BULL | -19.1 |
| CERS Cerus Corporation | $470M | -66.3 | -10.8 | -7.4 | -5.1 | 15.1 | 5 | LEAN BULL | 56.9 |
| CCCC C4 Therapeutics, Inc. | $380M | -3.2 | -48.1 | -175.0 | -355.9 | 2.3 | 4 | LEAN BULL | 31.0 |
| ZURA Zura Bio Limited | $320M | -3.8 | -65.4 | 806.5 | — | — | 2 | LEAN BULL | 15.7 |
| STIM Neuronetics, Inc. | $160M | -5.1 | -135.3 | -21.3 | -8.3 | 39.6 | 4 | LEAN BULL | -29.8 |
| EKDHF EKF Diagnostics Holdings plc | $140M | 42.1 | 3.5 | 5.2 | 9.3 | 2.5 | 7 | LEAN BULL | -17.8 |
| LOBEF Lobe Sciences Ltd. | $10M | -2.7 | 359.0 | 181.6 | — | — | 2 | LEAN BULL | 29.6 |
| BIVI BioVie Inc. | $10M | -0.4 | -0.0 | -0.0 | — | — | 3 | LEAN BULL | -23.4 |
| VSBC VitaSpring Biomedical Co. Ltd. | $10M | -13.8 | 10.3 | 15.9 | — | -100.0 | 4 | LEAN BULL | -96.8 |
| HEPA Hepion Pharmaceuticals, Inc. | — | -0.6 | -125.6 | 710.2 | — | — | 3 | LEAN BULL | 92.1 |
| TGIFF 1933 Industries Inc. | — | 6.2 | -14.6 | -33.1 | 8.9 | -11.8 | 5 | LEAN BULL | -48.0 |
| BTAX Biostax Corp. | — | -0.0 | 7.3 | 5.8 | — | — | 2 | LEAN BULL | 100.0 |
| OMHE OMNI Health, Inc. | — | 0.0 | 30.4 | -8.8 | -6.1 | 2046.4 | 4 | LEAN BULL | 233.3 |
| CENBF CEN Biotech, Inc. | — | -0.0 | 32.0 | -64.0 | 569.4 | -54.9 | 5 | LEAN BULL | 100.0 |
| CNFHF CanaFarma Hemp Products Corp. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| VAXX Vaxxinity, Inc. | — | -0.2 | -150.6 | 2534.7 | — | — | 0 | LEAN BULL | 23.3 |
| REVB Revelation Biosciences, Inc. | — | -0.1 | -154.8 | 1317.2 | — | — | 4 | LEAN BULL | 194.5 |
| AFIB Acutus Medical, Inc. | — | -0.0 | 153.1 | -0.4 | -19.7 | 375.7 | 2 | LEAN BULL | -87.5 |
| PBIO Pressure BioSciences, Inc. | — | -0.0 | 100.6 | 84.5 | -1687.2 | -25.3 | 3 | LEAN BULL | -98.7 |
| BGMD BG Medicine, Inc. | — | -0.0 | 747.3 | 104.5 | -311.0 | -43.8 | 5 | LEAN BULL | 0.0 |
| HPMM Hemp Naturals, Inc. | — | -0.0 | -141.5 | -78.5 | — | — | 3 | LEAN BULL | -80.0 |
| ERGO Entia Biosciences, Inc. | — | -0.0 | 106.8 | 92.5 | -1021.5 | -23.5 | 5 | LEAN BULL | 900.0 |
| BGXXQ Bright Green Corporation | — | — | — | — | — | — | — | LEAN BULL | — |
| ESMC Escalon Medical Corp. | — | 0.7 | 102.3 | -0.0 | 46.1 | 5.7 | 7 | LEAN BULL | 10.1 |
| MDCN Medican Enterprises, Inc. | — | -3.4 | 40.4 | -2.1 | — | -38.5 | 3 | LEAN BULL | -0.0 |
| SMAS Somatic Systems, Inc. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| SONX Sonendo, Inc. | — | -0.4 | -166.8 | -185.6 | -76.7 | -27.7 | 5 | LEAN BULL | 212.2 |
| PXMD PaxMedica, Inc. Common Stock | — | -0.0 | -7716.2 | 572.1 | — | — | 2 | LEAN BULL | 600.0 |
| INNV Innovage Holding Corp. | $1.3B | -440.6 | -1.1 | -89.6 | 3.2 | 16.4 | 6 | LEAN BULL | 73.1 |
| COLL Collegium Pharmaceutical, Inc. | $750M | 15.0 | 17.6 | 9.4 | -7.5 | 14.3 | 6 | LEAN BULL | -34.8 |
| HITI High Tide Inc. | $230M | -9.9 | -27.0 | 0.8 | 5.7 | 26.8 | 3 | LEAN BULL | -19.6 |
| VASO Vaso Corporation | $50M | 17.9 | 10.0 | -3055.8 | 7.5 | -8.0 | 8 | LEAN BULL | 150.0 |
| ACHFF Arch Biopartners Inc. | $40M | -20.5 | 73.5 | 165.4 | — | 100.0 | 2 | LEAN BULL | -12.6 |
| CBIH Cannabis Bioscience International Holdings, Inc. | — | -0.0 | 48.2 | 34.0 | -341.5 | -58.2 | 1 | LEAN BULL | -50.0 |
| PRLD Prelude Therapeutics Incorporated | $210M | -4.9 | -57.7 | 14236.3 | -244.1 | 220.3 | 5 | LEAN BULL | 139.5 |
| BRVE Braveheart Bio, Inc. | $1.5B | — | — | — | — | — | — | LEAN BULL | — |
| SRZN Surrozen, Inc. | $190M | -0.7 | 387.2 | 11.1 | 1003.5 | -8.8 | 2 | LEAN BULL | 114.8 |
| TRIB Trinity Biotech plc | $150M | -0.2 | 69.8 | -14.6 | -157.8 | -28.8 | 2 | LEAN BULL | 615.0 |
| MDNAF Medicenna Therapeutics Corp. | $20M | — | — | — | — | — | — | LEAN BULL | — |
| ABPO Abpro Holdings, Inc. | — | — | — | — | — | — | — | LEAN BULL | — |
| GMRS GMR Solutions Inc. | $580M | — | — | — | — | — | — | LEAN BULL | — |
| CYDY CytoDyn Inc. | $380M | -5.0 | 57.8 | 24.6 | — | 100.0 | 4 | LEAN BULL | -16.2 |
| SPRB Spruce Biosciences, Inc. | $130M | -1.1 | -106.0 | 772.2 | — | -100.0 | 4 | LEAN BULL | -65.7 |
| VYYRF Voyageur Pharmaceuticals Ltd. | $20M | -6.5 | -527.9 | -47345.4 | -6124.5 | — | 3 | LEAN BULL | -8.4 |
| PIIIW P3 Health Partners Inc. | $20M | -0.1 | -168.8 | -64.8 | 1.9 | 2.8 | 4 | LEAN BULL | -18.1 |
| OCEA Ocean Biomedical, Inc. | — | -0.0 | 36.5 | 0.3 | — | — | 1 | LEAN BULL | -20.0 |
| PVLA Palvella Therapeutics, Inc. | $1.8B | -27.5 | -46.6 | 137.5 | — | — | 3 | LEAN BULL | 82.1 |
| TYRA Tyra Biosciences, Inc. | $1.2B | -9.0 | -45.3 | -2390.9 | — | — | 2 | LEAN BULL | 51.2 |
| STLN Starling Oncology, Inc. | $670M | — | — | — | — | — | — | LEAN BULL | — |
| PRTA Prothena Corporation plc | $420M | -10.6 | -14.4 | -871.5 | -1839.9 | 427.3 | 5 | LEAN BULL | -10.3 |
| ENTA Enanta Pharmaceuticals, Inc. | $340M | -5.1 | -70.1 | 141.5 | -135.8 | 0.7 | 4 | LEAN BULL | 15.9 |
| GLSI Greenwich LifeSciences, Inc. | $240M | -11.3 | -951.6 | 299.9 | — | — | 2 | LEAN BULL | 74.4 |
| CLNN Clene Inc. | $60M | -1.1 | 237.2 | 132.5 | -14915.6 | -31.1 | 2 | LEAN BULL | -52.4 |
| POSC Positron Corporation | $60M | -5.5 | 1961.0 | -1406.8 | -734.6 | -22.9 | 2 | LEAN BULL | 11.0 |
| CRYM Cryomass Technologies Inc. | — | -0.0 | 137.2 | 57.9 | -22040.0 | -96.0 | 2 | LEAN BULL | -60.0 |
| EHOS Ehouse Global, Inc. | — | -0.0 | 161.0 | 52.5 | — | — | 1 | LEAN BULL | 0.0 |
| BBBT Black Bird Biotech, Inc. | — | -0.0 | 129.1 | 137.7 | -3333.2 | -61.0 | 2 | LEAN BULL | 0.0 |
| FWDG FutureWorld Corp. | — | -0.1 | -1.2 | -0.5 | -507.1 | 153.6 | 5 | LEAN BULL | 0.0 |
| ATEC Alphatec Holdings, Inc. | $1.7B | -15.1 | -623.1 | -7.6 | -12.1 | 19.5 | 5 | LEAN BULL | -32.5 |
| IUSDF AS ONE Corporation | $1.0B | 19.1 | 12.2 | 13.4 | 8.1 | 5.7 | 6 | LEAN BULL | -39.5 |
| KJFI Comjoyful International Company | $210M | -98.4 | 171.5 | -1549.9 | 44.3 | 38.8 | 6 | LEAN BULL | 459.8 |
| ETBI Eastgate Biotech Corp. | $10M | -2.6 | 93.4 | 134.9 | -7057.2 | -53.0 | 3 | LEAN BULL | 66.7 |
| HCTI Healthcare Triangle, Inc. | $10M | -0.0 | -57.4 | -19.3 | -48.0 | 116.4 | 3 | LEAN BULL | -95.8 |
| RSCF Reflect Scientific, Inc. | — | 15.8 | 12.1 | 17.0 | 15.2 | 76.0 | 6 | LEAN BULL | 20.6 |
| DNAG DNAPrint Genomics, Inc. | — | -0.0 | 63.1 | -156.0 | -826.7 | -15.2 | 3 | LEAN BULL | 100.0 |
| WHSI Wearable Health Solutions, Inc. | — | -0.1 | 37.4 | 155.3 | 98.4 | -29.7 | 2 | LEAN BULL | 0.0 |
| PXYN Praxsyn Corporation | — | -0.0 | 159.9 | 101.7 | 14.5 | 14.7 | 4 | LEAN BULL | 0.0 |
| REFG Medical Cannabis Payment Solutions | — | -3.0 | 1.2 | 1.5 | — | — | 2 | LEAN BULL | 200.0 |
| ONCSQ OncoSec Medical Incorporated | — | -0.0 | -410.2 | 452.1 | — | — | 2 | LEAN BULL | -90.0 |
| RBSH Rebus Holdings, Inc. | — | -0.0 | -9.7 | 8.9 | — | — | 2 | LEAN BULL | 0.0 |
| RBII Rising Biosciences, Inc. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| XBRAF Xebra Brands Ltd. | — | -0.1 | -542.1 | -2373.1 | — | -100.0 | 1 | LEAN BULL | -98.5 |
| PMHS Polomar Health Services, Inc. | — | — | — | — | — | — | — | LEAN BULL | — |
| DVLP Golden Developing Solutions, Inc. | — | -0.0 | 450.9 | 46.1 | -166.7 | — | 6 | LEAN BULL | -90.0 |
| LPTI Longport, Inc. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| ALGWF Alliance Growers Corp. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| CPMV Mosaic ImmunoEngineering Inc. | — | -2.8 | 9.2 | 7.5 | — | — | 2 | LEAN BULL | -51.2 |
| CNGGF Cann Group Limited | — | 0.3 | 157.4 | -25.1 | -150.3 | -35.4 | 5 | LEAN BULL | -40.8 |
| ELIXF Elixxer Ltd. | — | -0.2 | 27.1 | 280.4 | — | — | 2 | LEAN BULL | -58.1 |
| SRPT Sarepta Therapeutics, Inc. | $1.9B | -13.1 | -9.5 | -6.3 | -1.2 | -20.4 | 4 | NEUTRAL | -17.2 |
| MLAB Mesa Laboratories, Inc. | $720M | 150.3 | 2.7 | 4.4 | 4.7 | 3.0 | 8 | NEUTRAL | 63.6 |
| OFIX Orthofix Medical Inc. | $400M | -6.3 | -13.9 | -3.6 | -7.5 | 3.0 | 6 | NEUTRAL | -39.2 |
| SERA Sera Prognostics, Inc. | $80M | -3.1 | -45.0 | -184.9 | -30463.3 | -35.2 | 3 | NEUTRAL | -43.8 |
| ABVC ABVC BioPharma, Inc. | $30M | -3.6 | -82.2 | -43.0 | — | -100.0 | 2 | NEUTRAL | -64.4 |
| REZNF Street Capital Inc. | — | -3.3 | 20.7 | 15.0 | — | -44.3 | 5 | NEUTRAL | 566.7 |
| VSEED VSee Health, Inc. | — | — | — | — | — | — | — | NEUTRAL | — |
| SLDX Stella Diagnostics Inc. | — | -0.7 | 18.1 | 21.7 | -195.2 | — | 4 | NEUTRAL | -60.2 |
| PJET Priority Aviation, Inc. | — | -0.1 | 19.5 | 31.9 | — | -83.3 | 2 | NEUTRAL | 0.0 |
| BTTX Better Therapeutics, Inc. | — | -0.0 | 2351.8 | 1050.0 | — | -100.0 | 1 | NEUTRAL | 0.0 |
| NPNKF Nippon Shinyaku Co., Ltd. | $1.6B | 7.2 | 11.6 | 12.5 | 20.6 | 12.8 | 4 | NEUTRAL | -1.1 |
| ANAB AnaptysBio, Inc. | $1.5B | 7.4 | -1146.3 | 466.0 | 668.9 | 92.9 | 5 | NEUTRAL | 112.3 |
| CSCIF COSCIENS Biopharma Inc. | $10M | -0.5 | -19.9 | -18.7 | -6.4 | — | 1 | NEUTRAL | -16.7 |
| STAB Statera Biopharma, Inc. | — | -0.0 | -298.8 | 2085.4 | -769.5 | 1459.1 | 3 | NEUTRAL | -50.0 |
| POM Pomdoctor Limited | $10M | -0.1 | 48.5 | 554.8 | -124.2 | — | 3 | NEUTRAL | -70.0 |
| THMO ThermoGenesis Holdings, Inc. | — | -0.0 | -417.9 | -71.5 | -67.8 | -7.5 | 3 | NEUTRAL | 0.0 |
| LFCR Lifecore Biomedical, Inc. | $240M | -5.9 | 202.6 | 0.1 | -18.0 | -4.1 | 5 | NEUTRAL | -5.0 |
| TLTFF Theralase Technologies Inc. | $50M | -14.1 | -93.5 | -173.9 | -646.5 | -24.8 | 4 | NEUTRAL | -2.7 |
| SNWV SANUWAVE Health Inc. | $40M | 3.1 | -238.8 | 4.8 | -7.0 | 12.0 | 7 | NEUTRAL | -83.4 |
| OBX Obsidian Therapeutics Inc. | $10M | — | — | — | — | — | — | NEUTRAL | — |
| SETO SETO Holdings, Inc. | — | -13.8 | -22.5 | -8.5 | -32.2 | 9760.2 | 6 | NEUTRAL | 103.7 |
| EDXC Endexx Corporation | — | -0.0 | 51.8 | 0.5 | — | -125.6 | 2 | NEUTRAL | -95.5 |
| GBIM GlobeImmune, Inc. | — | -0.0 | -66.2 | 25.0 | -91.5 | 55.1 | 4 | NEUTRAL | 0.0 |
| PMI Picard Medical, Inc. | $730M | -0.3 | -1631.2 | -469.0 | -191.6 | — | 2 | NEUTRAL | 28.2 |
| CNSP CNS Pharmaceuticals, Inc. | $10M | -0.2 | -106.6 | 748.6 | — | — | 3 | NEUTRAL | -38.4 |
| NXGL NEXGEL, Inc. | — | -0.0 | -128.6 | -35.8 | -98.6 | 3.4 | 2 | NEUTRAL | -91.8 |
| OSSFF Embla Medical hf. | $1.9B | 18.0 | 10.4 | 7.7 | 10.5 | 9.9 | 7 | NEUTRAL | -5.6 |
| CSSPF NIOX Group Plc | $380M | 41.3 | 10.8 | 13.0 | 24.6 | 3.5 | 7 | NEUTRAL | -2.3 |
| CAIHF CPBIO Holding Company Limited | $270M | 10.2 | 10.0 | 8.1 | 3.4 | 73.4 | 8 | NEUTRAL | 282.1 |
| NWBO Northwest Biotherapeutics, Inc. | $260M | -6.5 | 55.8 | -188.7 | -1142.6 | 98.6 | 3 | NEUTRAL | -33.7 |
| SABS SAB Biotherapeutics, Inc. | $260M | 0.9 | -11.3 | -48.4 | — | -100.0 | 3 | NEUTRAL | 1.3 |
| DIUXF Diaceutics PLC | $200M | -626.6 | -0.8 | -2.3 | -15.9 | 20.4 | 4 | NEUTRAL | 68.6 |
| MLLCF Molecular Partners AG | $150M | -2.3 | -62.1 | 650.3 | — | -100.0 | 2 | NEUTRAL | 14.6 |
| CRVW CareView Communications, Inc. | $20M | -6.4 | 6.4 | -1.4 | -10.0 | 8.5 | 7 | NEUTRAL | 12.7 |
| EXHI Exlites Holdings International, Inc. | $20M | -750.0 | -66.7 | -65.8 | -35.4 | 283.9 | 4 | NEUTRAL | 97.4 |
| PAOG PAO Group, Inc. | — | -5.8 | -20.2 | 11.2 | — | — | 4 | NEUTRAL | 200.0 |
| HESG Health Sciences Group, Inc. | — | -0.0 | 69.4 | 44.6 | -19219.1 | 101.6 | 3 | NEUTRAL | 900.0 |
| CBDD CBD of Denver, Inc. | — | -7.7 | -0.1 | -28.9 | -2.7 | 19.0 | 3 | NEUTRAL | 14900.0 |
| TRCNF Transnational Cannabis Ltd. | — | -0.0 | -178.2 | -75.5 | — | — | 1 | NEUTRAL | -96.0 |
| VRAYQ ViewRay, Inc. | — | -0.0 | -108.9 | -146.1 | -128.1 | 44.1 | 1 | NEUTRAL | 9900.0 |
| NEPTF Neptune Wellness Solutions Inc. | — | -2.7 | 606.5 | 1351.5 | -233.6 | -24.7 | 2 | NEUTRAL | -96.0 |
| STHZF StateHouse Holdings Inc. | — | -0.1 | 36.1 | 3.8 | 0.8 | -2.6 | 4 | NEUTRAL | -99.3 |
| ADVT Advantis Corp. | — | -0.4 | -8.4 | -3.2 | -1775.1 | — | 1 | NEUTRAL | 0.0 |
| SFWJ Software Effective Solutions Corp. | — | -1.3 | -21.8 | -12.6 | -51.5 | 26679.3 | 6 | NEUTRAL | 20.8 |
| BTCY Biotricity, Inc. | — | -0.4 | 8.3 | -17.1 | -22.4 | 13.4 | 6 | NEUTRAL | -90.6 |
| FCGD First Colombia Gold Corp. | — | -95.6 | 23.1 | 122.7 | — | -93.9 | 2 | NEUTRAL | 9900.0 |
| STEK Stemtech Corporation | — | -0.0 | 58.2 | 37.1 | -46.5 | -38.6 | 2 | NEUTRAL | -98.5 |
| MDCE Medical Care Technologies Inc. | — | 1.0 | 28.0 | 28.7 | 23.9 | 0.6 | 7 | NEUTRAL | -66.7 |
| PSNL Personalis, Inc. | $1.7B | -14.7 | -50.3 | -149.3 | -141.7 | -13.3 | 2 | NEUTRAL | 65.1 |
| HUMDF Hua Medicine (Shanghai) Ltd. | $300M | -18.2 | -10.3 | -30.2 | -8.0 | 73.9 | 3 | NEUTRAL | -26.1 |
| LFWD Lifeward Ltd. | $10M | -0.4 | -225.6 | -129.9 | -173.9 | -10.7 | 4 | NEUTRAL | -22.4 |
| CTXR Citius Pharmaceuticals, Inc. | $10M | -0.2 | -70.3 | -85.4 | -593.3 | 4456.8 | 3 | NEUTRAL | -71.9 |
| CFRXQ ContraFect Corp. | — | -0.0 | 544.7 | 276.9 | — | — | 1 | NEUTRAL | -90.0 |
| AUSAF Australis Capital Inc. | — | -0.0 | -52.8 | -42.1 | -1022.3 | 1388076.3 | 3 | NEUTRAL | -90.0 |
| RDDTF Radient Technologies Inc. | — | — | 98.9 | 263.2 | -131.7 | -20.4 | 3 | NEUTRAL | 0.0 |
| ISOLF Isodiol International Inc. | — | -0.0 | -220.6 | -602.3 | -73.2 | -17.7 | 4 | NEUTRAL | 0.0 |
| INLB Item 9 Labs Corp. | — | -0.0 | -47.3 | -18.4 | -117.7 | -17.4 | 2 | NEUTRAL | 0.0 |
| CSTF CuraScientific Corp | — | -0.0 | -72.1 | 17.4 | -2482.5 | 954.6 | 5 | NEUTRAL | 0.0 |
| VPHIF Valeo Pharma Inc. | — | -0.0 | 65.5 | 19863.3 | -65.0 | -0.2 | 2 | NEUTRAL | -66.7 |
| SPBBF Speakeasy Cannabis Club Ltd. | — | -0.0 | -55.1 | -4.0 | -803.2 | 16129.5 | 3 | NEUTRAL | 0.0 |
| RVVQF RavenQuest BioMed Inc. | — | -0.0 | -112.5 | -40.6 | -440.2 | 93.6 | 2 | NEUTRAL | 0.0 |
| CLVR Clever Leaves Holdings Inc. | — | -0.0 | -55.4 | -63.3 | -109.6 | 3.6 | 4 | NEUTRAL | 11100.0 |
| JWCAF James E. Wagner Cultivation Corporation | — | -0.0 | -50.3 | -16.2 | -493.1 | 315.1 | 2 | NEUTRAL | 0.0 |
| BMGP Biomagnetics Diagnostics Corp. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| RGIN Regenicin, Inc. | — | -0.0 | 16.9 | 4.1 | — | — | 4 | NEUTRAL | 0.0 |
| MSPR MSP Recovery, Inc. | — | -0.0 | 127.6 | -506.2 | -84750.5 | — | 2 | NEUTRAL | -100.0 |
| HEWA HealthWarehouse.com, Inc. | — | -4.8 | 24.7 | 44.2 | -6.8 | -42.5 | 3 | NEUTRAL | -34.0 |
| RCAR RenovaCare, Inc. | — | -0.0 | -436.6 | 812.3 | — | — | 2 | NEUTRAL | 9900.0 |
| FRLI Frélii, Inc. | — | -0.0 | -671.6 | -265.5 | -10546.4 | 378.8 | 4 | NEUTRAL | 0.0 |
| VRSYF VMS Rehab Systems, Inc. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| NMTRQ 9 Meters Biopharma, Inc. | — | — | — | — | — | — | — | NEUTRAL | 900.0 |
| WMGR Wellness Matrix Group, Inc. | — | -0.0 | 24.4 | 19.3 | — | — | 2 | NEUTRAL | 0.0 |
| LYCA Lycia Therapeutics Inc. | $1.6B | — | — | — | — | — | — | N/A | — |
| NUTX Nutex Health, Inc. | $1.4B | 7.9 | 49.2 | 53.9 | 31.2 | 6.9 | 7 | NEUTRAL | 65.8 |
| CTY City Therapeutics Inc. | $200M | — | — | — | — | — | — | N/A | — |
| DAVI Davion Healthcare Plc | $150M | — | — | — | — | — | — | N/A | — |
| IAM Iambic Therapeutics Inc. | $130M | — | — | — | — | — | — | N/A | — |
| TRXB TRex Bio Inc. | $120M | — | — | — | — | — | — | N/A | — |
| RTSN Retension Pharmaceuticals Inc. | $60M | — | — | — | — | — | — | N/A | — |
| ATOS Atossa Therapeutics, Inc. | $30M | -0.5 | -89.2 | -4213.1 | — | — | 2 | NEUTRAL | -83.0 |
| LONA LeonaBio, Inc. | $20M | — | — | — | — | — | — | NEUTRAL | — |
| ODYY Odyssey Health, Inc. | — | -0.2 | 43.4 | 10.0 | — | -100.0 | 4 | NEUTRAL | -90.2 |
| MDVLQ MedAvail Holdings, Inc. | — | -0.0 | -164.8 | -243.8 | -1429.9 | -28.6 | 4 | NEUTRAL | 0.0 |
| INDR Indie Ranch Media, Inc. | — | — | — | — | — | — | — | N/A | -90.0 |
| ORGS Orgenesis Inc. | — | -0.2 | 764.3 | 1083.0 | 2628.2 | -192.0 | 1 | NEUTRAL | 66.7 |
| NRTSF Nobilis Health Corp. | — | 0.0 | 1.1 | 2.8 | 1.3 | -11.1 | 3 | N/A | -100.0 |
| JANX Janux Therapeutics, Inc. | $1.0B | -10.5 | -10.7 | 516.9 | -214.0 | 7162.0 | 4 | NEUTRAL | -30.7 |
| VHIBF Vitalhub Corp. | $340M | 62.1 | 3.3 | 10.7 | 6.1 | 53.9 | 7 | NEUTRAL | -31.4 |
| BIEL Bioelectronics Corporation | $10M | -13.9 | 6.3 | 24.0 | -132.4 | -63.1 | 1 | NEUTRAL | -40.0 |
| ODTX Odyssey Therapeutics, Inc. | $940M | — | — | — | — | — | — | NEUTRAL | — |
| DRUG Bright Minds Biosciences Inc. | $520M | -26.2 | -13.7 | -105758.3 | — | — | 3 | NEUTRAL | -11.7 |
| EDVA Endovia Health Sciences, Inc. | — | — | — | — | — | — | — | NEUTRAL | — |
| PHMMF Pharma Mar, S.A. | $1.6B | 21.2 | 24.9 | 35.9 | -2.0 | 15.5 | 7 | NEUTRAL | 1.7 |
| RKAGY RHÃN-KLINIKUM Aktiengesellschaft | $1.1B | 22.3 | 2.8 | 3.1 | 2.1 | 2.5 | 6 | NEUTRAL | 10.7 |
| NVYTF Novacyt S.A. | $40M | -0.8 | -59.6 | -45.1 | -50.1 | -44.9 | 3 | NEUTRAL | 14.0 |
| AJYG AJ1G, Inc. | — | — | — | — | — | — | — | NEUTRAL | 380.1 |
| NMAD NOMAD Power Solutions, Inc. | $50M | — | — | — | — | — | — | NEUTRAL | — |
| NIVF NewGenIvf Group Limited | — | -0.0 | 50.6 | -147.7 | -8.5 | — | 2 | NEUTRAL | -100.0 |
| EMED Electromedical Technologies, Inc. | — | -0.2 | 44.6 | 29.8 | -8153.1 | -66.6 | 2 | NEUTRAL | 0.0 |
| CNNA Cann American Corp. | — | 0.4 | -312.1 | -287.6 | -7986.6 | -64.9 | 3 | NEUTRAL | 120.0 |
| DHBUF Delivra Health Brands Inc. | — | -2.5 | -19.4 | -34.1 | -82.4 | -10.7 | 2 | NEUTRAL | -70.2 |
| KLDO Kaleido Biosciences, Inc. | — | -0.0 | -591.2 | 1121.9 | -4292.5 | 13.2 | 2 | NEUTRAL | -96.7 |
| CNBX CNBX Pharmaceuticals Inc. | — | -0.5 | 17.8 | 13.3 | — | 100.0 | 3 | NEUTRAL | -57.1 |
| CALC CalciMedica, Inc. | — | -0.2 | -365.7 | 118.3 | — | — | 4 | NEUTRAL | -91.3 |
| YARW Yarrow Bioscience Inc | $180M | — | — | — | — | — | — | NEUTRAL | — |
| ELUT Elutia Inc | $40M | 0.6 | -397.0 | -290.2 | -315.0 | -48.8 | 6 | NEUTRAL | -10.6 |
| NSTM NovelStem International Corp. | — | -1.5 | 15.3 | 31.5 | — | -100.0 | 3 | NEUTRAL | -50.0 |
| LOWLF Lowell Farms Inc. | — | -0.0 | -146.8 | -63.3 | -111.9 | -35.7 | 5 | NEUTRAL | -99.3 |
| DOGP Dogecoin Cash, Inc. | — | -1.9 | 30.1 | 16.3 | -76.3 | 0.2 | 3 | NEUTRAL | -74.5 |
| BFRGW Bullfrog AI Holdings, Inc. Warrants | — | -1.0 | -130.7 | -3026.9 | -636.8 | 798.5 | 6 | NEUTRAL | -92.9 |
| GSTC GlobeStar Therapeutics Corporation | — | -0.0 | 60.9 | 49.1 | — | — | 4 | NEUTRAL | 9900.0 |
| YDESW YD Bio Limited Warrants | — | — | — | — | — | — | — | NEUTRAL | -69.4 |
| ISCNF Isracann Biosciences Inc. | — | -0.5 | -252.3 | 2640.8 | — | — | 2 | NEUTRAL | 0.0 |
| AEGY Alternative Energy Partners, Inc. | — | -0.0 | 190.5 | 67.0 | — | -165.0 | 4 | NEUTRAL | -80.0 |
| GRST Ethema Health Corporation | — | -1.0 | 18.3 | 0.0 | 1.2 | 171.7 | 6 | NEUTRAL | -50.0 |
| BPTH Bio-Path Holdings, Inc. | — | -0.0 | 49.0 | 15.2 | — | -100.0 | 1 | NEUTRAL | -99.6 |
| GCTK GlucoTrack, Inc. | — | -0.0 | -620.6 | 427.4 | — | — | 2 | NEUTRAL | -98.3 |
| MPXOF MPX International Corp. | — | -0.0 | -179.4 | -42.1 | -411.8 | 14.3 | 4 | NEUTRAL | -0.0 |
| RNXT RenovoRx, Inc. | $60M | -4.4 | -125.2 | 4391.9 | -320.2 | 198.5 | 3 | NEUTRAL | 17.8 |
| TUTH Standard Dental Labs Inc. | — | -3.0 | 22.6 | 1394.1 | -117.5 | -7.5 | 6 | NEUTRAL | 26.4 |
| ARYC Arrayit Corporation | — | -0.0 | 116.8 | 89.8 | -513.1 | -30.5 | 2 | NEUTRAL | -90.0 |
| PPJE PPJ Healthcare Enterprises, Inc. | — | 56.8 | -0.0 | -0.0 | 0.0 | -1.2 | 4 | NEUTRAL | -50.0 |
| IDCN Indocan Resources Inc. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| USRM U.S. Stem Cell, Inc. | — | -0.0 | 20.8 | 23.4 | -2836.8 | -59.1 | 5 | NEUTRAL | 100.0 |
| ZBIO Zenas BioPharma, Inc. | $1.8B | -2.8 | -199.0 | 5842.1 | -11145.6 | -93.3 | 2 | NEUTRAL | 14.2 |
| FLGT Fulgent Genetics, Inc. | $550M | -7.3 | -8.0 | -12.6 | -34.6 | 6.8 | 4 | NEUTRAL | -12.8 |
| VCRE Vicore Pharma Holding AB | $260M | — | — | — | — | — | — | NEUTRAL | — |
| SIGA SIGA Technologies, Inc. | $220M | -73.4 | -1.5 | -18.3 | 30.4 | -70.1 | 1 | NEUTRAL | -62.1 |
| ENGNW enGene Holdings Inc. Warrants | $10M | -5.5 | -2.3 | 134.1 | — | -100.0 | 2 | NEUTRAL | -64.6 |
| EGRX Eagle Pharmaceuticals, Inc. | $10M | 0.3 | 6.4 | 3.6 | 8.0 | -5.4 | 3 | NEUTRAL | -5.0 |
| SESI SES Solar Inc. | — | -0.5 | 16.7 | 1.7 | 28.0 | 324.6 | 7 | NEUTRAL | 0.0 |
| LITH BioELife Corp. | — | -0.0 | -598.1 | 467.7 | — | — | 2 | NEUTRAL | 0.0 |
| BIOCQ Biocept, Inc. | — | -0.0 | -13593.8 | -631.8 | -616.5 | — | 2 | NEUTRAL | 200.0 |
| PBLA Panbela Therapeutics, Inc. | — | -0.0 | 270.3 | 240.0 | — | 100.0 | 3 | NEUTRAL | 0.0 |
| AMPH Amphastar Pharmaceuticals, Inc. | $1.1B | 14.7 | 10.3 | 7.5 | 16.5 | 1.4 | 6 | NEUTRAL | 4.3 |
| NXTC NextCure, Inc. | $20M | -0.5 | -195.2 | 949.7 | — | — | 2 | NEUTRAL | -37.8 |
| EVAX Evaxion Biotech A/S | $20M | -0.5 | -109.8 | -260.4 | — | 135.9 | 6 | NEUTRAL | -48.4 |
| ATXI Avenue Therapeutics, Inc. | — | -0.5 | -120.0 | 178.4 | — | -100.0 | 2 | NEUTRAL | -43.9 |
| CBDY Target Group Inc. | — | -0.3 | 23.2 | -10.4 | -17.4 | -30.4 | 2 | NEUTRAL | -44.4 |
| ERBB American Green, Inc. | — | 0.1 | 33.3 | -15.0 | -629.5 | 17.7 | 3 | NEUTRAL | 0.0 |
| MRPI Mera Pharmaceuticals, Inc. | — | -10000.0 | 24.3 | 18.3 | -159.9 | 4.8 | 5 | NEUTRAL | 0.0 |
| CANN Trees Corporation | — | -2.5 | 284.2 | -3.9 | -15.1 | -24.7 | 4 | NEUTRAL | -61.1 |
| VDRM ViaDerma, Inc. | — | 28.7 | 133.1 | -25.3 | -214.1 | 5.3 | 3 | NEUTRAL | -50.0 |
| PTLF Petlife Pharmaceuticals, Inc. | — | -0.0 | 257.0 | 178.4 | — | — | 2 | NEUTRAL | 1.0 |
| AHCO AdaptHealth Corp. | $820M | -3.5 | -15.5 | -0.2 | -18.1 | 22.9 | 6 | LEAN BEAR | -37.6 |
| MCTA Charming Medical Limited Class A Ordinary Shares | $450M | — | — | — | — | — | — | LEAN BEAR | — |
| MBXBF Microbix Biosystems Inc. | $30M | -8.6 | -16.4 | -14.6 | -19.9 | -27.1 | 3 | LEAN BEAR | 24.3 |
| STSEY Stratec SE | $1.7B | -575.0 | -0.2 | -0.2 | 7.0 | -4.8 | 4 | LEAN BEAR | -17.8 |
| SAFLY Safilo Group S.p.A. | $1.4B | 15.4 | 12.0 | 10.0 | 8.7 | -3.4 | 7 | LEAN BEAR | 40.1 |
| AGYTF Allergy Therapeutics plc | $760M | -4.3 | 3372.3 | -97.9 | -54.9 | 19.9 | 3 | LEAN BEAR | 36.4 |
| INRLF Valneva SE | $640M | -2.8 | -118.0 | -54.8 | -89.3 | -27.2 | 1 | LEAN BEAR | -25.4 |
| OPORF hVIVO plc | $80M | -3.1 | -32.7 | -34.7 | -39.7 | -23.6 | 2 | LEAN BEAR | -54.3 |
| POLBF Poolbeg Pharma PLC | $70M | -8.5 | -58.8 | -255.9 | — | — | 1 | LEAN BEAR | 125.4 |
| QPTFF Quest PharmaTech Inc. | $10M | 1.6 | 3.9 | -1.7 | — | — | 4 | LEAN BEAR | 125.6 |
| CLYYF Celyad Oncology S.A. | $10M | 2.5 | -11.7 | -979.7 | 64360.6 | -88.7 | 5 | LEAN BEAR | 40.0 |
| SWNM Southwestern Medical Solutions, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -70.0 |
| OKUR OnKure Therapeutics, Inc. | $100M | -0.7 | -46.9 | 1464.5 | — | — | 4 | LEAN BEAR | -21.7 |
| SNGX Soligenix, Inc. | $10M | -0.3 | -241.7 | 304.6 | — | — | 4 | LEAN BEAR | -86.5 |
| INND InnerScope Hearing Technologies, Inc. | — | -0.0 | -1.4 | -0.4 | — | -56.8 | 4 | LEAN BEAR | -95.2 |
| ENDV Endonovo Therapeutics, Inc. | — | -0.2 | 9.2 | 4.5 | — | -100.0 | 3 | LEAN BEAR | -50.0 |
| DECN Decision Diagnostics Corp. | — | -0.0 | -8643.1 | -51.3 | -107.0 | -2.7 | 4 | LEAN BEAR | 0.0 |
| NPCE NeuroPace, Inc. | $440M | -22.8 | -122.1 | -39.6 | -27.2 | 11.6 | 4 | LEAN BEAR | 24.2 |
| APLMW Apollomics, Inc. | $170M | -2.6 | -233.7 | 845.7 | 1188.0 | -75.9 | 3 | LEAN BEAR | -56.5 |
| ARMP Armata Pharmaceuticals, Inc. | $140M | -0.7 | 127.8 | -54.7 | 2953.8 | -35.1 | 2 | LEAN BEAR | -42.4 |
| EQ Equillium, Inc. | $80M | -5.3 | -59.0 | 2703.6 | — | -100.0 | 3 | LEAN BEAR | -3.5 |
| ONMD OneMedNet Corporation | $30M | -2.6 | 231.2 | 252.1 | -743.8 | 216.5 | 3 | LEAN BEAR | -81.3 |
| KPTI Karyopharm Therapeutics Inc. | $10M | -0.0 | 79.0 | 36.3 | -200.5 | 6.8 | 2 | LEAN BEAR | -92.4 |
| LEXX Lexaria Bioscience Corp. | $10M | -0.6 | -150.3 | -504.2 | — | -68.5 | 4 | LEAN BEAR | -78.8 |
| FLWPF The Flowr Corporation | — | — | -335.3 | 207.1 | -1827.8 | 38.5 | 3 | LEAN BEAR | 0.0 |
| ADXN Addex Therapeutics Ltd | — | -0.4 | -150.5 | -168.4 | -17543.0 | -48.1 | 2 | LEAN BEAR | -68.8 |
| VIVE Viveve Medical, Inc. | — | -0.0 | -222.0 | -1442.3 | -314.1 | 2.4 | 3 | LEAN BEAR | 100.0 |
| FFNTF 4Front Ventures Corp. | — | -0.0 | 73.3 | -15.3 | -37.4 | -34.7 | 3 | LEAN BEAR | 900.0 |
| MBCI MabCure Inc. | — | -0.0 | -127.0 | -14.0 | -2239.0 | — | 3 | LEAN BEAR | 0.0 |
| DROR Dror Ortho-Design, Inc. | $10M | -0.0 | 15.8 | 36.4 | — | — | 1 | LEAN BEAR | — |
| VPTDF VentriPoint Diagnostics Ltd. | $10M | -6.1 | 58.8 | 122.3 | -3487.7 | 8.8 | 4 | LEAN BEAR | -19.0 |
| REPCF RepliCel Life Sciences Inc. | — | -9.4 | -248.8 | -13.9 | -80.9 | 200.0 | 6 | LEAN BEAR | 0.0 |
| IMVIF IMV Inc. | — | -0.2 | -503.3 | -2870.5 | — | — | 1 | LEAN BEAR | 1900.0 |
| LCDX Caliber Imaging & Diagnostics, Inc. | — | -0.0 | 54.6 | 46.8 | -212.5 | 20.6 | 3 | LEAN BEAR | 100.0 |
| JUNS Jupiter Neurosciences, Inc. | — | -0.1 | -1888.7 | 5586.0 | -9380.9 | — | 3 | LEAN BEAR | -97.7 |
| MCET MultiCell Technologies, Inc. | — | -0.1 | 101.2 | 99.1 | -81.8 | 1532.7 | 5 | LEAN BEAR | 900.0 |
| THCBF THC Biomed Intl Ltd. | — | -1.1 | -56.5 | -34.0 | -196.4 | -17.5 | 2 | LEAN BEAR | 0.0 |
| NSVGF Nass Valley Gateway Ltd. | — | -3.7 | 12.1 | 2.9 | — | -95.8 | 1 | LEAN BEAR | 0.0 |
| DRWN Quantum Medical Transport, Inc. | — | 0.3 | 25.7 | 20.8 | 2.2 | -96.3 | 4 | LEAN BEAR | 0.0 |
| MDIN MedGen, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| SRBCF Sirona Biochem Corp. | — | -0.7 | 111.4 | 1025.7 | -34808.5 | -119.4 | 2 | LEAN BEAR | -50.5 |
| NKGN NKGen Biotech, Inc. | — | -0.0 | 150.9 | — | -4511.3 | — | 3 | LEAN BEAR | -47.5 |
| CGNSF Cognetivity Neurosciences Ltd. | — | -0.1 | 78.7 | 25.2 | -6985.2 | — | 2 | LEAN BEAR | 0.0 |
| VLXC Veltex Corporation | — | -2.6 | 49.0 | -433.9 | -89.4 | 3.2 | 3 | LEAN BEAR | -28.7 |
| EVRRF Molecule Holdings Inc. | — | -0.1 | 97.7 | -3110.1 | -110.2 | 11.6 | 4 | LEAN BEAR | 0.0 |
| LFCOF Lift & Co. Corp. | — | -0.0 | 149.0 | -666.2 | -170.0 | — | 2 | LEAN BEAR | 0.0 |
| AORT Artivion, Inc. | $1.1B | -384.9 | -0.7 | -3.4 | -10.7 | 16.4 | 4 | LEAN BEAR | -47.1 |
| RSLBF RaySearch Laboratories AB (publ) | $510M | 31.8 | 26.1 | 21.8 | 7.2 | 1.2 | 6 | LEAN BEAR | -35.8 |
| COGZF Cogstate Limited | $410M | 35.2 | 22.4 | 37.3 | 22.4 | -14.8 | 3 | LEAN BEAR | 44.9 |
| SLGL Sol-Gel Technologies Ltd. | $230M | -12.1 | -35.9 | -228.0 | 36.4 | 282.9 | 3 | LEAN BEAR | 74.8 |
| MMIRF MedMira Inc. | $30M | -11.4 | 11.8 | 21.7 | -200.5 | 45.7 | 4 | LEAN BEAR | -20.4 |
| RMSL REMSleep Holdings, Inc. | — | -0.0 | 4286484750.6 | 1769.6 | -702.2 | -27.1 | 2 | LEAN BEAR | -57.5 |
| YUKA Yuka Group, Inc. | — | -2.6 | 24.0 | 81.8 | -50.7 | -8.2 | 5 | LEAN BEAR | 145.7 |
| GMVDF G Medical Innovations Holdings Ltd | — | -0.0 | 5665.0 | 622.9 | -585.5 | 49.0 | 1 | LEAN BEAR | 0.0 |
| JBIO Jade Biosciences, Inc. | $930M | -5.4 | -47.8 | 629.9 | — | — | 3 | LEAN BEAR | 47.4 |
| CGEM Cullinan Therapeutics, Inc. | $880M | -4.4 | -50.3 | 1635.6 | — | — | 1 | LEAN BEAR | 91.2 |
| ACRS Aclaris Therapeutics, Inc. | $550M | -6.5 | -59.1 | -206.5 | -1320.1 | -51.0 | 3 | LEAN BEAR | 76.3 |
| ANGO AngioDynamics, Inc. | $520M | -15.5 | -19.2 | -20.5 | -8.8 | 8.2 | 5 | LEAN BEAR | -0.7 |
| SRTA Strata Critical Medical, Inc. | $410M | 9.5 | 16.0 | -6.2 | -14.5 | 0.6 | 3 | LEAN BEAR | -6.2 |
| IFRX InflaRx N.V. | $230M | -3.1 | -38.5 | 251.5 | — | -106.2 | 4 | LEAN BEAR | 18.6 |
| ZJYL Jin Medical International Ltd. | $20M | 13.6 | 4.0 | 1.9 | -1.2 | -13.6 | 3 | LEAN BEAR | 460.8 |
| GBCS Selectis Health, Inc. | $20M | 1.2 | 1850.1 | -22.2 | 171.7 | -21.3 | 4 | LEAN BEAR | 172.9 |
| LYRA Lyra Therapeutics, Inc. | — | -0.0 | -6595.0 | -671.6 | -99300.0 | -74.1 | 4 | LEAN BEAR | -97.6 |
| PARD Poniard Pharmaceuticals, Inc. | — | -0.0 | -210.4 | -442.5 | — | — | 3 | LEAN BEAR | 0.0 |
| PAIYY Aesthetic Medical International Holdings Group Limited | — | — | — | — | — | — | — | LEAN BEAR | -94.1 |
| CSDX CS Diagnostics Corp. | — | — | — | — | — | — | — | LEAN BEAR | — |
| BACK IMAC Holdings, Inc. | — | -0.0 | 109.1 | 67.3 | -14505.6 | 100.5 | 2 | LEAN BEAR | -99.2 |
| LADX LadRx Corporation | — | -0.0 | 278.9 | 118.4 | — | -61.0 | 1 | LEAN BEAR | -99.0 |
| JNDOF JINS HOLDINGS Inc. | $810M | 17.6 | 22.7 | 27.1 | 5.1 | 15.0 | 6 | LEAN BEAR | 51.6 |
| CWBHF Charlotte's Web Holdings, Inc. | $70M | -1.1 | -97.1 | -27.9 | -38.0 | -6.9 | 5 | LEAN BEAR | 44.1 |
| COCH Envoy Medical, Inc. | $50M | -1.0 | 176.2 | 119.9 | -11729.4 | -6.8 | 5 | LEAN BEAR | -23.4 |
| ITNS Itonis, Inc. | — | -51.2 | 2.9 | 16.1 | -299.0 | -55.8 | 3 | LEAN BEAR | 0.0 |
| ADRX ADARx Pharmaceuticals, Inc. | $1.9B | — | — | — | — | — | — | LEAN BEAR | — |
| MDRSF Medartis Holding AG | $1.4B | 78.9 | 5.5 | 0.7 | 3.2 | 29.6 | 6 | LEAN BEAR | 72.5 |
| JMDMF Japan Medical Dynamic Marketing, Inc. | $130M | — | — | — | — | — | — | LEAN BEAR | 49.7 |
| BGM BGM Group Ltd. | $100M | -1.9 | -0.5 | -0.2 | -8.7 | — | 3 | LEAN BEAR | -96.9 |
| TCLIF Theraclion S.A. | $40M | -6.3 | -342.1 | 1171.9 | -543.9 | 61.2 | 2 | LEAN BEAR | 312841.2 |
| NDATF nDatalyze Corp. | — | -16.7 | -61.8 | 1180.9 | — | -100.0 | 3 | LEAN BEAR | 633.9 |
| HDRPF Epsilon Healthcare Limited | — | 73.3 | -33.3 | -22.6 | -9.6 | 161.1 | 5 | LEAN BEAR | 614.3 |
| CCM Concord Medical Services Holdings Limited | — | -0.0 | 7.5 | -26.9 | -13.5 | -22.5 | 2 | LEAN BEAR | -31.8 |
| LANZ Lancer Orthodontics, Inc. | — | 4.0 | 3.3 | 2.5 | -4.3 | 4.5 | 4 | LEAN BEAR | 2566.7 |
| AOBI American Oriental Bioengineering, Inc. | — | -0.0 | -28.2 | -16.5 | -118.1 | -10.2 | 3 | LEAN BEAR | 983.3 |
| HSTC HST Global, Inc. | $210M | -538.5 | -2.5 | -1.2 | -13.7 | 564.0 | 5 | LEAN BEAR | 349900.0 |
| PLSH Panacea Life Sciences Holdings, Inc. | — | -0.8 | 128.5 | -48.4 | -1581.6 | -90.2 | 5 | LEAN BEAR | 14.0 |
| AMRN Amarin Corporation plc | $240M | -8.4 | -6.0 | -19.6 | -18.1 | -15.1 | 6 | LEAN BEAR | -39.4 |
| DBVT DBV Technologies S.A. | $230M | -2.6 | -142.6 | -2201.5 | — | -100.0 | 2 | LEAN BEAR | -34.3 |
| RNA Atrium Therapeutics, Inc. | $140M | -2.2 | -36.9 | 455.9 | -672.0 | 235.3 | 5 | LEAN BEAR | -82.9 |
| MRAI Marpai, Inc. | $80M | -3.9 | 47.4 | 28.0 | -110.0 | -29.7 | 3 | LEAN BEAR | 114.1 |
| ADAPY Adaptimmune Therapeutics plc | $10M | -0.1 | -1341.1 | 268.4 | -221.8 | -54.0 | 0 | LEAN BEAR | -55.3 |
| PBIGF Paradigm Biopharmaceuticals Limited | $10M | -1.6 | -456.6 | 1081.8 | -60158.9 | 53.6 | 4 | LEAN BEAR | -96.1 |
| FPMI FluoroPharma Medical, Inc. | — | -0.0 | 22.7 | 39.7 | — | — | 2 | LEAN BEAR | 100.0 |
| PREDQ Predictive Discovery Limited | — | — | — | — | — | — | — | LEAN BEAR | — |
| GBLX GB Sciences, Inc. | — | -0.0 | 19.5 | 17.2 | -103.2 | — | 3 | LEAN BEAR | -75.0 |
| IMMB Immunotech Laboratories, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 100.0 |
| FOXO FOXO Technologies Inc. | — | 0.0 | -62.5 | -3.2 | 172.6 | 44.0 | 3 | LEAN BEAR | 7042.9 |
| MNDR Mobile-health Network Solutions Class A Ordinary Shares | — | -0.0 | -43.7 | -41.6 | -21.7 | -42.3 | 4 | LEAN BEAR | -99.2 |
| FENC Fennec Pharmaceuticals Inc. | $350M | -81.7 | -18.6 | -76.2 | 11.0 | 77.8 | 6 | LEAN BEAR | 18.1 |
| MEDXF Medexus Pharmaceuticals Inc. | $110M | -46.3 | -4.7 | 8.1 | 1.9 | -2.9 | 5 | LEAN BEAR | 70.7 |
| INBS Intelligent Bio Solutions Inc. | $10M | -0.2 | -292.3 | -304.3 | -341.0 | 38.1 | 4 | LEAN BEAR | -83.0 |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $10M | -1.0 | -130.7 | -3026.9 | -636.8 | 798.5 | 6 | LEAN BEAR | -66.5 |
| MRRCF Wayland Group Corp. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| ECGS Eco-Growth Strategies Inc. | — | -1.7 | 15.4 | 46.1 | — | — | 3 | LEAN BEAR | -89.2 |
| FITX Creative Edge Nutrition, Inc. | — | -0.0 | 242.9 | 120.2 | -98.6 | — | 3 | LEAN BEAR | 0.0 |
| NLVVF New Leaf Ventures Inc | — | -0.2 | -2466.1 | -179.6 | -152.9 | -39.2 | 1 | LEAN BEAR | 9900.0 |
| INBX Inhibrx Biosciences Inc. | $1.4B | -10.8 | -1773.6 | 55.8 | — | -100.0 | 4 | LEAN BEAR | 67.0 |
| LJUIF SSY Group Limited | $1.2B | 15.0 | 6.7 | 4.6 | 13.6 | -4.4 | 5 | LEAN BEAR | 0.0 |
| KARD Kardigan, Inc. | $1.1B | — | — | — | — | — | — | LEAN BEAR | — |
| SHEZF Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | $690M | 65.9 | 2.8 | 2.7 | 7.0 | -0.3 | 6 | LEAN BEAR | 0.0 |
| YDES YD Bio Limited Ordinary Shares | $350M | — | — | — | — | — | — | LEAN BEAR | -64.9 |
| FATE Fate Therapeutics, Inc. | $250M | -2.0 | -60.7 | -140.1 | -1448.6 | -23.4 | 2 | LEAN BEAR | 115.1 |
| RXST RxSight, Inc. | $210M | -4.3 | -17.3 | -66.9 | -35.9 | -18.8 | 3 | LEAN BEAR | -43.1 |
| BDTX Black Diamond Therapeutics, Inc. | $110M | -2.4 | -37.2 | -1604.9 | — | -100.0 | 1 | LEAN BEAR | -55.5 |
| NTHI Neonc Technologies Holdings, Inc. | $90M | — | — | — | — | — | — | LEAN BEAR | -66.1 |
| TLPH Talphera, Inc. | $60M | -3.4 | -143.4 | 436.3 | — | -96.3 | 2 | LEAN BEAR | -5.2 |
| SGMOQ Sangamo Therapeutics, Inc. | $50M | — | — | — | — | — | — | LEAN BEAR | — |
| ENVB Enveric Biosciences, Inc. | $10M | -0.1 | -170.0 | 3225.6 | — | — | 4 | LEAN BEAR | -80.8 |
| TDSGF Telo Genomics Corp. | $10M | -2.1 | -2858.5 | 258.3 | — | — | 2 | LEAN BEAR | -10.2 |
| ELLXF Elixinol Wellness Limited | — | -0.7 | -52.3 | -22.6 | -14.9 | -4.8 | 1 | LEAN BEAR | -56.2 |
| WIBFF West Island Brands Inc. | — | -0.3 | -99.5 | -95.1 | -40.3 | 165.1 | 4 | LEAN BEAR | 0.0 |
| NNLX NanoLogix, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -20.0 |
| CLAZF Claritas Pharmaceuticals, Inc. | — | 0.0 | -170.1 | 15.9 | — | — | 3 | LEAN BEAR | 0.0 |
| NMRD Nemaura Medical Inc. | — | -0.0 | 45.5 | -457.0 | — | -491.0 | 1 | LEAN BEAR | -50.0 |
| GRPS Trans American Aquaculture, Inc. | — | -0.5 | 114.2 | 17.8 | — | -96.0 | 3 | LEAN BEAR | -60.8 |
| IMRSQ IMRIS Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| CRFTF BC Craft Supply Co. Ltd. | — | -0.0 | 152.6 | 13.1 | — | -82.0 | 2 | LEAN BEAR | 0.0 |
| RLLVF Relevium Technologies Inc. | — | -0.3 | 969.5 | 2839.9 | -218.6 | — | 1 | LEAN BEAR | 0.0 |
| BHNGF Bhang Inc. | — | -0.0 | 782.7 | 270.1 | -248.2 | 78.7 | 3 | LEAN BEAR | 0.0 |
| SPPH Spencer Pharmaceutical Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| CNNXF CannAmerica Brands Corp. | — | -0.0 | 53.3 | 23.6 | -127.3 | 39.6 | 4 | LEAN BEAR | 0.0 |
| EVARF Lombard Medical, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| NNBP Nanobac Pharmaceuticals, Incorporated | — | 0.0 | 358.0 | 221.2 | -26718.6 | -92.2 | 3 | LEAN BEAR | 0.0 |
| PEMTF Thoughtful Brands Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| VRTHF Indigenous Bloom Hemp Corp. | — | -0.3 | 77.3 | 21.2 | — | — | 3 | LEAN BEAR | 0.0 |
| AHGIF Alternate Health Corp. | — | -0.0 | -611.4 | -2862.3 | -21.3 | 171.0 | 4 | LEAN BEAR | 0.0 |
| LRSV Link Reservations Inc. | — | -7.6 | 103.3 | 152.0 | -20.7 | 73995.4 | 5 | LEAN BEAR | -50.0 |
| HCANF Halo Collective Inc. | — | -0.0 | -132.7 | -43.7 | -192.0 | -43.0 | 2 | LEAN BEAR | 0.0 |
| GEGP Gold Entertainment Group, Inc. | — | -2.5 | 39.4 | 1402.0 | -16.8 | 39.5 | 6 | LEAN BEAR | -90.0 |
| EWPI Emerging World Pharma, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| PZRXQ PhaseRx, Inc. | — | -0.0 | -228.2 | 8803.4 | — | — | 2 | LEAN BEAR | 0.0 |
| GEATF Radiko Holdings Corp | — | -0.0 | 178.7 | -374.3 | -40.1 | -30.5 | 3 | LEAN BEAR | 0.0 |
| SKYI Sky Century Investment, Inc. | — | -2.5 | 26.2 | 61.1 | -11.3 | 180.9 | 3 | LEAN BEAR | 5086.8 |
| SKTO SK3 Group, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| TCNAF TransCanna Holdings Inc. | — | -0.0 | -246.6 | -38.8 | -338.7 | 90.3 | 3 | LEAN BEAR | 0.0 |
| NOBDF North Bud Farms Inc. | — | -0.0 | -30.5 | -29.8 | — | — | 2 | LEAN BEAR | 0.0 |
| FSPM FusionPharm, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| ASFX American Scientific Resources, Incorporated | — | — | — | — | — | — | — | LEAN BEAR | -25.0 |
| ULGX Urologix, Inc. | — | -0.0 | 80.8 | 96.5 | -12.5 | -19.4 | 3 | LEAN BEAR | -0.0 |
| BNYN Banyan Corp. | — | -0.0 | 719.9 | -36.9 | -121.9 | -37.7 | 3 | LEAN BEAR | 0.0 |
| HENC Hero Technologies Inc. | — | -0.1 | -10112.1 | 3310.9 | — | 100.0 | 4 | LEAN BEAR | 0.0 |
| HTGMQ HTG Molecular Diagnostics, Inc. | — | -0.0 | -343.2 | 734.2 | -489.6 | -28.2 | 2 | LEAN BEAR | 0.0 |
| JXFGF Jinxin Fertility Group Limited | $730M | 26.8 | 1.9 | 1.8 | 7.8 | 1.4 | 7 | LEAN BEAR | 3.6 |
| GWIN Glorywin Entertainment Group, Inc. | $360M | -26081.4 | 11.7 | 5.1 | — | — | 1 | LEAN BEAR | 229.5 |
| FGHQF Frontage Holdings Corporation | $360M | 36.5 | 3.1 | 3.0 | 4.6 | 9.8 | 7 | LEAN BEAR | 16.8 |
| CLVSF CellaVision AB (publ) | $330M | 31.6 | 15.1 | 17.1 | 16.3 | -1.9 | 6 | LEAN BEAR | -27.4 |
| KNTPF Kintor Pharmaceutical Limited | $120M | -3.0 | -116.6 | -74.4 | -145.6 | 2237.9 | 3 | LEAN BEAR | -10.2 |
| MILFF 1CM Inc. | $30M | 4.5 | 15.1 | 7.4 | 2.5 | 7.3 | 7 | LEAN BEAR | 42.7 |
| HSTI High Sierra Technologies, Inc. | $30M | -22.8 | 225.7 | 189.7 | — | — | 4 | LEAN BEAR | 0.0 |
| LVCLF Algorae Pharmaceuticals Limited | $20M | -5.1 | -47.4 | -24288.6 | — | -100.0 | 3 | LEAN BEAR | 51.6 |
| PLLWF Polarean Imaging plc | $10M | -0.1 | -83.4 | -772.7 | -852.0 | 39.1 | 2 | LEAN BEAR | -40.0 |
| BCLI Brainstorm Cell Therapeutics Inc. | $10M | -0.8 | 119.2 | 76.7 | — | -100.0 | 1 | LEAN BEAR | 12.7 |
| RTSL Rapid Therapeutic Science Laboratories, Inc. | — | -0.0 | -3.4 | 35.5 | — | -100.0 | 2 | LEAN BEAR | -86.7 |
| AIDA Aida Pharmaceuticals, Inc. | — | 0.0 | -20.7 | 25.4 | 19.3 | 40.9 | 6 | LEAN BEAR | 50.0 |
| HRAL Hear AtLast Holdings, Inc. | — | -0.3 | 16.3 | 89.4 | — | — | 3 | LEAN BEAR | -20.0 |
| NVOS Novo Integrated Sciences, Inc. | — | -0.0 | -81.4 | -35.0 | 162.4 | 5.7 | 3 | LEAN BEAR | -90.0 |
| BRSF Brain Scientific Inc. | — | -0.0 | -633.9 | -94.8 | -77714.6 | -19.3 | 3 | LEAN BEAR | 500.0 |
| CMND Clearmind Medicine Inc. | — | -0.1 | -104.0 | 593.4 | — | — | 2 | LEAN BEAR | -99.8 |
| BLMS Bloomios, Inc. | — | -0.0 | 221.4 | 58.3 | -3817.0 | 46.5 | 2 | LEAN BEAR | 200.0 |
| VINC Vincerx Pharma, Inc. | — | -0.0 | -3136.4 | 910.2 | — | -18.7 | 5 | LEAN BEAR | -53.1 |
| GRHY Green Hygienics, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -93.0 |
| XSVT Xsovt Brands, Inc. | — | -0.0 | 241.0 | 189.8 | -134.3 | 300584.1 | 4 | LEAN BEAR | 233.3 |
| FORU ForU Holdings, Inc. | — | -0.0 | 759.2 | -476.4 | — | -100.0 | 2 | LEAN BEAR | 100.0 |
| CHNXF ChitogenX Inc. | — | -0.2 | 23.2 | 36.2 | — | — | 2 | LEAN BEAR | 586.4 |
| NMSCA Nutrition Management Services Company | — | 0.0 | 4.0 | 6.5 | -0.5 | -7.8 | 5 | LEAN BEAR | 200.0 |
| ELXMF Nova Eye Medical Limited | — | -9.9 | -26.1 | -22.0 | -5.3 | 19.0 | 5 | LEAN BEAR | -85.7 |
| OMWS Omnia Wellness Inc. | — | -0.0 | 91.7 | -520.4 | -2231.0 | -14.0 | 1 | LEAN BEAR | 100.0 |
| REMI Remedent, Inc. | — | -0.1 | -11.3 | -4.3 | -86.4 | 14.2 | 6 | LEAN BEAR | 300.0 |
| HLSQ Tessera Defense and Homeland Security Inc | — | — | — | — | — | — | — | LEAN BEAR | — |
| HYHY Hydrogen Hybrid Technologies, Inc. | — | -0.0 | -138.6 | -342.9 | — | 16.1 | 4 | LEAN BEAR | 0.0 |
| NURPF Neuren Pharmaceuticals Limited | $1.8B | 121.2 | 6.2 | 22.4 | 14.6 | -68.5 | 5 | LEAN BEAR | 20.8 |
| BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited | $540M | 10.1 | 20.8 | 23.4 | 32.9 | 697.9 | 9 | LEAN BEAR | 0.0 |
| ACB Aurora Cannabis Inc. | $250M | -3.0 | -20.5 | -17.0 | -6.0 | -16.6 | 3 | LEAN BEAR | -20.9 |
| CPHI China Pharma Holdings, Inc. | $30M | -0.6 | -21.0 | -8.7 | -153.8 | -11.0 | 4 | LEAN BEAR | -66.5 |
| AEMD Aethlon Medical, Inc. | — | -0.4 | -160.9 | -883.2 | — | — | 3 | LEAN BEAR | -81.2 |
| CUBT Curative Biotechnology, Inc. | — | -2.0 | 31.0 | 15.3 | — | — | 4 | LEAN BEAR | 8.5 |
| EMYSF Easy Technologies Inc. | — | -0.3 | 192.7 | 227.8 | — | -100.0 | 1 | LEAN BEAR | 0.0 |
| DYNTQ Dynatronics Corporation | — | — | — | — | — | — | — | LEAN BEAR | — |
| ASTH Astrana Health, Inc. | $1.9B | 44.6 | 5.1 | 4.7 | 2.0 | 58.9 | 5 | LEAN BEAR | 10.9 |
| CLHLF COLTENE Holding AG | $330M | 19.7 | 16.1 | 12.5 | 3.6 | -2.5 | 5 | LEAN BEAR | -8.4 |
| PARK Park Dental Partners, Inc. Common Stock | $90M | -23.3 | -16.0 | 0.0 | 2.0 | — | 3 | LEAN BEAR | — |
| KZIA Kazia Therapeutics Ltd ADR | $10M | -1.1 | -104.5 | 62.7 | — | -99.2 | 4 | LEAN BEAR | 17.1 |
| WUHN Wuhan General Group (China), Inc. | — | -0.0 | 106.5 | 1.0 | -155074.0 | — | 2 | LEAN BEAR | 100.0 |
| STME Stimcell Energetics, Inc. | — | -6.8 | 24.8 | 29.2 | — | — | 2 | LEAN BEAR | — |
| LIANY LianMedical | — | 1.3 | 74.7 | -612.1 | — | — | 6 | LEAN BEAR | -28.6 |
| GSAC GelStat Corporation | — | -2.8 | 25.1 | 80.4 | -124.9 | 62.9 | 6 | LEAN BEAR | -25.0 |
| EOCN Eocene Ltd. | — | — | — | — | — | — | — | LEAN BEAR | — |
| SXTC China SXT Pharmaceuticals, Inc. | — | -0.0 | -32.7 | -254.3 | 13.7 | 42.5 | 6 | LEAN BEAR | -100.0 |
| TSHA Taysha Gene Therapies, Inc. | $1.3B | -10.1 | -47.1 | 961.0 | — | -32.3 | 3 | BEARISH | -10.5 |
| MDRX Veradigm Inc. | $830M | -7.1 | 4.3 | 7.0 | 6.2 | -39.7 | 5 | BEARISH | 0.0 |
| ARVN Arvinas, Inc. | $470M | 39.2 | 1.6 | -519.3 | 67.8 | -15.0 | 4 | BEARISH | -19.1 |
| CAMP CAMP4 Therapeutics Corporation | $210M | -1.6 | -545.9 | 48.4 | -1884.8 | 40.2 | 2 | BEARISH | -1.9 |
| BEAT HeartBeam, Inc. | $20M | -0.8 | -328.4 | 2958.2 | — | — | 3 | BEARISH | -75.2 |
| XCRT Xcelerate Inc. | $10M | -10.9 | 71.8 | 24.0 | — | -142.3 | 2 | BEARISH | 101.5 |
| GELS Gelteq Limited Ordinary Shares | — | — | — | — | — | — | — | BEARISH | -63.0 |
| CARM Carisma Therapeutics, Inc. | — | 0.0 | -134.1 | -376.4 | 98.8 | 159.7 | 3 | BEARISH | -99.2 |
| TRVN Trevena, Inc. | — | -0.0 | 344.3 | -3198.4 | -1745.2 | -82.9 | 3 | BEARISH | -7.5 |
| NPHC Nutra Pharma Corp. | — | -0.1 | 23.1 | 4.7 | -11458.0 | 55.8 | 3 | BEARISH | 0.0 |
| PKTX ProtoKinetix, Incorporated | — | -1.0 | -117.2 | -115.0 | — | — | 2 | BEARISH | -95.4 |
| OWCP OWC Pharmaceutical Research Corp. | — | -0.0 | -34.4 | 1662.7 | — | — | 2 | BEARISH | -90.0 |
| HKPD Cellyan Biotechnology Co., Ltd | — | -4.9 | -15.6 | -7.4 | -20.5 | 45.7 | 6 | BEARISH | -92.4 |
| PBMWW Psyence Biomedical Ltd. Warrant | — | — | — | — | — | — | — | BEARISH | -58.1 |
| CELG-RI Bristol-Myers Squibb Company Ce | $250M | 0.0 | 46.7 | 22.0 | 25.6 | 3.1 | 8 | BEARISH | 247.9 |
| PROF Profound Medical Corp. | $200M | -5.8 | -73.1 | -148.0 | -384.2 | 35.5 | 3 | BEARISH | 2.7 |
| EBRCZ EBR Systems, Inc. | $80M | -0.9 | -102.2 | 22812.5 | -661.9 | 305113.7 | 3 | BEARISH | -87.9 |
| INNMF Amplia Therapeutics Limited | $30M | -4.9 | -24.9 | -86.9 | — | -100.0 | 2 | BEARISH | -35.3 |
| PETV PetVivo Holdings, Inc. | $30M | -2.1 | -384.4 | -353.6 | -478.1 | -9.5 | 4 | BEARISH | -53.5 |
| ROMJF Rubicon Organics Inc. | $20M | -16.3 | -4.1 | -24.0 | 2.2 | 16.7 | 1 | BEARISH | -27.5 |
| IMUC EOM Pharmaceuticals Holdings, Inc. | $10M | -4.9 | 64.4 | 131.0 | — | — | 4 | BEARISH | -42.8 |
| FUNI Hypha Labs, Inc. | — | -0.3 | 26.8 | 31.4 | — | — | 2 | BEARISH | — |
| VVOS Vivos Therapeutics, Inc. | — | -0.1 | -6663.0 | -267.4 | -106.4 | 45.2 | 3 | BEARISH | -95.7 |
| PRPH ProPhase Labs, Inc. | — | -0.0 | -544.0 | -207.6 | -301.8 | -5.5 | 3 | BEARISH | -99.8 |
| NXGT Nexteligent Holdings, Inc. | — | -14.0 | 2.7 | -1.5 | 5.3 | -0.2 | 3 | BEARISH | -30.9 |
| RDHL RedHill Biopharma Ltd. | — | -3.3 | 428.1 | 117.9 | -101.3 | 157.6 | 6 | BEARISH | -72.7 |
| BXRXQ Baudax Bio, Inc. | — | — | — | — | — | — | — | BEARISH | 900.0 |
| RQHTF Reliq Health Technologies Inc. | — | -5.4 | -4.5 | -8.2 | 15.4 | 119.4 | 5 | BEARISH | -33.3 |
| AAGH America Great Health | — | 2.0 | -12.2 | 22.4 | -635.8 | -5.1 | 4 | BEARISH | 33.3 |
| PHRX Pharmagen, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SNBIF SanBio Company Limited | $1.3B | -19.9 | -55.8 | -2935.2 | — | — | 3 | BEARISH | 0.0 |
| CVSGF CVS Group plc | $1.1B | 52.6 | 5.9 | 7.3 | 2.7 | -22.7 | 6 | BEARISH | 0.7 |
| PKBFF PeakBirch Commerce Inc. | $540M | -0.0 | -16609.0 | 16544.6 | -58.8 | -69.1 | 3 | BEARISH | 0.0 |
| OVID Ovid Therapeutics Inc. | $420M | -4.7 | -26.0 | -43.7 | -2047.6 | -76.2 | 3 | BEARISH | 38.6 |
| CYH Community Health Systems, Inc. | $410M | -1.3 | 19.9 | -79.1 | 1.7 | 77.2 | 5 | BEARISH | -30.7 |
| RZLT Rezolute, Inc. | $370M | -5.4 | -59.0 | 1060.6 | — | — | 2 | BEARISH | -55.3 |
| TSNLF Tristel PLC | $280M | 24.4 | 23.4 | 31.6 | 15.8 | 10.3 | 8 | BEARISH | 8.5 |
| MDWD MediWound Ltd. | $150M | -7.8 | -72.4 | -255.1 | -239.1 | -40.3 | 2 | BEARISH | -31.9 |
| LPCUF Lee's Pharmaceutical Holdings Limited | $110M | 3.8 | 9.9 | 0.2 | 11.9 | 81.2 | 8 | BEARISH | 1.1 |
| CSBR Champions Oncology, Inc. | $70M | -61.1 | -30.7 | -7.8 | -2.8 | 6.7 | 3 | BEARISH | -29.9 |
| DTCFF Defence Therapeutics Inc. | $20M | -3.8 | -237.8 | -86.8 | — | — | 4 | BEARISH | -53.1 |
| MRKR Marker Therapeutics, Inc. | $20M | -2.0 | -76.9 | -1014.3 | — | -77.1 | 2 | BEARISH | -7.6 |
| HSCS HeartSciences Inc. | $20M | -1.0 | -1851.9 | 26.8 | -151064.0 | -27.7 | 1 | BEARISH | -0.3 |
| AMS American Shared Hospital Services | $10M | -5.0 | -7.5 | -5.5 | -6.1 | 4.0 | 5 | BEARISH | -42.5 |
| XCUR Exicure, Inc. | $10M | -0.8 | -168.4 | 779.8 | — | — | 2 | BEARISH | -78.0 |
| PTKFY PT Kalbe Farma Tbk | $10M | 9.1 | 15.5 | 17.8 | 9.1 | 13.6 | 6 | BEARISH | -45.4 |
| BNVIF Binovi Technologies Corp. | — | -0.0 | -433.7 | 182.0 | 17056.9 | -74.4 | 1 | BEARISH | 400.0 |
| HAVLF HAVN Life Sciences Inc. | — | -0.0 | -275.3 | -163.4 | 5734.1 | 876.8 | 3 | BEARISH | 0.0 |
| CRRVF CVR Medical Corp. | — | -0.0 | 49.0 | 11.5 | — | — | 1 | BEARISH | 0.0 |
| DMSI Dermisonics, Inc. | — | -0.0 | -392.2 | 1105.0 | — | — | 1 | BEARISH | 0.0 |
| INSD Instadose Pharma Corp. | — | -0.0 | -9.7 | -3.7 | — | — | 4 | BEARISH | -90.9 |
| WCUI Wellness Center USA, Inc. | — | -0.0 | 44.8 | 1728.1 | -86.5 | 140.9 | 5 | BEARISH | -0.0 |
| IONM Assure Holdings Corp. | — | -0.0 | 237.0 | 462.9 | -25500.0 | -64.6 | 1 | BEARISH | -99.0 |
| PSYBF PsyBio Therapeutics Corp | — | -0.0 | 344.6 | 135.0 | — | — | 2 | BEARISH | -90.0 |
| CAAOF INDVR Brands Inc. | — | -0.0 | -111.6 | -22.0 | -159.3 | 22.0 | 4 | BEARISH | 0.0 |
| TLOG TetraLogic Pharmaceuticals Corporation | — | -0.0 | 382.3 | 479.8 | — | — | 1 | BEARISH | 0.0 |
| CBIA Canopus Biopharma, Inc. | — | -0.0 | 1457.1 | 15327.7 | — | — | 1 | BEARISH | 0.0 |
| RGDXQ Response Genetics, Inc | — | -0.0 | 1186.4 | -243.6 | -110.9 | -8.1 | 3 | BEARISH | 0.0 |
| IGRW Interactive Health Network | — | 0.2 | 1090.1 | 947.6 | -29882.2 | — | 2 | BEARISH | 0.0 |
| DSOL Drug Free Solution, Inc. | — | -16.9 | 255.8 | 197.9 | — | — | 2 | BEARISH | -63.6 |
| IMEXF Imagin Medical Inc. | — | -0.0 | 31.8 | 185.9 | — | — | 3 | BEARISH | 0.0 |
| MRZM Marizyme, Inc. | — | -0.0 | 117.5 | -190.1 | — | -69.0 | 3 | BEARISH | 0.0 |
| CYPS Cyclo3pss Corporation | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ROSGQ Rosetta Genomics Ltd. | — | -0.0 | -44.3 | -306.4 | 136.0 | — | 1 | BEARISH | 0.0 |
| ALID Allied Corp. | — | -0.0 | 266.4 | 484.7 | -207842.5 | -53.9 | 2 | BEARISH | -95.5 |
| IBXG iBX Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| AVTI Avitar, Inc. | — | -0.0 | 26.0 | -62.7 | -263.1 | -47.4 | 2 | BEARISH | 0.0 |
| UPPR Upper Street Marketing Inc. | — | -0.0 | 228.5 | -53.9 | -715.0 | — | 1 | BEARISH | 42.9 |
| FORZ Forza Innovations Inc. | — | -0.0 | 91.9 | 0.0 | 11330.0 | 8.7 | 3 | BEARISH | 0.0 |
| PRCNF Pure Global Cannabis Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| VRCI Verde Science, Inc. | — | -0.0 | 72.3 | 23.0 | — | — | 5 | BEARISH | 100.0 |
| HLUN HEALTHeUNIVERSE, Inc. | — | — | — | — | — | — | — | BEARISH | 900.0 |
| SNNAQ Sienna Biopharmaceuticals, Inc. | — | -0.0 | -140.9 | -331.4 | — | — | 2 | BEARISH | 0.0 |
| IBOGF Universal Ibogaine Inc. | — | -0.5 | -94.8 | 5.5 | -9.4 | 208.2 | 4 | BEARISH | -98.4 |
| NTII Neurobiological Technologies, Inc. | — | 0.0 | 48.7 | 441.6 | 89.7 | 99.7 | 4 | BEARISH | 0.0 |
| WLDFF Wildflower Brands Inc. | — | -0.0 | -27.7 | -4.7 | 1.9 | 319.8 | 7 | BEARISH | 0.0 |
| GLSHQ Gelesis Holdings, Inc. | — | -0.0 | 391.0 | -233.6 | -693.9 | -45.8 | 3 | BEARISH | 0.0 |
| OMDD Ormand Industries Inc | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SHOM Southern Home Medical, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PSIQ Profile Solutions, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ROTH PharmaRoth Labs, Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| CWWBF Plant-Based Investment Corp. | — | -0.0 | -95.9 | -3827.0 | 167.3 | -218.9 | 3 | BEARISH | 0.0 |
| CMRA Comera Life Sciences Holdings, Inc. | — | -0.0 | 235.6 | 124.2 | -1580.0 | 81.8 | 4 | BEARISH | 0.0 |
| DGEN Deltagen Inc. | — | 0.0 | 19.8 | 182.7 | -27.2 | -65.8 | 4 | BEARISH | 0.0 |
| TRVI Trevi Therapeutics, Inc. | $1.8B | -39.5 | -19.7 | -1451.7 | — | — | 3 | BEARISH | 27.0 |
| QURE uniQure N.V. | $1.6B | -6.0 | -157.6 | 37.9 | -1387.8 | 30.2 | 4 | BEARISH | -60.2 |
| BPMUF Basilea Pharmaceutica AG | $960M | 16.9 | 39.5 | 75.9 | 23.5 | 4.5 | 7 | BEARISH | 27.1 |
| DNA Ginkgo Bioworks Holdings, Inc. | $670M | -2.2 | -56.3 | -44.0 | -231.7 | -51.5 | 2 | BEARISH | -16.9 |
| BOIRF Boiron S.A. | $550M | 12.7 | 7.2 | 7.8 | 2.0 | 97.0 | 5 | BEARISH | 10.5 |
| CTEV Claritev Corporation | $400M | -1.3 | 169.3 | 0.9 | -23.0 | 110.3 | 4 | BEARISH | -67.5 |
| IMPZY Implanet S.A. | $230M | -5.1 | 275.6 | -110.9 | -30.0 | 24.3 | 5 | BEARISH | 0.2 |
| INKT MiNK Therapeutics, Inc. | $50M | -4.4 | 57.9 | 42.8 | — | — | 4 | BEARISH | -29.0 |
| CURX Curanex Pharmaceuticals Inc Common Stock | $10M | -0.6 | -218.7 | -392.2 | — | — | 1 | BEARISH | -64.0 |
| MEDS DataMEDS AI, Inc. | $10M | -0.0 | -142327.8 | -322403.1 | -1031.7 | 339160.3 | 4 | BEARISH | -22.9 |
| ABMT Advanced BioMedical Technologies Inc. | — | -0.1 | 6.0 | 9.6 | 3842.6 | 264.3 | 3 | BEARISH | 400.0 |
| IDYLF Imaging Dynamics Company Ltd. | — | -0.3 | 18.7 | 39.1 | -2277.3 | -65.6 | 4 | BEARISH | 152.7 |
| ASBP Aspire Biopharma Holdings, Inc. | — | -1.1 | -1032.1 | 1368.4 | -2009.6 | — | 6 | BEARISH | -98.0 |
| SYDRF Delota Corp. | — | -3.8 | -139.4 | -20.5 | -1.7 | -13.0 | 4 | BEARISH | 0.0 |
| OLMM OneLife Technologies Corp. | — | -0.0 | 454.4 | -594.1 | — | — | 3 | BEARISH | 900.0 |
| MSIU Medical Supply International USA, Inc. | — | — | — | — | — | — | — | BEARISH | 300.0 |
| SYGGF Synairgen plc | — | -0.2 | -71.9 | -381.4 | — | — | 1 | BEARISH | -50.0 |
| PFSA Profusa, Inc. Common Stock | — | -0.0 | 158.4 | 181.7 | — | — | 2 | BEARISH | 168.8 |
| ANTCF Aion Therapeutic Inc. | — | -0.2 | 365.1 | 64.7 | -53.7 | 563.3 | 3 | BEARISH | 17.6 |
| BSPM Biostar Pharmaceuticals, Inc. | — | -0.0 | 2.7 | 1.9 | — | -91.9 | 5 | BEARISH | 0.0 |
| TNON Tenon Medical, Inc. | — | -0.0 | -549.9 | -452.2 | -316.7 | 80.9 | 4 | BEARISH | 72.6 |
| CHYPF Health Logic Interactive Inc. | — | -3.5 | 20.0 | 14.2 | — | — | 1 | BEARISH | -45.2 |
| RAPP Rapport Therapeutics, Inc. Common Stock | $1.2B | -9.1 | -40.0 | 3981.5 | — | — | 4 | BEARISH | 6.2 |
| RYHTY Ryman Healthcare Limited | $1.0B | -10.9 | -4.2 | -0.3 | -30.8 | 10.6 | 7 | BEARISH | -23.4 |
| ATGGF Actinogen Medical Limited | $140M | -8.5 | -77.5 | -235.8 | — | -100.0 | 1 | BEARISH | 17.2 |
| NRXP NRx Pharmaceuticals, Inc. | $110M | -3.6 | 131.2 | 61.3 | -1500.5 | — | 5 | BEARISH | -14.6 |
| GWLL Goldenwell Biotech, Inc. | $60M | -240.7 | 31.8 | 137.0 | — | 319257.9 | 5 | BEARISH | 225.0 |
| CANQF CanaQuest Medical Corp. | — | -0.0 | 177.1 | 159.9 | -1515.1 | 102.7 | 4 | BEARISH | 0.0 |
| SQZB SQZ Biotechnologies Company | — | -0.0 | -203.4 | -410.2 | — | -44.6 | 0 | BEARISH | 4.3 |
| IGNT Ingen Technologies, Inc. | — | — | — | — | — | — | — | BEARISH | -50.0 |
| MJNA Medical Marijuana, Inc. | — | -2.5 | -1.3 | -2.2 | -0.9 | -22.1 | 2 | BEARISH | -66.7 |
| CGNH CardioGenics Holdings Inc | — | -0.0 | 58.8 | 40.3 | — | — | 3 | BEARISH | 0.0 |
| ADMT ADM Tronics Unlimited, Inc. | — | -8.6 | -49.5 | -22.1 | 3.7 | -2.2 | 3 | BEARISH | -48.8 |
| MEOBF Mesoblast Limited | $2.0B | -30.0 | -9.9 | -14.4 | -23.4 | 613.8 | 5 | BEARISH | -20.0 |
| BIOGY BioGaia AB (publ) | $1.3B | 32.0 | 31.8 | 52.6 | 27.5 | 13.1 | 5 | BEARISH | 19.9 |
| CBGL Cannabis Global Inc. | — | -0.5 | 5.4 | 17.3 | — | 520.3 | 3 | BEARISH | -80.0 |
| PCLOF PharmaCielo Ltd. | $10M | -2.7 | 39.6 | -31.4 | -103.5 | 11.2 | 4 | BEARISH | 71.2 |
| CEROW CERo Therapeutics Holdings, Inc. | — | -0.0 | 101.5 | 60.5 | — | -100.0 | 1 | BEARISH | -75.2 |
| HMPQ HempAmericana, Inc | — | -0.5 | 25.6 | 14.8 | — | 184.6 | 2 | BEARISH | 0.0 |
| BCRX BioCryst Pharmaceuticals, Inc. | $1.9B | -5.6 | 87.8 | 62.3 | 35.9 | 68.7 | 5 | BEARISH | 12.5 |
| TRLV Trulieve Cannabis Corp. | $1.8B | — | — | — | — | — | — | BEARISH | — |
| LYPHF Luye Pharma Group Ltd. | $1.1B | 7.8 | 4.5 | 6.7 | 13.0 | -2.1 | 6 | BEARISH | 0.8 |
| HROW Harrow Health, Inc. | $1.1B | -29.3 | -114.8 | 1.9 | -24.4 | 21.1 | 5 | BEARISH | -24.5 |
| APMD Apnimed, Inc. | $790M | — | — | — | — | — | — | BEARISH | — |
| STTK Shattuck Labs, Inc. | $550M | -11.3 | -39.2 | -29.3 | — | -66.6 | 4 | BEARISH | 200.5 |
| BNTC Benitec Biopharma Inc. | $300M | -8.9 | -33.2 | 1840.8 | — | — | 3 | BEARISH | -35.5 |
| ELDN Eledon Pharmaceuticals, Inc. | $190M | -2.4 | -110.7 | 411.1 | — | — | 2 | BEARISH | -30.8 |
| CHRS Coherus Oncology, Inc. | $160M | -1.0 | -145.4 | 1854.0 | -144.2 | -64.3 | 2 | BEARISH | -35.1 |
| MAYNF Mayne Pharma Group Limited | $150M | 8.3 | 6.4 | -13.8 | 23.0 | -6.1 | 3 | BEARISH | -52.7 |
| FHTX Foghorn Therapeutics Inc. | $120M | -2.1 | 81.9 | 26.3 | -44.7 | 52.0 | 4 | BEARISH | -49.6 |
| MAIA MAIA Biotechnology, Inc. | $70M | -1.8 | -218.7 | 330.4 | — | — | 3 | BEARISH | -18.2 |
| AURX Nuo Therapeutics, Inc. | $60M | -31.1 | 170.6 | 280.3 | -15.7 | 166.6 | 3 | BEARISH | -47.8 |
| RNTX Rein Therapeutics Inc. | $50M | -0.4 | -753.6 | 53.9 | — | — | 3 | BEARISH | -51.1 |
| ELTX Elicio Therapeutics, Inc. | $40M | -0.9 | -774.6 | 2147.3 | — | — | 4 | BEARISH | -81.1 |
| QTI QT Imaging Holdings, Inc. | $30M | -1.5 | -1915.2 | 88.4 | -148.9 | -99.4 | 5 | BEARISH | 356.1 |
| JSPR Jasper Therapeutics, Inc. | $20M | -0.3 | -255.0 | 773.9 | — | — | 2 | BEARISH | -78.1 |
| GDTC CytoMed Therapeutics Limited | $10M | -2.6 | -66.1 | -87.8 | -1125.6 | -11.3 | 0 | BEARISH | -62.8 |
| RVVTF Revive Therapeutics Ltd. | $10M | -0.8 | -1114.6 | 25.7 | — | — | 2 | BEARISH | 95.0 |
| NCNA NuCana plc | $10M | -0.3 | -70.7 | -739.9 | — | — | 4 | BEARISH | -74.2 |
| FLOOF Flower One Holdings Inc. | — | -0.0 | 111.5 | -21.8 | -15.4 | -19.8 | 2 | BEARISH | 0.0 |
| WLSI Wellstar International, Inc. | — | -0.0 | 24.2 | 35.0 | — | — | 3 | BEARISH | 0.0 |
| BIXT Bioxytran, Inc. | — | -0.7 | 92.2 | 68.7 | — | — | 4 | BEARISH | -56.8 |
| SRUTF Sproutly Canada Inc. | — | -0.0 | 7045.7 | -519.2 | -1194.7 | 28.2 | 4 | BEARISH | 0.0 |
| FIORF Fiore Cannabis Ltd. | — | -0.0 | -417.3 | -33.3 | -383.4 | -6.2 | 2 | BEARISH | 0.0 |
| ITMC Itoco Inc. | — | -0.0 | 303.4 | 96.7 | — | — | 2 | BEARISH | 0.0 |
| ICBU iMD Companies, Inc. | — | -11.8 | 27.7 | 30.0 | — | -100.0 | 3 | BEARISH | -63.5 |
| OTRKQ Ontrak, Inc. | — | -0.0 | -215.7 | -149.5 | -341.6 | -21.0 | 1 | BEARISH | -99.9 |
| RLFTY MindMaze Therapeutics Holding S.A. | — | -4.6 | -36.8 | -30.3 | -1182.3 | -95.8 | 2 | BEARISH | -95.4 |
| PZOO Pazoo, Inc. | — | -0.0 | 49.0 | 21.1 | -972321.6 | -100.0 | 4 | BEARISH | 0.0 |
| JAGX Jaguar Health, Inc. | — | -0.0 | -501.9 | -118.9 | -1035.3 | 135.5 | 4 | BEARISH | -99.8 |
| CBDHF Hempfusion Wellness Inc. | — | 0.0 | -82.5 | -84.6 | -190.5 | — | 1 | BEARISH | 0.0 |
| KGET CaliPharms, Inc. | — | -0.4 | 72.6 | 7.6 | -6979.1 | — | 2 | BEARISH | 3900.0 |
| HTDS Hard to Treat Diseases Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PPTDF PeptiDream Inc. | $870M | -39.2 | -7.1 | -9.6 | -25.7 | 47.8 | 4 | BEARISH | -38.7 |
| TRDA Entrada Therapeutics, Inc. | $170M | -1.1 | -54.1 | -236.6 | -4762.0 | -94.1 | 1 | BEARISH | -35.4 |
| LFMDP LifeMD, Inc. | $150M | -4.2 | -687.6 | 135.4 | -15.0 | -16.7 | 4 | BEARISH | -10.6 |
| MRES Institute of Biomedical Research Corp. | — | -2.3 | 301783.0 | -6062.7 | — | — | 1 | BEARISH | -81.2 |
| ALUR Allurion Technologies Inc. | — | -0.0 | 45.2 | 39.3 | -206.8 | -55.5 | 3 | BEARISH | -99.5 |
| ADGM Adagio Medical Holdings, Inc. | — | -0.1 | -657.8 | -87.8 | — | -100.0 | 2 | BEARISH | -91.9 |
| BJDX Bluejay Diagnostics, Inc. | — | -0.0 | -98.9 | 5625.8 | — | — | 4 | BEARISH | -93.8 |
| ERNA Ernexa Therapeutics Inc. | — | -0.1 | -320.7 | 626.9 | — | -100.0 | 5 | BEARISH | -93.6 |
| WGS GeneDx Holdings Corp. | $1.7B | -17.2 | -40.8 | -17.2 | -15.5 | 25.4 | 4 | BEARISH | -51.3 |
| CSPHF CStone Pharmaceuticals | $1.4B | -15.3 | -51.4 | -340.2 | -123.0 | 135.6 | 5 | BEARISH | -15.4 |
| DRTSW Alpha Tau Medical Ltd. | $1.2B | -13.0 | -141.7 | -17.1 | — | — | 3 | BEARISH | 807.7 |
| OMDA Omada Health | $1.2B | 280.0 | 1.8 | -1.5 | 6.0 | 404.7 | 7 | BEARISH | -26.5 |
| SMSZF SMS Co., Ltd. | $700M | -14.7 | -40.8 | 31.1 | 18.4 | 6.9 | 6 | BEARISH | 0.0 |
| ZRSEF DocMorris AG | $520M | -10.1 | -30.1 | -29.3 | -8.9 | 11.0 | 2 | BEARISH | 0.0 |
| DCTH Delcath Systems, Inc. | $500M | 1340.9 | 0.5 | -2.7 | 9.2 | 35.8 | 6 | BEARISH | 44.2 |
| EOLS Evolus, Inc. | $460M | -14.2 | 138.6 | -20.7 | -9.6 | 13.9 | 5 | BEARISH | 8.5 |
| EBS Emergent BioSolutions Inc. | $320M | -1.9 | -40.3 | -5.5 | -76.9 | -9.6 | 5 | BEARISH | -31.5 |
| BHCCF Benchmark Holdings plc | $230M | -4.1 | 16.4 | -17.9 | 377.4 | -62.6 | 6 | BEARISH | 0.0 |
| UNHLF EC Healthcare | $100M | -1.6 | -25.3 | 1.7 | -21.3 | -9.0 | 3 | BEARISH | 0.0 |
| RLYB Rallybio Corporation | $90M | 3.5 | 34.5 | -1198.7 | — | -35.6 | 6 | BEARISH | 2511.5 |
| POCI Precision Optics Corporation, Inc. | $50M | -9.5 | -22.3 | -19.0 | -1.2 | 65.2 | 5 | BEARISH | 2.6 |
| NEPH Nephros, Inc. | $40M | 21.8 | 16.1 | 20.0 | 19.9 | 24.2 | 5 | BEARISH | -35.6 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $40M | 118.8 | 228.3 | 11.8 | -21.1 | 6.2 | 3 | BEARISH | 0.0 |
| NSYS Nortech Systems Incorporated | $30M | 28.7 | 3.0 | 3.2 | 0.9 | 6.0 | 7 | BEARISH | 9.7 |
| AEON AEON Biopharma, Inc. | $10M | -0.1 | 350.0 | 98.0 | — | — | 2 | BEARISH | -73.5 |
| LSTA Lisata Therapeutics, Inc. | $10M | -0.6 | -99.9 | 590.1 | — | -90.7 | 2 | BEARISH | -56.6 |
| CABR Caring Brands, Inc. | $10M | — | — | — | — | — | — | BEARISH | -69.2 |
| DHAI DIH Holding US, Inc. | — | -0.0 | 24.9 | 14.2 | -34.8 | 262.3 | 3 | BEARISH | -100.0 |
| PFND Pathfinder Cell Therapy, Inc. | — | -0.0 | 22.4 | 46.3 | — | — | 2 | BEARISH | 0.0 |
| ARPC Arem Pacific Corporation | — | -9.0 | -104.2 | 50.1 | -12.7 | -7.6 | 5 | BEARISH | 0.0 |
| KONEF Wellbeing Digital Sciences Inc. | — | — | 10994.4 | -1249.0 | -349.5 | — | 2 | BEARISH | 0.0 |
| VIVXF Avivagen Inc. | — | -0.1 | 63.9 | 92.2 | -2302.1 | -7.9 | 3 | BEARISH | 0.0 |
| SCRCQ ScripsAmerica, Inc. | — | -0.0 | 168.2 | 144.2 | -17.6 | 3510.5 | 5 | BEARISH | 0.0 |
| CTVEF Certive Solutions Inc. | — | -0.2 | 13.8 | 16.9 | -129.9 | 8.5 | 4 | BEARISH | 0.0 |
| CDXI Cardax, Inc. | — | -0.0 | 81.1 | 38.5 | -1740.8 | -27.3 | 2 | BEARISH | 0.0 |
| ZMSPF Zecotek Photonics Inc. | — | -0.0 | 21.5 | 53.8 | 1884.0 | 2081.2 | 3 | BEARISH | 0.0 |
| CVHIF Ventura Cannabis & Wellness Corporation | — | -0.0 | -24592.2 | -12731.6 | -112.6 | -64.0 | 4 | BEARISH | 0.0 |
| MOTS Motus GI Holdings, Inc. | — | -0.0 | -1069.0 | -1348.2 | -3301.6 | -47.9 | 4 | BEARISH | -0.0 |
| ADYX Adynxx, Inc. | — | -0.0 | 1148.3 | 259.7 | — | -95.1 | 2 | BEARISH | 0.0 |
| IYXI Inyx, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PANC Panacos Pharmaceuticals, Inc. | — | -0.0 | -168.8 | -792.8 | -33966.7 | -45.9 | 1 | BEARISH | 0.0 |
| ENCW Enchanted World Inc. | — | — | — | — | — | — | — | BEARISH | -87.5 |
| MCDA KMA Holding, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SYVC Synovics Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SOFE SOAFEE, Inc. | — | 0.1 | 12.0 | -337.1 | 21.4 | 1539.1 | 4 | BEARISH | 45.5 |
| SPDE Speedus Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| BIOIF Biome Grow Inc. | — | -0.0 | 56.7 | 86.9 | — | — | 3 | BEARISH | 0.0 |
| PROT Proteonomix, Inc. | — | -0.0 | 77.5 | -1239.4 | — | -63.1 | 4 | BEARISH | 0.0 |
| NBIO Nascent Biotech, Inc. | — | -0.0 | 230.6 | 328.8 | — | — | 5 | BEARISH | -75.0 |
| SECI Sector 10, Inc. | — | 0.0 | 0.5 | 0.3 | — | — | 3 | BEARISH | 0.0 |
| SLNX Solanbridge Group, Inc. | — | -7.0 | 149.0 | 74.1 | — | — | 2 | BEARISH | 400.0 |
| SIGY Sigyn Therapeutics, Inc. | — | -0.0 | 61.7 | 32.8 | — | -100.0 | 1 | BEARISH | -98.5 |
| LBLTF Lattice Biologics Ltd. | — | -0.0 | 27.4 | -482.6 | — | -28.9 | 4 | BEARISH | 0.0 |
| ADLI American Medical Technologies Inc. | — | -0.0 | -34.0 | 1108.3 | -19.7 | -21.7 | 3 | BEARISH | 0.0 |
| XCRP Xcorporeal, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ONCO Onconetix, Inc. | — | -0.1 | -105.2 | -83.7 | -16748.3 | -51.3 | 3 | BEARISH | -86.8 |
| RNUGF ReNeuron Group plc | — | -0.0 | -106.8 | 210.1 | -1809.6 | -68.2 | 1 | BEARISH | 0.0 |
| VIAP VIA Pharmaceuticals, Inc. | — | -0.0 | 64.7 | 103.9 | — | — | 2 | BEARISH | 0.0 |
| UAHC United American Healthcare Corporation | — | 180.0 | 4.6 | -10.0 | — | -100.0 | 6 | BEARISH | -18.6 |
| GSRX GSRX Industries Inc. | — | -0.0 | -119.6 | -84.3 | -81.5 | -5.5 | 5 | BEARISH | 0.0 |
| BRAXF Braxia Scientific Corp. | — | -0.1 | -254.6 | -2393.3 | -184.2 | 27.6 | 3 | BEARISH | -99.9 |
| BNKL Bionik Laboratories Corp. | — | -0.0 | -787.6 | -1107.0 | -282.5 | 41.7 | 3 | BEARISH | 0.0 |
| EXETF Extendicare Inc. | $1.9B | 20.4 | 43.8 | 14.1 | 5.0 | 31.2 | 3 | BEARISH | 74.0 |
| UTMD Utah Medical Products, Inc. | $240M | 21.9 | 8.8 | 24.1 | 31.5 | -7.0 | 7 | BEARISH | 21.6 |
| WHWK Whitehawk Therapeutics Inc | $180M | -3.0 | -45.0 | 963.4 | — | -100.0 | 1 | BEARISH | 38.2 |
| ATRA Atara Biotherapeutics, Inc. | $90M | -7.0 | 46.3 | 30.3 | -767.3 | -96.7 | 2 | BEARISH | -42.7 |
| OCLG Oncologix Tech Inc. | — | -0.0 | 255.0 | — | — | -20.4 | 2 | BEARISH | 0.0 |
| SDCCQ SmileDirectClub Inc Class A | — | -0.0 | -72.6 | -19.0 | -17.5 | -23.4 | 3 | BEARISH | 0.0 |
| ALHC Alignment Healthcare, Inc. | $1.7B | 40.4 | 20.0 | -54.4 | 2.7 | 37.2 | 8 | BEARISH | -54.0 |
| TKNO Alpha Teknova, Inc. | $340M | -22.6 | -24.2 | -17.2 | -26.0 | 12.3 | 4 | BEARISH | 25.2 |
| HNSBF Hansa Biopharma AB (publ) | $330M | -4.6 | 159.8 | 1182.7 | -541.7 | -3.7 | 2 | BEARISH | -28.2 |
| CTOR Citius Oncology, Inc. | $50M | -1.3 | -126.6 | -109.8 | -597.4 | — | 3 | BEARISH | -64.5 |
| VICP Vicapsys Life Sciences, Inc. | $10M | -20.5 | 31.3 | 17.6 | — | — | 5 | BEARISH | -73.3 |
| LMLLF Pharmadrug Inc. | — | -0.9 | 37.6 | 446.5 | — | — | 2 | BEARISH | -36.3 |
| SDNI Scandia, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| RMRK Rimrock Gold Corp. | — | 204.0 | 8.6 | 6.4 | — | -100.0 | 2 | BEARISH | 0.0 |
| VOGX Vogenx Inc. | $260M | — | — | — | — | — | — | BEARISH | — |
| CASIF CASI Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| IDRSF Idorsia Ltd | $1.4B | -3.5 | 27.1 | -344.5 | -203.1 | -8.1 | 1 | BEARISH | 19.6 |
| VBIZF Viva Biotech Holdings | $400M | 13.3 | 4.5 | 4.2 | 8.0 | 2.9 | 7 | BEARISH | -35.1 |
| RCKT Rocket Pharmaceuticals, Inc. | $250M | -15.3 | -4.8 | -137.8 | — | — | 3 | BEARISH | -36.4 |
| ACBM Acro Biomedical Co., Ltd. | — | -10.8 | 36.8 | 262.2 | — | 100.0 | 3 | BEARISH | 3614.3 |
| CGHC Capital Group Holdings, Inc. | — | -0.0 | -44.6 | -14.9 | -24.2 | — | 5 | BEARISH | 0.0 |
| VICA Rafina Innovations Inc. | — | -0.1 | -51.0 | -15.7 | — | 873.6 | 3 | BEARISH | 233.3 |
| BBLNF Babylon Holdings Limited | — | -0.0 | 348.4 | -1412.2 | -20.3 | 198.9 | 3 | BEARISH | 0.0 |
| NMXS Net Medical Xpress Solutions, Inc. | — | -0.0 | -362.8 | -352.4 | -6733.3 | -89.2 | 2 | BEARISH | 600.0 |
| CRVS Corvus Pharmaceuticals, Inc. | $890M | -16.5 | -35.4 | -415.6 | — | — | 4 | BEARISH | 43.4 |
| SVRA Savara Inc. | $870M | -8.4 | -105.5 | -15438.9 | — | — | 2 | BEARISH | 11.5 |
| IMRX Immuneering Corporation | $240M | -3.7 | -52.1 | -112.8 | — | — | 4 | BEARISH | -36.6 |
| PMN ProMIS Neurosciences, Inc. | $70M | -0.6 | -172.3 | 844.3 | — | — | 2 | BEARISH | -10.3 |
| GGBXF Green Growth Brands Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| ANIP ANI Pharmaceuticals, Inc. | $1.7B | 14.7 | 20.0 | 20.7 | 9.3 | 30.9 | 7 | BEARISH | -24.5 |
| IMTX Immatics N.V. | $1.1B | -4.1 | -47.8 | -858.3 | -683.4 | -68.0 | 2 | BEARISH | -28.7 |
| KURA Kura Oncology, Inc. | $850M | -2.9 | -167.7 | 56.3 | -327.3 | -7.3 | 1 | BEARISH | 2.1 |
| ATTO Attovia Therapeutics, Inc. | $630M | -16.1 | -294.4 | -1137.2 | -4597.1 | -50.5 | 4 | BEARISH | 272.2 |
| OCS Oculis Holding AG | $490M | -4.6 | -44.0 | -31.0 | — | -6.9 | 3 | BEARISH | -63.1 |
| LUCD Lucid Diagnostics Inc. | $80M | -0.9 | -556.3 | -1646.4 | -792.9 | 24.9 | 6 | BEARISH | -65.8 |
| DYAI Dyadic International, Inc. | $20M | -1.8 | 522.6 | 1288.0 | -221.0 | 1.5 | 3 | BEARISH | -65.5 |
| DVHGF Devonian Health Group, Inc. | $20M | — | -76.1 | -75.1 | -1098.1 | -91.5 | 1 | BEARISH | 37.7 |
| ALLR Allarity Therapeutics, Inc. | $10M | -1.2 | -157.1 | -96.5 | — | — | 2 | BEARISH | -33.8 |
| AVTBF Avant Brands Inc. | $10M | -0.7 | -39.8 | -15.3 | 2.7 | 5.1 | 5 | BEARISH | -18.2 |
| PNPL Pineapple, Inc. | — | -10.4 | 63.1 | -28.2 | -276.2 | 943.8 | 7 | BEARISH | -99.6 |
| GBHPF Global Hemp Group Inc. | — | -0.1 | 61.0 | 8.0 | — | — | 2 | BEARISH | -99.2 |
| SCPS Scopus BioPharma Inc. | — | -0.0 | 132.3 | 53.6 | — | — | 2 | BEARISH | 33.3 |
| RSCI Redwood Scientific Technologies, Inc. | — | -0.0 | 2488.8 | 821.0 | — | — | 2 | BEARISH | -99.9 |
| VNRX VolitionRX Ltd | — | -0.0 | 80.1 | 66.5 | -1837.7 | 86.3 | 3 | BEARISH | -58.3 |
| BIORQ Biora Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| BIIO Bionovate Technologies Corp | — | -0.0 | 47.5 | 16.6 | — | — | 3 | BEARISH | 0.0 |
| BITRF Biotron Limited | — | -3.6 | -87.5 | -87.8 | -113.4 | -71.0 | 0 | BEARISH | -90.7 |
| BSPK Bespoke Extracts, Inc. | — | -0.0 | 37.1 | 45.4 | -16.7 | 284.5 | 4 | BEARISH | -99.8 |
| THER Theralink Technologies, Inc. | — | -0.0 | 6.0 | -69.7 | 5363.6 | 32.8 | 2 | BEARISH | 0.0 |
| WHTCF WELL Health Technologies Corp. | $770M | 162.1 | 0.5 | 5.4 | -2.7 | 38.6 | 6 | BEARISH | -17.4 |
| GNMLF Genomma Lab Internacional, S.A.B. de C.V. | $710M | 9.0 | 14.3 | 13.4 | 11.4 | 22.0 | 4 | BEARISH | -22.7 |
| AURA Aura Biosciences, Inc. | $650M | -3.5 | -53.5 | -1360.0 | — | — | 4 | BEARISH | 7.5 |
| SENS Senseonics Holdings, Inc. | $400M | -3.7 | -118.2 | -901.4 | -253.4 | 79.0 | 3 | BEARISH | 18.8 |
| TTRX Turn Therapeutics Inc. | $310M | -35.8 | -952.4 | 115.0 | — | — | 2 | BEARISH | 105.1 |
| ARCT Arcturus Therapeutics Holdings Inc. | $280M | -3.4 | -46.3 | -2501.0 | -803.8 | -79.1 | 1 | BEARISH | 0.1 |
| SPHRY Starpharma Holdings Limited | $220M | -26.9 | -46.5 | -441.4 | -725.1 | 186.8 | 4 | BEARISH | 73.3 |
| BDSX Biodesix, Inc. | $170M | -6.9 | -540.0 | -31.9 | -27.1 | 34.5 | 6 | BEARISH | 226.2 |
| BETRF BetterLife Pharma Inc. | $110M | -10.2 | 34.9 | 21.6 | — | — | 4 | BEARISH | 243.4 |
| NTRB Nutriband Inc. | $70M | -10.4 | -100.7 | -264.9 | -201.3 | -37.3 | 3 | BEARISH | -16.8 |
| WORX SCWorx Corp. | $40M | -0.4 | -38.1 | -8.2 | -17.1 | 3.1 | 6 | BEARISH | 343.7 |
| HRGN Harvard Apparatus Regenerative Technology Inc. | $30M | -4.9 | 239.0 | 256.6 | -409.4 | — | 2 | BEARISH | — |
| PVCT Provectus Biopharmaceuticals, Inc. | $20M | -4.3 | 78.1 | 83.4 | — | -100.0 | 5 | BEARISH | -33.9 |
| ADIA Adia Med Inc. | $10M | -0.1 | 32.2 | -16.3 | 8.3 | — | 1 | BEARISH | 247.2 |
| CNVIF Conavi Medical Corp. | $10M | 13.3 | 57.4 | 363.8 | -4867.7 | — | 2 | BEARISH | — |
| NDRA ENDRA Life Sciences Inc. | $10M | -0.8 | -152.0 | -105.1 | — | — | 4 | BEARISH | -6.1 |
| CVGRF City View Green Holdings Inc. | — | -1.7 | 75.6 | 105.0 | — | — | 4 | BEARISH | -32.4 |
| EXMT Anything Technologies Media, Inc. | — | -8.4 | 27.0 | -24.5 | — | -100.0 | 2 | BEARISH | -31.8 |
| SBFM Sunshine Biopharma, Inc. | — | -0.0 | -21.9 | -31.4 | -16.9 | -2.7 | 5 | BEARISH | -99.2 |
| UTRS Minerva Surgical, Inc. | — | -0.0 | -170.1 | -43.9 | -60.0 | 3.1 | 1 | BEARISH | 0.0 |
| APUS Apimeds Pharmaceuticals US, Inc | — | -0.1 | -100.1 | -12.6 | — | — | 2 | BEARISH | -85.1 |
| PDMI Paradigm Medical Industries, Inc. | — | -0.0 | 47.4 | -40.4 | -184.3 | -30.7 | 4 | BEARISH | -90.0 |
| ERNAW Ernexa Therapeutics Inc. Warrants | — | — | — | — | — | — | — | BEARISH | — |
| RNAZ TransCode Therapeutics, Inc. | — | -0.0 | -59.2 | -21.0 | — | — | 1 | BEARISH | -87.5 |
| CHME China Medicine Corp. | — | -145.9 | 9.7 | 9.7 | 12.7 | -4.3 | 6 | BEARISH | -16.4 |
| VRPX Virpax Pharmaceuticals, Inc. | — | -0.0 | 2.6 | 0.4 | — | — | 1 | BEARISH | -96.2 |
| VRAX Virax Biolabs Group Limited | — | -0.0 | -110.9 | -481.7 | -40439.1 | 121.6 | 4 | BEARISH | 103.4 |
| OWPC One World Products, Inc. | — | 0.0 | -124.8 | -16.4 | 10538.7 | 1987.1 | 5 | BEARISH | -99.7 |
| SCNI Scinai Immunotherapeutics Ltd. | — | -0.0 | -19.2 | -53.3 | -435.4 | 162.7 | 2 | BEARISH | -63.6 |
| NUGS Cannabis Strategic Ventures | — | -0.2 | 115.4 | -142.7 | -3106.7 | -29.3 | 2 | BEARISH | 4500.0 |
| GHRS GH Research PLC | $1.2B | -20.0 | -18.8 | 2015.5 | — | — | 2 | BEARISH | 43.5 |
| ABUS Arbutus Biopharma Corp | $830M | 5.4 | 89.6 | 86.7 | -507.2 | 1078.8 | 4 | BEARISH | -1.6 |
| QTTB Q32 Bio Inc. | $260M | 3.1 | 72.1 | 435.2 | — | — | 5 | BEARISH | 193.3 |
| HOPHF Hemogenyx Pharmaceuticals Plc | $20M | -3.7 | -628.5 | -474.6 | — | — | 4 | BEARISH | 0.0 |
| SAGD South American Gold Corp. | — | -0.5 | 106.5 | 49.7 | — | — | 1 | BEARISH | 900.0 |
| NWCI NewCardio, Inc. | — | -0.0 | 258.3 | 352.6 | -23059.8 | 40.9 | 2 | BEARISH | 0.0 |
| AOLS Aeolus Pharmaceuticals, Inc. | — | -0.0 | -186.4 | 1650.1 | -7300.0 | -68.7 | 1 | BEARISH | -0.0 |
| LFPI LifePoint, Inc. | — | -0.0 | -288.4 | -229.2 | -52133.6 | 161.6 | 3 | BEARISH | 1400.0 |
| ANL Adlai Nortye Ltd. | $560M | -5.5 | -22.4 | -317.5 | -36.3 | 223.4 | 4 | BEARISH | 549.1 |
| AUNA Auna S.A. | $380M | -17.4 | 0.8 | 4.5 | 2.4 | 9.2 | 7 | BEARISH | -21.1 |
| SMTI Sanara MedTech Inc. | $300M | -8.8 | -147.7 | 19.8 | -1.6 | 12.9 | 5 | BEARISH | 5.7 |
| ARTV Artiva Biotherapeutics, Inc. | $300M | -1.3 | -36.6 | -954.6 | — | — | 3 | BEARISH | -21.1 |
| ELTP Elite Pharmaceuticals, Inc. | $270M | 4.8 | 74.3 | 43.6 | 18.3 | 33.7 | 5 | BEARISH | -60.6 |
| PLX Protalix BioTherapeutics, Inc. | $210M | 10.5 | 31.2 | 47.1 | 19.0 | 30.1 | 5 | BEARISH | 7.2 |
| FBIOP Fortress Biotech, Inc. | $130M | 0.6 | 107.5 | -87.8 | -2.5 | 15.5 | 6 | BEARISH | 131.0 |
| ALZN Alzamend Neuro Inc | $10M | -0.5 | -163.2 | 401.5 | — | — | 1 | BEARISH | -54.6 |
| ADVB Advanced Biomed Inc. Common Stock | $10M | 6.5 | 0.4 | -42.2 | 544.5 | — | 4 | BEARISH | -65.9 |
| XBIO Xenetic Biosciences, Inc. | — | -1.5 | -47.0 | 523.4 | -140.7 | 33.3 | 4 | BEARISH | -54.6 |
| CPMD CannaPharmaRX, Inc. | — | -0.1 | 42.4 | 22.4 | -691.1 | 24.8 | 3 | BEARISH | -58.3 |
| AFFY Affymax, Inc. | — | -0.0 | 98.1 | -302.0 | 17164.3 | -99.9 | 5 | BEARISH | -11.1 |
| PLYX Polaryx Therapeutics, Inc. Common Stock | $90M | -15.4 | -35.9 | 437.3 | — | — | 2 | BEARISH | — |
| CMOPF Cosmo N.V. | $1.1B | -158.0 | -1.2 | -2.9 | -9.5 | -43.8 | 1 | BEARISH | -22.4 |
| BTMD biote Corp. | $50M | 7.0 | -7.8 | 19.7 | -14.8 | -7.8 | 5 | BEARISH | -59.2 |
| NVLPF Nova Leap Health Corp. | $30M | 20.3 | 7.0 | 5.6 | 6.9 | 20.3 | 5 | BEARISH | 72.9 |
| PUMD ProUroCare Medical Inc. | — | — | — | — | — | — | — | BEARISH | -50.0 |
| SYRS Syros Pharmaceuticals, Inc. | — | -0.0 | -777.0 | 960.6 | — | -90.5 | 0 | BEARISH | 0.0 |
| LTHO Legacy Technology Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MLYS Mineralys Therapeutics, Inc. | $1.8B | -5.0 | -80.9 | 2274.6 | — | — | 2 | BEARISH | -47.0 |
| GENB Generate Biomedicines, Inc. | $1.6B | -7.8 | -28.2 | -175.0 | -1065.2 | — | 1 | BEARISH | — |
| CMPS COMPASS Pathways plc | $1.6B | -2.1 | -319.1 | 48.8 | — | — | 2 | BEARISH | 88.1 |
| NKTR Nektar Therapeutics | $1.1B | -5.7 | -35.8 | -29.2 | -401.0 | -27.2 | 3 | BEARISH | -36.8 |
| AVBP ArriVent BioPharma, Inc. | $1.0B | -4.2 | -53.1 | 2345.1 | — | — | 3 | BEARISH | -17.2 |
| ALMS Alumis Inc. | $880M | -1.7 | -93.6 | 2645.2 | -8557.2 | -63.1 | 2 | BEARISH | 47.2 |
| SANA Sana Biotechnology, Inc. | $700M | -3.3 | -152.9 | -242.3 | — | — | 3 | BEARISH | -55.8 |
| FULC Fulcrum Therapeutics, Inc. | $280M | -3.1 | -32.4 | 2389.1 | — | — | 4 | BEARISH | -59.9 |
| IPSC Century Therapeutics, Inc. | $260M | -1.4 | -49.7 | -60.0 | — | -100.0 | 2 | BEARISH | 151.2 |
| CPHRF Cipher Pharmaceuticals Inc. | $240M | 8.2 | 23.5 | 24.9 | 33.3 | 3.7 | 6 | BEARISH | -9.6 |
| CYBQF CYBERDYNE Inc. | $200M | 156.2 | 0.7 | -1.4 | 36.4 | -8.1 | 3 | BEARISH | 0.0 |
| NNNN Anbio Biotechnology Class A Ordinary Shares | $170M | — | — | — | — | — | — | BEARISH | -83.2 |
| TARA Protara Therapeutics, Inc. | $140M | -1.8 | -45.8 | -41.3 | — | — | 2 | BEARISH | -51.6 |
| OTLK Outlook Therapeutics, Inc. | $130M | -0.5 | 256.9 | 1372.0 | -225766.7 | -169.4 | 3 | BEARISH | -61.9 |
| VERU Veru Inc. | $40M | -3.8 | -62.3 | -211.2 | — | -100.0 | 3 | BEARISH | -40.0 |
| SEOVF Sernova Corp. | $30M | -3.7 | 57.0 | 76.3 | — | — | 3 | BEARISH | -35.6 |
| NSRX Nasus Pharma Ltd. | $30M | — | — | — | — | — | — | BEARISH | -57.9 |
| AKTX Akari Therapeutics, Plc | $20M | -0.0 | -139.9 | -175.8 | — | — | 3 | BEARISH | -71.0 |
| SNANF Sona Nanotech Inc. | $20M | -12.9 | 526.4 | 252.2 | — | — | 1 | BEARISH | -58.7 |
| SNTI Senti Biosciences, Inc. | $10M | -0.1 | -466.5 | -430.9 | -75000.0 | — | 2 | BEARISH | -91.0 |
| PLRZ Polyrizon Ltd. | $10M | -1.9 | -21.4 | -68.2 | — | — | 0 | BEARISH | 39.6 |
| ANEB Anebulo Pharmaceuticals, Inc. | $10M | -1.7 | -69.7 | 650.7 | — | — | 1 | BEARISH | -90.5 |
| LTRN Lantern Pharma Inc. | $10M | -0.4 | -400.9 | 115.9 | — | — | 2 | BEARISH | -84.3 |
| HMTXF Hemostemix Inc. | $10M | -2.0 | 69.9 | 190.1 | — | — | 1 | BEARISH | -44.5 |
| ADIL Adial Pharmaceuticals, Inc. | $10M | -0.2 | -2011.6 | 159.6 | — | — | 3 | BEARISH | -58.8 |
| AOXG Aoxing Pharmaceutical Company, Inc. | — | -37.5 | -0.2 | -13.9 | -405.2 | -99.8 | 1 | BEARISH | -69.7 |
| SLXN Silexion Therapeutics Ltd. | — | -0.0 | -17022.0 | -931.4 | — | — | 3 | BEARISH | -95.0 |
| LIPO Lipella Pharmaceuticals Inc. | — | -0.0 | -361.8 | 4105.8 | — | -64.1 | 1 | BEARISH | -99.9 |
| EVGN Evogene Ltd. | — | -0.4 | 265.3 | 101.3 | -509.5 | -80.4 | 3 | BEARISH | -69.6 |
| CTTH CTT Pharmaceutical Holdings, Inc. | — | -40.5 | -272.8 | -210.7 | — | — | 2 | BEARISH | -4.4 |
| CYIO CYIOS Corporation | — | 1.2 | 60.5 | 46.3 | — | -48.3 | 2 | BEARISH | -86.0 |
| SKVI Skinvisible, Inc. | — | -0.8 | 10.0 | 7.2 | -5110.7 | 0.0 | 2 | BEARISH | -61.0 |
| EVAHF EGF Theramed Health Corp. | — | -0.2 | 102.2 | 4.7 | — | — | 2 | BEARISH | -71.0 |
| AMPE Ampio Pharmaceuticals, Inc. | — | -0.0 | -114.0 | 1652.6 | -838.4 | — | 4 | BEARISH | 5806.4 |
| PBFFF Planet Based Foods Global Inc. | — | -0.7 | 69.6 | 63.1 | — | 100.0 | 2 | BEARISH | -80.8 |
| MDIT Medite Cancer Diagnostics, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | — | — | — | — | — | — | — | BEARISH | -72.0 |
| AMBS Amarantus BioScience Holdings, Inc. | — | -0.0 | 7.3 | 3.8 | -4080.5 | — | 3 | BEARISH | -66.7 |
| LVRLF CordovaCann Corp. | — | -1.0 | 47.4 | -18.4 | -6.5 | -2.8 | 4 | BEARISH | 3.5 |
| EMGE Emergent Health Corp | — | -0.0 | 23.7 | 51.7 | — | -80.0 | 1 | BEARISH | 9900.0 |
| IVRO InVitro International | — | 17.1 | 3.7 | 4.6 | 4.8 | -14.0 | 5 | BEARISH | -25.0 |
| ANTH Anthera Pharmaceuticals, Inc. | — | -0.0 | -251.4 | 1107.5 | — | — | 1 | BEARISH | 0.0 |
| ATRX Adhera Therapeutics Inc | — | -0.0 | 18.6 | 6.5 | — | — | 1 | BEARISH | 0.0 |
| PLWY Peoplesway.com Inc. | — | -0.0 | -6.5 | -4001.9 | -1.4 | -22.7 | 5 | BEARISH | 0.0 |
| NXEN Nexien BioPharma, Inc. | — | -0.0 | 48.5 | 112.0 | — | — | 2 | BEARISH | -99.2 |
| OILFF Nextleaf Solutions Ltd. | — | -1.8 | -41.0 | -53.4 | -19.9 | -18.2 | 3 | BEARISH | -63.8 |
| ORIC ORIC Pharmaceuticals, Inc. | $1.4B | -6.7 | -39.8 | -102.9 | — | — | 3 | BEARISH | -31.3 |
| KSPHF Kissei Pharmaceutical Co., Ltd. | $1.0B | 11.3 | 6.5 | -1.9 | 20.2 | 10.7 | 6 | BEARISH | -2.4 |
| XGN Exagen Inc. | $180M | -9.5 | -113.8 | -79.2 | -16.0 | 20.8 | 3 | BEARISH | -35.0 |
| CPIX Cumberland Pharmaceuticals Inc. | $130M | -6.9 | -46.7 | -41.6 | -2472.5 | -25.7 | 3 | BEARISH | 41.8 |
| TRUFF Rhelion Life Sciences Corp. | $10M | -2.1 | -37.0 | -58.5 | -804.7 | -34.3 | 3 | BEARISH | -20.4 |
| IMRN Immuron Limited | $10M | -2.7 | -40.2 | -187.8 | -54.4 | -29.7 | 5 | BEARISH | -56.7 |
| INBP Integrated BioPharma, Inc. | $10M | -1.9 | -15.0 | -13.1 | -13.9 | -19.3 | 2 | BEARISH | -43.3 |
| NXL Nexalin Technology, Inc. | — | -0.1 | -240.3 | -1401.4 | -18412.7 | 24.2 | 4 | BEARISH | 13.9 |
| EVIO EVIO, Inc. | — | 1.7 | 65.3 | 33.5 | 8.3 | -26.9 | 4 | BEARISH | 0.0 |
| BCTXZ BriaCell Therapeutics Corp. Warrant | — | -0.3 | -168.1 | -2016.9 | — | — | 1 | BEARISH | -68.2 |
| KHRNF Khiron Life Sciences Corp. | — | -0.2 | -74.7 | -41.4 | -105.6 | 76.2 | 2 | BEARISH | 0.0 |
| BDPT BioAdaptives Inc. | — | -0.0 | 80.2 | 56.3 | 3009.0 | 169.7 | 3 | BEARISH | -93.4 |
| MDRM Modern Mobility Aids, Inc. | — | -63.9 | 146.1 | 120.5 | — | — | 2 | BEARISH | -47.1 |
| ANRO Alto Neuroscience, Inc. | $860M | -9.4 | -49.2 | -201.4 | — | — | 3 | BEARISH | 110.7 |
| DSGN Design Therapeutics, Inc. | $640M | -9.0 | -34.1 | 1787.8 | — | — | 1 | BEARISH | 85.5 |
| BRIBF Brii Biosciences Limited | $90M | -3.4 | -10.3 | -62.6 | — | 22.5 | 4 | BEARISH | -46.0 |
| ELOX Eloxx Pharmaceuticals, Inc. | $40M | -8.8 | -107.5 | 81.5 | — | — | 4 | BEARISH | 13339900.4 |
| TELA TELA Bio, Inc. | $40M | -1.2 | 1232.5 | -260.3 | -58.4 | 6.1 | 3 | BEARISH | -35.1 |
| IDXG Interpace Biosciences, Inc. | $40M | 0.2 | 221.9 | 123.7 | 1.7 | -20.3 | 6 | BEARISH | 18.0 |
| SGIPF Sugi Holdings Co.,Ltd. | $1.8B | 16.0 | 10.0 | 11.6 | 2.2 | 46.6 | 7 | BEARISH | 0.9 |
| AUTL Autolus Therapeutics plc | $410M | -1.5 | -132.9 | 451.5 | -85.6 | 292.0 | 3 | BEARISH | 1.3 |
| STSN Stemsation International, Inc. | $10M | -4.8 | -2.8 | -1.6 | — | — | 3 | BEARISH | 16.3 |
| BVAXF BioVaxys Technology Corp. | — | -0.9 | 310.6 | 48.4 | — | — | 1 | BEARISH | -45.4 |
| IGEX Indo Global Exchange(s) PTE, Ltd. | — | -16.1 | -12.1 | -3.5 | — | -100.0 | 5 | BEARISH | -20.0 |
| HBRM Herborium Group, Inc. | — | -2.3 | 0.6 | 0.6 | 0.7 | -2.7 | 5 | BEARISH | -50.0 |
| AVLN Avalyn Pharma Inc. Common Stock | $1.1B | — | — | — | — | — | — | BEARISH | — |
| BCAX Bicara Therapeutics Inc. Common Stock | $1.1B | -5.6 | -41.0 | 583.9 | — | — | 2 | BEARISH | 2.0 |
| MNKD MannKind Corporation | $1.0B | -23.6 | 71.4 | 4.0 | -17.4 | 30.5 | 2 | BEARISH | -38.0 |
| GLUE Monte Rosa Therapeutics, Inc. | $920M | -4.9 | -42.7 | 149.9 | -483.9 | -83.9 | 3 | BEARISH | -4.3 |
| WVE Wave Life Sciences Ltd. | $630M | -3.2 | -80.0 | -1243.7 | -470.5 | -35.1 | 4 | BEARISH | -51.6 |
| LRMR Larimar Therapeutics, Inc. | $240M | -1.2 | -139.6 | 590.9 | — | — | 2 | BEARISH | -43.2 |
| TSNDF TerrAscend Corp. | $170M | -3.9 | -22.6 | -28.1 | -13.6 | — | 3 | BEARISH | — |
| ALXO ALX Oncology Holdings Inc. | $160M | -1.0 | -80.6 | -851.1 | — | — | 4 | BEARISH | -37.1 |
| OGI Organigram Global Inc. | $130M | 2.1 | 18.4 | -1.3 | 99.8 | 38.1 | 5 | BEARISH | -46.3 |
| HUMA Humacyte, Inc. | $120M | -0.9 | -547.9 | -500.7 | -9064.5 | -73.6 | 3 | BEARISH | -73.9 |
| IMUX Immunic, Inc. | $100M | -1.6 | -138.2 | 345.6 | — | — | 5 | BEARISH | -0.9 |
| JYNT The Joint Corp. | $100M | 27.2 | 19.4 | -33.1 | 4.3 | 220.6 | 8 | BEARISH | -14.1 |
| ADAG Adagene Inc. | $90M | -5.5 | -28.6 | 111.8 | -1011.1 | 8927.0 | 5 | BEARISH | 45.8 |
| IMDX Insight Molecular Diagnostics Inc. | $90M | -2.1 | 488.7 | 92.7 | -4711.3 | -60.8 | 2 | BEARISH | -52.3 |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | $70M | -0.7 | -213.1 | 3515.1 | — | — | 4 | BEARISH | -32.0 |
| RECEF Recce Pharmaceuticals Ltd | $70M | -6.0 | 151.4 | 200.5 | — | -100.0 | 2 | BEARISH | -56.0 |
| TENX Tenax Therapeutics, Inc. | $50M | -1.2 | -59.8 | 1235.8 | — | — | 1 | BEARISH | -76.7 |
| CVM CEL-SCI Corporation | $30M | -0.6 | -252.5 | -142.9 | — | -100.0 | 4 | BEARISH | -82.9 |
| ARTL Artelo Biosciences, Inc. | $10M | -0.0 | -705.7 | -1031.2 | — | — | 5 | BEARISH | -92.8 |
| SYBE SYBLEU Inc | — | -3.1 | 71.5 | -202.2 | -685.7 | — | 2 | BEARISH | 0.0 |
| YCBD cbdMD, Inc. | — | -1.2 | -40.3 | -27.6 | -20.3 | 10.0 | 2 | BEARISH | -64.3 |
| RGRX RegeneRx Biopharmaceuticals, Inc. | — | -0.0 | 53.5 | 45.8 | -2006.3 | -0.0 | 3 | BEARISH | 450.0 |
| LNDZF Evome Medical Technologies Inc. | — | -2.2 | -294.8 | -10.4 | -11.5 | -15.9 | 4 | BEARISH | -98.3 |
| TRGM Targeted Medical Pharma, Inc. | — | -0.0 | 26.6 | 20.9 | -45.1 | -26.0 | 4 | BEARISH | -90.0 |
| BICTF Biocure Technology Inc. | — | -0.1 | -889.9 | 60.0 | — | — | 1 | BEARISH | 0.0 |
| USAQ QHSLab, Inc. | — | 6.8 | 114.6 | 6.2 | 4.5 | 24.6 | 6 | BEARISH | 56.5 |
| BIMI BIMI International Medical Inc. | — | -0.0 | -159.5 | -56.3 | -124.0 | -65.7 | 4 | BEARISH | 300.0 |
| CPYT CarePayment Technologies, Inc. | — | -0.0 | 1607.0 | -66.2 | -585.5 | — | 2 | BEARISH | 0.0 |
| OHCS Optimus Healthcare Services, Inc. | — | -0.0 | 99.2 | 130.3 | -469.4 | 43.7 | 4 | BEARISH | -99.0 |
| NEXI NexImmune, Inc. | — | -0.0 | -230.1 | 1048.5 | — | — | 4 | BEARISH | -0.0 |
| FNAM Evolutionary Genomics, Inc. | — | -0.0 | 62.2 | -99.6 | — | — | 2 | BEARISH | 0.0 |
| RBOT Vicarious Surgical Inc. | — | -0.0 | -223.8 | -476.5 | — | — | 1 | BEARISH | -99.7 |
| WINT Windtree Therapeutics, Inc. | — | -0.0 | 1111.0 | -2375.5 | — | — | 3 | BEARISH | -99.6 |
| NVCR Novocure Ltd | $1.7B | -11.2 | -43.2 | -93.1 | -8.5 | 11.0 | 6 | BEARISH | 6.3 |
| INVA Innoviva, Inc. | $1.5B | 4.3 | 36.7 | 15.0 | -69.8 | 19.8 | 7 | BEARISH | 18.2 |
| LTGO Latigo Biotherapeutics Inc. | $900M | — | — | — | — | — | — | BEARISH | — |
| MTLZF Metall Zug AG | $680M | -34.8 | -2.8 | -1.4 | -5.6 | -0.3 | 6 | BEARISH | 0.0 |
| ACHV Achieve Life Sciences, Inc. | $670M | -4.5 | -845.0 | 24.6 | — | — | 2 | BEARISH | 38.6 |
| HELP Helus Pharma Inc. | $630M | -2.5 | -56.3 | -143.0 | — | — | 2 | BEARISH | — |
| IRWD Ironwood Pharmaceuticals, Inc. | $570M | 4.4 | -55.3 | 93.9 | 45.4 | 26.2 | 7 | BEARISH | 111.5 |
| EIKN Eikon Therapeutics, Inc. Common Stock | $390M | — | — | — | — | — | — | BEARISH | — |
| TECX Tectonic Therapeutic, Inc. | $390M | -4.5 | -33.8 | -6371.3 | — | — | 1 | BEARISH | 18.6 |
| VRNO Verano Holdings Corp | $370M | -1.4 | -4.5 | 1.5 | -6.0 | — | 3 | BEARISH | — |
| CLVLF Clinuvel Pharmaceuticals Limited | $250M | 10.6 | 13.2 | 126.7 | 41.1 | -1.1 | 6 | BEARISH | -32.0 |
| ELMD Electromed, Inc. | $220M | 19.5 | 23.3 | 32.5 | 17.5 | 15.3 | 8 | BEARISH | 9.8 |
| EDTXF Spectral Medical Inc. | $210M | -7.5 | 64.9 | 19.4 | 53.3 | 1.5 | 2 | BEARISH | -37.5 |
| PDEX Pro-Dex, Inc. | $200M | 14.8 | 32.4 | 17.5 | 14.0 | 16.4 | 8 | BEARISH | 119.3 |
| RNAC Cartesian Therapeutics, Inc. | $190M | -1.1 | 241.0 | 37.3 | — | 44.0 | 2 | BEARISH | -29.5 |
| NAGE Niagen Bioscience Inc | $190M | 12.9 | 21.8 | 44.7 | 3.2 | 11.0 | 6 | BEARISH | -67.0 |
| VRXA Veraxa Biotech Holding AG | $140M | — | — | — | — | — | — | BEARISH | — |
| CNXU Conexeu Sciences Inc. | $90M | — | — | — | — | — | — | BEARISH | — |
| TNXP Tonix Pharmaceuticals Holding Corp. | $90M | -0.4 | -81.8 | -276.2 | -299.4 | 196.0 | 3 | BEARISH | -72.3 |
| GNLX Genelux Corporation | $90M | -2.3 | -168.9 | 20537.7 | — | — | 2 | BEARISH | -73.8 |
| SHIEF Shield Therapeutics plc | $80M | -7.4 | 65.2 | 698.4 | -7.4 | 152.4 | 3 | BEARISH | -24.5 |
| INO Inovio Pharmaceuticals, Inc. | $60M | -0.8 | -409.9 | 257.7 | — | -100.0 | 1 | BEARISH | -61.8 |
| NDTP NDT Pharmaceuticals Inc. | $50M | -39.2 | -3.8 | -1.5 | -458.3 | — | 4 | BEARISH | -83.3 |
| ONCY Oncolytics Biotech Inc. | $50M | -1.9 | 90135.4 | 285.1 | — | — | 1 | BEARISH | -61.5 |
| VEXTF Vext Science, Inc. | $40M | -2.3 | -23.2 | -8.7 | -2.6 | 14.2 | 5 | BEARISH | -12.2 |
| BMKDF BioMark Diagnostics Inc. | $40M | -34.8 | -149.8 | -103.7 | -5198.4 | -82.1 | 2 | BEARISH | 39.9 |
| CLCS Cell Source, Inc. | $40M | -4.6 | 27.7 | 34.5 | — | — | 4 | BEARISH | 24.0 |
| INIS Radnostix, Inc. | $30M | -0.0 | -29489557.0 | -23.1 | -33.0 | -23.7 | 1 | BEARISH | -22.0 |
| NSPR InspireMD, Inc. | $20M | -0.9 | -148.8 | -1383.2 | -808.8 | 53.4 | 4 | BEARISH | -79.9 |
| BIAF bioAffinity Technologies, Inc. | $20M | -0.0 | -1860.2 | -352.6 | -222.8 | -23.2 | 4 | BEARISH | -92.5 |
| CNTX Context Therapeutics Inc. | $20M | -0.5 | -76.1 | 841.7 | — | — | 2 | BEARISH | -81.4 |
| RVXCF Resverlogix Corp. | $20M | -1.5 | 11.5 | 25.3 | — | — | 4 | BEARISH | -30.1 |
| NEUP Neuphoria Therapeutics Inc. | $20M | -0.5 | -0.2 | -0.2 | -417.7 | -91.9 | 4 | BEARISH | -45.7 |
| BICX BioCorRx Inc. | $10M | -1.7 | 25.4 | 84.3 | -1096.7 | 151.2 | 3 | BEARISH | -47.2 |
| ICU SeaStar Medical Holding Corporation | $10M | -0.6 | -356.9 | 415.0 | -606.5 | 123.6 | 4 | BEARISH | -59.0 |
| PHIO Phio Pharmaceuticals Corp. | $10M | -0.7 | -113.7 | 2701.6 | — | — | 2 | BEARISH | -57.1 |
| NMTC NeuroOne Medical Technologies Corporation | $10M | -0.9 | -119.7 | -335.0 | -101.7 | 50.8 | 5 | BEARISH | 4.2 |
| LPCN Lipocine Inc. | $10M | -0.8 | -60.9 | 662.3 | -1379.6 | -62.7 | 2 | BEARISH | -49.7 |
| MODD Modular Medical, Inc. | $10M | -0.2 | -247.9 | -302.8 | — | — | 2 | BEARISH | -90.0 |
| PMEDF Qscreen Ai Inc. | — | -13.1 | 145.2 | 82.8 | — | — | 3 | BEARISH | -46.7 |
| SYUP Anbc, Inc. | — | — | — | — | — | — | — | BEARISH | 50.0 |
| LVVV LiveWire Ergogenics, Inc. | — | -0.4 | -188.5 | -4.0 | -2585.3 | -89.5 | 3 | BEARISH | -84.6 |
| POAS Phaos Technology Holdings (Caym | — | — | — | — | — | — | — | BEARISH | — |
| SPRC SciSparc Ltd. | — | -0.0 | -519.9 | -161.9 | -1891.2 | -26.8 | 5 | BEARISH | -78.9 |
| SSKN STRATA Skin Sciences, Inc. | — | -0.0 | -164.6 | -42.5 | 0.6 | -8.5 | 4 | BEARISH | -100.0 |
| YOURF YourWay Cannabis Brands Inc. | — | -0.0 | 19.0 | 18.4 | 3.3 | 253.3 | 8 | BEARISH | 0.0 |
| MTNB Matinas BioPharma Holdings, Inc. | — | -0.1 | -154.3 | -504.1 | — | — | 4 | BEARISH | -92.4 |
| BMCS BioTech Medics, Inc. | — | -13.9 | -0.0 | -0.0 | — | — | 5 | BEARISH | -97.7 |
| UDOCF Unidoc Health Corp. | — | -2.4 | 392.6 | 140.6 | -352.4 | 606.8 | 3 | BEARISH | -72.2 |
| BLEG Branded Legacy, Inc. | — | -0.0 | 2011.7 | 147.0 | — | -29.4 | 2 | BEARISH | -99.5 |
| GRI GRI Bio, Inc. | — | -0.0 | -142.0 | 1227.5 | — | — | 5 | BEARISH | -97.2 |
| GXXY Galexxy Holdings, Inc. | — | -0.0 | 370.1 | 271.5 | -385.0 | -88.8 | 2 | BEARISH | -98.5 |
| VCNX Vaccinex, Inc. | — | -0.4 | 776.6 | 414.6 | -1584.0 | 226.6 | 3 | BEARISH | -20.1 |
| ENMI DH Enchantment Inc. | — | -0.5 | 52.9 | -49.5 | -32.2 | 26.9 | 5 | BEARISH | 0.0 |
| LNAI Lunai Bioworks Inc. | — | -0.3 | -21.6 | 30.2 | — | — | 2 | BEARISH | -97.1 |
| BMMJ Body and Mind Inc. | — | -0.1 | 267.1 | 411.6 | -58.9 | -48.9 | 2 | BEARISH | -98.0 |
| CLABF Core One Labs Inc. | — | -0.3 | -233.7 | -70.3 | -897.6 | -69.3 | 3 | BEARISH | -90.0 |
| DRMA Dermata Therapeutics, Inc. | — | -0.2 | -183.9 | 734.5 | — | — | 2 | BEARISH | -80.8 |
| MCIC Multicorp International, Inc. | — | -15.7 | -1.1 | -0.2 | — | — | 3 | BEARISH | -0.0 |
| HLTHQ Cue Health Inc. | — | -0.0 | -90.3 | -100.6 | -789.6 | -85.3 | 1 | BEARISH | 0.0 |
| VIVS VivoSim Labs, Inc. | — | -0.0 | -343.1 | 241.9 | -7433.3 | 202.7 | 2 | BEARISH | -93.5 |
| APPB Applied Biosciences Corp. | — | -0.0 | -297.6 | -188.8 | -798.1 | 75.3 | 4 | BEARISH | 0.0 |
| CDT CDT Equity Inc. | — | -0.0 | 13.1 | 5.4 | 9.1 | — | 7 | BEARISH | -97.3 |
| TTOO T2 Biosystems, Inc. | — | -0.0 | 277.6 | -638.9 | -509.7 | -30.2 | 3 | BEARISH | -95.8 |
| AKAN Akanda Corp. | — | -0.0 | 855.2 | -259.9 | -1532.3 | 84.2 | 3 | BEARISH | -97.5 |
| PASO Patient Access Solutions, Inc. | — | -0.0 | 540.4 | 691.6 | 0.6 | — | 2 | BEARISH | -99.0 |
| BRGX BioRegenx, Inc. | — | -0.2 | 0.6 | 1.6 | -6.2 | — | 3 | BEARISH | — |
| IHGP Jun An Kang Group Inc. | — | 2.0 | 0.5 | 0.5 | 1.0 | 64.0 | 6 | BEARISH | -98.7 |
| BRTX BioRestorative Therapies, Inc. | — | -0.1 | -241.1 | 2112.9 | -9298.3 | -8.5 | 3 | BEARISH | -95.7 |
| BBLG Bone Biologics Corporation | — | -0.2 | -47.5 | 1744.6 | — | — | 2 | BEARISH | -83.6 |
| AFMDQ Affimed N.V. | — | — | — | — | — | — | — | BEARISH | — |
| SXTP 60 Degrees Pharmaceuticals, Inc. | — | -0.1 | -321.8 | -390.2 | -1089.2 | 68.0 | 3 | BEARISH | -50.5 |
| ICCO InterCare DX, Inc. | — | -0.0 | 16.1 | 3053.3 | — | — | 5 | BEARISH | 0.0 |
| NPRRF Nipro Corporation | $1.4B | — | — | — | — | — | — | BEARISH | 5.8 |
| LITS Lite Strategy, Inc. | $40M | -0.1 | -170.9 | -28.2 | — | — | 2 | BEARISH | -40.2 |
| AYTU Aytu BioPharma, Inc. | $20M | -1.4 | -52.6 | -24.3 | -0.1 | -13.3 | 4 | BEARISH | -16.3 |
| ETON Eton Pharmaceuticals, Inc. | $1.4B | 110.0 | 36.0 | 33.3 | 30.8 | 81.5 | 7 | BEARISH | 177.1 |
| DRTS Alpha Tau Medical Ltd | $1.2B | -13.0 | -141.7 | -17.1 | — | — | 3 | BEARISH | 219.4 |
| SLDB Solid Biosciences Inc. | $630M | -3.2 | -65.5 | -1012.6 | — | — | 3 | BEARISH | 10.1 |
| ORMP Oramed Pharmaceuticals Inc. | $170M | 1.0 | 74.1 | -4.3 | — | -100.0 | 4 | BEARISH | 74.1 |
| AMGXF AnGes, Inc. | $140M | -2.9 | -160.6 | -111.8 | -531.3 | -16.1 | 4 | BEARISH | 0.0 |
| ANTX AN2 Therapeutics, Inc. | $130M | -3.6 | -50.1 | 1243.3 | — | — | 2 | BEARISH | 229.9 |
| BBIXF Bonus BioGroup Ltd. | $50M | -17.4 | 3245.0 | 2543.1 | — | — | 2 | BEARISH | 13233.3 |
| INTI Inhibitor Therapeutics, Inc. | $10M | -4.2 | 358.8 | 88.0 | — | — | 1 | BEARISH | 59.8 |
| CMHSF Comprehensive Healthcare Systems, Inc. | $10M | -1.8 | 78.3 | 144.6 | -37.9 | -22.6 | 3 | BEARISH | -35.0 |
| RMTG Regenerative Medical Technology Group Inc. | — | -0.1 | 9.6 | -3.3 | -72.2 | — | 3 | BEARISH | — |
| SLHPF Skylight Health Group Inc. | — | -0.0 | -109.3 | -44.8 | -21.4 | — | 2 | BEARISH | -90.0 |
| IRME IR-Med Inc. | — | -0.1 | 1793.9 | 264.1 | — | -23.5 | 2 | BEARISH | -93.8 |
| MYMX Mymetics Corporation | — | -0.0 | 16.6 | 357.9 | -3012.0 | -62.8 | 2 | BEARISH | 0.0 |
| XAIR Beyond Air, Inc. | — | -0.0 | -429.9 | 409.7 | -448.8 | 60.7 | 6 | BEARISH | 3.3 |
| IHTI Integrative Health Technologies, Inc. | — | 0.0 | -13.8 | -11.8 | 53.8 | 263.8 | 4 | BEARISH | -95.0 |
| NWPHF Newron Pharmaceuticals S.p.A. | $410M | -6.7 | 83.9 | -32.1 | -513.4 | — | 1 | BEARISH | — |
| FOCL EDAP TMS S.A. American Depositary Shares | $160M | — | — | — | — | — | — | BEARISH | — |
| KKUR ChromoCure, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| VRXAW Veraxa Biotech AG | — | — | — | — | — | — | — | BEARISH | — |
| BLEVF Beleave Inc. | — | -0.0 | -105.9 | -25.1 | -653.1 | 117.7 | 4 | BEARISH | -99.0 |
| SRNE Sorrento Therapeutics, Inc. | — | -0.0 | 1502.8 | 468.4 | -633.7 | 16.9 | 2 | BEARISH | -96.7 |
| OLMA Olema Pharmaceuticals, Inc. | $560M | -3.3 | -52.7 | 585.3 | — | — | 2 | BEARISH | -12.3 |
| CBIO Crescent Biopharma, Inc. | $480M | -1.8 | -107.7 | 1928.6 | — | — | 5 | BEARISH | 4.6 |
| BWAY BrainsWay Ltd. | $440M | 46.3 | 13.0 | 31.1 | 15.8 | 32.3 | 5 | BEARISH | 38.3 |
| BLSM BlossomHill Therapeutics, Inc. | $430M | — | — | — | — | — | — | BEARISH | — |
| APYX Apyx Medical Corporation | $100M | -12.1 | -96.4 | -12.3 | -23.4 | 25.6 | 5 | BEARISH | -22.1 |
| MBOT Microbot Medical Inc. | $70M | -4.0 | -32.9 | -600.2 | -2334.9 | — | 3 | BEARISH | -57.4 |
| GOSS Gossamer Bio, Inc. | $60M | -0.2 | 178.7 | 117.2 | 182.9 | 32.4 | 3 | BEARISH | -95.1 |
| CVRX CVRx, Inc. | $40M | -0.7 | -133.4 | -260.4 | -89.4 | 12.0 | 3 | BEARISH | -86.4 |
| IBO Impact BioMedical Inc. | $30M | -2.9 | 10.8 | -30.4 | -23300.0 | — | 5 | BEARISH | -50.1 |
| ETST Earth Science Tech, Inc. | $30M | 6.8 | 66.8 | 212.2 | 8.0 | 8.0 | 6 | BEARISH | -49.5 |
| MEDIF MediPharm Labs Corp. | $20M | -5.6 | -13.2 | -15.4 | 0.0 | -6.7 | 4 | BEARISH | -13.1 |
| ORXOY Orexo AB (publ) | $20M | -0.5 | 3924.8 | -872.8 | -12050.0 | -97.8 | 4 | BEARISH | -83.4 |
| AIM AIM ImmunoTech Inc. | $10M | -0.0 | -2382.3 | -513.5 | -14569.2 | -21.5 | 5 | BEARISH | -93.5 |
| NSCIF Nanalysis Scientific Corp. | $10M | -3.5 | -33.5 | -6.2 | -6.9 | -6.2 | 5 | BEARISH | -33.8 |
| FITY Fifty 1 Labs, Inc. | — | -1.0 | 132.4 | 345.2 | -58137.6 | -75.6 | 4 | BEARISH | -84.6 |
| SILO Silo Pharma, Inc. | — | -0.2 | -91.2 | 645.1 | — | -25.0 | 3 | BEARISH | 116.9 |
| ACNV Accelera Innovations, Inc | — | -0.0 | 197.1 | 28.9 | — | -97.0 | 1 | BEARISH | 0.0 |
| SHMN SOHM, Inc. | — | 9.0 | -15.3 | -2.9 | -130.8 | -3.6 | 4 | BEARISH | -30.8 |
| LGVN Longeveron Inc. | — | -0.2 | -203.6 | -2062.6 | -2116.0 | -42.7 | 4 | BEARISH | -81.2 |
| LUDG Ludwig Enterprises, Inc. | — | -0.4 | 43.5 | 103.5 | — | 100.0 | 4 | BEARISH | -94.3 |
| RNVA Rennova Health, Inc. | — | -0.5 | 23.5 | -4.3 | -241.1 | 43.3 | 5 | BEARISH | 0.0 |
| BTAIQ BioXcel Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| BFLY Butterfly Network, Inc. | $1.8B | -25.5 | -35.5 | -74.8 | -39.6 | 28.1 | 4 | BEARISH | 231.8 |
| AAPG Ascentage Pharma Group International | $1.4B | -6.4 | -236.8 | -144.8 | -270.2 | 170.9 | 3 | BEARISH | -58.7 |
| OMER Omeros Corporation | $1.2B | 9.2 | -89.2 | 71.8 | 46.4 | — | 5 | BEARISH | 131.7 |
| ASCLF Ascletis Pharma Inc. | $770M | -8.0 | -28.4 | -7144.0 | — | -60.6 | 2 | BEARISH | -40.0 |
| NVCT Nuvectis Pharma, Inc. | $650M | -14.1 | -214.6 | 174.4 | — | — | 1 | BEARISH | 197.4 |
| FDMT 4D Molecular Therapeutics, Inc. | $600M | -4.4 | -43.3 | -182.0 | -1929.0 | 278712.1 | 4 | BEARISH | 5.5 |
| PHAT Phathom Pharmaceuticals, Inc. | $460M | -4.7 | 26.4 | 8.9 | -23.7 | 110.2 | 4 | BEARISH | -55.7 |
| EPRX Eupraxia Pharmaceuticals Inc. | $450M | -7.0 | -68.6 | 8742.2 | — | — | 3 | BEARISH | 29.4 |
| AGEN Agenus Inc. | $290M | 2.4 | -33.2 | -20.4 | -1.6 | 30.5 | 6 | BEARISH | 60.6 |
| TLSI TriSalus Life Sciences, Inc. | $220M | -2.9 | 438.3 | 453.7 | -80.5 | 25.2 | 4 | BEARISH | -25.8 |
| GALT Galectin Therapeutics Inc. | $210M | -7.9 | 21.9 | 99.4 | — | — | 2 | BEARISH | -35.4 |
| CGEN Compugen Ltd. | $180M | 5.2 | 49.6 | -90.2 | -269.3 | 886.7 | 5 | BEARISH | 9.4 |
| HCAT Health Catalyst, Inc. | $130M | -0.4 | -118.1 | -27.1 | -57.5 | -7.5 | 5 | BEARISH | -51.5 |
| CORBF Global Cord Blood Corporation | $130M | 1.5 | 104.3 | -167.2 | 35.9 | — | 4 | BEARISH | 26.7 |
| SEER Seer, Inc. | $110M | -1.6 | -26.4 | -58.8 | -544.8 | -13.3 | 3 | BEARISH | -15.2 |
| VANI Vivani Medical, Inc. | $100M | -3.3 | -220.4 | -127.1 | — | — | 4 | BEARISH | -29.6 |
| COYA Coya Therapeutics, Inc. | $90M | -3.9 | -60.5 | -18820.6 | -2723.4 | 1793.8 | 4 | BEARISH | -34.6 |
| PXMBF Paxman AB (publ) | $80M | -305.7 | -1.2 | -1.7 | 2.4 | 33.5 | 3 | BEARISH | 0.0 |
| SKIN SkinHealth Systems Inc. | $70M | -2.2 | -43.8 | -1.6 | -3.7 | -6.5 | 4 | BEARISH | -63.6 |
| PMVP PMV Pharmaceuticals, Inc. | $70M | -0.9 | -70.9 | 815.8 | — | — | 2 | BEARISH | -19.9 |
| MNOV MediciNova, Inc. | $70M | -6.5 | -25.6 | -78.2 | -504.8 | 583.9 | 3 | BEARISH | 14.6 |
| HRTX Heron Therapeutics, Inc. | $60M | -1.6 | 334.6 | -7.6 | -14.6 | 1.0 | 3 | BEARISH | -74.9 |
| OSTX OS Therapies Incorporated | $60M | -1.1 | 1924.5 | 268.9 | — | — | 1 | BEARISH | -34.4 |
| SPRO Spero Therapeutics, Inc. | $60M | 8.1 | 19.2 | -128.5 | — | -7.0 | 7 | BEARISH | -48.4 |
| ALPS Alps Group Inc | $50M | — | — | — | — | — | — | BEARISH | — |
| INCR InterCure Ltd. | $50M | -4.0 | -15.9 | -10.2 | -1.3 | -10.8 | 2 | BEARISH | -40.8 |
| XLO Xilio Therapeutics, Inc. | $50M | -5.4 | -55.0 | 43.1 | -34.1 | 327.3 | 6 | BEARISH | 913.9 |
| MREO Mereo BioPharma Group plc | $40M | -1.6 | -67.8 | 6194.3 | — | -100.0 | 2 | BEARISH | -85.4 |
| CRVO CervoMed Inc. | $30M | -0.7 | -107.6 | 1244.8 | — | — | 2 | BEARISH | -68.6 |
| ITHUF iAnthus Capital Holdings, Inc. | $30M | -0.5 | 53.1 | -9.2 | -40.8 | -9.9 | 1 | BEARISH | -44.8 |
| DGNOF DIAGNOS Inc. | $30M | -8.7 | -988.8 | -2061.6 | -7539.8 | -36.9 | 3 | BEARISH | 6.7 |
| COCP Cocrystal Pharma, Inc. | $20M | -1.2 | -311.7 | -3697.6 | -3013.3 | — | 2 | BEARISH | -16.9 |
| SCYX SCYNEXIS, Inc. | $20M | -2.1 | -18.4 | -120.7 | 3147.7 | 489.8 | 5 | BEARISH | 393.5 |
| RVLWF Revitalist Lifestyle and Wellness Ltd. | $10M | -0.1 | 613.5 | -129.3 | -263.6 | — | 2 | BEARISH | 0.0 |
| KPRX Kiora Pharmaceuticals, Inc. | $10M | -0.9 | -56.4 | -2884.1 | — | — | 2 | BEARISH | -10.2 |
| GTHP Guided Therapeutics, Inc. | $10M | -3.6 | 66.3 | 57.9 | — | 450.8 | 3 | BEARISH | -48.2 |
| GLWLF Glow Lifetech Corp. | $10M | -50.0 | -11.1 | -21.1 | -26.6 | 59.2 | 5 | BEARISH | -16.1 |
| HLYK HealthLynked Corp. | $10M | -1.4 | 63.5 | -580.7 | -328.1 | -46.7 | 3 | BEARISH | 55.6 |
| PASG Passage Bio, Inc. | $10M | -0.3 | -169.1 | 159.0 | — | — | 3 | BEARISH | -53.1 |
| LUCY Lucyd, Inc | $10M | -0.6 | -84.6 | -209.4 | -165.3 | 72.5 | 4 | BEARISH | -56.0 |
| RHEPB Regional Health Properties, Inc. | $10M | 0.5 | -328.8 | -0.6 | -3.2 | 200.4 | 6 | BEARISH | -3.2 |
| ASAPF Aurora Spine Corporation | $10M | -5.5 | -35.3 | -14.8 | -22.8 | -4.5 | 5 | BEARISH | -62.9 |
| OTLC Oncotelic Therapeutics, Inc. | $10M | 0.0 | 181.4 | -1.4 | 155.3 | — | 5 | BEARISH | -79.2 |
| INNPF InnoCan Pharma Corporation | $10M | -6.5 | -21.0 | -13488.5 | -0.6 | -19.2 | 3 | BEARISH | -86.2 |
| PHYOF IXICO plc | $10M | -6.0 | -15.8 | -23.6 | -28.5 | 13.2 | 2 | BEARISH | 0.0 |
| HEMP Hemp, Inc | — | -0.2 | -38.7 | -6.0 | -4131.8 | 333.7 | 4 | BEARISH | 0.0 |
| SIGO Sunset Island Group, Inc. | — | -0.0 | 185.8 | 85.4 | — | — | 4 | BEARISH | 0.0 |
| CHMMF Chimeric Therapeutics Limited | — | -0.0 | 655.2 | 80.8 | — | -100.0 | 2 | BEARISH | 0.0 |
| CVKD Cadrenal Therapeutics, Inc. Common Stock | — | -0.2 | -275.2 | -540.4 | — | — | 3 | BEARISH | -93.6 |
| CBDL CBD Life Sciences Inc. | — | -115.1 | -79.7 | -382.6 | 45.8 | -47.8 | 3 | BEARISH | -66.7 |
| PTPI Petros Pharmaceuticals, Inc. | — | 0.0 | -124.4 | 96.3 | — | -100.0 | 1 | BEARISH | -90.5 |
| ABTI Alterola Biotech, Inc. | — | -0.1 | -27.4 | 216.7 | — | — | 3 | BEARISH | 0.0 |
| AGNPF Grey Matters Health Inc. | — | — | -140.9 | -64.7 | — | — | 3 | BEARISH | -55.6 |
| NHEL Natural Health Farm Holdings Inc. | — | -0.0 | -37.2 | -15.8 | 9.3 | 6892.6 | 4 | BEARISH | 0.0 |
| HIGR Hi-Great Group Holding Company | — | -11.1 | 30.7 | 30.8 | -177.4 | -40.3 | 1 | BEARISH | -93.5 |
| MAJI Nextel Medical Corp. | — | 0.5 | -2.6 | 42.9 | — | — | 1 | BEARISH | — |
| AIMLF AI/ML Innovations Inc. | — | -1.5 | 1433.6 | -1620.8 | -92486.4 | -73.9 | 1 | BEARISH | -32.8 |
| LIMNW Liminatus Pharma, Inc. Warrants | — | -0.1 | -4165.9 | 252.1 | — | — | 2 | BEARISH | -83.3 |
| BBRRF Blueberries Medical Corp. | — | -7.1 | -218.7 | -2675.7 | -588.1 | -36.9 | 4 | BEARISH | -24.4 |
| RGBPP Regen BioPharma, Inc. | — | -0.0 | 20.3 | 12.8 | -1079.8 | 0.0 | 4 | BEARISH | -98.9 |
| AMBD American Mobile Dental Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HTPRF HTC Purenergy Inc. | — | -0.0 | 13.4 | -6.6 | — | 100.0 | 5 | BEARISH | -99.8 |
| BBAL New York Health Care, Inc. | — | -0.0 | -9.2 | -21.4 | -1.7 | 3.5 | 6 | BEARISH | 0.0 |
| ADTX Aditxt, Inc. | — | -0.0 | 622.6 | 49.4 | -131159.8 | -74.1 | 1 | BEARISH | -100.0 |
| LLBO Lifeline Biotechnologies, Inc. | — | — | — | — | — | — | — | BEARISH | -57.1 |
| EVLO Evelo Biosciences, Inc. | — | -0.0 | 948.0 | 605.0 | — | — | 2 | BEARISH | -80.0 |
| ISCO International Stem Cell Corporation | — | -2.4 | 30.4 | -10.8 | -2.7 | 3.4 | 6 | BEARISH | 2.4 |
| WPHM Winston Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | -66.7 |
| PHMB PharmaCom BioVet, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| BIGG Big Tree Group, Inc. | — | 0.0 | 0.4 | -0.6 | -0.6 | 55.4 | 5 | BEARISH | 0.0 |
| GPFT Grapefruit USA, Inc. | — | -0.2 | 11.4 | 5.9 | — | — | 2 | BEARISH | -66.7 |
| GREH Green Rain Energy Holdings Inc. | — | 0.4 | 28.6 | -43.9 | -94.2 | — | 3 | BEARISH | 138.8 |
| YECO EV Biologics, Inc. | — | -0.0 | 16.2 | 18.1 | 18.6 | 264.7 | 5 | BEARISH | -99.9 |
| ELAB PMGC Holdings Inc. | — | -0.0 | -73.0 | -66.6 | -225.1 | 408.6 | 3 | BEARISH | -100.0 |
| HMGN Hemagen Diagnostics, Inc. | — | -0.0 | 29.1 | -24.6 | -18.6 | -21.4 | 2 | BEARISH | 100.0 |
| VSMD Vasamed, Inc. | — | -0.0 | 54566.1 | 395.4 | -334.5 | 70.0 | 4 | BEARISH | 0.0 |
| ZCMD Zhongchao Inc. | — | -0.0 | -32.0 | -103.3 | -92.6 | -28.3 | 4 | BEARISH | -99.9 |
| AZFL Amazonas Florestal, Ltd | — | 3.3 | 19.8 | 13.9 | 13.6 | — | 5 | BEARISH | 0.0 |
| DKSC Dakshidin Corporation | — | -34.4 | -113.2 | -9.1 | — | — | 2 | BEARISH | 200.0 |
| IMCC IM Cannabis Corp. | — | -0.0 | 1556.1 | -129.3 | -57.5 | -21.1 | 1 | BEARISH | -98.1 |
| FCHS First Choice Healthcare Solutions, Inc. | — | -0.0 | 61.1 | 51.6 | — | 140.3 | 4 | BEARISH | -33.3 |
| OXIHF Oxford Investments Holdings Inc. | — | -0.2 | 19.5 | 9.8 | 6887.8 | -90.6 | 2 | BEARISH | 0.0 |
| EWLL eWellness Healthcare Corp. | — | -0.2 | 69.3 | 46.3 | — | -99.2 | 1 | BEARISH | 0.0 |
| CURLF Curaleaf Holdings, Inc. | $1.8B | -61.9 | -4.2 | 0.5 | 3.7 | 2.7 | 7 | BEARISH | -2.1 |
| NUVB Nuvation Bio Inc. | $1.6B | -10.5 | -47.8 | 70.2 | -198.3 | 1083.6 | 4 | BEARISH | -6.2 |
| NVAX Novavax, Inc. | $1.6B | -6.6 | 323.7 | 29.2 | -94.2 | -61.6 | 2 | BEARISH | 17.6 |
| MEDOF Medios AG | $1.3B | 23.5 | 2.1 | 2.8 | 0.6 | 10.0 | 6 | BEARISH | 0.0 |
| CSBTF Kuros Biosciences AG | $950M | 109.9 | 9.6 | 9.2 | 4.8 | 29.1 | 4 | BEARISH | -39.6 |
| MGTX MeiraGTx Holdings plc | $880M | 12.4 | 72.3 | 96.7 | 50.0 | 948.3 | 7 | BEARISH | 7.8 |
| INMD InMode Ltd. | $800M | 10.9 | 12.3 | 44.5 | 17.9 | -6.7 | 5 | BEARISH | -11.3 |
| LXRX Lexicon Pharmaceuticals, Inc. | $630M | -9.8 | -40.2 | -99.7 | -4591.8 | -29.0 | 3 | BEARISH | 24.4 |
| CLYM Climb Bio, Inc. | $590M | -11.5 | -27.1 | -88.6 | — | — | 2 | BEARISH | 380.9 |
| MDXG MiMedx Group, Inc. | $570M | 97.5 | 2.9 | 5.8 | -23.1 | -2.4 | 6 | BEARISH | -42.3 |
| AVR Anteris Technologies Global Corp. | $570M | -2.2 | -75.1 | 3136.2 | -2884.3 | 31.1 | 5 | BEARISH | 20.0 |
| MNPR Monopar Therapeutics Inc. | $470M | -30.7 | -19.5 | 523.8 | — | — | 2 | BEARISH | -11.9 |
| AVIR Atea Pharmaceuticals, Inc. | $320M | -2.0 | -58.1 | 974.6 | — | — | 3 | BEARISH | 29.9 |
| SY So-Young International Inc. | $280M | -7.6 | -15.7 | -22.3 | -11.4 | 14.1 | 4 | BEARISH | -29.9 |
| PRQR ProQR Therapeutics N.V. | $180M | -3.0 | -57.9 | 139.7 | -99.6 | 12.7 | 2 | BEARISH | -54.0 |
| PFGTF Pacific Edge Limited | $170M | -6.0 | -194.5 | -709.2 | -299.7 | -49.4 | 2 | BEARISH | 36.9 |
| PYXS Pyxis Oncology, Inc. | $110M | -1.3 | -179.1 | 1953.9 | — | 291.4 | 2 | BEARISH | -46.8 |
| RTGN RetinalGenix Technologies Inc. | $80M | -36.0 | 90.4 | -10.3 | — | -100.0 | 4 | BEARISH | 12.7 |
| ECOR electroCore, Inc. | $60M | -4.6 | 1761.5 | 336.0 | -32.4 | 33.5 | 3 | BEARISH | 55.8 |
| INMB INmune Bio, Inc. | $40M | -2.2 | -74.8 | -475.4 | — | -100.0 | 2 | BEARISH | -20.0 |
| BMEA Biomea Fusion, Inc. | $40M | -1.3 | -164.1 | 210.3 | — | — | 2 | BEARISH | -56.0 |
| MLSS Milestone Scientific Inc. | $30M | -6.3 | -121.7 | -160.5 | -37.3 | 3.7 | 4 | BEARISH | -26.6 |
| TVGN Tevogen Bio Holdings Inc. | $30M | -1.1 | 235.3 | 244.1 | — | — | 5 | BEARISH | 842.5 |
| CELU Celularity Inc. | $30M | -0.4 | 150.9 | 40592.8 | 13.0 | -58.1 | 4 | BEARISH | -61.4 |
| RMTI Rockwell Medical, Inc. | $30M | -4.9 | -15.5 | -14.8 | -6.6 | -21.1 | 6 | BEARISH | 491.4 |
| SER Serina Therapeutics, Inc. | $20M | -0.9 | -206.3 | 1868.6 | — | -100.0 | 3 | BEARISH | -67.7 |
| AVEFF Avecho Biotechnology Limited | $20M | -9.3 | -268.2 | 103.4 | -3227.5 | -46.6 | 3 | BEARISH | 0.0 |
| BNGO Bionano Genomics, Inc. | $10M | -0.3 | -83.6 | -89.6 | -90.8 | 10.0 | 6 | BEARISH | -34.8 |
| SYBX Synlogic, Inc. | $10M | -19.6 | -5.3 | 306.3 | — | — | 2 | BEARISH | -39.0 |
| CMMB Chemomab Therapeutics Ltd. | $10M | -1.0 | -82.7 | -314.7 | — | — | 1 | BEARISH | -68.6 |
| CMPD CompuMed, Inc. | $10M | -28.3 | -8.7 | -11.2 | 1.1 | 22.4 | 6 | BEARISH | 90.0 |
| BFRI Biofrontera Inc. | $10M | -1.4 | -988.4 | -39.2 | -5.0 | 17.8 | 4 | BEARISH | -23.6 |
| OZYMF Strategic Partners A/S | — | 19.0 | 0.8 | -117.5 | 1019.0 | — | 6 | BEARISH | 0.0 |
| GNLKQ GeneLink, Inc. | — | -0.0 | 73.0 | 82.1 | -183.0 | -33.6 | 3 | BEARISH | 0.0 |
| IVIXF Invion Limited | — | -0.6 | -83.6 | -69.7 | -537.3 | — | 3 | BEARISH | 0.0 |
| GLABF Gemina Laboratories Ltd. | — | -3.0 | 42.7 | 32.4 | -7838.5 | — | 5 | BEARISH | -78.3 |
| RXEI RxElite, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HXBM Helix BioMedix, Inc. | — | — | — | — | — | — | — | BEARISH | -6.0 |
| PAVS Paranovus Entertainment Technology Ltd. | — | -0.0 | -25.4 | -20.6 | -5.5 | 3788.4 | 3 | BEARISH | -95.5 |
| PAIOF Paion AG | — | -0.6 | -385.3 | -130.5 | -98.8 | -18.0 | 1 | BEARISH | 0.0 |
| XRTX XORTX Therapeutics Inc. | — | -0.4 | -99.1 | -68.5 | — | — | 3 | BEARISH | 66.6 |
| XTLB XTL Biopharmaceuticals Ltd. | — | -0.6 | -26.8 | -38.7 | -88.2 | — | 3 | BEARISH | 47.1 |
| PRMD PrimeMD Inc | — | -0.0 | 42.8 | 34.3 | 159.9 | — | 3 | BEARISH | 200.0 |
| KRSA Korsana Biosciences, Inc. | $150M | — | — | — | — | — | — | BEARISH | — |
| HBMHF HBM Holdings Limited | $1.3B | 12.9 | 24.1 | 53.0 | 53.0 | 54.6 | 4 | BEARISH | -38.1 |
| RAFLF Raffles Medical Group Ltd | $1.2B | 22.4 | 5.8 | 7.3 | 8.2 | -2.8 | 7 | BEARISH | -20.0 |
| MCRPF MicroPort Scientific Corp. | $1.1B | 31.2 | 6.1 | -1.7 | 21.3 | -3.5 | 5 | BEARISH | -63.2 |
| EBOSY EBOS Group Limited | $1.0B | 15.1 | 5.0 | 4.4 | 1.7 | -8.1 | 6 | BEARISH | -47.5 |
| GERN Geron Corporation | $720M | -11.5 | -29.2 | -74.1 | -29.0 | 24.4 | 2 | BEARISH | -7.3 |
| XVIPY Xvivo Perfusion AB (publ) | $690M | 49.4 | 5.9 | 4.6 | 17.7 | 17.5 | 6 | BEARISH | — |
| SLBT SL Science Holding Ltd | $640M | — | — | — | — | — | — | BEARISH | — |
| GYRE Gyre Therapeutics, Inc. | $620M | -32.8 | -15.6 | -22.3 | -36.4 | 16.8 | 3 | BEARISH | -20.1 |
| ANNX Annexon, Inc. | $610M | -3.2 | -105.3 | -11323.3 | — | — | 2 | BEARISH | 17.1 |
| AGMB AgomAb Therapeutics N.V. American Depositary Shares | $450M | — | — | — | — | — | — | BEARISH | — |
| SSII SS Innovations International, Inc. | $450M | -38.3 | -26.1 | -15.6 | -19.1 | 108.5 | 3 | BEARISH | -72.1 |
| ASMB Assembly Biosciences, Inc. | $400M | 36.9 | -0.0 | 56.2 | -28.8 | 125.1 | 4 | BEARISH | -30.6 |
| SWDCF Swedencare AB (publ) | $370M | 35.2 | 1.2 | 1.7 | 3.9 | 1.4 | 7 | BEARISH | -46.5 |
| RLMD Relmada Therapeutics, Inc. | $350M | -3.5 | -55.7 | 460.5 | — | — | 3 | BEARISH | 52.9 |
| MPLT MapLight Therapeutics, Inc. | $340M | -1.6 | -57.5 | -366.6 | — | — | 2 | BEARISH | — |
| CTNM Contineum Therapeutics, Inc. | $270M | -5.2 | -28.0 | -541.6 | — | — | 4 | BEARISH | -18.6 |
| LXEO Lexeo Therapeutics, Inc. Common Stock | $230M | -2.5 | -46.8 | -249.1 | — | — | 3 | BEARISH | -68.9 |
| BOVNF BioInvent International AB (publ) | $220M | -2.8 | -88.2 | 20101.5 | -964.0 | -87.2 | 1 | BEARISH | 0.0 |
| BBOT BridgeBio Oncology Therapeutics Inc. | $210M | -0.0 | -56.4 | -157.3 | — | — | 1 | BEARISH | -75.5 |
| CRLBF Cresco Labs Inc. | $210M | -2.0 | -25.8 | 5.5 | 9.7 | -4.5 | 2 | BEARISH | -49.8 |
| MFCSF Medical Facilities Corporation | $170M | 8.1 | 46.9 | 50.2 | 2.5 | 3.2 | 7 | BEARISH | -2.4 |
| ONVVF Oneview Healthcare PLC | $130M | -6.9 | -147.3 | -2982.0 | -100.1 | -2.9 | 3 | BEARISH | -6.2 |
| MENS Jyong Biotech Ltd. Ordinary Shares | $130M | — | — | — | — | — | — | BEARISH | -96.9 |
| MIST Milestone Pharmaceuticals Inc. | $80M | -1.0 | -35522.6 | 587.8 | -5118.8 | — | 5 | BEARISH | -64.0 |
| NMRA Neumora Therapeutics, Inc. Common Stock | $70M | -0.3 | -187.1 | 231.9 | — | — | 2 | BEARISH | -79.1 |
| HYPR Hyperfine, Inc. | $70M | -2.0 | -97.0 | -395.6 | -238.2 | 53.2 | 5 | BEARISH | -41.4 |
| HBPCF Helix BioPharma Corp. | $60M | -23.6 | -50.8 | -21.5 | — | — | 3 | BEARISH | -55.5 |
| IMA ImageneBio Inc | $50M | -0.8 | -40.7 | -594.7 | — | — | 3 | BEARISH | -49.8 |
| OTCFF Ocumetics Technology Corp. | $40M | -6.8 | 174.3 | 2137.7 | — | — | 1 | BEARISH | -66.1 |
| RPID Rapid Micro Biosystems, Inc. | $40M | -0.7 | -141.6 | -183.2 | -160.5 | 16.1 | 2 | BEARISH | -73.1 |
| COSM Cosmos Health Inc. | $30M | -0.4 | -104.0 | -41.2 | -32.1 | 33.8 | 4 | BEARISH | -76.9 |
| PRRUF Immutep Limited | $20M | -0.4 | -77.3 | 1092.5 | -328.8 | 255.0 | 3 | BEARISH | -89.5 |
| LDDD Longduoduo Company Limited | $20M | -26.6 | 47.5 | -421.7 | -13.8 | -36.8 | 5 | BEARISH | -45.4 |
| AIXN AiXin Life International, Inc. | $10M | -4.9 | 37.6 | 39.5 | -191.9 | -61.1 | 4 | BEARISH | 42.9 |
| VYND Vynleads, Inc. | $10M | -27.0 | 74.2 | 89.5 | — | — | 4 | BEARISH | 62.6 |
| JMPHF Leveljump Healthcare Corp. | $10M | -1.5 | -21.1 | 0.7 | -9.7 | 5.4 | 3 | BEARISH | 677.3 |
| CLRB Cellectar Biosciences, Inc. | $10M | -0.3 | -119.6 | 717.6 | — | — | 3 | BEARISH | -69.8 |
| CNSY Cerenome, Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| UNVC Univec, Inc. | — | -3.8 | 6.9 | 5.9 | -1481.4 | 78.3 | 4 | BEARISH | -47.4 |
| IPAH Interpharm Holdings, Inc. | — | -0.0 | -342.5 | -47.0 | -67.2 | -5.1 | 1 | BEARISH | -99.8 |
| ENLV Enlivex Therapeutics Ltd. | — | 0.0 | 209.7 | -0.4 | — | — | 5 | BEARISH | -99.0 |
| ICCM IceCure Medical Ltd | — | -0.2 | -228.3 | 36140.9 | -496.3 | 41.6 | 7 | BEARISH | -95.7 |
| MDXL Medixall Group, Inc. | — | -0.1 | 48.8 | 48.2 | 678.9 | 29.4 | 6 | BEARISH | 3200.0 |
| MHUAF Meihua International Medical Technologies Co., Ltd. | — | — | — | — | — | — | — | BEARISH | — |
| MYNDF MYND Life Sciences Inc. | — | -2.2 | 9.5 | 34.0 | — | — | 5 | BEARISH | -41.3 |
| AQSZF Aequus Pharmaceuticals Inc. | — | 3.1 | 10.0 | 17.6 | 147.2 | 122.3 | 5 | BEARISH | -85.7 |
| SEPSF Asep Medical Holdings Inc | — | -0.3 | -36.4 | -75.5 | -844.8 | 208.8 | 5 | BEARISH | -97.2 |
| ARUXF Acrux Limited | — | -7.1 | -48.5 | -74.2 | -26.5 | 289.9 | 7 | BEARISH | -99.0 |
| RSHN RushNet, Inc. | — | -1.0 | -1202.9 | -22.5 | — | -43.0 | 2 | BEARISH | -98.0 |
| WLSS Welsis Corp. | — | -51.7 | 6.2 | 3.3 | — | — | 1 | BEARISH | -82.9 |
| TSTTF TripSitter Clinic Ltd. | — | -19.2 | -0.1 | 30.7 | — | 100.0 | 4 | BEARISH | -56.2 |
| AYURF Ayurcann Holdings Corp. | — | -0.5 | 315.5 | 53.8 | -13.0 | 47.1 | 4 | BEARISH | -98.8 |
| ARNI Arno Therapeutics, Inc. | — | -0.0 | 250.7 | 111.6 | — | — | 3 | BEARISH | 0.0 |
| SCNX Scienture Holdings, Inc. | — | -0.1 | -53.5 | -15.4 | -821.3 | 540.6 | 4 | BEARISH | -91.8 |
| STJO St. Joseph, Inc. | — | 0.6 | 9.1 | 6.7 | 89.6 | -23.9 | 7 | BEARISH | -86.0 |
| RSLT Resilient Healthcare Corp | — | — | — | — | — | — | — | BEARISH | — |
| BIOAF Bioasis Technologies Inc. | — | -0.1 | 135.1 | 538.8 | -661.8 | 614.1 | 2 | BEARISH | -50.0 |
| IRMD IRadimed Corporation | $1.1B | 46.1 | 23.5 | 50.1 | 25.5 | 11.2 | 6 | BEARISH | 7.8 |
| ZVRA Zevra Therapeutics, Inc. | $580M | 10.5 | 34.8 | -1356.4 | 22.1 | 119.4 | 6 | BEARISH | -5.2 |
| AQST Aquestive Therapeutics, Inc. | $500M | -6.3 | 121.1 | 43.4 | -165.5 | 22.6 | 5 | BEARISH | -40.5 |
| IRD Opus Genetics, Inc. | $290M | -2.7 | -4796.5 | 59.8 | -1072.6 | -36.1 | 3 | BEARISH | 73.9 |
| ETRA Electra Therapeutics Inc. | $180M | — | — | — | — | — | — | BEARISH | — |
| MGNX MacroGenics, Inc. | $140M | -11.1 | -32.6 | 33.8 | 59.4 | 2.3 | 2 | BEARISH | 32.6 |
| LOVFF Cannara Biotech Inc. | $140M | 17.6 | 11.4 | 12.2 | 15.2 | 15.4 | 7 | BEARISH | 15.3 |
| CUE Cue Biopharma, Inc. | $140M | -0.7 | -1603.5 | 1241.9 | -1943.2 | 354.4 | 3 | BEARISH | -22.2 |
| AAWH Ascend Wellness Holdings, Inc. | $80M | -0.7 | 388.6 | 3.1 | -7.8 | -8.4 | 3 | BEARISH | -52.2 |
| ACRV Acrivon Therapeutics, Inc. Common Stock | $70M | -0.9 | -64.6 | 5251.5 | — | — | 1 | BEARISH | -15.9 |
| MYO Myomo, Inc. | $50M | -3.4 | -123.8 | -74.2 | -34.4 | 6.1 | 3 | BEARISH | 5.4 |
| LEEEF Leef Brands Inc. | $30M | -1.6 | 222.4 | -39.5 | -17.9 | 8.4 | 5 | BEARISH | -27.5 |
| SKYE Skye Bioscience, Inc. | $10M | -0.1 | -233.9 | 389.5 | — | — | 3 | BEARISH | -5.8 |
| SNOA Sonoma Pharmaceuticals, Inc. | $10M | -0.9 | -41.1 | -55.7 | -5.2 | 47.0 | 4 | BEARISH | -70.2 |
| RVLPQ RVL Pharmaceuticals plc | — | -0.0 | -182.4 | -101.1 | -289.3 | 5.6 | 3 | BEARISH | 0.0 |
| ESVNF Apptly Health Technologies Corp. | — | -1.5 | -22.3 | -40.4 | — | — | 2 | BEARISH | -33.8 |
| UPC Universe Pharmaceuticals Inc. | — | -0.6 | -3.5 | -4.6 | -17.2 | -8.0 | 2 | BEARISH | -56.2 |
| TOMDF Todos Medical Ltd. | — | -0.0 | 89.6 | -253.6 | -355.9 | -37.1 | 3 | BEARISH | -90.0 |
| JUVAF Juva Life Inc. | — | -0.0 | -105.0 | -21.4 | -24.6 | 43.5 | 4 | BEARISH | -90.0 |
| PTIX Protagenic Therapeutics, Inc. | — | 0.2 | -485.4 | -367.8 | — | 100.0 | 6 | BEARISH | -78.7 |
| CHOOF Choom Holdings Inc. | — | -0.0 | 3772.9 | -35.1 | -140.0 | 4.6 | 4 | BEARISH | -90.0 |
| EMMA Emmaus Life Sciences, Inc. | — | -0.4 | 9.9 | -9.3 | 21.2 | 11.0 | 4 | BEARISH | 292.2 |
| PHRRF PharmaTher Holdings Ltd. | — | -7.6 | -76.9 | 234.4 | — | — | 2 | BEARISH | -56.0 |
| ARSUF Fagron N.V. | $2.0B | 18.9 | 16.7 | 10.8 | 8.4 | 11.8 | 4 | BEARISH | 9.8 |
| URGN UroGen Pharma Ltd. | $1.7B | -17.1 | 86.5 | 119.0 | -19.8 | 169.5 | 2 | BEARISH | 78.8 |
| SNDA Sonida Senior Living, Inc. | $1.6B | -5.3 | -25.2 | -2.9 | -11.8 | 49.4 | 4 | BEARISH | 23.9 |
| ELEAF EL.En. S.p.A. | $1.4B | 13.7 | 13.2 | 29.1 | 6.0 | 25.8 | 8 | BEARISH | 37.9 |
| MDCLF MedinCell S.A. | $1.1B | -29.2 | 472.2 | 81.6 | -152.1 | -14.8 | 3 | BEARISH | 333.5 |
| IART Integra LifeSciences Holdings Corporation | $930M | 71.5 | 1.2 | 13.4 | 3.6 | 0.8 | 6 | BEARISH | -25.6 |
| IMMX Immix Biopharma, Inc. | $680M | -9.1 | -34.2 | 1509.2 | — | — | 4 | BEARISH | 123.0 |
| CADL Candel Therapeutics, Inc. | $610M | -5.9 | -81.8 | 219.4 | — | — | 2 | BEARISH | 52.8 |
| GNFTF Genfit S.A. | $470M | -5.2 | -5084.0 | -322.7 | -124.0 | 27.5 | 3 | BEARISH | 153.5 |
| VREOF Vireo Growth Inc. | $310M | -4.1 | -4.6 | -0.7 | -0.0 | — | 3 | BEARISH | — |
| IKT Inhibikase Therapeutics, Inc. | $220M | -3.3 | -52.0 | 920.5 | — | — | 3 | BEARISH | 1.9 |
| VMTHF Venus Medtech (Hangzhou) Inc. | $180M | -0.8 | -25.6 | -18.2 | -141.2 | -40.7 | 4 | BEARISH | -57.5 |
| CRDL Cardiol Therapeutics Inc. | $140M | -4.7 | -204.6 | 1592.3 | — | — | 4 | BEARISH | -4.2 |
| TRGNF Transgene S.A. | $120M | -4.1 | -64.1 | -184.9 | -5760.7 | -185.8 | 4 | BEARISH | -53.1 |
| GRUSF Grown Rogue International Inc. | $90M | -22.0 | -5.5 | -18.8 | -14.6 | 31.1 | 6 | BEARISH | -17.3 |
| PRNAF Alterity Therapeutics Limited | $50M | -2.2 | -55.0 | -401.1 | — | -100.0 | 2 | BEARISH | 8233.3 |
| BOLD Boundless Bio, Inc. | $50M | -0.8 | -67.9 | 807.9 | — | — | 2 | BEARISH | 65.1 |
| PRPO Precipio, Inc. | $40M | -29.1 | -9.0 | -8.1 | -3.1 | 33.5 | 6 | BEARISH | -8.0 |
| VRHI Veri Medtech Holdings Inc. | $40M | — | — | — | — | — | — | BEARISH | — |
| ABDXF Abingdon Health Plc | $30M | -16.4 | -36.9 | -48.9 | 3.9 | 28.3 | 4 | BEARISH | 83.0 |
| CLIFF Cordlife Group Limited | $30M | -2.9 | -9.9 | -15.8 | -11.3 | 11.3 | 5 | BEARISH | 2.6 |
| BMNDF Biomind Labs Inc. | $20M | -13.3 | 85.8 | 101.7 | — | — | 2 | BEARISH | 1483.5 |
| PBM Psyence Biomedical Ltd. | — | — | — | — | — | — | — | BEARISH | -9.9 |
| PCYN Procyon Corporation | — | 78.3 | -13.9 | -10.8 | 2.7 | 6.4 | 3 | BEARISH | 48.8 |
| ADDLF AddLife AB (publ) | $1.9B | 34.5 | 11.3 | 7.0 | 4.9 | 1.1 | 4 | BEARISH | -62.5 |
| GENSF Genus plc | $1.8B | 5.4 | 45.4 | 9.0 | 80.4 | -3.8 | 5 | BEARISH | -19.4 |
| VIMGF Vimian Group AB (publ) | $1.5B | 48.7 | 5.4 | 6.4 | 7.4 | 8.9 | 7 | BEARISH | -8.0 |
| OCUL Ocular Therapeutix, Inc. | $1.4B | -4.7 | -73.0 | -31671.3 | -584.5 | -8.1 | 3 | BEARISH | -41.5 |
| GTBIF Green Thumb Industries Inc. | $1.4B | 11.7 | 7.0 | 2.5 | 1.6 | 4.8 | 7 | BEARISH | -16.3 |
| GPCR Structure Therapeutics Inc. | $1.2B | -7.1 | -20.2 | -1134.3 | — | — | 3 | BEARISH | -18.3 |
| SNDX Syndax Pharmaceuticals, Inc. | $1.2B | -5.4 | -255.9 | -270.9 | -67.8 | 222.3 | 4 | BEARISH | 1.2 |
| SHPHF Sihuan Pharmaceutical Holdings Group Ltd. | $1.1B | 18.5 | 5.7 | 8.4 | 19.4 | 24.4 | 6 | BEARISH | 20.0 |
| AKTS Aktis Oncology, Inc. | $850M | -15.7 | -29.9 | 276.4 | -713.5 | -36.1 | 5 | BEARISH | 373763.6 |
| CHIZF China Traditional Chinese Medicine Holdings Co. Limited | $820M | -4.9 | -4.9 | 0.0 | -14.3 | 5.6 | 6 | BEARISH | -40.3 |
| ARDX Ardelyx, Inc. | $770M | -13.3 | -38.6 | -22.7 | -13.8 | 16.8 | 4 | BEARISH | -40.5 |
| TGRNF Tong Ren Tang Technologies Co. Ltd. | $660M | 10.7 | 4.1 | 12.2 | 8.2 | -18.2 | 6 | BEARISH | -43.0 |
| CRWRF Craneware plc | $620M | 25.8 | 6.0 | 6.8 | 9.7 | 4.2 | 7 | BEARISH | -43.9 |
| EVOTF Evotec SE | $590M | -2.6 | -26.1 | -14.9 | -32.5 | -7.7 | 2 | BEARISH | -54.3 |
| CTMX CytomX Therapeutics, Inc. | $510M | -5.1 | -37.8 | 305.9 | -1457.4 | -87.0 | 2 | BEARISH | -29.1 |
| KSRBF Kossan Rubber Industries Bhd | $480M | 16.8 | 5.0 | 8.5 | 11.3 | 1.0 | 5 | BEARISH | -43.2 |
| PROK ProKidney Corp. | $470M | -2.7 | 9.2 | 13.2 | -18948.0 | 55.2 | 1 | BEARISH | -52.5 |
| FTH Faeth Therapeutics, Inc. | $440M | — | — | — | — | — | — | BEARISH | — |
| ALLO Allogene Therapeutics, Inc. | $430M | -1.8 | -42.4 | -81.9 | -919.8 | — | 5 | BEARISH | 2.5 |
| AVCTF Avacta Group Plc | $420M | -6.7 | -2083.2 | -753.6 | -33970.3 | -99.7 | 5 | BEARISH | -18.7 |
| SPRY ARS Pharmaceuticals, Inc. | $400M | -1.7 | -210.3 | -424.3 | -185.2 | 4.1 | 2 | BEARISH | -59.1 |
| CAPR Capricor Therapeutics, Inc. | $340M | -2.5 | -73.7 | -107.5 | — | -100.0 | 3 | BEARISH | -1.6 |
| KYTX Kyverna Therapeutics, Inc. | $330M | -1.9 | -87.2 | 14267.8 | — | — | 2 | BEARISH | -24.3 |
| CGC Canopy Growth Corporation | $290M | -1.4 | -40.1 | -11.7 | -18.0 | 6.8 | 4 | BEARISH | -49.3 |
| SPHDF Santhera Pharmaceuticals Holding AG | $280M | -6.6 | 729.6 | 111.3 | -44.5 | 106.3 | 7 | BEARISH | 49.1 |
| CLPT ClearPoint Neuro, Inc. | $280M | -8.2 | -226.5 | -54.1 | -104.2 | 25.9 | 3 | BEARISH | -60.8 |
| ABEO Abeona Therapeutics Inc. | $250M | -3.9 | -43.1 | -5983.3 | -177.4 | 6280.0 | 2 | BEARISH | -18.8 |
| OCGN Ocugen, Inc. | $250M | -3.0 | 1211.7 | 190.2 | -1671.8 | -3.7 | 2 | BEARISH | -52.4 |
| CUVL Clinuvel Pharmaceuticals Ltd. | $250M | — | — | — | — | — | — | BEARISH | — |
| ORYZF Oryzon Genomics S.A. | $250M | -80.4 | -3.0 | -7.2 | -1.6 | 12.6 | 4 | BEARISH | -14.1 |
| HLOSF Healios K.K. | $240M | 57.7 | 3.7 | -129.2 | 17028.6 | -47.1 | 4 | BEARISH | -48.6 |
| LAB Standard BioTools Inc. | $240M | -2.7 | -18.1 | -69.4 | -133.1 | -45.2 | 5 | BEARISH | -56.6 |
| VNDA Vanda Pharmaceuticals Inc. | $240M | -0.9 | -77.8 | -201.0 | -123.7 | 6.0 | 3 | BEARISH | -27.4 |
| IPHYF Innate Pharma S.A. | $210M | -2.5 | 267.9 | 119.2 | -343.8 | 32.0 | 3 | BEARISH | -24.5 |
| EVMN Evommune, Inc. | $190M | -1.5 | -29.6 | -82.4 | — | — | 2 | BEARISH | — |
| BIOA BioAge Labs Inc. | $190M | -2.3 | -28.2 | -142.3 | -1064.7 | 168.1 | 4 | BEARISH | -28.0 |
| GLAS Glass House Brands Inc | $190M | — | — | — | — | — | — | BEARISH | — |
| ZNTL Zentalis Pharmaceuticals, Inc. | $160M | -0.8 | -83.7 | -2245.4 | — | -100.0 | 2 | BEARISH | 15.8 |
| SION Sionna Therapeutics, Inc. | $160M | -1.8 | -32.3 | -137.7 | — | — | 0 | BEARISH | -90.1 |
| NBP NovaBridge Biosciences | $160M | -2.2 | -45.7 | -617.8 | — | — | 1 | BEARISH | -70.4 |
| AKBA Akebia Therapeutics, Inc. | $160M | -6.1 | -109.4 | 15.6 | -18.1 | 7.5 | 6 | BEARISH | -78.2 |
| STRO Sutro Biopharma, Inc. | $150M | -0.5 | 266.8 | 43.6 | -391.6 | -56.3 | 4 | BEARISH | -15.5 |
| NGEN NervGen Pharma Corp. Common stock | $150M | — | — | — | — | — | — | BEARISH | — |
| CNTN Canton Strategic Holdings Inc | $150M | -1.2 | -14.6 | -7.2 | -1287.2 | — | 2 | BEARISH | — |
| PHCUF Photocure ASA | $150M | 16.9 | 14.5 | 37.4 | -0.5 | 29.5 | 5 | BEARISH | 1.2 |
| QTRX Quanterix Corporation | $140M | -1.1 | -46.5 | -59.0 | -148.7 | 23.4 | 2 | BEARISH | -49.5 |
| DERM Journey Medical Corporation | $140M | -22.0 | -23.8 | -7.4 | -1.7 | 20.9 | 5 | BEARISH | -33.5 |
| CDXS Codexis, Inc. | $140M | -3.8 | -69.4 | -37.8 | -80.5 | 35.9 | 3 | BEARISH | -52.6 |
| NKTX Nkarta, Inc. | $130M | -1.1 | -38.8 | -75.4 | — | — | 1 | BEARISH | -15.0 |
| AVXL Anavex Life Sciences Corp. | $120M | -5.0 | -23.6 | 411.7 | — | — | 2 | BEARISH | -84.8 |
| OWLT Owlet, Inc. | $120M | -9.7 | 180.6 | -50.5 | -1.8 | 28.0 | 6 | BEARISH | -54.8 |
| UNCY Unicycive Therapeutics, Inc. | $110M | -2.2 | -101.1 | 349.9 | — | — | 4 | BEARISH | -29.6 |
| CBUS Cibus, Inc. | $110M | -0.8 | -225.9 | -157.2 | -2227.9 | -10.3 | 2 | BEARISH | -11.0 |
| FRNM Freenome, Inc. | $100M | — | — | — | — | — | — | BEARISH | — |
| STXS Stereotaxis, Inc. | $100M | -4.2 | -184.3 | -142.6 | -58.3 | -5.5 | 5 | BEARISH | -66.7 |
| ORPOF OSE Immunotherapeutics S.A. | $100M | — | — | — | — | — | — | BEARISH | — |
| VXRT Vaxart, Inc. | $100M | 2.7 | 67.0 | 149.6 | -49.6 | 201.1 | 6 | BEARISH | 10.8 |
| CLLS Cellectis S.A. | $100M | -1.7 | -94.6 | 118.6 | -417.3 | 0.5 | 2 | BEARISH | -69.8 |
| AIRS AirSculpt Technologies, Inc. | $90M | -7.0 | -12.0 | -6.0 | -2.6 | -8.7 | 5 | BEARISH | -88.8 |
| TNYA Tenaya Therapeutics, Inc. | $90M | -0.8 | -121.9 | 1769.3 | -3909.3 | — | 3 | BEARISH | -75.8 |
| RVRC Revium Recovery Inc. | $90M | -6.4 | -0.0 | 0.0 | — | — | 2 | BEARISH | 175.0 |
| JWCTF JW (Cayman) Therapeutics Co. Ltd | $80M | -2.3 | -49.0 | -68.1 | -45.3 | 60.7 | 3 | BEARISH | -55.3 |
| EAPIF Euroapi S.A. | $80M | -0.2 | -39.9 | 2.1 | -39.7 | -10.3 | 3 | BEARISH | -76.5 |
| ABSCF AB Science S.A. | $80M | -6.6 | 21.5 | 34.7 | -1813.1 | 12.3 | 5 | BEARISH | -11.1 |
| NYXH Nyxoah S.A. | $80M | -0.4 | -125.8 | -181.3 | -429.5 | 359.2 | 2 | BEARISH | -83.8 |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | $80M | -0.6 | -95.6 | 738.2 | — | — | 1 | BEARISH | -75.4 |
| LNSR LENSAR Inc | $70M | 4.7 | 1231.0 | -218.4 | 21.4 | 3.3 | 5 | BEARISH | -50.4 |
| CGTX Cognition Therapeutics, Inc. | $70M | -4.0 | -83.8 | 6061.8 | — | — | 3 | BEARISH | -56.1 |
| THOXF BioPorto A/S | $70M | 77.4 | 12.3 | 43.6 | 520.6 | 3.4 | 4 | BEARISH | -48.3 |
| CRDF Cardiff Oncology, Inc. | $70M | -1.5 | -94.1 | 443.4 | -8876.9 | -7.0 | 3 | BEARISH | -60.8 |
| CRBU Caribou Biosciences, Inc. | $60M | -0.4 | -78.3 | -695.0 | -1619.9 | 10.0 | 3 | BEARISH | -81.5 |
| LDXHF Lumos Diagnostics Holdings Limited | $60M | -6.4 | -34.8 | -85.3 | -1.0 | 6.4 | 5 | BEARISH | -71.5 |
| MDAI Spectral AI, Inc. | $50M | -4.4 | 99.0 | 97.9 | -118.5 | -45.0 | 2 | BEARISH | -31.1 |
| VTIAF FamiCord AG | $50M | -6.4 | -84.3 | -13.6 | -5.1 | 0.1 | 5 | BEARISH | -55.7 |
| HYFT MindWalk Holdings Corp. | $50M | -4.5 | -123.5 | -481.3 | -158.7 | -15.9 | 4 | BEARISH | -29.3 |
| MYCOF Noveris Health Sciences Inc. | $50M | -6.6 | 22.3 | 49.3 | — | — | 5 | BEARISH | 265.0 |
| CNTB Connect Biopharma Holdings Limited | $50M | -1.0 | -105.5 | 1034.1 | -1249.0 | 49.8 | 2 | BEARISH | -50.4 |
| DXR Daxor Corporation | $50M | 7.2 | 14.2 | 13.5 | -14382.9 | -78.3 | 3 | BEARISH | -35.4 |
| IBIO iBio, Inc. | $50M | -2.4 | -65.7 | 21688.6 | — | -75.0 | 4 | BEARISH | -36.6 |
| SRTS Sensus Healthcare, Inc. | $50M | -3.0 | -34.8 | -47.6 | -382.1 | -53.4 | 3 | BEARISH | -16.5 |
| EUDA EUDA Health Holdings Limited | $40M | -6.6 | -50.6 | -26.7 | -22.9 | 49.4 | 5 | BEARISH | -68.7 |
| SNZZF Senzime AB (publ) | $40M | -4.0 | -35.1 | -36.2 | -86.6 | 27.1 | 3 | BEARISH | -63.8 |
| ANVS Annovis Bio, Inc. | $40M | -0.6 | -703.7 | 170.2 | — | — | 1 | BEARISH | -49.8 |
| RANI Rani Therapeutics Holdings, Inc. | $40M | -2.3 | -179.1 | 245.5 | -432.7 | 306.4 | 5 | BEARISH | -66.5 |
| DWTX Dogwood Therapeutics, Inc. | $40M | -0.1 | -47.8 | -39.7 | — | — | 2 | BEARISH | -80.3 |
| DRIO DarioHealth Corp. | $40M | 5.0 | 113.8 | -93.8 | -153.1 | -22.6 | 3 | BEARISH | -78.5 |
| ALDX Aldeyra The | $40M | -1.7 | -49.5 | 269.3 | — | — | 4 | BEARISH | -87.8 |
| EXOZ eXoZymes, Inc. | $40M | -3.2 | -187.2 | 913.0 | — | — | 2 | BEARISH | -68.4 |
| TIL Instil Bio, Inc. | $40M | -1.3 | -25.3 | -69.1 | — | — | 4 | BEARISH | -69.9 |
| XTNT Xtant Medical Holdings, Inc. | $40M | -3.4 | -25.2 | -14.8 | -40.9 | -14.3 | 4 | BEARISH | -64.4 |
| DCGO DocGo Inc. | $30M | -0.1 | -92.4 | -73.3 | -21.5 | -32.4 | 3 | BEARISH | -77.1 |
| GRCE Grace Therapeutics, Inc. | $30M | -1.5 | -38.4 | -58.9 | — | — | 2 | BEARISH | -40.5 |
| FLNA Filana Therapeutics, Inc. | $30M | -0.7 | -13.5 | 38.9 | — | — | 2 | BEARISH | — |
| BCTX BriaCell Therapeutics Corp. | $30M | -0.3 | -179.9 | -2435.2 | — | — | 2 | BEARISH | -74.2 |
| AIRDF Rocket Doctor AI Inc. | $30M | -1.7 | -6105.0 | -2497.4 | -909.1 | — | 2 | BEARISH | -49.9 |
| IGC IGC Pharma, Inc. | $30M | -3.0 | -129.2 | -127.6 | -1107.9 | -15.4 | 1 | BEARISH | -39.1 |
| IXHL Incannex Healthcare Limited | $30M | -2.3 | -31.9 | 5284.2 | — | -100.0 | 4 | BEARISH | -75.0 |
| TDMMF Mach7 Technologies Limited | $30M | -7.0 | -22.3 | -41.4 | -22.3 | -17.5 | 3 | BEARISH | -72.0 |
| PAVM PAVmed Inc. | $20M | -0.1 | -31.9 | -43.6 | -16315.2 | -89.0 | 3 | BEARISH | 424.0 |
| ATYR aTyr Pharma, Inc. | $20M | -0.2 | -98.4 | -1890.1 | — | — | 2 | BEARISH | -87.4 |
| YI 111, Inc. | $20M | -1.7 | 30.0 | 15.9 | -1.7 | -20.9 | 2 | BEARISH | -33.0 |
| MDXH MDxHealth S.A. | $20M | -0.3 | 193.7 | -23.4 | -42.4 | -19.1 | 2 | BEARISH | -95.6 |
| SCLX Scilex Holding Company | $20M | -0.0 | 160.5 | 105.7 | -1485.2 | -28.5 | 3 | BEARISH | -87.4 |
| RVP Retractable Technologies, Inc. | $20M | -4.9 | -4.5 | -53.2 | 39.3 | -11.2 | 4 | BEARISH | -38.1 |
| ARAY Accuray Incorporated | $20M | -0.3 | -80.1 | -11.3 | -1.9 | -12.3 | 2 | BEARISH | -91.3 |
| MVMDF More Life Company Corp. | $20M | -5.2 | -167.0 | -602.2 | -5006.5 | 43.0 | 4 | BEARISH | 115.8 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $20M | -1.2 | -234.4 | -475.2 | -504.1 | 36.6 | 3 | BEARISH | -34.1 |
| BYSI BeyondSpring Inc. | $20M | -2.8 | 20.3 | 15.7 | — | 100.0 | 2 | BEARISH | -77.0 |
| ITOC iTonic Holdings Ltd. | $20M | — | — | — | — | — | — | BEARISH | — |
| ACH Accendra Health, Inc. | $20M | -0.1 | -1.1 | 4.3 | -14.5 | -99.1 | 3 | BEARISH | -97.9 |
| QNTM Quantum BioPharma Ltd. | $10M | -0.4 | -425.3 | 175.1 | — | — | 4 | BEARISH | -83.3 |
| GSGTF GenSight Biologics S.A. | $10M | -1.0 | 46.5 | 47.3 | 1190.6 | -401.7 | 3 | BEARISH | -57.9 |
| SINT Sintx Technologies, Inc. | $10M | -0.3 | -408.3 | -216.8 | -598.7 | 0.2 | 3 | BEARISH | -54.4 |
| KTTA Pasithea Therapeutics Corp. | $10M | -0.2 | -65.5 | -453.2 | — | — | 4 | BEARISH | -44.7 |
| MGRX Mangoceuticals, Inc. | $10M | -0.2 | -95.1 | -82.6 | -1909.1 | -38.9 | 4 | BEARISH | -89.4 |
| GTBP GT Biopharma, Inc. | $10M | -0.1 | -798.9 | 927.8 | — | — | 2 | BEARISH | -67.4 |
| PDRX PD-Rx Pharmaceuticals, Inc. | $10M | — | — | — | — | — | — | BEARISH | 6.9 |
| PXXLF Poxel S.A. | $10M | -0.4 | 34.8 | 129.6 | -624.6 | 41.5 | 4 | BEARISH | -12.0 |
| TVRD Tvardi Therapeutics, Inc. | $10M | -0.3 | -126.2 | 296.9 | — | — | 1 | BEARISH | -82.6 |
| DARE Dare Bioscience, Inc. | $10M | -0.8 | 165.3 | 136.8 | -1590.4 | 7816.7 | 3 | BEARISH | -68.6 |
| IMNN Imunon, Inc. | $10M | -0.2 | -429.7 | -226.7 | — | — | 2 | BEARISH | -81.9 |
| RGNT Regentis Biomaterials Ltd. | $10M | — | — | — | — | — | — | BEARISH | — |
| INTS Intensity Therapeutics, Inc. | $10M | -0.7 | -195.9 | 4123.4 | — | — | 5 | BEARISH | -46.4 |
| MDXHF Medx Health Corp. | $10M | — | 63.5 | 166.6 | -1353.4 | 19.2 | 3 | BEARISH | 150.0 |
| VRCDF Verici Dx plc | $10M | -0.6 | -192.7 | -151.0 | -227.8 | 84.7 | 3 | BEARISH | -60.5 |
| BLRX BioLineRx Ltd. | $10M | -1.0 | -63.5 | -113.0 | -1029.3 | -94.3 | 3 | BEARISH | -44.6 |
| INAB IN8bio, Inc. | $10M | -0.5 | -111.1 | -576.1 | — | — | 4 | BEARISH | -55.1 |
| RDTCF Rapid Dose Therapeutics Corp. | $10M | -4.2 | 49.3 | 80.2 | -86.2 | 4.3 | 4 | BEARISH | -58.4 |
| PTN Palatin Technologies, Inc. | $10M | -0.9 | -877.5 | 1176.9 | -1449.1 | — | 5 | BEARISH | -20.5 |
| VTGN VistaGen Therapeutics, Inc. | $10M | -0.1 | -166.5 | 851.1 | -882.8 | 287.3 | 4 | BEARISH | -95.7 |
| QNRX Quoin Pharmaceuticals, Ltd. | $10M | -0.3 | -578.6 | 221.3 | — | — | 1 | BEARISH | -68.7 |
| TPST Tempest Therapeutics, Inc. | $10M | -0.1 | -931.1 | -564.2 | — | — | 1 | BEARISH | -95.2 |
| MSLE Satellos Bioscience Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| CDIO Cardio Diagnostics Holdings, Inc. | $10M | -0.6 | -75.4 | -230.9 | -28012.5 | -25.9 | 3 | BEARISH | -58.0 |
| GUTS Fractyl Health, Inc. | $10M | -0.1 | 1063.0 | -568.7 | — | -100.0 | 5 | BEARISH | -94.7 |
| OPTBF OptiBiotix Health Plc | $10M | -1.4 | -102.1 | -102.1 | -231.5 | -12.9 | 4 | BEARISH | 109900.0 |
| AVCNF Avicanna Inc. | $10M | -3.1 | -109.4 | -64.5 | -18.1 | -0.2 | 3 | BEARISH | -62.3 |
| APRE Aprea Therapeutics, Inc. | $10M | -0.5 | -47.4 | 378.1 | — | -99.8 | 2 | BEARISH | -62.7 |
| BMRA Biomerica, Inc. | $10M | -1.0 | -113.8 | -132.4 | -97.4 | -11.2 | 1 | BEARISH | -42.2 |
| TRAW Traws Pharma, Inc. | $10M | -0.7 | -711.4 | 133.9 | — | -100.0 | 1 | BEARISH | -87.4 |
| IMMVF Immunovia AB | $10M | -0.4 | -425.5 | 808.2 | -5991.9 | 31.4 | 3 | BEARISH | -80.8 |
| TOVX Theriva Biologics, Inc. | $10M | -0.3 | -101.9 | -213.5 | — | — | 2 | BEARISH | -45.5 |
| PLSM Pulsenmore Ltd. Ordinary Shares | $10M | — | — | — | — | — | — | BEARISH | — |
| TCRX TScan Therapeutics, Inc. | $10M | -0.2 | -95.8 | -159.4 | -2888.6 | 2.2 | 2 | BEARISH | -91.7 |
| ALRTF ALR Technologies Inc. | $10M | -0.4 | 54.2 | 8.3 | -151734.7 | — | 2 | BEARISH | -16.8 |
| RAFA Rafarma Pharmaceuticals, Inc. | — | 7.8 | 2.9 | 3.4 | 26.6 | -66.0 | 3 | BEARISH | -58.3 |
| NBRVF Nabriva Therapeutics plc | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CLCFF Christina Lake Cannabis Corp. | — | -1.6 | -37.8 | -14.8 | -10.0 | -18.1 | 2 | BEARISH | -52.0 |
| SZLSF StageZero Life Sciences Ltd. | — | -0.0 | 23.1 | 18.6 | -79.9 | -29.3 | 2 | BEARISH | -80.4 |
| BNIGF Beroni Group Limited | — | -0.1 | -1153.4 | -274.8 | -15945.7 | 40.9 | 5 | BEARISH | 0.0 |
| PNDHF Pond Technologies Holdings Inc. | — | -0.4 | 43.2 | 90.7 | -114.9 | -47.3 | 2 | BEARISH | -27.3 |
| SVSO SheerVision, Inc. | — | -0.0 | 31.8 | -24.5 | 42.2 | -32.8 | 3 | BEARISH | 0.0 |
| ISPC iSpecimen Inc. | — | -0.0 | -968.5 | 305.3 | -896.9 | -92.1 | 4 | BEARISH | -97.4 |
| GRPI Grupo International Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CATV Opus Holdings, Inc. | — | -16.9 | -0.8 | -1.4 | 91.7 | 47.8 | 5 | BEARISH | -99.6 |
| AQQRF Aquarius Surgical Technologies Inc. | — | -0.3 | 26.1 | -39.2 | -855.7 | 8.7 | 4 | BEARISH | 0.0 |
| ZVSA ZyVersa Therapeutics, Inc. | — | -0.0 | 817.1 | 242.0 | — | -100.0 | 1 | BEARISH | -99.3 |
| AMHD HLK Biotech Holding Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| IONKF Ionic Brands Corp. | — | -0.0 | -395.1 | -29.9 | -53.6 | 179.4 | 4 | BEARISH | 0.0 |
| JNHMF Jack Nathan Medical Corp. | — | -0.7 | -152.9 | 25.0 | -471.3 | -108.0 | 4 | BEARISH | -75.0 |
| NIKI Niki BioSolutions, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| PRFX PRF Technologies Ltd. | — | -0.1 | -57.8 | -88.3 | -19978.6 | 137249010644668.4 | 6 | BEARISH | -42.1 |
| QMDT Quick-Med Technologies, Inc. | — | -0.0 | 8.3 | 3.4 | -78.6 | -6.9 | 5 | BEARISH | 400.0 |
| ALST AllStar Health Brands Inc | — | -0.3 | 12.9 | 2.5 | — | — | 4 | BEARISH | -50.0 |
| MBGNF Many Bright Ideas Technologies Inc. | — | -2.2 | 20.4 | 126.7 | — | — | 2 | BEARISH | 0.0 |
| CHHE China Health Industries Holdings, Inc. | — | -0.0 | -6.9 | -35.0 | -164082.8 | 77.5 | 2 | BEARISH | -0.0 |
| NSRS Medcann Industries, Inc. | — | -0.0 | -92.1 | -21.1 | — | — | 2 | BEARISH | 0.0 |
| GENPF Genix Pharmaceuticals Corporation | — | -5.1 | 19.6 | 11.6 | — | -100.0 | 2 | BEARISH | -20.7 |
| GOVX GeoVax Labs, Inc. | — | -0.0 | -891.6 | 1530.7 | — | -100.0 | 3 | BEARISH | -98.6 |
| KLYG Kelyniam Global, Inc. | — | -23.3 | -26.9 | 10.0 | -16.7 | 2.0 | 5 | BEARISH | -24.8 |
| DTMXF Quanta AI Inc. | — | — | 6074.2 | 6923.2 | -413.2 | 15.3 | 3 | BEARISH | -74.8 |
| NNRX Nutranomics, Inc. | — | -0.1 | 58.6 | -70.9 | -150.9 | 46.4 | 4 | BEARISH | -98.0 |
| LVCE LiveCare, Inc. | — | — | — | — | — | — | — | BEARISH | -77.2 |
| USPS Ultimate Sports, Inc. | — | -15.1 | 14.7 | 11.0 | — | — | 1 | BEARISH | -60.4 |
| IVF INVO Fertility, Inc. | — | -0.0 | -55.3 | -28.1 | 40.9 | 13.8 | 4 | BEARISH | -97.3 |
| VBIO Valion Bio, Inc. | — | -0.0 | -240.8 | -48.0 | — | -281.4 | 2 | BEARISH | — |
| AXIM AXIM Biotechnologies, Inc. | — | -1.6 | 3.0 | 24.9 | -90.9 | 2142.6 | 5 | BEARISH | -62.2 |
| MMTC Micro Imaging Technology, Inc. | — | -0.0 | 83.3 | 72.6 | — | — | 1 | BEARISH | 0.0 |
| TNGNQ Tengion, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| WOK WORK Medical Technology Group Ltd. Class A | — | -0.0 | -20.9 | -10.5 | -63.0 | -0.2 | 4 | BEARISH | -64.5 |
| WEQL WellQuest Medical & Wellness Corporation | — | -0.0 | 16.1 | -19.9 | -36.3 | 126.5 | 3 | BEARISH | 100.0 |
| ECIA Encision Inc. | — | -0.7 | -21.1 | -7.4 | 2.0 | -8.7 | 3 | BEARISH | -94.0 |
| APYI Aspyra Inc. | — | -0.0 | -102.5 | 49.8 | -82.7 | -15.6 | 1 | BEARISH | 0.0 |
| XENO Xeno Transplants Corporation | — | -0.0 | -286.5 | 78.1 | — | — | 1 | BEARISH | 0.0 |
| ZHCLF Zenith Capital Corp. | — | -0.2 | 35107.2 | 37766.2 | -360.0 | — | 3 | BEARISH | 3233.3 |
| MLECW Moolec Science S.A. | — | -0.0 | -174.7 | -31.5 | -91.8 | 170.4 | 3 | BEARISH | -38.8 |
| AYRWF Ayr Wellness Inc. | — | -0.0 | -65.7 | -16.1 | -53.2 | -2.4 | 3 | BEARISH | -100.0 |
| MDCX Medicus Pharma Ltd. Common Stock | — | -0.0 | -3904.0 | -693.1 | — | — | 3 | BEARISH | -98.2 |
| PERCF Percheron Therapeutics Limited | — | — | — | — | — | — | — | BEARISH | — |
| NEUN Neurogenesis, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| VPRO Viropro Inc. | — | -0.0 | -19.7 | -4.8 | -269.7 | 155.0 | 2 | BEARISH | 0.0 |
| MJARF MJardin Group, Inc. | — | -0.0 | 59.5 | -11.0 | -1614.6 | -42.3 | 3 | BEARISH | -99.0 |
| DPAT Dental Patient Care America, Inc. | — | 320.0 | 117.2 | 10.7 | 26.9 | -3.7 | 5 | BEARISH | 64.1 |
| AREVF AREV Life Sciences Global Corp | — | -1.9 | 23.9 | 15.1 | — | -96.1 | 2 | BEARISH | -95.0 |
| STMH Stem Holdings, Inc. | — | -0.0 | -274.8 | 873.4 | 98.5 | -100.0 | 3 | BEARISH | 900.0 |
| RPGLF Regent Pacific Group Limited | — | -16.2 | 38.3 | 5.9 | 10.3 | 491.5 | 6 | BEARISH | -94.1 |
| CBDX Curative Biosciences, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| AJOY Ayujoy Herbals Ltd. | — | -1.0 | -54.8 | 142.7 | — | -100.0 | 3 | BEARISH | -53.7 |
| GENX Genex Pharmaceutical, Inc. | — | 0.0 | 7.8 | 5.1 | -8.1 | 32.8 | 5 | BEARISH | 0.0 |
| PMSNF Proteome Sciences plc | — | -2.0 | 25.2 | -36.8 | -74.6 | -16.5 | 4 | BEARISH | -66.7 |
| USMJ North American Cannabis Holdings, Inc. | — | -3.5 | 40.1 | 1.5 | — | 14.2 | 2 | BEARISH | 0.0 |
| SUVZ Suvanza Pharma, LLC | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HCWB HCW Biologics Inc. | — | -0.0 | -133.5 | -36.8 | -3849.9 | 707.0 | 3 | BEARISH | -95.2 |
| LIFS Life Stem Genetics Inc. | — | -2.5 | -126.7 | -111.5 | — | — | 2 | BEARISH | -50.0 |
| NUNZ Nunzia Pharmaceutical Company | — | -0.0 | 69398.6 | 176728.6 | — | — | 2 | BEARISH | 0.0 |
| OVATF Ovation Science Inc. | — | -1.7 | 44.0 | 34.6 | -690.6 | -27.1 | 3 | BEARISH | -74.6 |
| EDNEF Eden Empire Inc. | — | — | 64.3 | -88.8 | -1382.1 | — | 2 | BEARISH | -90.9 |
| OJSY OJsys, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| RADX Radiopharm Theranostics Limited | — | — | — | — | — | — | — | BEARISH | -83.1 |
| MBAI MBody AI Ltd. | — | — | — | — | — | — | — | BEARISH | — |
| AMIX Autonomix Medical, Inc. | — | -0.0 | -316.0 | 4343.4 | — | — | 2 | BEARISH | -91.2 |
| APVO Aptevo Therapeutics Inc. | — | -0.0 | -420.3 | -4688.7 | — | — | 1 | BEARISH | -95.2 |
| PPRG Patient Portal Technologies, Inc. | — | -0.0 | -4.5 | -0.3 | -3.5 | -23.2 | 2 | BEARISH | 0.0 |
| MRDH Meridian Holdings, Inc. | — | -0.6 | 29.2 | -2410.8 | — | -100.0 | 1 | BEARISH | -21.3 |
| ACUS Acusphere, Inc. | — | -0.0 | -363.3 | -4565.0 | -3033.3 | -5.2 | 2 | BEARISH | 0.0 |
| HRTT Heart Tronics, Inc. | — | -0.0 | -1320.1 | -1322.8 | — | — | 1 | BEARISH | 0.0 |
| KAPA Kairos Pharma, Ltd. | — | -0.3 | -114.0 | -301.0 | — | — | 3 | BEARISH | -93.0 |
| AVCRF Avricore Health Inc. | — | -2.6 | -131.4 | -548.9 | -354.9 | -93.8 | 2 | BEARISH | -97.7 |
| AXRX Amexdrug Corporation | — | — | — | — | — | — | — | BEARISH | 0.0 |
| WOWU WOWI, Inc. | — | 0.0 | 51.5 | 49.7 | -38.1 | — | 4 | BEARISH | -50.0 |
| OMID OMID Holdings, Inc. | — | 25.2 | -127.5 | -314.5 | 40.6 | 57.1 | 5 | BEARISH | -62.9 |
| CEVE Ceres Ventures, Inc. | — | -0.0 | 175.9 | 280.3 | — | — | 3 | BEARISH | 0.0 |
| LUFFF Herbal Dispatch Inc. | — | -1.0 | -124.8 | -42.8 | -26.7 | 4.6 | 6 | BEARISH | 46.0 |
| BUDZ WEED, Inc. | — | -1.2 | 176.9 | 220.9 | — | -100.0 | 1 | BEARISH | -65.2 |
| DCOY Decoy Therapeutics Inc. | — | — | — | — | — | — | — | BEARISH | — |
| NGMDF NuGen Medical Devices Inc. | — | -0.3 | 81.2 | -448.2 | -19565.6 | -86.3 | 2 | BEARISH | -70.9 |
| XTXXF Adastra Holdings Ltd. | — | -0.7 | -227.3 | -93.3 | -9.6 | -33.9 | 2 | BEARISH | -98.6 |
| ENZC Enzolytics Inc. | — | -11.2 | 105.9 | 1.4 | — | — | 7 | BEARISH | -25.0 |
| RASP Actavia Life Sciences, Inc. | — | -0.1 | 20.1 | 14.5 | — | — | 2 | BEARISH | -87.5 |
| EVFM Evofem Biosciences, Inc. | — | -0.1 | 20.1 | 26.0 | -419.1 | 4.5 | 2 | BEARISH | -27.3 |
| CLDI Calidi Biotherapeutics, Inc. | — | -0.0 | -713.6 | -1404.6 | — | — | 4 | BEARISH | -97.3 |
| CHALF Chalice Brands Ltd | — | -0.0 | -51.3 | -9.0 | 9.4 | 36.2 | 5 | BEARISH | -99.0 |
| PPII Coenzyme-A Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MBIO Mustang Bio, Inc. | — | -0.8 | -58.1 | 36.6 | — | — | 2 | BEARISH | -75.9 |
| LIMN Liminatus Pharma, Inc. Class A Common Stock | — | -0.1 | 294.4 | 252.1 | — | — | 4 | BEARISH | -95.3 |
| STLNW Starling Oncology Inc. Wt | — | — | — | — | — | — | — | BEARISH | — |
| GNPX Genprex, Inc. | — | -0.0 | -203.9 | 3484.8 | — | — | 4 | BEARISH | -99.1 |
| KALA KALA BIO, Inc. | — | -0.0 | -345.3 | -913.5 | — | -100.0 | 4 | BEARISH | -99.6 |
| TSOI Therapeutic Solutions International, Inc. | — | -0.1 | -187.6 | -130.3 | -5123.0 | -99.7 | 4 | BEARISH | -99.0 |
| WSNAF Wesana Health Holdings Inc. | — | -0.1 | 1113.6 | 90.8 | — | — | 3 | BEARISH | -80.1 |
| MCOA Marijuana Company of America, Inc. | — | -0.1 | 295.5 | 51.6 | — | -72.4 | 1 | BEARISH | 0.0 |
| IBXXF Imagion Biosystems Limited | — | -0.4 | 127.1 | 360.0 | -376.2 | -50.2 | 3 | BEARISH | -86.7 |
| CYDX CYduct Diagnostics, Inc. | — | -11.1 | 15.8 | 13.7 | -394.2 | -16.3 | 3 | BEARISH | 148.6 |
| ETAOF Etao International Co., Ltd. | — | -0.0 | -1369.5 | 4843.5 | -1544.0 | — | 5 | BEARISH | -66.7 |
| HSMD Healthcare Solutions Management Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| NCEL NewcelX Ltd. | — | 8.3 | -48.0 | -39.1 | — | — | 2 | BEARISH | -79.5 |
| OVIT OncoVista Innovative Therapies, Inc. | — | -0.0 | 61.2 | 43.6 | — | — | 1 | BEARISH | 0.0 |
| BZYR Burzynski Research Institute, Inc. | — | -0.0 | 2902.9 | 1462.7 | — | — | 4 | BEARISH | -99.4 |
| OGEN Oragenics, Inc. | — | -0.1 | -1307.1 | 4273.7 | — | — | 3 | BEARISH | -72.3 |
| ISHI Islet Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| KALY Kali, Inc. | — | -8.6 | 32.3 | 47.0 | 20.9 | 28.1 | 4 | BEARISH | -98.0 |
| KAYS Kaya Holdings, Inc. | — | -0.0 | 141.1 | -11929.1 | -158865.8 | -102.0 | 3 | BEARISH | -97.1 |
| ULIHF The United Laboratories International Holdings Limited | $1.9B | 20.8 | 3.3 | 4.4 | 5.6 | -16.6 | 4 | BEARISH | -49.9 |
| FDMDF 4DMedical Limited | $1.6B | -8.8 | -174.5 | 43.4 | -1194.8 | 20.5 | 3 | BEARISH | 94.2 |
| LFTSF LifeTech Scientific Corporation | $1.0B | 107.2 | 7.3 | 6.9 | -5.7 | 103.7 | 4 | BEARISH | -14.3 |
| TTALF Terveystalo Oyj | $910M | 13.3 | 10.3 | 6.3 | 2.1 | -8.7 | 4 | BEARISH | -44.5 |
| IVEVF Inventiva S.A. | $750M | -6.2 | -988.4 | -371.6 | -347346.6 | -99.7 | 3 | BEARISH | -22.8 |
| NNCSF Nanosonics Limited | $620M | 50.9 | 8.3 | 15.6 | 8.1 | 2.4 | 4 | BEARISH | -39.9 |
| RGNX REGENXBIO Inc. | $440M | -1.7 | -137.6 | -368.4 | 21.0 | 12.0 | 2 | BEARISH | -49.4 |
| CALZF PolyNovo Limited | $430M | 81.4 | 8.4 | 9.3 | 10.0 | 12.8 | 7 | BEARISH | -38.6 |
| ALT Altimmune, Inc. | $410M | -2.6 | -28.9 | -43.1 | — | 55.0 | 4 | BEARISH | -46.0 |
| NIKA Nika Pharmaceuticals Inc. | $370M | -4711.6 | 26.8 | 18.5 | — | 100.0 | 3 | BEARISH | 8.5 |
| AVTX Avalo Therapeutics, Inc. | $370M | -1.4 | -36.3 | -148.4 | — | -86.6 | 4 | BEARISH | -61.6 |
| TLRY Tilray Brands, Inc. | $310M | -2.0 | -8.8 | -3.4 | -16.8 | -16.9 | 3 | BEARISH | -81.4 |
| DMTRF 3-D Matrix, Ltd. | $310M | 12.3 | 75.0 | 31.1 | 9.4 | 57.0 | 6 | BEARISH | 61.3 |
| SCTX Scribe Therapeutics Inc. | $250M | — | — | — | — | — | — | BEARISH | — |
| ACIU AC Immune S.A. | $250M | -4.3 | -78.5 | 96.7 | 12.4 | -39.5 | 2 | BEARISH | -30.8 |
| CABA Cabaletta Bio, Inc. | $250M | -0.9 | -93.2 | -1308.0 | — | — | 3 | BEARISH | -40.9 |
| PALI Palisade Bio, Inc. | $230M | -2.3 | -51.4 | 815.6 | -2114.8 | — | 5 | BEARISH | -31.0 |
| SPOK Spok Holdings, Inc. | $220M | 17.0 | 8.4 | 10.0 | 11.8 | -3.4 | 5 | BEARISH | -36.0 |
| IVVD Invivyd, Inc. | $180M | -1.5 | -95.9 | -302.5 | -310.8 | 26.3 | 2 | BEARISH | -73.2 |
| CATX Perspective Therapeutics, Inc. | $180M | -0.8 | -39.5 | -108.8 | -33069.1 | -35.3 | 3 | BEARISH | -60.2 |
| CHHHF CareRx Corporation | $150M | 7.8 | 27.3 | 40.1 | 0.4 | 3.0 | 6 | BEARISH | -10.8 |
| HWAIF Healwell AI Inc. | $150M | -5.4 | -21.9 | -10.8 | 19.4 | 54.1 | 5 | BEARISH | -55.4 |
| UPB Upstream Bio, Inc. | $150M | -1.0 | -46.0 | -1266.4 | -5136.1 | 49.2 | 3 | BEARISH | -83.0 |
| CMPX Compass Therapeutics, Inc. | $140M | -1.8 | -56.7 | 1526.3 | — | — | 4 | BEARISH | -81.2 |
| ORGO Organogenesis Holdings Inc. | $130M | -1.1 | -27.8 | -7.7 | -227.0 | 6.4 | 3 | BEARISH | -78.5 |
| VYGR Voyager Therapeutics, Inc. | $110M | -1.0 | -54.1 | -131.1 | -773.2 | -19.1 | 2 | BEARISH | -62.8 |
| NERV Minerva Neurosciences, Inc. | $110M | -0.1 | 337.5 | 10.0 | — | — | 1 | BEARISH | -52.5 |
| ENGN enGene Holdings Inc. | $100M | -5.5 | -2.3 | 134.1 | — | -100.0 | 2 | BEARISH | -81.3 |
| VTVT vTv Therapeutics Inc. | $100M | -233.8 | -11.7 | 91.2 | — | 216600.0 | 4 | BEARISH | 23.1 |
| LENZ LENZ Therapeutics, Inc. | $100M | -0.8 | -59.2 | 17313.3 | -581.8 | 329.5 | 3 | BEARISH | -90.2 |
| CCLD CareCloud, Inc. | $80M | 24.9 | 21.8 | 15.7 | 3.5 | 15.1 | 4 | BEARISH | -46.5 |
| PTHS Pelthos Therapeutics Inc. | $70M | -0.3 | 4767.3 | -97.0 | -150.1 | — | 2 | BEARISH | -54.0 |
| VRCA Verrica Pharmaceuticals Inc. | $60M | -2.0 | 473.3 | 437.4 | -224.4 | 106.2 | 5 | BEARISH | -9.9 |
| XBIT XBiotech Inc. | $60M | -1.2 | -29.9 | -201.2 | — | — | 2 | BEARISH | -28.0 |
| TLSA Tiziana Life Sciences Ltd | $60M | -4.3 | -780.6 | 375.0 | — | — | 1 | BEARISH | -55.0 |
| GANX Gain Therapeutics, Inc. | $50M | -2.3 | -268.3 | 1288.8 | — | — | 4 | BEARISH | -40.9 |
| SOMNF SomnoMed Limited | $50M | -25.6 | -5.6 | 2.2 | -6.4 | 2.6 | 6 | BEARISH | -64.2 |
| PLRX Pliant Therapeutics, Inc. | $50M | -0.6 | -50.3 | -438.3 | — | — | 3 | BEARISH | -53.6 |
| ACET Adicet Bio, Inc. | $40M | -0.3 | -78.1 | -553.5 | — | — | 4 | BEARISH | -73.2 |
| KLRS Kalaris Therapeutics Inc | $40M | -0.9 | -79.9 | 109.5 | — | — | 0 | BEARISH | -61.0 |
| MGX Metagenomi, Inc. Common Stock | $30M | -0.3 | -60.6 | -268.2 | 10693.4 | -59.8 | 1 | BEARISH | -72.3 |
| AARD Aardvark Therapeutics, Inc. Common Stock | $30M | -0.4 | -66.0 | -3642.4 | — | — | 1 | BEARISH | -87.8 |
| NNOX Nano-X Imaging Ltd. | $30M | -0.2 | -99.0 | -164.5 | -1335.1 | 31.5 | 2 | BEARISH | -92.1 |
| BSEM BioStem Technologies, Inc. | $30M | -0.9 | -74.7 | -84.3 | -113.6 | -119.6 | 2 | BEARISH | -69.0 |
| PLNH Planet 13 Holdings Inc. | $30M | -0.4 | -90.5 | -50.0 | -24.4 | -21.2 | 2 | BEARISH | -65.5 |
| NRXBF NurExone Biologic Inc. | $30M | — | — | — | — | — | — | BEARISH | — |
| EDSA Edesa Biotech, Inc. | $30M | -1.6 | -122.9 | 759.6 | — | — | 1 | BEARISH | -2.5 |
| MDDVF Medical Developments International Limited | $30M | 66.5 | 1.1 | 3.6 | 4.1 | 8.9 | 7 | BEARISH | -15.1 |
| EYPT EyePoint Pharmaceuticals, Inc. | $30M | -0.1 | -148.7 | -3014.8 | -18633.1 | -94.6 | 2 | BEARISH | -97.0 |
| MIRA MIRA Pharmaceuticals, Inc. | $30M | -0.4 | -710.9 | -15187.8 | — | — | 3 | BEARISH | -63.3 |
| ALGS Aligos Therapeutics, Inc. | $30M | -0.6 | -113.6 | -1246.4 | -5.4 | 893.0 | 2 | BEARISH | -51.1 |
| BIOQ Bioqual, Inc. | $30M | -6.2 | -2.8 | -4.3 | -0.8 | -16.6 | 3 | BEARISH | -23.4 |
| ORXOF Orexo AB | $20M | -0.5 | 3924.8 | -872.8 | -12050.0 | -97.8 | 4 | BEARISH | -81.0 |
| TXMD TherapeuticsMD, Inc. | $20M | -94.7 | -0.8 | -12.9 | 17.8 | 27.8 | 6 | BEARISH | 38.0 |
| MRMD MariMed Inc. | $20M | -1.4 | -28.4 | -0.9 | -8.6 | 4.2 | 4 | BEARISH | -66.1 |
| MCRB Seres Therapeutics, Inc. | $20M | -0.8 | -66.6 | -87.8 | 622.4 | — | 3 | BEARISH | -89.9 |
| TELIF Telescope Innovations Corp. | $20M | 5.8 | -229.2 | -80.7 | -116.8 | 66.3 | 2 | BEARISH | -21.7 |
| KYNB Kyntra Bio, Inc. | $20M | 0.1 | -115.2 | 29.6 | -812.3 | — | 2 | BEARISH | — |
| RDGL Vivos Inc. | $20M | -5.7 | -132.5 | -427.2 | -2280.7 | 91.5 | 3 | BEARISH | -39.0 |
| QUCY Quantum Cyber N.V. | $20M | — | — | — | — | — | — | BEARISH | — |
| ACIXF Acarix AB (publ) | $20M | -5.4 | -86.1 | -207.4 | -410.8 | 65.2 | 4 | BEARISH | -33.1 |
| OPTH Optimi Health Corp. | $20M | — | — | — | — | — | — | BEARISH | — |
| SYMQY SymBio Pharmaceuticals Limited | $20M | -0.5 | -334.3 | 639.4 | -515.2 | -54.2 | 1 | BEARISH | -57.1 |
| BXPHF Botanix Pharmaceuticals Limited | $20M | -0.3 | -96.3 | -131.6 | -203.1 | 495.6 | 4 | BEARISH | -91.5 |
| BCDA BioCardia, Inc. | $10M | -1.2 | -1803.2 | 519.4 | — | — | 3 | BEARISH | -33.7 |
| HIND Vyome Holdings, Inc. | $10M | -0.1 | -193.1 | 516.3 | -2543.3 | -98.0 | 4 | BEARISH | -69.0 |
| RVPH Reviva Pharmaceuticals Holdings, Inc. | $10M | -0.1 | -32.2 | 45.6 | — | — | 4 | BEARISH | -33.4 |
| UEEC United Health Products, Inc. | $10M | -6.7 | 37.4 | 34.4 | — | — | 4 | BEARISH | -43.3 |
| BNR Burning Rock Biotech Limited | $10M | -1.2 | -12.8 | -41.7 | -13.7 | -6.6 | 2 | BEARISH | -5.0 |
| IPDQF ImpediMed Limited | $10M | -0.3 | -162.3 | 295.0 | -177.9 | 14.7 | 3 | BEARISH | -67.0 |
| CBSC Cardiac Biotech Solutions Inc. | $10M | -6.8 | 87.3 | 51.1 | -341.6 | 78.5 | 3 | BEARISH | -26.1 |
| ACON Aclarion, Inc. | $10M | -0.3 | -59.0 | -1069.5 | -10899.5 | 33.1 | 3 | BEARISH | -74.6 |
| MTVA MetaVia Inc. | $10M | -0.3 | -175.7 | 209.3 | — | — | 0 | BEARISH | -89.3 |
| ACTU Actuate Therapeutics Inc | $10M | -0.4 | 2457.6 | 541.3 | — | — | 3 | BEARISH | -94.5 |
| CNTMF Fluent Corp. | $10M | -0.1 | 119.7 | -49.4 | -65.1 | -34.7 | 4 | BEARISH | -72.8 |
| IZOZF Izotropic Corporation | $10M | -4.3 | 40.2 | 39.2 | — | — | 3 | BEARISH | -70.3 |
| FEMY Femasys Inc. | $10M | -0.3 | -443.7 | -188.1 | -1346.8 | 21.9 | 5 | BEARISH | -89.2 |
| ANPCF CelLBxHealth plc | $10M | — | -239.7 | -609.1 | -452.4 | -32.8 | 2 | BEARISH | -60.8 |
| BDMD Baird Medical Investment Holdings Limited | $10M | -0.5 | -45.3 | -23.2 | 0.4 | -23.1 | 4 | BEARISH | -79.9 |
| FBLG FibroBiologics, Inc. Common Stock | $10M | -0.2 | -660.1 | -511.6 | — | — | 4 | BEARISH | -89.3 |
| AIMD Ainos, Inc. | $10M | -0.3 | -196.3 | -69.4 | -3022849.3 | -87.7 | 1 | BEARISH | -77.5 |
| ACXP Acurx Pharmaceuticals, Inc. | $10M | -0.3 | -128.1 | 241.9 | — | — | 3 | BEARISH | -83.7 |
| MDBIF TrivarX Limited | $10M | -0.0 | -61.2 | -48.7 | — | -100.0 | 4 | BEARISH | -70.8 |
| EKGGF CardioComm Solutions, Inc. | — | — | 92.7 | 515.6 | -152.3 | -41.9 | 2 | BEARISH | 51.1 |
| OMRX Orthometrix, Inc. | — | 0.0 | 30.7 | -48.6 | -238.0 | -29.6 | 2 | BEARISH | -99.0 |
| DOSEF Doseology Sciences Inc. | — | -0.7 | -95.4 | -103.8 | -1609.9 | 161.1 | 1 | BEARISH | -90.4 |
| JRSS JRSIS Health Care Corporation | — | -6.8 | -10.1 | -10.3 | 4.5 | -94.6 | 6 | BEARISH | 80.6 |
| CXBS Corix Bioscience, Inc. | — | — | — | — | — | — | — | BEARISH | -99.0 |
| SNNVF Sunniva Inc. | — | -0.2 | -85.4 | -22.5 | -381.7 | 126.7 | 3 | BEARISH | -90.0 |
| ATTBF Abattis Bioceuticals Corp. | — | -0.0 | -27.0 | -30.2 | -400.9 | 4163.2 | 4 | BEARISH | -96.7 |
| NRSN NeuroSense Therapeutics Ltd. | — | -0.3 | 779.3 | 571.3 | — | — | 3 | BEARISH | -90.0 |
| NMLSF Restart Life Sciences Corp. | — | -1.8 | -214.3 | -153.9 | -307.0 | — | 2 | BEARISH | -63.3 |
| ZLDAF Zelira Therapeutics Limited | — | -1.6 | 80.8 | 147.8 | -185107971.7 | -99.3 | 1 | BEARISH | -7.8 |
| AIDX 20/20 Biolabs Inc. | — | — | — | — | — | — | — | BEARISH | — |
| UPDC UPD Holding Corp. | — | -0.0 | 198.3 | 1243.8 | -858.8 | — | 2 | BEARISH | 0.0 |
| EAPH Parallel Industries Inc. | — | -0.2 | 26.8 | 19.0 | — | 0.0 | 4 | BEARISH | -90.0 |
| DXBRF BellRock Brands Inc. | — | — | — | — | — | — | — | BEARISH | -99.0 |
| VYCO Vycor Medical, Inc. | — | -19.4 | 1.5 | -1.1 | -5.3 | 1.6 | 6 | BEARISH | -76.7 |
| MEDVF Medivolve Inc. | — | -0.2 | 149.7 | 23.5 | -322.7 | -93.6 | 3 | BEARISH | -100.0 |
| PMCB PharmaCyte Biotech, Inc. | — | -0.1 | -44.0 | 793.8 | — | — | 2 | BEARISH | -64.9 |
| SCPX Scorpius Holdings, Inc. | — | -0.0 | 0.0 | 0.0 | -428.3 | -75.5 | 0 | BEARISH | -66.7 |
| CELZ Creative Medical Technology Holdings, Inc. | — | -0.3 | -78.0 | 8335.2 | — | -50.0 | 2 | BEARISH | -85.9 |
| NVNO enVVeno Medical Corporation | — | -0.0 | -58.5 | 4255.8 | — | — | 4 | BEARISH | 827.2 |
| MILC Millennium Sustainable Ventures Corp. | — | -0.0 | 763.2 | -36.7 | — | 584982.1 | 2 | BEARISH | -50.0 |
| IAGX Imagenetix, Inc. | — | -0.1 | -88.3 | -8.5 | -12.9 | -69.1 | 4 | BEARISH | 0.0 |
| CDIX Cardiff Lexington Corporation | — | -0.0 | -481.3 | -3.3 | -114.8 | 0.3 | 2 | BEARISH | -100.0 |
| TWSI Tristar Wellness Solutions Inc. | — | -1.5 | 61.9 | 93.6 | -80.6 | -29.1 | 3 | BEARISH | -99.7 |
| MAHN Mid-Atlantic Home Health Network, Inc. | — | — | — | — | — | — | — | BEARISH | -93.0 |
| CRIS Curis, Inc. | — | -0.0 | 455.3 | -23281.0 | — | -62.2 | 3 | BEARISH | -98.8 |
| OXBOF Oxford BioDynamics Plc | — | -0.3 | -214.9 | -155.8 | -649.8 | 33.6 | 3 | BEARISH | -81.1 |
| BLFE BioLife Sciences Inc. | — | -0.0 | 318059.1 | -92210.0 | — | — | 2 | BEARISH | 0.0 |
| XSNX NovAccess Global Inc. | — | -0.0 | 27.7 | 18.0 | — | — | 3 | BEARISH | 0.0 |
| NAVBQ Navidea Biopharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| CODX Co-Diagnostics, Inc. | — | -0.0 | -174.8 | -218.8 | -3782.4 | -28.1 | 3 | BEARISH | -95.5 |
| TRLFF Maven Brands Inc. | — | -0.3 | 54.0 | -28.1 | — | -200.0 | 3 | BEARISH | -99.0 |
| CVSI CV Sciences, Inc. | — | -1.0 | -118.9 | -46.0 | -26.0 | -14.9 | 1 | BEARISH | -76.7 |
| LABT Lakewood-Amedex Biotherapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| LTUS Lotus Pharmaceuticals, Inc. | — | -315.8 | 14.7 | -340.1 | — | — | 3 | BEARISH | -10.0 |
| ACAI Safeplus International Holdings Limited | — | -0.3 | -205.0 | -617.4 | -224.7 | -94.2 | 1 | BEARISH | 100.0 |
| SCAL Stem Cell Authority, Ltd. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CLRD Clearday, Inc. | — | -0.0 | 41.6 | 33.3 | -296.5 | -39.1 | 3 | BEARISH | -90.0 |
| FAMDF Futura Medical plc | — | -0.3 | -145.8 | -370.5 | -72.8 | -70.7 | 2 | BEARISH | -86.7 |
| NUMD Nu-Med Plus, Inc. | — | -24.0 | 8.1 | 29.2 | — | -100.0 | 4 | BEARISH | -76.0 |
| MEDD Medical Imaging Corp. | — | — | — | — | — | — | — | BEARISH | 100.0 |
| NASC Nascent Pharma Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| NSHSF NanoSphere Health Sciences Inc. | — | 9.5 | 4.6 | 11.1 | — | — | 0 | BEARISH | 0.0 |
| SPLM Sentry Petroleum Ltd | — | -0.1 | -184.2 | -129.4 | — | — | 1 | BEARISH | -99.0 |
| CANF Can-Fite BioPharma Ltd. | — | -0.3 | -184.2 | 353.7 | -2277.7 | -40.1 | 2 | BEARISH | -81.7 |
| PPBT Purple Biotech Ltd. | — | -0.0 | -111.3 | -99.1 | — | — | 2 | BEARISH | 56.6 |
| LXGTF Registered Plan Private Investments Inc. | — | -0.0 | 7.6 | 5.5 | — | — | 1 | BEARISH | -99.0 |
| TBRIF Therma Bright Inc. | — | -0.4 | 711.8 | 33.4 | -336.3 | 202.0 | 3 | BEARISH | -51.2 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
LYEL vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F